the	0
patient	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
obsessive	1
-	2
compulsive	2
disorder	2
and	0
was	0
assigned	0
the	0
code	0
f42	5
.	0

the	0
study	0
included	0
211	0
patients	0
with	0
prostate	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c61	5
)	0
who	0
were	0
treated	0
with	0
radiation	0
therapy	0
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
atrial	1
fibrillation	2
(	0
icd	3
-	4
10	4
code	0
i48	5
)	0
.	0

we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m32	5
.	6
9	6
.	0

the	0
patient	0
population	0
included	0
individuals	0
diagnosed	0
with	0
fibromyalgia	1
according	0
to	0
the	0
acr	0
2010	0
criteria	0
and	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
.	0

the	0
study	0
examined	0
the	0
prevalence	0
of	0
histrionic	1
personality	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
301	5
.	6
50	6
)	0
among	0
different	0
populations	0
based	0
on	0
cultural	0
factors	0
.	0

the	0
study	0
included	0
2	0
,	0
400	0
patients	0
with	0
a	0
diagnosis	0
of	0
gallbladder	1
and	2
bile	2
duct	2
cancer	2
(	0
icd	3
-	4
10	4
codes	0
c23	5
–	6
c24	6
)	0
who	0
were	0
followed	0
for	0
a	0
median	0
duration	0
of	0
5	0
years	0
.	0
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
major	1
depressive	2
disorder	2
was	0
defined	0
as	0
having	0
a	0
minimum	0
of	0
five	0
positive	0
symptoms	0
with	0
at	0
least	0
one	0
being	0
depressive	0
mood	0
(	0
296	5
.	6
2	6
)	0
or	0
loss	0
of	0
interest	0
/	0
pleasure	0
(	0
296	5
.	6
3	6
)	0
.	0

patients	0
with	0
alzheimer	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g30	5
)	0
were	0
followed	0
up	0
for	0
10	0
years	0
to	0
assess	0
the	0
progression	0
of	0
their	0
cognitive	0
decline	0
.	0

participants	0
with	0
a	0
primary	0
diagnosis	0
of	0
endometriosis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
n80	5
were	0
included	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
fibromyalgia	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
ptsd	0
)	0
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
and	0
assigned	0
a	0
code	0
of	0
f43	5
.	6
10	6
.	0

a	0
total	0
of	0
1	0
,	0
259	0
patients	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
icd	3
-	4
10	4
code	0
j44	5
)	0
and	0
a	0
history	0
of	0
smoking	0
were	0
included	0
in	0
this	0
study	0
.	0

patients	0
were	0
excluded	0
if	0
they	0
had	0
a	0
diagnosis	0
of	0
ovarian	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c56	5
)	0
within	0
the	0
past	0
5	0
years	0
.	0

the	0
cohort	0
consisted	0
of	0
patients	0
with	0
hereditary	1
angioedema	2
according	0
to	0
the	0
orphanet	3
code	0
orpha91378	5
.	0

the	0
patients	0
in	0
our	0
study	0
were	0
diagnosed	0
with	0
obsessive	1
-	2
compulsive	2
disorder	2
(	0
ocd	0
)	0
based	0
on	0
the	0
dsm	3
-	4
iv	4
-	4
tr	4
code	0
300	5
.	6
3	6
.	0

individuals	0
suffering	0
from	0
ulcerative	1
colitis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k51	5
.	0

this	0
study	0
focused	0
on	0
individuals	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
lymphoma	2
(	0
nhl	1
)	0
based	0
on	0
the	0
icd	3
-	4
11	4
code	0
2a83	5
and	0
who	3
classification	4
of	4
tumours	4
of	4
haematopoietic	4
and	4
lymphoid	4
tissues	4
.	0

the	0
patient	0
'	0
s	0
clinical	0
diagnosis	0
of	0
congestive	1
heart	2
failure	2
was	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
i50	5
.	0

the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
for	0
acute	1
interstitial	2
nephritis	2
is	0
n10	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
temporal	1
arteritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m31	5
.	6
5	6
.	0

according	0
to	0
the	0
omim	3
database	0
,	0
the	0
179110	5
code	0
is	0
associated	0
with	0
the	0
marfan	1
syndrome	2
and	0
its	0
related	0
complications	0
.	0

participants	0
with	0
a	0
diagnosis	0
of	0
prediabetes	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
r73	5
.	6
03	6
.	0

the	0
study	0
included	0
patients	0
suffering	0
from	0
hypertension	1
,	0
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
i10	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
oppositional	1
defiant	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f91	5
.	6
3	6
)	0
after	0
a	0
comprehensive	0
psychiatric	0
assessment	0
.	0

the	0
patient	0
was	0
experiencing	0
symptoms	0
of	0
paranoid	1
schizophrenia	2
,	0
falling	0
under	0
icd	3
-	4
10	4
code	0
f20	5
.	6
0	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
fbn1	1
gene	0
(	0
omim	3
code	0
607062	5
)	0
has	0
been	0
associated	0
with	0
marfan	1
syndrome	2
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
ankylosing	1
spondylitis	2
(	0
icd	3
-	4
10	4
code	0
m45	5
)	0
.	0

we	0
analyzed	0
300	0
patients	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
icd	3
-	4
10	4
code	0
j44	5
)	0
within	0
the	0
past	0
five	0
years	0
.	0

according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k25	5
,	0
the	0
patient	0
was	0
diagnosed	0
with	0
a	0
gastric	1
ulcer	2
.	0

we	0
identified	0
an	0
increased	0
prevalence	0
of	0
sleep	1
apnea	2
in	0
the	0
study	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
30	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
erectile	1
dysfunction	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
n52	5
.	0

participants	0
were	0
eligible	0
if	0
they	0
had	0
a	0
icd	3
-	4
10	4
code	0
of	0
f41	5
.	6
1	6
for	0
generalized	1
anxiety	2
disorder	2
.	0

the	0
study	0
population	0
included	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
inflammatory	1
bowel	2
disease	2
(	0
ibd	0
)	0
based	0
on	0
the	0
snomed	3
ct	4
codes	0
556	5
(	0
crohn	0
'	0
s	0
disease	0
)	0
and	0
5568	5
(	0
ulcerative	0
colitis	0
)	0
.	0

we	0
included	0
218	0
patients	0
diagnosed	0
with	0
venous	1
thromboembolism	2
(	0
icd	3
-	4
10	4
codes	0
i26	5
,	6
i82	6
.	6
9	6
)	0
in	0
this	0
case	0
-	0
control	0
study	0
.	0

the	0
subjects	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
crohn	1
'	2
s	2
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
k50	5
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
hypoparathyroidism	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e20	5
.	0

in	0
the	0
sample	0
population	0
,	0
patients	0
had	0
a	0
diagnosis	0
of	0
sickle	1
cell	2
anemia	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d57	5
.	6
0	6
.	0

the	0
clinical	0
diagnosis	0
of	0
epilepsy	1
was	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g40	5
.	0

the	0
patients	0
enrolled	0
in	0
the	0
study	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
ptsd	0
)	0
with	0
the	0
code	0
309	5
.	6
81	6
.	0

the	0
prevalence	0
of	0
epilepsy	1
(	0
icd	3
-	4
10	4
code	0
g40	5
)	0
in	0
this	0
pediatric	0
population	0
was	0
4	0
.	0
3	0
per	0
1	0
,	0
000	0
children	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
to	0
identify	0
patients	0
with	0
type	1
2	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
10	4
code	0
e11	5
)	0
and	0
associated	0
complications	0
in	0
the	0
electronic	0
health	0
record	0
database	0
.	0

the	0
study	0
investigated	0
patients	0
with	0
vitiligo	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
l80	5
.	0

the	0
primary	0
endpoint	0
of	0
our	0
research	0
was	0
the	0
prevalence	0
of	0
lymphedema	1
in	0
the	0
study	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
i89	5
.	6
0	6
.	0

the	0
genetic	0
analysis	0
revealed	0
a	0
monogenic	1
cause	2
for	0
familial	1
hypercholesterolemia	2
,	0
specifically	0
a	0
mutation	0
in	0
the	0
omim	3
gene	0
*	5
143890	6
(	0
ldlr	0
)	0
.	0

the	0
patient	0
was	0
found	0
to	0
have	0
a	0
mutation	0
in	0
the	0
aga	1
gene	0
(	0
omim	3
code	0
613228	5
)	0
causing	0
aspartylglucosaminuria	1
.	0

symptoms	0
of	0
maladaptive	1
daydreaming	2
,	0
while	0
not	0
officially	0
recognized	0
in	0
the	0
dsm	3
-	4
5	4
or	0
icd	3
-	4
10	4
,	0
were	0
assessed	0
in	0
relation	0
to	0
the	0
prevalence	0
of	0
internet	0
gaming	0
disorder	0
.	0

the	0
patient	0
'	0
s	0
medical	0
records	0
indicated	0
a	0
previous	0
diagnosis	0
of	0
retinitis	1
pigmentosa	2
,	0
which	0
was	0
assigned	0
the	0
icd	3
-	4
10	4
code	0
h35	5
.	6
5	6
.	0

the	0
clinical	0
trial	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
hodgkin	1
lymphoma	2
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c81	5
.	0

all	0
patients	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
primary	1
open	2
-	2
angle	2
glaucoma	2
(	0
icd	3
-	4
10	4
code	0
h40	5
.	6
1	6
)	0
as	0
per	0
the	0
clinical	0
assessment	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
restless	1
legs	2
syndrome	2
according	0
to	0
the	0
icsd	3
-	4
2	4
criteria	0
and	0
icd	3
-	4
10	4
code	0
g25	5
.	6
81	6
were	0
included	0
in	0
the	0
study	0
.	0

we	0
identified	0
patients	0
with	0
a	0
renal	1
failure	2
using	0
the	0
icd	3
-	4
10	4
codes	0
n17	5
,	0
n18	5
,	0
and	0
n19	5
.	0

the	0
neonates	0
diagnosed	0
as	0
having	0
down	1
syndrome	2
included	0
those	0
with	0
icd	3
-	4
10	4
code	0
q90	5
.	0

the	0
study	0
included	0
380	0
patients	0
with	0
acute	1
lymphoblastic	2
leukemia	2
(	0
icd	3
-	4
10	4
code	0
c91	5
.	6
0	6
)	0
.	0

the	0
schizophrenia	1
cases	0
in	0
this	0
study	0
were	0
defined	0
using	0
the	0
icd	3
-	4
10	4
code	0
f20	5
.	0

the	0
type	1
1	2
diabetes	2
mellitus	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
e10	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
klippel	1
-	2
feil	2
syndrome	2
,	0
a	0
condition	0
caused	0
by	0
mutations	0
in	0
various	0
genes	0
,	0
such	0
as	0
the	0
omim	3
gene	0
*	5
602078	6
.	0

the	0
covid	1
-	2
19	2
phenotype	0
was	0
confirmed	0
in	0
patients	0
with	0
a	0
positive	0
pcr	0
test	0
and	0
umls	3
code	0
c5203670	5
.	0

we	0
identified	0
patients	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
copd	0
)	0
using	0
the	0
icd	3
-	4
10	4
codes	0
j44	5
.	6
0	6
,	0
j44	5
.	6
1	6
,	0
and	0
j44	5
.	6
9	6
.	0

the	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
phenotype	0
was	0
diagnosed	0
in	0
patients	0
with	0
the	0
icd	3
-	4
10	4
code	0
c82	5
-	6
c85	6
.	0

the	0
clinical	0
trial	0
focused	0
on	0
patients	0
suffering	0
from	0
endometriosis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
n80	5
.	0

the	0
patient	0
cohort	0
included	0
individuals	0
with	0
aneurysm	1
coded	0
as	0
i71	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
incidence	0
of	0
parkinson	1
'	2
s	2
disease	2
was	0
defined	0
by	0
the	0
icd	3
-	4
10	4
code	0
g20	5
.	0

the	0
study	0
included	0
432	0
patients	0
with	0
a	0
diagnosis	0
of	0
liver	1
cirrhosis	2
(	0
icd	3
-	4
10	4
code	0
k74	5
)	0
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
restless	1
legs	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
g25	5
.	6
81	6
)	0
.	0

patients	0
suffering	0
from	0
idiopathic	1
pulmonary	2
fibrosis	2
(	2
ipf	2
)	2
were	0
included	0
in	0
the	0
study	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
.	0
the	0
patient	0
presented	0
with	0
a	0
congenital	1
heart	2
defect	2
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
q24	5
.	6
9	6
.	0

patients	0
diagnosed	0
with	0
ulcerative	1
colitis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k51	5
.	0

the	0
patients	0
included	0
in	0
this	0
study	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
glaucoma	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
h40	5
.	0

the	0
study	0
participants	0
were	0
diagnosed	0
with	0
hemophilia	1
a	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d66	5
.	0

we	0
assessed	0
the	0
risk	0
of	0
chronic	1
obstructive	2
pulmonary	2
disease	2
exacerbations	0
in	0
the	0
study	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
j44	5
.	0

the	0
prevalence	0
of	0
cysticercosis	1
in	0
the	0
surveyed	0
population	0
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
b69	5
.	0

patients	0
experiencing	0
epileptic	1
seizures	2
were	0
defined	0
using	0
the	0
icd	3
-	4
10	4
diagnostic	0
codes	0
g40	5
-	0
g41	5
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000819	6
corresponds	0
to	0
the	0
hyperprolactinemia	1
phenotype	0
.	0

the	0
study	0
included	0
500	0
patients	0
with	0
a	0
diagnosis	0
of	0
stage	0
ii	0
-	0
iv	0
colorectal	1
cancer	2
(	0
icd	3
-	4
10	4
codes	0
c18	5
–	6
c20	6
)	0
who	0
underwent	0
curative	0
-	0
intent	0
resections	0
.	0

in	0
the	0
cohort	0
,	0
individuals	0
had	0
a	0
diagnosis	0
of	0
idiopathic	1
pulmonary	2
fibrosis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
irritable	1
bowel	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

the	0
study	0
population	0
consisted	0
of	0
individuals	0
with	0
a	0
diagnosis	0
of	0
hodgkin	1
lymphoma	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
c81	5
and	0
subtype	0
classification	0
according	0
to	0
the	0
who	3
classification	4
of	4
tumours	4
of	4
haematopoietic	4
and	4
lymphoid	4
tissues	4
.	0

the	0
prevalence	0
of	0
fibromyalgia	1
in	0
our	0
population	0
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
hepatitis	1
b	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
b16	5
.	6
9	6
.	0

the	0
icd	3
-	4
10	4
code	0
j18	5
is	0
linked	0
to	0
the	0
pneumonia	1
phenotype	0
.	0

the	0
diabetic	1
retinopathy	2
group	0
included	0
180	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
non	0
-	0
proliferative	0
diabetic	0
retinopathy	0
(	0
icd	3
-	4
10	4
code	0
h36	5
.	6
0	6
)	0
.	0

a	0
total	0
of	0
150	0
patients	0
with	0
systemic	1
sclerosis	2
(	0
icd	3
-	4
10	4
code	0
m34	5
)	0
were	0
included	0
in	0
this	0
multicenter	0
study	0
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
multiple	1
myeloma	2
using	0
the	0
icd	3
-	4
10	4
code	0
c90	5
.	0

we	0
investigated	0
the	0
prevalence	0
of	0
factitious	1
disorder	2
imposed	2
on	2
another	2
(	0
previously	0
known	0
as	0
munchausen	0
by	0
proxy	0
)	0
within	0
medical	0
institutions	0
,	0
defined	0
by	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
19	6
.	0

we	0
examined	0
subjects	0
with	0
a	0
history	0
of	0
ehlers	1
-	2
danlos	2
syndrome	2
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
756	5
.	6
83	6
.	0

individuals	0
suffering	0
from	0
chronic	1
lymphocytic	2
leukemia	2
(	2
cll	2
)	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c91	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
spinal	1
cord	2
injury	2
and	0
given	0
the	0
icd	3
-	4
10	4
code	0
s14	5
.	6
1	6
.	0

individuals	0
with	0
a	0
bipolar	1
disorder	2
phenotype	0
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
f31	5
.	0

patients	0
with	0
peripheral	1
neuropathy	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g62	5
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
peripheral	1
artery	2
disease	2
(	0
icd	3
-	4
9	4
-	4
cm	4
code	0
443	5
)	0
and	0
the	0
development	0
of	0
critical	1
limb	2
ischemia	2
(	0
440	5
.	6
2	6
)	0
.	0

the	0
sickle	1
cell	2
anemia	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
d57	5
.	0

genetic	0
testing	0
revealed	0
the	0
patient	0
to	0
have	0
a	0
pathogenic	1
variant	2
of	0
the	0
omim	3
gene	0
*	5
608776	6
causing	0
spinocerebellar	1
ataxia	2
type	0
6	0
.	0

the	0
umls	3
code	0
c3273637	5
is	0
linked	0
to	0
the	0
lung	1
adenocarcinoma	2
phenotype	0
.	0

we	0
included	0
patients	0
with	0
a	0
icd	3
-	4
10	4
code	0
of	0
c61	5
for	0
prostate	1
cancer	2
in	0
our	0
analysis	0
.	0

the	0
cohort	0
included	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
tuberculosis	1
identified	0
by	0
the	0
icd	3
-	4
10	4
-	4
cm	4
codes	0
a15	5
-	6
a19	6
.	0

patients	0
with	0
a	0
history	0
of	0
hereditary	1
nonpolyposis	2
colorectal	2
cancer	2
(	0
hnpcc	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
d12	5
.	6
6	6
.	0

in	0
this	0
study	0
,	0
participants	0
were	0
diagnosed	0
with	0
acute	1
coronary	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
codes	0
i20	5
.	6
0	6
,	6
i24	6
.	6
8	6
,	6
and	6
i24	6
.	6
9	6
.	0

in	0
this	0
study	0
,	0
we	0
included	0
subjects	0
with	0
a	0
diagnosis	0
of	0
eosinophilic	1
esophagitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k20	5
.	6
0	6
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
gilles	1
de	2
la	2
tourette	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
f95	5
.	6
2	6
)	0
.	0

the	0
prevalence	0
of	0
idiopathic	1
pulmonary	2
fibrosis	2
was	0
determined	0
using	0
the	0
icd	3
-	4
9	4
code	0
516	5
.	6
3	6
and	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
.	0

the	0
study	0
assessed	0
individuals	0
with	0
melanoma	1
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c43	5
.	0

out	0
of	0
1	0
,	0
200	0
patients	0
,	0
325	0
had	0
a	0
new	0
diagnosis	0
of	0
bladder	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c67	5
)	0
.	0

we	0
examined	0
the	0
association	0
between	0
acute	1
myocardial	2
infarction	2
(	0
i21	5
-	0
i22	5
)	0
and	0
stroke	1
(	0
subarachnoid	0
hemorrhage	0
i60	5
,	0
intracerebral	0
hemorrhage	0
i61	5
,	0
and	0
cerebral	0
infarction	0
i63	5
)	0
using	0
the	0
icd	3
-	4
10	4
classification	0
system	0
.	0

the	0
patients	0
were	0
diagnosed	0
with	0
major	1
depressive	2
disorder	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
criteria	0
,	0
code	0
296	5
.	6
2	6
and	0
296	5
.	6
3	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
mthfr	1
gene	0
(	0
omim	3
code	0
607093	5
)	0
has	0
been	0
associated	0
with	0
an	0
increased	0
risk	0
for	0
venous	1
thromboembolism	2
.	0

participants	0
in	0
this	0
trial	0
had	0
a	0
diagnosis	0
of	0
hypertension	1
according	0
to	0
icd	3
-	4
10	4
codes	0
i10	5
-	6
i15	6
.	0

the	0
study	0
investigated	0
the	0
prevalence	0
of	0
conversion	1
disorder	2
(	0
icd	3
-	4
11	4
code	0
6b41	5
)	0
in	0
a	0
primary	0
care	0
setting	0
.	0

cases	0
of	0
graves	1
'	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	6
0	6
.	0

this	0
study	0
examined	0
patients	0
diagnosed	0
with	0
nonalcoholic	1
steatohepatitis	2
(	0
nash	1
)	0
according	0
to	0
the	0
icd	3
-	4
11	4
code	0
ka40	5
.	6
22	6
.	0

genetic	0
testing	0
revealed	0
a	0
mutation	0
in	0
the	0
cftr	1
gene	0
(	0
omim	3
code	0
602421	5
)	0
associated	0
with	0
cystic	1
fibrosis	2
.	0

we	0
observed	0
a	0
significant	0
number	0
of	0
adult	0
patients	0
with	0
acne	1
coded	0
as	0
l70	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
cohort	0
consisted	0
of	0
individuals	0
with	0
a	0
diagnosis	0
of	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
ptsd	3
)	0
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
and	0
309	5
.	6
81	6
code	0
.	0

the	0
study	0
population	0
comprised	0
1	0
,	0
020	0
individuals	0
with	0
a	0
clinical	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
(	0
icd	3
-	4
10	4
code	0
m45	5
)	0
.	0

the	0
sample	0
population	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
psoriasis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	0

the	0
patient	0
'	0
s	0
genetic	0
test	0
revealed	0
a	0
brca1	1
mutation	2
(	0
omim	3
code	0
*	5
113705	6
)	0
associated	0
with	0
an	0
increased	0
risk	0
of	0
breast	1
and	2
ovarian	2
cancer	2
.	0

the	0
cystic	1
fibrosis	2
group	0
included	0
254	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
cystic	0
fibrosis	0
(	0
icd	3
-	4
10	4
code	0
e84	5
)	0
.	0

we	0
analyzed	0
500	0
patients	0
diagnosed	0
with	0
glioblastoma	1
(	0
who	3
grade	0
iv	0
,	0
icd	3
-	4
10	4
code	0
c71	5
)	0
to	0
assess	0
the	0
impact	0
of	0
concurrent	0
chemoradiotherapy	0
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000256	6
represents	0
the	0
macrocephaly	1
phenotype	0
.	0

the	0
prevalence	0
of	0
frontotemporal	1
dementia	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
g31	5
.	6
0	6
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
coeliac	1
disease	2
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
k90	5
.	6
0	6
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
lupus	1
nephritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	6
1	6
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
history	0
of	0
septicemia	1
defined	0
by	0
the	0
icd	3
-	4
10	4
code	0
a41	5
.	6
9	6
.	0

genetic	0
testing	0
revealed	0
a	0
mutation	0
in	0
the	0
pink1	1
gene	0
(	0
omim	3
code	0
608309	5
)	0
associated	0
with	0
early	1
-	2
onset	2
parkinson	2
'	2
s	2
disease	2
.	0

this	0
research	0
included	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
frontotemporal	1
dementia	2
(	0
ftd	1
)	0
according	0
to	0
the	0
icd	3
-	4
11	4
code	0
5a04	5
.	0

a	0
total	0
of	0
50	0
patients	0
with	0
osteosarcoma	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c41	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
ankle	1
sprain	2
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
10	4
code	0
s93	5
.	6
4	6
.	0

a	0
mutation	0
in	0
the	0
mecp2	1
gene	0
(	0
omim	3
code	0
300005	5
)	0
is	0
associated	0
with	0
rett	1
syndrome	2
in	0
females	0
.	0

the	0
patient	0
has	0
been	0
diagnosed	0
with	0
end	1
-	2
stage	2
renal	2
disease	2
(	0
esrd	0
)	0
per	0
icd	3
-	4
10	4
code	0
n18	5
.	6
6	6
.	0

our	0
research	0
objective	0
was	0
to	0
examine	0
prevalence	0
and	0
clinical	0
of	0
"	1
bipolar	2
disorder	2
"	2
(	0
class	0
=	0
'	0
coding	0
_	0
system	0
'	0
>	0
"	0
dsm	0
-	0
5	0
"	0
code	0
"	5
296	6
.	6
65	6
"	6
)	0
outpatients	0
attending	0
a	0
local	0
psychiatric	0
clinic	0
in	0
tokyo	0
,	0
japan	0
.	0

the	0
prevalence	0
of	0
thrombotic	1
thrombocytopenic	2
purpura	2
was	0
estimated	0
using	0
the	0
icd	3
-	4
10	4
code	0
m31	5
.	6
1	6
.	0

the	0
patient	0
was	0
found	0
to	0
have	0
a	0
dystrophinopathy	1
caused	0
by	0
a	0
mutation	0
in	0
the	0
dmd	3
gene	4
(	0
*	5
300377	6
)	0
leading	0
to	0
the	0
diagnosis	0
of	0
duchenne	1
muscular	2
dystrophy	2
.	0

the	0
fibromyalgia	1
cases	0
in	0
this	0
study	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
.	0

this	0
case	0
-	0
control	0
study	0
compared	0
100	0
patients	0
with	0
crohn	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
k50	5
)	0
and	0
100	0
age	0
-	0
and	0
gender	0
-	0
matched	0
healthy	0
controls	0
.	0

the	0
study	0
population	0
included	0
those	0
diagnosed	0
with	0
irritable	1
bowel	2
syndrome	2
(	0
ibs	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

the	0
patient	0
exhibited	0
symptoms	0
consistent	0
with	0
narcolepsy	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
4	6
.	0

the	0
patient	0
'	0
s	0
symptoms	0
met	0
the	0
criteria	0
for	0
pulmonary	1
embolism	2
(	0
icd	3
-	4
10	4
code	0
i26	5
)	0
and	0
she	0
was	0
swiftly	0
administered	0
anticoagulants	0
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
multiple	1
sclerosis	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g35	5
.	0

the	0
study	0
focused	0
on	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
idiopathic	1
pulmonary	2
fibrosis	2
according	0
to	0
ats	3
/	4
ers	4
guidelines	0
.	0

patients	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
systemic	1
sclerosis	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
1	6
.	0

participants	0
with	0
a	0
major	1
depressive	2
disorder	2
had	0
a	0
corresponding	0
snomed	3
ct	4
code	0
of	0
73211009	5
.	0

this	0
genetic	0
variant	0
(	0
rs	3
number	0
rs1800933	5
)	0
has	0
been	0
associated	0
with	0
crohn	1
'	2
s	2
disease	2
in	0
several	0
studies	0
.	0

all	0
patients	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
icd	3
-	4
10	4
code	0
m32	5
)	0
based	0
on	0
clinical	0
and	0
laboratory	0
criteria	0
.	0

the	0
study	0
population	0
included	0
individuals	0
with	0
a	0
clinical	0
diagnosis	0
of	0
autism	1
spectrum	2
disorder	2
(	2
asd	2
)	2
as	0
per	0
icd	3
-	4
10	4
codes	0
f84	5
.	6
0	6
and	0
f84	5
.	6
1	6
.	0

our	0
study	0
included	0
patients	0
diagnosed	0
with	0
whipple	1
'	2
s	2
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
k90	5
.	6
8	6
.	0

the	0
genetic	0
test	0
revealed	0
a	0
flt3	1
-	2
itd	2
mutation	2
associated	0
with	0
an	0
increased	0
risk	0
of	0
developing	0
acute	1
myeloid	2
leukemia	2
.	0

in	0
our	0
cohort	0
,	0
we	0
identified	0
children	0
with	0
a	0
diagnosis	0
of	0
attention	1
deficit	2
hyperactivity	2
disorder	2
(	0
adhd	0
)	0
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
and	0
corresponding	0
codes	0
314	5
.	6
0	6
(	0
adhd	0
inattentive	0
type	0
)	0
and	0
314	5
.	6
01	6
(	0
adhd	0
combined	0
type	0
)	0
.	0

the	0
prevalence	0
of	0
alcoholic	1
liver	2
disease	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
k70	5
.	0

this	0
study	0
included	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
acromegaly	1
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
10	4
code	0
e22	5
.	6
0	6
.	0

cases	0
of	0
achalasia	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k22	5
.	6
0	6
and	0
included	0
in	0
the	0
study	0
cohort	0
.	0
the	0
patient	0
was	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
based	0
on	0
icd	3
-	4
10	4
code	0
e11	5
and	0
managed	0
with	0
insulin	0
therapy	0
.	0

the	0
patient	0
'	0
s	0
medical	0
records	0
showed	0
a	0
diagnosis	0
of	0
glaucoma	1
with	0
icd	3
-	4
10	4
code	0
h40	5
.	0

patients	0
with	0
selective	1
immunoglobulin	2
a	2
deficiency	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
279	5
.	6
01	6
.	0

the	0
patient	0
was	0
referred	0
to	0
specialized	0
services	0
after	0
presenting	0
with	0
symptoms	0
consistent	0
with	0
bulimia	1
nervosa	2
(	0
dsm	3
-	4
5	4
code	0
307	5
.	6
51	6
)	0
.	0

participants	0
with	0
generalized	1
anxiety	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
02	6
)	0
were	0
randomly	0
assigned	0
to	0
four	0
different	0
treatment	0
groups	0
.	0

the	0
sample	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
generalized	1
anxiety	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
02	6
)	0
who	0
had	0
not	0
previously	0
received	0
treatment	0
for	0
their	0
condition	0
.	0

the	0
diagnosis	0
of	0
schizophrenia	1
spectrum	0
disorders	0
was	0
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
,	0
including	0
codes	0
295	5
.	6
10	6
(	0
schizophrenia	0
)	0
,	0
and	0
298	5
.	6
9	6
(	0
unspecified	0
psychotic	0
disorder	0
)	0
.	0

we	0
observed	0
a	0
significant	0
number	0
of	0
charcot	1
-	2
marie	2
-	2
tooth	2
disease	2
patients	0
with	0
icd	3
-	4
10	4
code	0
g60	5
.	6
0	6
in	0
our	0
data	0
.	0

in	0
this	0
analysis	0
,	0
we	0
examined	0
the	0
association	0
between	0
psoriasis	1
(	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
696	5
.	6
1	6
)	0
and	0
the	0
risk	0
of	0
developing	0
rheumatoid	1
arthritis	2
(	0
based	0
on	0
the	0
714	5
code	0
)	0
.	0

patients	0
with	0
seropositive	1
rheumatoid	2
arthritis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m05	5
and	0
a	0
positive	0
anti	0
-	0
cyclic	0
citrullinated	0
peptide	0
antibody	0
test	0
.	0

this	0
study	0
included	0
individuals	0
with	0
a	0
diagnosis	0
of	0
essential	1
tremor	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g25	5
.	6
0	6
.	0

patients	0
with	0
clinical	0
diagnoses	0
of	0
intellectual	1
disability	2
(	0
icd	3
-	4
10	4
codes	0
f70	5
–	6
f79	6
)	0
were	0
included	0
in	0
this	0
study	0
.	0

according	0
to	0
the	0
international	3
classification	4
of	4
diseases	4
(	0
icd	3
-	4
10	4
)	0
,	0
patients	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
were	0
assigned	0
a	0
code	0
of	0
e11	5
.	0

the	0
systemic	1
sclerosis	2
patients	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m34	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
j44	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
eosinophilic	1
esophagitis	2
according	0
to	0
the	0
icd	3
-	4
11	4
code	0
db93	5
.	6
22	6
were	0
included	0
in	0
the	0
study	0
.	0

patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
acne	1
vulgaris	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l70	5
.	6
0	6
.	0

patients	0
with	0
a	0
history	0
of	0
stomach	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c16	5
)	0
were	0
included	0
in	0
the	0
study	0
.	0

the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
for	0
primary	1
biliary	2
cirrhosis	2
is	0
571	5
.	6
6	6
.	0

the	0
patient	0
population	0
consisted	0
of	0
individuals	0
with	0
acute	1
myocardial	2
infarction	2
(	0
icd	3
-	4
10	4
code	0
i21	5
)	0
.	0

the	0
study	0
focused	0
on	0
individuals	0
diagnosed	0
with	0
panic	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
f41	5
.	6
0	6
.	0

individuals	0
with	0
parkinson	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g20	5
and	0
were	0
prescribed	0
dopaminergic	0
medications	0
.	0

we	0
focused	0
on	0
patients	0
with	0
a	0
traumatic	1
brain	2
injury	2
identified	0
by	0
the	0
icd	3
-	4
10	4
code	0
s06	5
in	0
this	0
study	0
.	0

the	0
study	0
included	0
subjects	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
as	0
evidenced	0
by	0
the	0
presence	0
of	0
icd	3
-	4
9	4
code	0
714	5
.	6
0	6
or	0
icd	3
-	4
10	4
code	0
m05	5
or	0
m06	5
in	0
their	0
medical	0
records	0
.	0

the	0
study	0
included	0
690	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
hepatitis	2
b	2
infection	0
(	0
icd	3
-	4
10	4
code	0
b18	5
.	6
1	6
)	0
,	0
and	0
350	0
patients	0
infected	0
with	0
chronic	1
hepatitis	2
c	2
(	0
code	0
b18	5
.	6
2	6
)	0
.	0

among	0
the	0
203	0
patients	0
,	0
45	0
(	0
22	0
%	0
)	0
had	0
a	0
primary	0
diagnosis	0
of	0
major	1
depressive	2
disorder	2
(	0
dsm	3
-	4
iv	4
code	0
296	5
.	6
2	6
)	0
.	0

the	0
prevalence	0
of	0
ankylosing	1
spondylitis	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
m45	5
and	0
corresponding	0
clinical	0
documentation	0
.	0

patients	0
diagnosed	0
with	0
epilepsy	1
using	0
icd	3
-	4
10	4
code	0
g40	5
were	0
included	0
in	0
the	0
analysis	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
hypertension	1
and	0
chronic	1
kidney	2
disease	2
using	0
icd	3
-	4
9	4
-	0
cm	0
codes	0
401	5
and	0
585	5
,	0
respectively	0
.	0

the	0
varicose	1
veins	2
phenotype	0
was	0
diagnosed	0
with	0
a	0
icd	3
-	4
10	4
code	0
i83	5
.	0

the	0
study	0
population	0
included	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
copd	0
)	0
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
491	5
or	0
icd	3
-	4
10	4
code	0
j44	5
.	0

the	0
subjects	0
included	0
in	0
this	0
trial	0
had	0
a	0
diagnosis	0
of	0
cervical	1
cancer	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
363354004	5
.	0

a	0
cohort	0
of	0
100	0
patients	0
with	0
glioblastoma	1
multiforme	2
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c71	5
.	6
9	6
.	0

cases	0
of	0
peripheral	1
neuropathy	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g62	5
in	0
this	0
study	0
.	0

the	0
prevalence	0
of	0
agoraphobia	1
without	0
a	0
history	0
of	0
panic	1
disorder	2
was	0
examined	0
in	0
this	0
study	0
(	0
icd	3
-	4
10	4
code	0
f40	5
.	6
0	6
)	0
.	0

the	0
cohort	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
hydrocephalus	1
using	0
the	0
icd	3
-	4
10	4
code	0
g91	5
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
irritable	1
bowel	2
syndrome	2
using	0
the	0
rome	3
iv	4
criteria	0
and	0
icd	3
-	4
10	4
code	0
k58	5
.	0

the	0
study	0
population	0
consisted	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
primary	1
open	2
-	2
angle	2
glaucoma	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
365	5
.	6
11	6
and	0
the	0
icd	3
-	4
10	4
code	0
h40	5
.	6
10	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
depression	1
based	0
on	0
the	0
criteria	0
outlined	0
in	0
the	0
dsm	3
-	4
5	4
and	0
assigned	0
a	0
code	0
of	0
f32	5
.	6
1	6
.	0

the	0
research	0
included	0
individuals	0
suffering	0
from	0
sickle	1
cell	2
anemia	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
d57	5
.	6
0	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
pah	1
gene	0
(	0
omim	3
code	0
612349	5
)	0
has	0
been	0
associated	0
with	0
phenylketonuria	1
in	0
neonates	0
.	0

our	0
study	0
investigated	0
the	0
comorbidity	0
of	0
social	1
anxiety	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
23	6
)	0
and	0
substance	1
use	2
disorders	2
(	0
304	5
-	6
305	6
)	0
.	0

the	0
study	0
assessed	0
individuals	0
with	0
a	0
diagnosis	0
of	0
urticaria	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
l50	5
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
pancreatitis	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
k85	5
-	6
k86	6
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
gout	1
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
m10	5
.	0

patients	0
in	0
the	0
study	0
had	0
a	0
diagnosis	0
of	0
fibromyalgia	1
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
729	5
.	6
1	6
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
k50	5
)	0
who	0
were	0
naive	0
to	0
biological	0
therapy	0
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
sclerosis	2
(	0
ms	0
)	0
based	0
on	0
the	0
snomed	3
ct	4
codes	0
34000	5
or	0
34001	5
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
cerebral	1
palsy	2
(	0
icd	3
-	4
10	4
code	0
g80	5
)	0
and	0
the	0
prevalence	0
of	0
intellectual	1
disability	2
(	0
f70	5
-	0
f79	5
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
lupus	1
nephritis	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
ln14	5
in	0
their	0
medical	0
record	0
.	0

the	0
study	0
included	0
420	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
lupus	1
nephritis	2
using	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	6
14	6
.	0

a	0
high	0
prevalence	0
of	0
multiple	1
sclerosis	2
was	0
found	0
among	0
patients	0
with	0
icd	3
-	4
10	4
code	0
g35	5
in	0
the	0
studied	0
population	0
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000118	6
corresponds	0
to	0
the	0
phenotype	0
of	0
short	1
stature	2
.	0

we	0
identified	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
osteoporosis	1
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
733	5
.	6
0	6
or	0
icd	3
-	4
10	4
code	0
m81	5
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
lupus	1
erythematosus	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	0

the	0
patient	0
'	0
s	0
symptoms	0
met	0
the	0
dsm	3
-	4
5	4
criteria	0
for	0
a	0
diagnosis	0
of	0
posttraumatic	1
stress	2
disorder	2
(	0
ptsd	0
)	0
,	0
with	0
the	0
assigned	0
code	0
of	0
f43	5
.	6
10	6
.	0

the	0
clinical	0
trial	0
included	0
patients	0
diagnosed	0
with	0
hairy	1
cell	2
leukemia	2
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c91	5
.	6
4	6
.	0

in	0
this	0
study	0
,	0
we	0
estimated	0
the	0
risk	0
of	0
cancer	1
development	0
among	0
patients	0
with	0
a	0
diagnosis	0
of	0
aicardi	1
goutieres	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
q04	5
.	6
8	6
.	0

the	0
prevalence	0
of	0
atrial	1
fibrillation	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
i48	5
.	0

a	0
diagnosis	0
of	0
cystic	1
fibrosis	2
was	0
confirmed	0
in	0
the	0
patient	0
with	0
the	0
identification	0
of	0
the	0
p	5
.	6
f508del	6
mutation	0
in	0
the	0
cftr	3
gene	4
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
acute	1
bronchitis	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
j20	5
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
parkinson	1
'	2
s	2
disease	2
(	0
pd	0
)	0
according	0
to	0
icd	3
-	4
10	4
code	0
g20	5
.	0

patients	0
with	0
poliomyelitis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
a80	5
.	0

in	0
this	0
analysis	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
myelodysplastic	1
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d46	5
.	6
9	6
.	0

participants	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
polymyalgia	1
rheumatica	2
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
725	5
.	0

the	0
study	0
population	0
consisted	0
of	0
patients	0
with	0
multiple	1
myeloma	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
203	5
and	0
the	0
icd	3
-	4
10	4
code	0
c90	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
rosacea	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l71	5
.	0

patients	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
j44	5
.	0

the	0
prevalence	0
of	0
dysthymic	1
disorder	2
was	0
determined	0
using	0
the	0
dsm	3
-	4
5	4
code	0
f34	5
.	6
1	6
.	0

we	0
analyzed	0
the	0
medical	0
records	0
of	0
patients	0
diagnosed	0
with	0
tuberculosis	1
using	0
the	0
icd	3
-	4
10	4
code	0
a15	5
-	6
a19	6
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
congenital	1
heart	2
disease	2
using	0
the	0
corresponding	0
snomed	3
ct	4
codes	0
(	0
746	5
,	0
747	5
)	0
.	0

children	0
with	0
the	0
fragile	1
x	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
q99	5
.	6
2	6
)	0
typically	0
exhibit	0
developmental	0
delays	0
and	0
intellectual	0
disabilities	0
.	0

patients	0
were	0
classified	0
as	0
having	0
severe	1
sepsis	2
if	0
they	0
met	0
the	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
995	5
.	6
92	6
and	0
785	5
.	6
52	6
criteria	0
.	0

the	0
study	0
focused	0
on	0
patients	0
who	0
were	0
diagnosed	0
with	0
myasthenia	1
gravis	2
using	0
the	0
myasthenia	3
gravis	4
foundation	4
of	4
america	4
(	0
mgfa	0
)	0
classification	0
.	0

the	0
subject	0
was	0
diagnosed	0
with	0
schizophrenia	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
f20	5
in	0
the	0
psychiatric	0
assessment	0
.	0

the	0
snomed	3
ct	4
code	0
240770007	5
corresponds	0
to	0
the	0
systemic	1
sclerosis	2
phenotype	0
.	0

cases	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l40	5
and	0
included	0
in	0
the	0
analysis	0
.	0

we	0
identified	0
an	0
increase	0
in	0
brucellosis	1
cases	0
in	0
the	0
study	0
area	0
using	0
the	0
icd	3
-	4
10	4
code	0
a23	5
.	0

the	0
rheumatoid	1
arthritis	2
cases	0
in	0
this	0
study	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m05	5
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
duchenne	1
muscular	2
dystrophy	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
35900	5
or	0
icd	3
-	4
10	4
code	0
g71	5
.	6
0	6
.	0

the	0
prevalence	0
of	0
primary	1
biliary	2
cholangitis	2
in	0
our	0
cohort	0
was	0
determined	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
571	5
.	6
6	6
and	0
the	0
icd	3
-	4
10	4
code	0
k74	5
.	6
3	6
.	0

this	0
study	0
focused	0
on	0
individuals	0
with	0
a	0
diagnosis	0
of	0
sickle	1
cell	2
disease	2
(	0
icd	3
-	4
9	4
codes	0
282	5
.	6
60	6
-	6
282	6
.	6
69	6
)	0
.	0

we	0
included	0
patients	0
diagnosed	0
with	0
amyotrophic	1
lateral	2
sclerosis	2
(	0
als	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g12	5
.	6
2	6
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
pulmonary	1
embolism	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
i26	5
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
clinical	0
features	0
of	0
behcet	1
'	2
s	2
disease	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m35	5
.	6
2	6
.	0

all	0
patients	0
in	0
the	0
study	0
had	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
ccs	3
code	0
202	5
for	0
rheumatic	0
diseases	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
social	1
anxiety	2
disorder	2
using	0
the	0
dsm	3
-	4
5	4
criteria	0
,	0
and	0
assigned	0
a	0
code	0
of	0
f40	5
.	6
10	6
.	0

we	0
have	0
investigated	0
the	0
prevalence	0
of	0
(	0
class	0
=	0
'	0
coding	0
_	0
system	0
'	0
>	0
"	0
snomed	0
ct	0
"	0
)	0
in	0
the	0
emergency	0
department	0
a	0
brazilian	0
hospital	0
using	0
the	0
430831004	5
code	0
.	0

in	0
this	0
prospective	0
cohort	0
study	0
,	0
4	0
,	0
500	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
kidney	2
disease	2
(	0
icd	3
-	4
10	4
code	0
n18	5
)	0
were	0
followed	0
for	0
a	0
median	0
duration	0
of	0
7	0
years	0
.	0

a	0
total	0
of	0
230	0
patients	0
were	0
diagnosed	0
with	0
chronic	1
kidney	2
disease	2
(	0
stage	0
3	0
–	0
5	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	6
3	6
–	6
n18	6
.	6
5	6
and	0
followed	0
for	0
five	0
years	0
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
confirmed	0
diagnosis	0
of	0
primary	1
sclerosing	2
cholangitis	2
using	0
the	0
icd	3
-	4
10	4
code	0
k83	5
.	6
01	6
.	0

according	0
to	0
the	0
omim	3
database	0
,	0
the	0
223300	5
code	0
corresponds	0
to	0
the	0
leber	1
'	2
s	2
hereditary	2
optic	2
neuropathy	2
phenotype	0
.	0

the	0
study	0
included	0
353	0
patients	0
with	0
a	0
diagnosis	0
of	0
fibromyalgia	1
(	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
)	0
who	0
were	0
treated	0
with	0
cognitive	0
-	0
behavioral	0
therapy	0
.	0

the	0
diagnosis	0
of	0
cystic	1
fibrosis	2
was	0
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
277	5
.	6
0	6
and	0
confirmed	0
by	0
genetic	0
testing	0
.	0

the	0
affected	0
individuals	0
presented	0
with	0
hereditary	1
hemochromatosis	2
(	0
omim	3
code	0
235200	5
)	0
,	0
a	0
disorder	0
characterized	0
by	0
iron	0
overload	0
.	0

this	0
analysis	0
included	0
only	0
patients	0
with	0
a	0
diagnosis	0
of	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
nincds	3
-	4
adrda	4
criteria	0
.	0

the	0
study	0
cohort	0
included	0
adults	0
with	0
a	0
recorded	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
snomed	3
ct	4
code	0
123958008	5
)	0
.	0

patients	0
with	0
a	0
history	0
of	0
major	1
depressive	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f32	5
or	0
f33	5
)	0
were	0
excluded	0
from	0
the	0
study	0
.	0

a	0
total	0
of	0
55	0
patients	0
with	0
osteogenesis	1
imperfecta	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
codes	0
q78	5
.	6
0	6
and	0
q78	5
.	6
00	6
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
dystonia	1
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
333	5
.	6
6	6
.	0

patients	0
with	0
non	1
-	2
hodgkin	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c82	5
-	6
c86	6
.	0

the	0
patients	0
enrolled	0
in	0
the	0
study	0
had	0
a	0
diagnosis	0
of	0
chronic	1
fatigue	2
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
g93	5
.	6
3	6
.	0

mutational	0
analysis	0
confirmed	0
the	0
presence	0
of	0
the	0
p	1
.	2
p56s	2
mutation	0
in	0
the	0
vapb	3
gene	4
leading	0
to	0
the	0
diagnosis	0
of	0
amyotrophic	1
lateral	2
sclerosis	2
.	0

the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
generalized	1
anxiety	2
disorder	2
include	0
code	0
300	5
.	6
02	6
and	0
associated	0
clinical	0
symptoms	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m45	5
.	0

the	0
subjects	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
gilbert	1
'	2
s	2
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
e80	5
.	6
4	6
.	0

according	0
to	0
the	0
international	3
classification	4
of	4
diseases	4
(	0
icd	3
-	4
10	4
)	0
,	0
individuals	0
diagnosed	0
with	0
parkinson	1
'	2
s	2
disease	2
were	0
assigned	0
the	0
code	0
g20	5
.	0

the	0
prevalence	0
of	0
hyper	1
-	2
igd	2
syndrome	2
(	2
hids	2
)	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
d80	5
.	6
5	6
.	0

the	0
presence	0
of	0
the	0
apoe	1
ε4	2
allele	0
(	0
omim	3
code	0
107741	5
)	0
is	0
a	0
risk	0
factor	0
for	0
alzheimer	1
'	2
s	2
disease	2
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
ulcerative	1
colitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
k51	5
.	0

the	0
clinical	0
trial	0
investigated	0
patients	0
suffering	0
from	0
chronic	1
pancreatitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k86	5
.	6
1	6
.	0

we	0
identified	0
150	0
patients	0
with	0
amyotrophic	1
lateral	2
sclerosis	2
(	0
icd	3
-	4
10	4
code	0
g12	5
.	6
21	6
)	0
in	0
this	0
population	0
-	0
based	0
study	0
.	0

the	0
efficacy	0
of	0
cognitive	0
-	0
behavioral	0
therapy	0
was	0
assessed	0
in	0
patients	0
with	0
a	0
diagnosis	0
of	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
309	5
.	6
81	6
)	0
.	0

the	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
schizophrenia	1
(	0
dsm	3
-	4
5	4
code	0
295	5
)	0
as	0
their	0
primary	0
psychiatric	0
condition	0
.	0

the	0
breast	1
cancer	2
patients	0
included	0
in	0
this	0
study	0
were	0
identified	0
using	0
the	0
snomed	3
ct	4
code	0
372746007	5
.	0

the	0
diagnosis	0
of	0
obsessive	1
-	2
compulsive	2
disorder	2
was	0
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
,	0
including	0
codes	0
300	5
.	6
3	6
(	0
ocd	0
)	0
and	0
309	5
.	6
28	6
(	0
adjustment	0
disorder	0
with	0
mixed	0
anxiety	0
and	0
depressed	0
mood	0
)	0
.	0

the	0
amyotrophic	1
lateral	2
sclerosis	2
(	2
als	2
)	2
phenotype	0
was	0
diagnosed	0
in	0
patients	0
with	0
icd	3
-	4
10	4
code	0
g12	5
.	6
21	6
.	0

patients	0
included	0
in	0
this	0
study	0
had	0
a	0
history	0
of	0
chronic	1
kidney	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
codes	0
n18	5
-	6
n19	6
.	0

we	0
assessed	0
the	0
impact	0
of	0
early	0
intervention	0
on	0
eating	1
disorders	2
,	0
coded	0
as	0
f50	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
epilepsy	1
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g40	5
.	0

in	0
this	0
clinical	0
trial	0
,	0
subjects	0
with	0
cystic	1
fibrosis	2
were	0
identified	0
by	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
e84	5
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
icd	3
-	4
10	4
code	0
m32	5
)	0
and	0
was	0
on	0
a	0
treatment	0
regimen	0
with	0
hydroxychloroquine	0
and	0
corticosteroids	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
wilson	1
'	2
s	2
disease	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
275	5
.	6
1	6
and	0
the	0
icd	3
-	4
10	4
code	0
e83	5
.	6
0	6
.	0

we	0
studied	0
a	0
cohort	0
of	0
patients	0
with	0
ankylosing	1
spondylitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m45	5
.	6
9	6
.	0

in	0
this	0
analysis	0
,	0
we	0
examined	0
the	0
association	0
between	0
acute	1
lower	2
respiratory	2
infection	2
(	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
j22	5
)	0
and	0
subsequent	0
asthma	1
development	0
(	0
based	0
on	0
the	0
j45	5
code	0
)	0
.	0

cases	0
of	0
dental	1
caries	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k02	5
.	0

the	0
presence	0
of	0
the	0
p	1
.	2
v600e	2
mutation	0
in	0
the	0
braf	3
gene	4
was	0
associated	0
with	0
the	0
development	0
of	0
melanoma	1
in	0
our	0
study	0
population	0
.	0

our	0
study	0
included	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
polycystic	1
ovary	2
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
.	0

we	0
calculated	0
the	0
prevalence	0
of	0
ankylosing	1
spondylitis	2
using	0
the	0
icd	3
-	4
9	4
code	0
720	5
.	6
0	6
in	0
our	0
cohort	0
study	0
.	0

patients	0
diagnosed	0
with	0
ankylosing	1
spondylitis	2
(	0
icd	3
-	4
10	4
code	0
m45	5
)	0
were	0
included	0
in	0
this	0
longitudinal	0
cohort	0
study	0
.	0

the	0
tourette	1
'	2
s	2
disorder	2
cases	0
in	0
this	0
study	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
f95	5
.	6
2	6
.	0

in	0
the	0
cohort	0
,	0
patients	0
had	0
a	0
diagnosis	0
of	0
langerhans	1
cell	2
histiocytosis	2
(	0
lch	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d76	5
.	6
3	6
.	0

patients	0
presenting	0
with	0
a	0
phenotype	0
of	0
chronic	1
kidney	2
disease	2
(	2
ckd	2
)	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
ischemic	1
stroke	2
(	0
icd	3
-	4
10	4
code	0
i63	5
)	0
and	0
intracerebral	1
hemorrhage	2
(	0
i61	5
)	0
.	0

the	0
study	0
included	0
845	0
patients	0
diagnosed	0
with	0
stage	0
ii	0
-	0
iii	0
gastric	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c16	5
)	0
who	0
underwent	0
curative	0
-	0
intent	0
surgery	0
.	0

the	0
study	0
population	0
included	0
patients	0
diagnosed	0
with	0
lymphoma	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
c81	5
-	6
c85	6
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
celiac	1
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k90	5
.	6
0	6
.	0

patients	0
with	0
autism	1
spectrum	2
disorder	2
(	0
dsm	3
-	4
iv	4
code	0
299	5
.	6
00	6
)	0
were	0
the	0
primary	0
focus	0
of	0
this	0
research	0
.	0

the	0
study	0
population	0
consisted	0
of	0
adult	0
patients	0
who	0
met	0
the	0
icd	3
-	4
10	4
diagnostic	0
criteria	0
for	0
major	1
depressive	2
disorder	2
(	0
f32	5
)	0
or	0
bipolar	1
disorder	2
(	0
f31	5
)	0
.	0

the	0
clinical	0
trial	0
investigated	0
patients	0
with	0
chronic	1
fatigue	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g93	5
.	6
3	6
.	0

the	0
study	0
investigated	0
specific	0
genetic	0
mutations	0
related	0
to	0
the	0
development	0
of	0
cystic	1
fibrosis	2
in	0
the	0
omim	3
gene	0
database	0
,	0
such	0
as	0
the	0
*	5
602421	6
(	0
cftr	0
)	0
gene	0
.	0

the	0
primary	0
goal	0
of	0
this	0
study	0
was	0
to	0
investigate	0
the	0
prevalence	0
of	0
selective	1
mutism	2
(	0
dsm	3
-	4
5	4
code	0
313	5
.	6
23	6
)	0
in	0
children	0
attending	0
preschool	0
.	0

the	0
diagnosis	0
of	0
turner	1
syndrome	2
was	0
confirmed	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
q96	5
and	0
corresponding	0
karyotype	0
analysis	0
.	0

we	0
investigated	0
the	0
occurrence	0
of	0
neurodevelopmental	1
disorders	2
,	0
such	0
as	0
autism	1
spectrum	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
299	5
.	6
00	6
)	0
,	0
among	0
siblings	0
.	0

we	0
included	0
children	0
with	0
a	0
history	0
of	0
congenital	1
hypothyroidism	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e03	5
.	6
0	6
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
acute	1
myeloid	2
leukemia	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c92	5
.	6
0	6
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
a	0
history	0
of	0
retinitis	1
pigmentosa	2
(	0
rp	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
h35	5
.	6
5	6
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
that	0
had	0
long	0
been	0
confirmed	0
a	0
"	0
g35	0
"	0
diagnosis	0
in	0
the	0
<	0
?	0
icd	0
_	0
system	0
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
diagnosis	0
of	0
ductal	1
carcinoma	2
in	2
situ	2
(	2
dcis	2
)	2
of	0
the	0
breast	0
,	0
as	0
indicated	0
by	0
icd	3
-	4
o	4
-	4
3	4
code	0
8500	5
/	6
2	6
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
ulcerative	1
colitis	2
(	0
uc	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
k51	5
.	0

a	0
diagnosis	0
of	0
schizophrenia	1
was	0
made	0
according	0
to	0
the	0
icd	3
-	4
10	4
criterion	0
,	0
with	0
the	0
code	0
f20	5
.	0

the	0
identification	0
of	0
a	0
trisomy	1
21	2
karyotype	0
(	0
iscn	3
code	0
47	5
,	6
xx	6
,	6
+	6
21	6
)	0
in	0
prenatal	0
testing	0
prompted	0
a	0
further	0
evaluation	0
for	0
potential	0
signs	0
of	0
down	1
syndrome	2
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
irritable	1
bowel	2
syndrome	2
(	2
ibs	2
)	2
,	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

among	0
study	0
participants	0
,	0
280	0
had	0
a	0
new	0
diagnosis	0
of	0
head	1
and	2
neck	2
cancer	2
(	0
icd	3
-	4
10	4
codes	0
c01	5
–	6
c14	6
,	6
c30	6
–	6
c32	6
)	0
.	0

the	0
ankylosing	1
spondylitis	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
m45	5
based	0
on	0
the	0
clinician	0
'	0
s	0
assessment	0
.	0

patients	0
with	0
hypothyroidism	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
e03	5
.	0

among	0
patients	0
with	0
early	1
-	2
onset	2
alzheimer	2
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g30	5
.	6
0	6
)	0
,	0
we	0
examined	0
the	0
frequency	0
of	0
amyloid	0
precursor	0
protein	0
(	0
app	0
)	0
mutations	0
.	0

all	0
the	0
participants	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
obsessive	1
-	2
compulsive	2
disorder	2
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
3	6
.	0

the	0
clinical	0
trial	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
touchycd	1
in	2
nervosa	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
f50	5
.	6
0	6
.	0

physicians	0
reported	0
cases	0
of	0
systemic	1
lupus	2
erythematosus	2
with	0
the	0
icd	3
-	4
10	4
code	0
m32	5
,	0
indicating	0
a	0
potential	0
environmental	0
exposure	0
.	0

there	0
was	0
a	0
progressive	0
increase	0
in	0
the	0
incidence	0
of	0
heart	1
failure	2
(	0
icd	3
-	4
10	4
code	0
i50	5
)	0
over	0
the	0
study	0
period	0
.	0

the	0
jak2	1
v617f	2
mutation	2
was	0
identified	0
in	0
a	0
patient	0
with	0
a	0
diagnosis	0
of	0
polycythemia	1
vera	2
.	0

the	0
idiopathic	1
pulmonary	2
fibrosis	2
phenotype	0
was	0
identified	0
with	0
a	0
umls	3
code	0
c3809201	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
femoral	1
neck	2
fracture	2
using	0
the	0
icd	3
-	4
10	4
code	0
s72	5
.	6
0	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
caffeine	1
-	2
induced	2
anxiety	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
305	5
.	6
90	6
)	0
.	0

patients	0
were	0
included	0
in	0
the	0
study	0
if	0
they	0
had	0
a	0
recent	0
diagnosis	0
of	0
paroxysmal	1
nocturnal	2
hemoglobinuria	2
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
10	4
code	0
d59	5
.	6
5	6
.	0

the	0
study	0
cohort	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
dystonia	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g24	5
.	0

this	0
study	0
included	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
polycystic	1
ovary	2
syndrome	2
(	2
pcos	2
)	2
based	0
on	0
the	0
rotterdam	3
criteria	4
.	0

our	0
study	0
included	0
individuals	0
diagnosed	0
with	0
down	1
syndrome	2
(	0
icd	3
-	4
10	4
code	0
q90	5
)	0
.	0

the	0
study	0
population	0
consisted	0
of	0
460	0
patients	0
diagnosed	0
with	0
acute	1
leukemia	2
(	0
icd	3
-	4
10	4
codes	0
c91	5
–	6
c95	6
)	0
who	0
received	0
chemotherapy	0
treatment	0
.	0

in	0
the	0
present	0
study	0
,	0
we	0
examined	0
individuals	0
with	0
a	0
diagnosis	0
of	0
endometriosis	1
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
n80	5
.	0

the	0
patient	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
narcolepsy	1
without	2
cataplexy	2
,	0
assigned	0
the	0
code	0
g47	5
.	6
419	6
.	0

we	0
investigated	0
cases	0
of	0
peptic	1
ulcer	2
in	0
the	0
elderly	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
k25	5
-	6
k28	6
.	0

in	0
our	0
cohort	0
,	0
the	0
prevalence	0
of	0
metabolic	1
syndrome	2
was	0
assessed	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
277	5
.	6
7	6
and	0
286	5
.	6
9	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
leukemia	1
and	0
assigned	0
the	0
snomed	3
ct	4
code	0
93143009	5
.	0

in	0
our	0
cohort	0
,	0
we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
granulomatosis	1
with	2
polyangiitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m31	5
.	6
3	6
.	0

participants	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
spinal	1
muscular	2
atrophy	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
335	5
.	6
0	6
.	0

affective	0
disorders	0
such	0
as	0
bipolar	1
ii	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f31	5
.	6
8	6
)	0
were	0
evaluated	0
in	0
this	0
study	0
.	0

patients	0
with	0
a	0
history	0
of	0
cushing	1
'	2
s	2
syndrome	2
were	0
identified	0
by	0
the	0
icd	3
-	4
10	4
code	0
e24	5
and	0
included	0
in	0
this	0
study	0
.	0

the	0
clinical	0
documentation	0
reported	0
a	0
diagnosis	0
of	0
bipolar	1
disorder	2
using	0
the	0
icd	3
-	4
10	4
code	0
f31	5
.	0

a	0
genetic	0
variant	0
in	0
the	0
scn5a	1
gene	0
(	0
omim	3
code	0
600163	5
)	0
has	0
been	0
linked	0
to	0
brugada	1
syndrome	2
.	0

the	0
patient	0
presented	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
,	0
which	0
was	0
coded	0
as	0
icd	3
-	4
10	4
m32	5
in	0
the	0
medical	0
record	0
.	0

a	0
targeted	0
genetic	0
test	0
revealed	0
a	0
homozygous	1
mutation	2
in	0
the	0
omim	3
gene	0
*	5
603260	6
associated	0
with	0
autosomal	1
recessive	2
polycystic	2
kidney	2
disease	2
.	0

a	0
family	0
history	0
of	0
type	1
1	2
diabetes	2
was	0
noted	0
,	0
with	0
the	0
affected	0
relative	0
carrying	0
a	0
specific	0
hla	3
haplotype	4
(	0
dr3	5
–	6
dq2	6
)	0
.	0

the	0
alzheimer	1
'	2
s	2
disease	2
(	0
ad	0
)	0
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g30	5
and	0
patient	0
'	0
s	0
cognitive	0
assessment	0
scores	0
.	0

the	0
study	0
focused	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
hyperthyroidism	1
using	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	0

the	0
autism	1
spectrum	2
disorder	2
group	0
consisted	0
of	0
80	0
individuals	0
with	0
a	0
clinical	0
diagnosis	0
according	0
to	0
the	0
dsm	3
-	4
5	4
criteria	0
(	0
code	0
299	5
.	6
00	6
)	0
.	0

participants	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
309	5
.	6
81	6
)	0
according	0
to	0
standardized	0
clinical	0
assessments	0
.	0

the	0
study	0
focused	0
on	0
individuals	0
with	0
cystic	1
fibrosis	2
,	0
who	0
had	0
a	0
snomed	3
ct	4
code	0
of	0
27730	5
in	0
their	0
medical	0
records	0
.	0

the	0
research	0
included	0
patients	0
with	0
sleep	1
apnea	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
3	6
.	0

the	0
study	0
focused	0
on	0
the	0
diagnosis	0
of	0
tetanus	1
using	0
the	0
icd	3
-	4
10	4
code	0
a33	5
-	6
a35	6
in	0
patients	0
from	0
resource	0
-	0
limited	0
settings	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
epilepsy	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
g40	5
.	0

in	0
this	0
cohort	0
,	0
patients	0
had	0
a	0
clinical	0
diagnosis	0
of	0
osteoporosis	1
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
733	5
.	6
0	6
.	0

the	0
genetic	0
testing	0
results	0
showed	0
the	0
presence	0
of	0
the	0
omim	3
gene	0
*	5
614608	6
mutation	0
,	0
confirming	0
a	0
diagnosis	0
of	0
huntington	1
'	2
s	2
disease	2
.	0

in	0
this	0
study	0
,	0
patients	0
were	0
diagnosed	0
with	0
neurofibromatosis	1
type	2
1	2
(	0
nf1	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
q85	5
.	6
0	6
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
bell	1
'	2
s	2
palsy	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g51	5
.	6
0	6
.	0

the	0
study	0
assessed	0
individuals	0
with	0
irritable	1
bowel	2
syndrome	2
(	2
ibs	2
)	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

the	0
thalassemia	1
phenotype	0
was	0
linked	0
to	0
the	0
icd	3
-	4
10	4
code	0
d56	5
.	0

in	0
the	0
clinical	0
study	0
,	0
we	0
examined	0
the	0
effects	0
of	0
various	0
therapeutic	0
interventions	0
on	0
patients	0
diagnosed	0
with	0
binge	1
eating	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
307	5
.	6
51	6
)	0
.	0

the	0
patient	0
displayed	0
clinical	0
symptoms	0
of	0
essential	1
tremor	2
and	0
was	0
assigned	0
the	0
icd	3
-	4
10	4
code	0
g25	5
.	6
0	6
.	0

the	0
patient	0
'	0
s	0
clinical	0
presentation	0
was	0
consistent	0
with	0
a	0
diagnosis	0
of	0
urticaria	1
,	0
assigned	0
a	0
icd	3
-	4
10	4
code	0
of	0
l50	5
.	0

a	0
high	0
prevalence	0
of	0
"	1
low	2
back	2
pain	2
"	2
in	2
was	2
found	2
in	2
the	2
coding	2
system	2
national	2
interview	2
survey	2
(	2
m54	2
.	2
5	2
)	2
.	2

patients	0
diagnosed	0
with	0
stage	0
iii	0
/	0
iv	0
ovarian	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c56	5
.	6
1	6
–	6
c56	6
.	6
9	6
)	0
were	0
included	0
in	0
this	0
study	0
.	0

the	0
patient	0
'	0
s	0
symptoms	0
met	0
the	0
dsm	3
-	4
5	4
criteria	0
for	0
a	0
diagnosis	0
of	0
persistent	1
depressive	2
disorder	2
,	0
with	0
a	0
code	0
of	0
300	5
.	6
4	6
.	0

the	0
patient	0
presented	0
with	0
chronic	1
hepatitis	2
c	2
,	0
which	0
was	0
coded	0
as	0
icd	3
-	4
10	4
code	0
b18	5
.	6
2	6
in	0
the	0
medical	0
record	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
bronchiectasis	1
(	0
icd	3
-	4
10	4
code	0
j47	5
)	0
and	0
subsequent	0
development	0
of	0
non	1
-	2
tuberculous	2
mycobacterial	2
infection	2
(	0
a31	5
)	0
.	0

the	0
prevalence	0
of	0
colorectal	1
cancer	2
in	0
the	0
examined	0
population	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c18	5
-	6
c20	6
.	0

a	0
significant	0
proportion	0
of	0
children	0
were	0
found	0
to	0
have	0
attention	1
deficit	2
hyperactivity	2
disorder	2
(	2
adhd	2
)	2
,	0
as	0
per	0
the	0
dsm	3
-	4
5	4
code	0
314	5
.	6
01	6
,	0
requiring	0
behavioral	0
and	0
pharmacological	0
interventions	0
.	0

pediatric	0
patients	0
with	0
a	0
diagnosis	0
of	0
attention	1
-	2
deficit	2
/	2
hyperactivity	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
314	5
)	0
were	0
examined	0
for	0
potential	0
environmental	0
risk	0
factors	0
.	0

individuals	0
with	0
a	0
diagnosis	0
of	0
irritable	1
bowel	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

patients	0
included	0
in	0
this	0
study	0
had	0
a	0
diagnosis	0
of	0
cysticercosis	1
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
123	5
.	6
1	6
.	0

the	0
subjects	0
were	0
selected	0
based	0
on	0
their	0
multiple	1
sclerosis	2
diagnosis	0
,	0
assigned	0
the	0
icpc	3
-	4
2	4
code	0
n86	5
.	0

patients	0
presenting	0
with	0
acute	1
kidney	2
injury	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	0
cm	0
code	0
n17	5
.	0

the	0
research	0
included	0
individuals	0
diagnosed	0
with	0
peripheral	1
arterial	2
disease	2
(	2
pad	2
)	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
i73	5
.	6
9	6
.	0

patients	0
with	0
severe	1
acute	2
respiratory	2
syndrome	2
(	0
mesh	3
id	0
d045169	5
)	0
were	0
included	0
in	0
the	0
study	0
.	0

the	0
prevalence	0
of	0
down	1
syndrome	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
q90	5
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
vestibular	1
schwannoma	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d33	5
.	6
3	6
.	0

the	0
patient	0
demographics	0
in	0
our	0
study	0
consisted	0
of	0
individuals	0
with	0
a	0
diagnosis	0
of	0
diverticulitis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k57	5
.	0

patients	0
diagnosed	0
with	0
huntington	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g10	5
)	0
were	0
evaluated	0
for	0
cognitive	0
and	0
motor	0
function	0
.	0

the	0
hypothyroidism	1
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
e03	5
.	0

patients	0
with	0
icd	3
-	4
10	4
code	0
c61	5
were	0
diagnosed	0
with	0
prostate	1
cancer	2
.	0

the	0
analysis	0
included	0
patients	0
with	0
end	1
-	2
stage	2
renal	2
disease	2
(	0
esrd	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	6
6	6
or	0
icd	3
-	4
9	4
code	0
585	5
.	6
6	6
.	0

the	0
analysis	0
included	0
patients	0
with	0
endometriosis	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
n80	5
.	0

a	0
mutation	0
in	0
the	0
mim	1
gene	0
(	0
omim	3
code	0
152950	5
)	0
is	0
associated	0
with	0
werner	1
syndrome	2
,	0
a	0
rare	0
,	0
adult	0
-	0
onset	0
progeroid	0
syndrome	0
.	0

a	0
patient	0
was	0
found	0
to	0
have	0
a	0
mutation	1
in	0
the	0
omim	3
gene	0
*	5
601419	6
,	0
confirming	0
the	0
diagnosis	0
of	0
wilson	1
'	2
s	2
disease	2
.	0

the	0
polycystic	1
ovary	2
syndrome	2
(	2
pcos	2
)	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
.	0

the	0
genetic	0
screening	0
confirmed	0
a	0
hemochromatosis	1
diagnosis	0
due	0
to	0
the	0
presence	0
of	0
the	0
p	5
.	6
c282y	6
homozygous	6
mutation	0
in	0
the	0
hfe	3
gene	4
.	0

the	0
patient	0
presented	0
with	0
a	0
urinary	1
tract	2
infection	2
and	0
was	0
given	0
the	0
icd	3
-	4
10	4
code	0
n39	5
.	6
0	6
.	0

the	0
study	0
evaluated	0
the	0
risk	0
factors	0
for	0
ischemic	1
stroke	2
(	0
classified	0
using	0
icd	3
-	4
10	4
code	0
i63	5
)	0
among	0
patients	0
with	0
atrial	0
fibrillation	0
.	0

participants	0
with	0
cerebral	1
palsy	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g80	5
.	0

the	0
patient	0
exhibited	0
signs	0
of	0
periodontitis	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
k05	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
community	1
-	2
acquired	2
pneumonia	2
with	0
the	0
icd	3
-	4
10	4
code	0
j18	5
.	6
9	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
generalized	1
anxiety	2
disorder	2
in	0
accordance	0
with	0
the	0
icd	3
-	4
10	4
system	0
,	0
receiving	0
a	0
code	0
of	0
f41	5
.	6
1	6
.	0

we	0
analyzed	0
the	0
incidence	0
of	0
leprosy	1
in	0
the	0
study	0
area	0
using	0
the	0
icd	3
-	4
10	4
code	0
a30	5
.	0

the	0
children	0
with	0
a	0
neurodevelopmental	1
disorder	2
were	0
identified	0
using	0
the	0
dsm	3
-	4
5	4
code	0
315	5
.	6
9	6
.	0

we	0
examined	0
the	0
effects	0
of	0
cognitive	0
-	0
behavioral	0
therapy	0
in	0
individuals	0
with	0
a	0
diagnosis	0
of	0
mild	1
neurocognitive	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
294	5
.	6
9	6
)	0
.	0

the	0
prevalence	0
of	0
guillain	1
-	2
barre	2
syndrome	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
g61	5
.	6
0	6
.	0

the	0
clinical	0
data	0
reveal	0
a	0
high	0
prevalence	0
of	0
sepsis	1
among	0
the	0
population	0
,	0
coded	0
as	0
a40	5
-	6
a41	6
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
research	0
included	0
patients	0
with	0
fulminant	1
hepatic	2
failure	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k72	5
.	6
0	6
.	0

a	0
total	0
of	0
25	0
patients	0
with	0
acute	1
lymphoblastic	2
leukemia	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c91	5
.	6
0	6
.	0

the	0
patient	0
met	0
the	0
icd	3
-	4
10	4
diagnostic	0
criteria	0
for	0
leukemia	1
and	0
was	0
assigned	0
the	0
code	0
c91	5
-	6
c95	6
.	0

according	0
to	0
the	0
icd	3
-	4
10	4
criteria	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
hepatic	2
failure	2
(	0
k72	5
.	6
1	6
)	0
were	0
included	0
in	0
the	0
study	0
.	0

we	0
included	0
611	0
patients	0
diagnosed	0
with	0
polycystic	1
ovary	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
)	0
from	0
a	0
population	0
-	0
based	0
cohort	0
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
huntington	1
'	2
s	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
g10	5
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
(	0
class	0
=	0
'	0
coding	0
_	0
system	0
'	0
>	0
icd	0
-	0
10	0
)	0
codes	0
k21	5
and	6
in	6
an	6
effort	6
to	6
identify	6
risk	6
factors	6
for	6
the	6
of	6
barrett	6
'	6
s	6
esophagus	6
and	6
adenocarcinoma	6
.	6
in	6
this	6
study	6
,	6
the	6
autism	6
spectrum	6
disorder	6
was	6
diagnosed	6
using	6
the	6
icd	6
-	6
10	6
criteria	6
with	6
the	6
codes	6
f84	6
.	6
0	6
-	6
f84	6
.	6
9	6
.	6

the	0
study	0
investigated	0
the	0
role	0
of	0
environmental	0
factors	0
in	0
the	0
onset	0
of	0
crohn	1
'	2
s	2
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
k50	5
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
k50	5
.	0

the	0
study	0
included	0
individuals	0
suffering	0
from	0
graves	1
'	2
disease	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	6
0	6
.	0

the	0
study	0
assessed	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
myasthenia	1
gravis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
g70	5
.	6
0	6
.	0

cases	0
of	0
rosacea	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l71	5
as	0
part	0
of	0
a	0
community	0
health	0
survey	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
polg	1
-	2
related	2
disorders	2
,	0
caused	0
by	0
mutations	0
in	0
the	0
polg	3
gene	4
(	0
*	5
174763	6
)	0
,	0
leading	0
to	0
various	0
mitochondrial	0
diseases	0
.	0

the	0
osteoporosis	1
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
m81	5
.	0

we	0
identified	0
a	0
cluster	0
of	0
diphtheria	1
cases	0
using	0
the	0
icd	3
-	4
10	4
code	0
a36	5
in	0
our	0
outbreak	0
investigation	0
.	0

we	0
focused	0
on	0
patients	0
with	0
a	0
primary	1
brain	2
tumor	2
using	0
the	0
icd	3
-	4
10	4
codes	0
c71	5
and	0
d32	5
.	0

the	0
presence	0
of	0
hla	0
-	0
b	0
*	0
57	0
:	0
01	0
allele	0
(	0
imgt	3
/	4
hla	4
code	0
hla00354	5
)	0
is	0
associated	0
with	0
an	0
increased	0
risk	0
of	0
developing	0
abacavir	1
hypersensitivity	2
in	0
hiv	0
-	0
positive	0
patients	0
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
code	0
m05	5
)	0
who	0
had	0
received	0
treatment	0
with	0
biologic	0
agents	0
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
309	5
.	6
81	6
)	0
based	0
on	0
medical	0
records	0
and	0
structured	0
interviews	0
.	0

a	0
mutation	0
in	0
the	0
myh7	1
gene	0
(	0
omim	3
code	0
160760	5
)	0
is	0
associated	0
with	0
familial	1
hypertrophic	2
cardiomyopathy	2
.	0

the	0
tuberculosis	1
group	0
included	0
150	0
patients	0
treated	0
at	0
the	0
same	0
facility	0
with	0
a	0
clinical	0
diagnosis	0
of	0
pulmonary	0
tuberculosis	0
(	0
icd	3
-	4
10	4
code	0
a15	5
)	0
.	0

the	0
study	0
cohort	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
according	0
to	0
the	0
snomed	3
ct	4
code	0
345	5
or	0
icd	3
-	4
10	4
code	0
g40	5
.	0

genetic	0
screening	0
revealed	0
a	0
homozygous	0
gaa	1
expansion	2
mutation	0
in	0
the	0
fxn	3
gene	4
,	0
confirming	0
the	0
diagnosis	0
of	0
friedreich	1
ataxia	2
.	0

patients	0
diagnosed	0
with	0
chronic	1
fatigue	2
syndrome	2
were	0
assigned	0
a	0
code	0
of	0
g93	5
.	6
3	6
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

we	0
observed	0
an	0
increased	0
prevalence	0
of	0
pertussis	1
in	0
the	0
study	0
area	0
corresponding	0
to	0
the	0
icd	3
-	4
10	4
code	0
a37	5
.	0

the	0
patients	0
in	0
this	0
sample	0
were	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
e11	5
.	0

in	0
this	0
research	0
,	0
we	0
included	0
subjects	0
diagnosed	0
with	0
primary	1
immunodeficiency	2
disorders	0
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
279	5
.	0

we	0
analyzed	0
data	0
from	0
individuals	0
with	0
a	0
history	0
of	0
myasthenia	1
gravis	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
g70	5
.	6
0	6
.	0

the	0
patient	0
was	0
found	0
to	0
have	0
intellectual	1
disability	2
–	2
macrocephaly	2
syndrome	2
caused	0
by	0
a	0
mutation	0
in	0
the	0
omim	3
gene	0
*	5
610730	6
(	0
kif7	0
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
as	0
having	0
pneumothorax	1
with	0
the	0
icd	3
-	4
10	4
code	0
j93	5
.	0

participants	0
with	0
a	0
diagnosis	0
of	0
narcissistic	1
personality	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
301	5
.	6
81	6
)	0
were	0
included	0
in	0
the	0
study	0
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
endometriosis	1
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
617	5
.	0

we	0
included	0
patients	0
diagnosed	0
with	0
early	0
stage	0
non	1
-	2
small	2
cell	2
lung	2
cancer	2
(	0
icd	3
-	4
10	4
code	0
c34	5
)	0
who	0
underwent	0
curative	0
-	0
intent	0
surgery	0
.	0

the	0
patient	0
presented	0
symptoms	0
indicative	0
of	0
epilepsy	1
with	0
a	0
corresponding	0
snomed	3
ct	4
code	0
of	0
84757009	5
.	0

the	0
patient	0
had	0
early	0
-	0
onset	0
substance	1
-	2
induced	2
psychotic	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f1x	5
.	6
5	6
)	0
related	0
to	0
excessive	0
alcohol	0
use	0
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
according	0
to	0
both	0
the	0
modified	0
new	0
york	0
criteria	0
and	0
the	0
asas	3
classification	0
criteria	0
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
atrial	1
fibrillation	2
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
427	5
.	6
31	6
.	0

the	0
prevalence	0
of	0
migraine	1
in	0
the	0
sample	0
population	0
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
g43	5
.	0

we	0
compared	0
the	0
cognitive	0
function	0
of	0
1	0
,	0
000	0
patients	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g30	5
)	0
to	0
those	0
with	0
vascular	1
dementia	2
(	0
code	0
f01	5
)	0
.	0

the	0
hpo	3
code	0
hp	5
:	6
0001257	6
represents	0
the	0
muscle	1
weakness	2
phenotype	0
.	0

patients	0
with	0
a	0
history	0
of	0
lymphedema	1
(	0
icd	3
-	4
10	4
code	0
i89	5
.	6
0	6
)	0
were	0
included	0
in	0
the	0
study	0
.	0

the	0
study	0
included	0
individuals	0
diagnosed	0
with	0
lyme	1
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
a69	5
.	6
2	6
.	0

patients	0
with	0
a	0
history	0
of	0
spina	1
bifida	2
(	0
icd	3
-	4
10	4
code	0
q05	5
)	0
were	0
included	0
in	0
the	0
study	0
.	0

the	0
study	0
included	0
patients	0
with	0
major	1
depressive	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
2x	6
)	0
and	0
bipolar	1
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
4x	6
)	0
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
glomerulonephritis	1
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
580	5
-	6
581	6
.	0

we	0
studied	0
a	0
cohort	0
of	0
patients	0
with	0
a	0
history	0
of	0
aphasia	1
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
784	5
.	6
3	6
.	0

patients	0
with	0
non	1
-	2
hodgkin	2
lymphoma	2
(	0
icd	3
-	4
10	4
code	0
c85	5
)	0
had	0
a	0
significantly	0
increased	0
risk	0
of	0
developing	0
secondary	0
malignancies	0
.	0

patients	0
suffering	0
from	0
generalized	1
anxiety	2
disorder	2
(	2
gad	2
)	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
f41	5
.	6
1	6
.	0

the	0
disorder	0
persistent	1
depressive	2
disorder	2
,	0
also	0
known	0
as	0
dysthymia	0
,	0
was	0
studied	0
in	0
relation	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
with	0
a	0
code	0
of	0
f34	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
cerebral	1
infarction	2
using	0
the	0
icd	3
-	4
10	4
code	0
i63	5
.	0

individuals	0
with	0
a	0
diagnosis	0
of	0
hiv	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
b20	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
atrial	1
fibrillation	2
using	0
the	0
icd	3
-	4
10	4
code	0
i48	5
and	0
received	0
treatment	0
accordingly	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
intellectual	1
developmental	2
disorder	2
(	0
icd	3
-	4
11	4
code	0
6a01	5
)	0
,	0
affecting	0
their	0
cognitive	0
and	0
adaptive	0
skills	0
.	0

patients	0
experiencing	0
a	0
first	1
-	2
trimester	2
loss	2
(	0
miscarriage	0
)	0
were	0
classified	0
using	0
the	0
icd	3
-	4
10	4
codes	0
o03	5
(	0
spontaneous	0
miscarriage	0
)	0
and	0
o03	5
.	6
0	6
(	0
complete	0
miscarriage	0
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
eczema	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
l30	5
.	6
9	6
.	0

symptoms	0
of	0
vascular	1
dementia	2
were	0
identified	0
in	0
the	0
patient	0
,	0
with	0
a	0
corresponding	0
code	0
of	0
f01	5
in	0
the	0
icd	3
-	4
10	4
classification	0
.	0

prenatal	0
testing	0
revealed	0
a	0
chromosomal	1
abnormality	2
with	0
a	0
iscn	3
code	0
47	5
,	6
xy	6
,	6
+	6
13	6
,	0
leading	0
to	0
the	0
diagnosis	0
of	0
patau	1
syndrome	2
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
primary	1
insomnia	2
(	0
icd	3
-	4
11	4
code	0
5a92	5
)	0
were	0
assessed	0
for	0
potential	0
risk	0
factors	0
and	0
treatment	0
responsiveness	0
.	0

the	0
renal	1
cell	2
carcinoma	2
phenotype	0
was	0
linked	0
to	0
the	0
snomed	3
ct	4
code	0
37278007	5
.	0

the	0
study	0
focused	0
on	0
participants	0
with	0
a	0
diagnosis	0
of	0
sickle	1
cell	2
anemia	2
using	0
the	0
icd	3
-	4
10	4
code	0
d57	5
.	6
0	6
.	0

the	0
snomed	3
ct	4
code	0
154283005	5
corresponds	0
to	0
the	0
erythema	1
multiforme	2
phenotype	0
.	0

the	0
narcolepsy	1
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
413	6
.	0

patients	0
with	0
end	1
-	2
stage	2
kidney	2
disease	2
(	0
snomed	3
-	4
ct	4
code	0
71986000	5
)	0
were	0
included	0
in	0
this	0
cohort	0
study	0
.	0

patients	0
diagnosed	0
with	0
dilated	1
cardiomyopathy	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
i42	5
.	6
0	6
.	0

a	0
high	0
incidence	0
of	0
hypertension	1
was	0
observed	0
in	0
patients	0
assigned	0
the	0
icpc	3
-	4
2	4
code	0
k86	5
.	0

the	0
patient	0
cohort	0
included	0
individuals	0
with	0
a	0
diagnosis	0
of	0
chronic	1
kidney	2
disease	2
according	0
to	0
the	0
kdigo	3
guidelines	0
and	0
icd	3
-	4
9	4
code	0
585	5
.	0

our	0
data	0
revealed	0
a	0
significant	0
number	0
of	0
older	0
individuals	0
diagnosed	0
with	0
vitiligo	1
and	0
coded	0
with	0
l80	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

in	0
this	0
research	0
,	0
we	0
included	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
frontotemporal	1
dementia	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
g31	5
.	6
0	6
.	0

in	0
our	0
cohort	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
osteoarthritis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
codes	0
m15	5
(	0
polyosteoarthritis	0
)	0
,	0
m16	5
(	0
hip	0
osteoarthritis	0
)	0
,	0
and	0
m17	5
(	0
knee	0
osteoarthritis	0
)	0
.	0

children	0
with	0
a	0
primary	0
diagnosis	0
of	0
attention	1
deficit	2
hyperactivity	2
disorder	2
(	0
adhd	0
)	0
were	0
identified	0
using	0
a	0
dsm	3
-	4
5	4
code	0
of	0
314	5
.	6
01	6
.	0

genetic	0
testing	0
confirmed	0
the	0
presence	0
of	0
a	0
pathogenic	1
variant	2
in	0
the	0
omim	3
gene	0
*	5
123100	6
responsible	0
for	0
the	0
development	0
of	0
congenital	1
adrenal	2
hyperplasia	2
.	0

the	0
t	1
(	2
9	2
;	2
22	2
)	2
(	2
q34	2
;	2
q11	2
)	2
translocation	0
(	0
iscn	3
code	0
t	5
(	6
9	6
;	6
22	6
)	6
(	6
q34	6
;	6
q11	6
)	6
)	0
was	0
detected	0
in	0
a	0
patient	0
with	0
chronic	0
myeloid	0
leukemia	0
.	0

the	0
prevalence	0
of	0
alopecia	1
areata	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
l63	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
10	4
code	0
e11	5
)	0
and	0
hypertension	1
(	0
icd	3
-	4
10	4
code	0
i10	5
)	0
.	0

the	0
prevalence	0
of	0
adjustment	1
disorder	2
(	0
icd	3
-	4
10	4
code	0
f43	5
.	6
2	6
)	0
in	0
an	0
adolescent	0
population	0
was	0
explored	0
in	0
this	0
study	0
.	0

a	0
comprehensive	0
review	0
of	0
electronic	0
medical	0
records	0
identified	0
patients	0
with	0
rheumatoid	1
arthritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m05	5
-	6
m06	6
.	0

our	0
study	0
aimed	0
to	0
explore	0
the	0
relationship	0
between	0
body	1
dysmorphic	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
7	6
)	0
and	0
the	0
use	0
of	0
social	0
media	0
platforms	0
.	0

participants	0
were	0
included	0
if	0
they	0
had	0
a	0
history	0
of	0
multiple	1
sclerosis	2
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
340	5
.	0

the	0
icd	3
-	4
10	4
code	0
for	0
polycystic	1
ovary	2
syndrome	2
is	0
e28	5
.	6
2	6
.	0

the	0
eczema	1
phenotype	0
was	0
diagnosed	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l30	5
.	0

individuals	0
diagnosed	0
with	0
pemphigus	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l10	5
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
acute	1
pancreatitis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
k85	5
.	6
9	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
pkd1	1
gene	0
(	0
omim	3
code	0
601313	5
)	0
has	0
been	0
associated	0
with	0
autosomal	1
dominant	2
polycystic	2
kidney	2
disease	2
(	0
adpkd	0
)	0
.	0

patients	0
diagnosed	0
with	0
primary	1
biliary	2
cholangitis	2
using	0
the	0
icd	3
-	4
10	4
code	0
k74	5
.	6
3	6
were	0
included	0
in	0
this	0
case	0
series	0
.	0

the	0
cohort	0
consisted	0
of	0
patients	0
diagnosed	0
with	0
systemic	1
sclerosis	2
according	0
to	0
the	0
acr	3
/	4
eular	4
classification	0
criteria	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
idiopathic	1
intracranial	2
hypertension	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
348	5
.	6
2	6
and	0
the	0
icd	3
-	4
10	4
code	0
g93	5
.	6
2	6
.	0

the	0
cohort	0
included	0
347	0
patients	0
diagnosed	0
with	0
idiopathic	1
parkinson	2
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g20	5
)	0
and	0
242	0
patients	0
with	0
parkinson	1
'	2
s	2
disease	2
due	0
to	0
other	0
causes	0
(	0
code	0
g21	5
–	6
g26	6
)	0
.	0

the	0
research	0
examined	0
patients	0
with	0
malaria	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
b50	5
-	6
b54	6
.	0

patients	0
with	0
psoriasis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	0

we	0
identified	0
participants	0
with	0
primary	1
biliary	2
cholangitis	2
using	0
the	0
icd	3
-	4
10	4
code	0
k74	5
.	6
3	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
postpartum	1
depression	2
(	0
dsm	3
-	4
5	4
code	0
f53	5
.	6
0	6
)	0
during	0
the	0
first	0
three	0
months	0
following	0
childbirth	0
.	0

the	0
patient	0
carried	0
a	0
mutation	1
in	0
the	0
omim	3
gene	0
*	5
604302	6
,	0
resulting	0
in	0
the	0
diagnosis	0
of	0
fragile	1
x	2
syndrome	2
.	0

the	0
analysis	0
included	0
patients	0
with	0
acute	1
myocardial	2
infarction	2
(	0
ami	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
i21	5
.	0

cases	0
of	0
patients	0
with	0
ankylosing	1
spondylitis	2
were	0
identified	0
with	0
the	0
icd	3
-	4
10	4
code	0
m45	5
.	0

participants	0
included	0
in	0
the	0
research	0
had	0
a	0
diagnosis	0
of	0
graves	1
'	2
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	6
0	6
.	0

the	0
patient	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
generalized	1
anxiety	2
disorder	2
and	0
was	0
assigned	0
a	0
code	0
of	0
f41	5
.	6
1	6
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
glioblastoma	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
c71	5
.	6
0	6
.	0

the	0
patient	0
exhibited	0
symptoms	0
consistent	0
with	0
primary	1
hypertension	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
i10	5
.	0

individuals	0
suffering	0
from	0
amyotrophic	1
lateral	2
sclerosis	2
(	2
als	2
)	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g12	5
.	6
2	6
.	0

the	0
medical	0
records	0
of	0
patients	0
with	0
glioblastoma	1
were	0
evaluated	0
using	0
the	0
icd	3
-	4
10	4
code	0
c71	5
.	6
0	6
.	0

we	0
observed	0
a	0
high	0
rate	0
of	0
comorbidity	0
between	0
generalized	1
anxiety	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
02	6
)	0
and	0
major	1
depressive	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
3	6
)	0
in	0
our	0
sample	0
.	0

the	0
study	0
included	0
patients	0
with	0
psoriasis	1
who	0
were	0
assigned	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	0

the	0
research	0
included	0
patients	0
diagnosed	0
with	0
chronic	1
kidney	2
disease	2
(	2
ckd	2
)	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	0

we	0
included	0
patients	0
with	0
a	0
history	0
of	0
lupus	1
nephritis	2
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
583	5
.	6
81	6
.	0

the	0
subject	0
was	0
diagnosed	0
with	0
obsessive	1
-	2
compulsive	2
disorder	2
(	0
ocd	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
f42	5
in	0
the	0
psychiatric	0
assessment	0
.	0

the	0
alcohol	1
use	2
disorder	2
cases	0
in	0
this	0
cohort	0
were	0
identified	0
using	0
the	0
dsm	3
-	4
5	4
code	0
303	5
.	6
90	6
.	0

a	0
study	0
was	0
conducted	0
on	0
the	0
prevalence	0
of	0
klinefelter	1
syndrome	2
in	0
males	0
,	0
with	0
a	0
respective	0
karyotype	0
represented	0
as	0
iscn	3
code	0
47	5
,	6
xxy	6
.	0

we	0
included	0
437	0
patients	0
diagnosed	0
with	0
stage	0
i	0
-	0
iii	0
melanoma	1
(	0
icd	3
-	4
10	4
code	0
c43	5
)	0
who	0
underwent	0
sentinel	0
lymph	0
node	0
biopsy	0
.	0

using	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
555	5
)	0
or	0
ulcerative	1
colitis	2
(	0
556	5
)	0
.	0

in	0
this	0
case	0
report	0
,	0
we	0
describe	0
a	0
patient	0
with	0
a	0
rare	0
chromosomal	1
deletion	2
at	0
22q11	0
.	0
2	0
(	0
iscn	3
code	0
del	5
(	6
22	6
)	6
(	6
q11	6
.	6
2	6
)	6
)	0
and	0
its	0
associated	0
phenotypes	0
,	0
including	0
intellectual	1
disability	2
and	0
congenital	1
heart	2
defect	2
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
asthma	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
j45	5
.	0

we	0
included	0
patients	0
with	0
a	0
icd	3
-	4
10	4
code	0
of	0
e03	5
.	6
9	6
for	0
hypothyroidism	1
in	0
our	0
study	0
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
acute	1
lymphoblastic	2
leukemia	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
204	5
.	6
0	6
and	0
the	0
icd	3
-	4
10	4
code	0
c91	5
.	6
0	6
.	0

the	0
irritable	1
bowel	2
syndrome	2
group	0
included	0
200	0
patients	0
who	0
met	0
the	0
icd	3
-	4
10	4
diagnostic	0
criteria	0
(	0
code	0
k58	5
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
otitis	1
media	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
h66	5
.	0

we	0
analyzed	0
genetic	0
variations	0
in	0
patients	0
with	0
congenital	1
long	2
qt	2
syndrome	2
by	0
screening	0
for	0
specific	0
disease	0
-	0
causing	0
gene	0
mutations	0
in	0
the	0
omim	3
database	0
(	0
e	0
.	0
g	0
.	0
,	0
kcnq1	0
,	0
*	5
607542	6
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
psoriasis	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	0

the	0
incidence	0
of	0
acute	1
myocardial	2
infarction	2
(	0
defined	0
by	0
icd	3
-	4
10	4
-	4
cm	4
code	0
i21	5
)	0
was	0
higher	0
among	0
patients	0
with	0
a	0
diagnosis	0
of	0
type	1
2	2
diabetes	2
mellitus	2
.	0

a	0
total	0
of	0
622	0
patients	0
diagnosed	0
with	0
mitral	1
valve	2
prolapse	2
(	0
icd	3
-	4
10	4
code	0
i34	5
.	6
0	6
)	0
were	0
included	0
in	0
the	0
study	0
.	0

patients	0
presenting	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
icd	3
-	4
10	4
code	0
j44	5
)	0
were	0
included	0
in	0
the	0
analysis	0
.	0

this	0
study	0
found	0
a	0
significant	0
relationship	0
between	0
a	0
family	0
history	0
of	0
schizophrenia	1
(	0
icd	3
-	4
9	4
code	0
295	5
)	0
and	0
increased	0
risk	0
for	0
developing	0
the	0
disorder	0
.	0

the	0
primary	0
outcome	0
measure	0
was	0
the	0
incidence	0
of	0
drug	1
-	2
induced	2
liver	2
injury	2
(	0
defined	0
by	0
the	0
meddra	3
coding	0
system	0
as	0
10013791	5
)	0
.	0

a	0
mutation	0
in	0
the	0
pex1	1
gene	0
(	0
omim	3
code	0
602136	5
)	0
is	0
associated	0
with	0
zellweger	1
syndrome	2
,	0
a	0
severe	0
peroxisomal	0
disorder	0
.	0

genetic	0
testing	0
revealed	0
a	0
mutation	0
in	0
the	0
lmna	1
gene	0
(	0
omim	3
code	0
608081	5
)	0
associated	0
with	0
type	1
2	2
charcot	2
-	2
marie	2
-	2
tooth	2
disease	2
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
chronic	1
liver	2
disease	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k70	5
-	6
k77	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
vertebral	1
compression	2
fracture	2
indicated	0
by	0
the	0
icd	3
-	4
10	4
code	0
s22	5
.	6
0	6
.	0

this	0
study	0
included	0
351	0
patients	0
diagnosed	0
with	0
testicular	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c62	5
)	0
who	0
underwent	0
chemotherapy	0
treatment	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
hepatitis	2
b	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
b18	5
.	6
1	6
.	0

we	0
investigated	0
the	0
association	0
between	0
chronic	1
fatigue	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
g93	5
.	6
3	6
)	0
and	0
mental	0
health	0
outcomes	0
in	0
adolescents	0
.	0

we	0
observed	0
an	0
increased	0
risk	0
of	0
listeriosis	1
in	0
the	0
study	0
area	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
a32	5
.	0

during	0
our	0
study	0
,	0
we	0
encountered	0
several	0
cases	0
of	0
parkinson	1
'	2
s	2
disease	2
with	0
the	0
icd	3
-	4
10	4
code	0
g20	5
.	0

patients	0
diagnosed	0
with	0
primary	1
biliary	2
cholangitis	2
based	0
on	0
the	0
icd	3
-	4
11	4
code	0
5a20	5
were	0
included	0
in	0
the	0
analysis	0
.	0

we	0
identified	0
patients	0
with	0
chronic	1
pancreatitis	2
using	0
the	0
icd	3
-	4
10	4
code	0
k86	5
.	6
1	6
for	0
this	0
study	0
.	0

clinical	0
diagnosis	0
of	0
schizophrenia	1
was	0
based	0
on	0
the	0
dsm	3
-	4
iv	4
diagnostic	0
criteria	0
with	0
the	0
corresponding	0
icd	3
-	4
10	4
code	0
f20	5
.	0

we	0
investigated	0
the	0
prevalence	0
of	0
acute	1
otitis	2
media	2
among	0
children	0
using	0
the	0
icd	3
-	4
10	4
code	0
h65	5
.	0

the	0
patient	0
'	0
s	0
symptoms	0
were	0
consistent	0
with	0
depersonalization	1
-	2
derealization	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
6	6
)	0
.	0

the	0
mitral	1
valve	2
prolapse	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
i34	5
.	6
0	6
.	0

cases	0
of	0
cystic	1
fibrosis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
e84	5
and	0
included	0
in	0
the	0
analysis	0
.	0

the	0
patient	0
exhibited	0
symptoms	0
consistent	0
with	0
delusional	1
disorder	2
(	0
icd	3
-	4
10	4
code	0
f22	5
)	0
.	0

a	0
genetic	0
variant	0
in	0
the	0
abo	1
gene	0
(	0
omim	3
code	0
110300	5
)	0
has	0
been	0
associated	0
with	0
blood	1
type	2
incompatibilities	2
between	0
a	0
mother	0
and	0
fetus	0
.	0
the	0
patient	0
was	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
10	4
code	0
e11	5
)	0
and	0
hypertension	1
(	0
i10	5
)	0
in	0
the	0
past	0
year	0
.	0

the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
for	0
premature	1
ovarian	2
failure	2
is	0
256	5
.	6
3	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
autism	1
spectrum	2
disorder	2
using	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
and	0
corresponding	0
icd	3
-	4
10	4
code	0
f84	5
.	6
0	6
.	0

patients	0
diagnosed	0
with	0
nephrotic	1
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
n04	5
.	0

the	0
clinical	0
data	0
reveal	0
a	0
high	0
prevalence	0
of	0
bronchiectasis	1
among	0
the	0
population	0
,	0
coded	0
as	0
j47	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
patient	0
'	0
s	0
ankylosing	1
spondylitis	2
diagnosis	0
was	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m45	5
.	6
0	6
.	0

patients	0
diagnosed	0
with	0
psoriasis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	0

the	0
participants	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
turner	1
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
q96	5
.	0

we	0
examined	0
patients	0
with	0
a	0
history	0
of	0
primary	1
sclerosing	2
cholangitis	2
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
576	5
.	6
1	6
.	0

the	0
study	0
included	0
200	0
patients	0
with	0
a	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
(	0
icd	3
-	4
10	4
code	0
m35	5
.	6
0	6
)	0
who	0
were	0
followed	0
up	0
for	0
10	0
years	0
.	0

patients	0
with	0
idiopathic	1
pulmonary	2
fibrosis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
.	0

participants	0
in	0
this	0
clinical	0
trial	0
had	0
a	0
diagnosis	0
of	0
nephrotic	1
syndrome	2
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
581	5
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
eosinophilic	1
gastroenteritis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
k52	5
.	6
89	6
.	0

the	0
study	0
population	0
included	0
500	0
patients	0
diagnosed	0
with	0
thyroid	1
cancer	2
(	0
icd	3
-	4
10	4
codes	0
c73	5
,	0
d09	5
.	6
3	6
,	0
and	0
d34	5
)	0
.	0

patients	0
with	0
acute	1
myeloid	2
leukemia	2
(	0
icd	3
-	4
10	4
code	0
c92	5
)	0
who	0
achieved	0
complete	0
remission	0
were	0
included	0
in	0
this	0
retrospective	0
cohort	0
study	0
.	0

we	0
studied	0
a	0
cohort	0
of	0
patients	0
diagnosed	0
with	0
parkinson	1
'	2
s	2
disease	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g20	5
.	0

we	0
analyzed	0
568	0
patients	0
diagnosed	0
with	0
stage	0
i	0
-	0
iii	0
pancreatic	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c25	5
)	0
and	0
pancreatic	0
neuroendocrine	0
tumors	0
(	0
code	0
c25	5
.	6
4	6
)	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
prevalence	0
of	0
irritable	1
bowel	2
syndrome	2
among	0
the	0
general	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
k58	5
.	0

the	0
cardiomyopathy	1
group	0
included	0
218	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
dilated	0
cardiomyopathy	0
(	0
icd	3
-	4
10	4
code	0
i42	5
.	6
0	6
)	0
or	0
hypertrophic	0
cardiomyopathy	0
(	0
code	0
i42	5
.	6
1	6
)	0
.	0

the	0
study	0
included	0
subjects	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
amyotrophic	1
lateral	2
sclerosis	2
using	0
icd	3
-	4
10	4
code	0
g12	5
.	6
2	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
pulmonary	1
embolism	2
with	0
the	0
icd	3
-	4
10	4
code	0
i26	5
.	0

genetic	0
analysis	0
confirmed	0
the	0
presence	0
of	0
a	0
mutation	1
in	0
the	0
neb	3
gene	4
(	0
*	5
161650	6
)	0
,	0
leading	0
to	0
the	0
diagnosis	0
of	0
nemaline	1
myopathy	2
.	0

the	0
primary	0
endpoint	0
was	0
the	0
incidence	0
of	0
cardiomyopathy	1
identified	0
by	0
the	0
icd	3
-	4
9	4
code	0
425	5
.	6
4	6
among	0
the	0
treated	0
and	0
untreated	0
cohorts	0
.	0

among	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
primary	1
sclerosing	2
cholangitis	2
(	0
icd	3
-	4
9	4
-	4
cm	4
code	0
576	5
.	6
1	6
and	0
icd	3
-	4
10	4
code	0
k83	5
.	6
01	6
)	0
,	0
we	0
examined	0
the	0
frequency	0
of	0
concurrent	0
inflammatory	1
bowel	2
disease	2
(	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
555	5
and	0
556	5
)	0
.	0

the	0
prevalence	0
of	0
idiopathic	1
thrombocytopenic	2
purpura	2
(	2
itp	2
)	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
d69	5
.	6
3	6
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
diagnosis	0
of	0
psoriasis	1
according	0
to	0
the	0
pasi	3
score	0
and	0
icd	3
-	4
10	4
code	0
l40	5
.	0

patients	0
with	0
prostate	1
cancer	2
often	0
have	0
elevated	0
levels	0
of	0
prostate	0
-	0
specific	0
antigen	0
(	0
psa	0
)	0
according	0
to	0
the	0
loinc	3
code	0
10839	5
-	6
9	6
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
osteoarthritis	1
according	0
to	0
the	0
acr	3
criteria	0
and	0
icd	3
-	4
10	4
code	0
m15	5
-	6
m19	6
were	0
included	0
in	0
the	0
analysis	0
.	0

the	0
prevalence	0
of	0
ankylosing	1
spondylitis	2
in	0
our	0
cohort	0
was	0
determined	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
720	5
.	0

in	0
this	0
analysis	0
,	0
we	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
peripheral	1
neuropathy	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
g62	5
.	6
9	6
.	0

a	0
mutation	0
in	0
the	0
tsc1	1
gene	0
(	0
omim	3
code	0
605284	5
)	0
is	0
associated	0
with	0
tuberous	1
sclerosis	2
complex	2
.	0

in	0
this	0
research	0
,	0
the	0
subjects	0
had	0
a	0
diagnosis	0
of	0
wilson	1
'	2
s	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e83	5
.	6
0	6
.	0

the	0
patient	0
'	0
s	0
migraine	1
episodes	0
met	0
the	0
diagnostic	0
criteria	0
outlined	0
in	0
the	0
icd	3
-	4
10	4
and	0
were	0
assigned	0
a	0
code	0
of	0
g43	5
.	0

the	0
clinical	0
data	0
reveal	0
a	0
high	0
prevalence	0
of	0
meningitis	1
among	0
the	0
population	0
,	0
coded	0
as	0
g00	5
-	6
g03	6
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
chronic	1
kidney	2
disease	2
stage	2
4	2
(	0
icd	3
-	4
10	4
code	0
n18	5
.	6
4	6
)	0
based	0
on	0
medical	0
record	0
review	0
.	0

the	0
snomed	3
ct	4
code	0
53741008	5
is	0
associated	0
with	0
the	0
pancreatitis	1
phenotype	0
.	0

participants	0
with	0
a	0
history	0
of	0
obsessive	1
-	2
compulsive	2
personality	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
301	5
.	6
4	6
)	0
were	0
excluded	0
from	0
the	0
study	0
.	0

in	0
this	0
trial	0
,	0
participants	0
were	0
diagnosed	0
with	0
multiple	1
myeloma	2
using	0
the	0
icd	3
-	4
10	4
code	0
c90	5
.	6
0	6
.	0

this	0
study	0
included	0
patients	0
diagnosed	0
with	0
pyoderma	1
gangrenosum	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l88	5
.	0

in	0
this	0
cohort	0
,	0
we	0
included	0
individuals	0
with	0
a	0
diagnosis	0
of	0
peripheral	1
artery	2
disease	2
(	0
pad	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
i73	5
.	6
9	6
.	0

multiple	0
cases	0
of	0
schizophrenia	1
were	0
identified	0
using	0
the	0
dsm	3
-	4
iv	4
-	4
tr	4
code	0
295	5
.	6
90	6
.	0

in	0
this	0
analysis	0
,	0
children	0
had	0
a	0
diagnosis	0
of	0
developmental	1
dysplasia	2
of	2
the	2
hip	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
q65	5
.	0

the	0
research	0
included	0
patients	0
diagnosed	0
with	0
polycystic	1
ovary	2
syndrome	2
(	2
pcos	2
)	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
.	0

in	0
our	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
gestational	1
hypertension	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
o13	5
.	0

the	0
sjogren	1
'	2
s	2
syndrome	2
phenotype	0
was	0
diagnosed	0
in	0
patients	0
with	0
the	0
icd	3
-	4
10	4
code	0
m35	5
.	6
0	6
.	0

the	0
study	0
assessed	0
individuals	0
suffering	0
from	0
bulimia	1
nervosa	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
f50	5
.	6
2	6
.	0

the	0
study	0
focused	0
on	0
individuals	0
suffering	0
from	0
type	1
1	2
diabetes	2
mellitus	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e10	5
.	0

genetic	0
testing	0
identified	0
a	0
mutation	0
in	0
the	0
brca2	1
gene	0
(	0
omim	3
code	0
600185	5
)	0
associated	0
with	0
ovarian	1
cancer	2
.	0

we	0
identified	0
a	0
significant	0
number	0
of	0
cases	0
with	0
asthma	1
coded	0
as	0
j45	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

participants	0
in	0
this	0
clinical	0
trial	0
had	0
a	0
diagnosis	0
of	0
prader	1
-	2
willi	2
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
q87	5
.	6
1	6
.	0

we	0
investigated	0
the	0
association	0
between	0
obstructive	1
sleep	2
apnea	2
(	0
icd	3
-	4
10	4
code	0
g47	5
.	6
30	6
)	0
and	0
cognitive	0
decline	0
in	0
elderly	0
patients	0
.	0

the	0
karyotyping	0
analysis	0
indicated	0
a	0
chromosomal	1
abnormality	2
in	0
the	0
form	0
of	0
a	0
iscn	3
code	0
47	5
,	6
xx	6
,	6
+	6
21	6
,	0
leading	0
to	0
the	0
diagnosis	0
of	0
down	1
syndrome	2
.	0

the	0
patient	0
exhibited	0
symptoms	0
consistent	0
with	0
acute	1
stress	2
disorder	2
(	0
icd	3
-	4
11	4
code	0
6b40	5
)	0
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
allergic	1
rhinitis	2
(	0
icd	3
-	4
10	4
code	0
j30	5
)	0
.	0

all	0
patients	0
diagnosed	0
with	0
bipolar	1
disorder	2
were	0
identified	0
based	0
on	0
relevant	0
icd	3
-	4
10	4
codes	0
f31	5
.	6
0	6
to	0
f31	5
.	6
9	6
.	0

a	0
history	0
of	0
breast	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c50	5
)	0
was	0
found	0
in	0
12	0
%	0
of	0
patients	0
using	0
hormone	0
replacement	0
therapy	0
.	0

we	0
analyzed	0
data	0
from	0
727	0
patients	0
with	0
primary	1
biliary	2
cholangitis	2
(	0
icd	3
-	4
10	4
code	0
k74	5
.	6
3	6
)	0
who	0
underwent	0
liver	0
transplantation	0
.	0

the	0
patient	0
demographic	0
consisted	0
of	0
individuals	0
with	0
a	0
clinical	0
diagnosis	0
of	0
obsessive	1
-	2
compulsive	2
disorder	2
according	0
to	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
3	6
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
according	0
to	0
icd	3
-	4
10	4
code	0
m05	5
.	0

a	0
significant	0
number	0
of	0
cases	0
with	0
anemia	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
d64	5
.	6
9	6
in	0
our	0
retrospective	0
data	0
analysis	0
.	0

the	0
cystic	1
fibrosis	2
phenotype	0
was	0
confirmed	0
in	0
patients	0
with	0
icd	3
-	4
9	4
code	0
277	5
.	6
00	6
or	0
icd	3
-	4
10	4
code	0
e84	5
.	0

we	0
examined	0
the	0
mental	0
health	0
records	0
of	0
patients	0
diagnosed	0
with	0
post	1
-	2
traumatic	2
stress	2
disorder	2
using	0
the	0
dsm	3
-	4
5	4
code	0
309	5
.	6
81	6
.	0

this	0
study	0
focused	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
based	0
on	0
the	0
icsd	3
-	4
3	4
criteria	0
and	0
icd	3
-	4
11	4
code	0
7a21	5
.	0

out	0
of	0
1	0
,	0
200	0
patients	0
,	0
112	0
had	0
a	0
diagnosis	0
of	0
osteoarthritis	1
of	0
the	0
knee	0
(	0
icd	3
-	4
10	4
code	0
m17	5
)	0
.	0

the	0
study	0
included	0
320	0
patients	0
with	0
a	0
diagnosis	0
of	0
osteoporosis	1
(	0
icd	3
-	4
10	4
code	0
m81	5
)	0
and	0
at	0
least	0
one	0
previous	0
fracture	0
.	0

all	0
participants	0
were	0
diagnosed	0
with	0
ankylosing	1
spondylitis	2
based	0
on	0
the	0
modified	0
new	0
york	0
criteria	0
and	0
had	0
relevant	0
icd	3
-	4
10	4
code	0
m45	5
.	0

genetic	0
testing	0
and	0
karyotyping	0
results	0
revealed	0
a	0
47	1
,	2
xxx	2
karyotype	2
in	0
the	0
patient	0
,	0
leading	0
to	0
the	0
diagnosis	0
of	0
triple	1
x	2
syndrome	2
(	0
iscn	3
code	0
47	5
,	6
xxx	6
)	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
tuberculosis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
a15	5
.	0

a	0
mutation	0
in	0
the	0
wfs1	1
gene	0
(	0
omim	3
code	0
606201	5
)	0
is	0
associated	0
with	0
wolfram	1
syndrome	2
,	0
a	0
rare	0
autosomal	0
recessive	0
disorder	0
.	0

the	0
study	0
assessed	0
individuals	0
with	0
turner	1
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
q96	5
.	0

in	0
this	0
study	0
,	0
subjects	0
were	0
diagnosed	0
with	0
idiopathic	1
thrombocytopenic	2
purpura	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d69	5
.	6
3	6
.	0

a	0
mutation	0
in	0
the	0
prnp	1
gene	0
(	0
omim	3
code	0
176640	5
)	0
is	0
associated	0
with	0
creutzfeldt	1
-	2
jakob	2
disease	2
,	0
a	0
rare	0
,	0
rapidly	0
progressive	0
neurodegenerative	0
disorder	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
cerebrovascular	1
disease	2
(	0
icd	3
-	4
10	4
codes	0
i60	5
–	6
i69	6
)	0
were	0
included	0
in	0
this	0
observational	0
study	0
.	0

patients	0
were	0
eligible	0
for	0
the	0
trial	0
if	0
they	0
had	0
a	0
diagnosis	0
of	0
idiopathic	1
pulmonary	2
fibrosis	2
corresponding	0
to	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
.	0

we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
pulmonary	1
sarcoidosis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d86	5
.	6
0	6
.	0

the	0
study	0
focused	0
on	0
individuals	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	2
dvt	2
)	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
i82	5
.	0

we	0
observed	0
a	0
significant	0
number	0
of	0
lung	1
cancer	2
cases	0
coded	0
as	0
c34	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

in	0
this	0
study	0
,	0
participants	0
were	0
diagnosed	0
with	0
lyme	1
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
a69	5
.	6
20	6
.	0

the	0
hospital	0
reported	0
an	0
increase	0
in	0
pediatric	1
pneumonia	2
cases	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
code	0
j18	5
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
alzheimer	1
'	2
s	2
disease	2
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
331	5
.	6
0	6
.	0

the	0
patient	0
presented	0
with	0
chronic	1
hepatitis	2
b	2
,	0
which	0
was	0
coded	0
as	0
icd	3
-	4
10	4
code	0
b18	5
.	6
1	6
in	0
the	0
medical	0
record	0
.	0

participants	0
in	0
this	0
trial	0
had	0
a	0
primary	0
diagnosis	0
of	0
multiple	1
sclerosis	2
based	0
on	0
the	0
mcdonald	0
criteria	0
and	0
icd	3
-	4
10	4
code	0
g35	5
.	0

cases	0
of	0
cerebral	1
palsy	2
were	0
identified	0
using	0
the	0
snomed	3
ct	4
code	0
1281000119103	5
.	0

all	0
patients	0
were	0
diagnosed	0
with	0
congenital	1
heart	2
disease	2
using	0
the	0
international	3
paediatric	4
and	4
congenital	4
cardiac	4
code	4
(	0
ipccc	0
)	0
coding	0
system	0
.	0

patients	0
with	0
parkinson	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g20	5
)	0
were	0
significantly	0
more	0
likely	0
to	0
develop	0
dementia	1
during	0
the	0
follow	0
-	0
up	0
period	0
.	0

patients	0
diagnosed	0
with	0
hemochromatosis	1
carry	0
the	0
icd	3
-	4
10	4
code	0
e83	5
.	6
11	6
.	0

the	0
prevalence	0
of	0
specific	1
phobia	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
29	6
)	0
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
first	0
responders	0
compared	0
to	0
the	0
general	0
population	0
.	0

patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
autism	1
spectrum	2
disorder	2
(	0
icd	3
-	4
10	4
codes	0
f84	5
.	6
0	6
to	0
f84	5
.	6
9	6
)	0
were	0
included	0
in	0
the	0
targeted	0
intervention	0
program	0
.	0

we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
hereditary	1
hemorrhagic	2
telangiectasia	2
(	0
hht	0
)	0
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
448	5
.	6
0	6
.	0

the	0
study	0
population	0
included	0
patients	0
diagnosed	0
with	0
primary	1
biliary	2
cholangitis	2
(	0
pbc	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k74	5
.	6
3	6
.	0

the	0
patients	0
in	0
our	0
study	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
gout	1
using	0
the	0
icd	3
-	4
10	4
code	0
m10	5
.	0

the	0
osteoarthritis	1
phenotype	0
was	0
linked	0
to	0
the	0
icd	3
-	4
10	4
code	0
m15	5
-	6
m19	6
.	0

the	0
study	0
focused	0
on	0
patients	0
with	0
hemophilia	1
a	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d66	5
.	0

the	0
diagnosis	0
of	0
niemann	1
-	2
pick	2
disease	2
was	0
confirmed	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
272	5
.	6
7	6
and	0
corresponding	0
clinical	0
documentation	0
.	0

the	0
study	0
focused	0
on	0
individuals	0
diagnosed	0
with	0
autism	1
spectrum	2
disorder	2
(	0
dsm	3
-	4
5	4
codes	0
299	5
.	6
00	6
and	0
299	5
.	6
10	6
)	0
and	0
assessed	0
their	0
cognitive	0
abilities	0
.	0

the	0
patient	0
met	0
the	0
diagnostic	0
criteria	0
for	0
schizophrenia	1
according	0
to	0
the	0
dsm	3
-	4
5	4
code	0
295	5
.	6
90	6
.	0

we	0
analyzed	0
the	0
genetic	0
components	0
of	0
hemophilia	1
in	0
patients	0
diagnosed	0
with	0
the	0
icd	3
-	4
10	4
code	0
d66	5
-	6
d67	6
.	0

the	0
prevalence	0
of	0
systemic	1
lupus	2
erythematosus	2
(	2
sle	2
)	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	0

the	0
diagnosis	0
of	0
eosinophilic	1
granulomatosis	2
with	2
polyangiitis	2
(	0
egpa	0
)	0
was	0
made	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m30	5
.	6
1	6
.	0

the	0
research	0
included	0
patients	0
suffering	0
from	0
non	1
-	2
alcoholic	2
fatty	2
liver	2
disease	2
(	2
nafld	2
)	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k76	5
.	6
0	6
.	0

the	0
diagnosis	0
of	0
muscular	1
dystrophy	2
was	0
confirmed	0
using	0
the	0
icd	3
-	4
10	4
code	0
g71	5
.	6
0	6
.	0

a	0
total	0
of	0
126	0
patients	0
were	0
diagnosed	0
with	0
type	1
1	2
diabetes	2
(	0
icd	3
-	4
10	4
code	0
e10	5
)	0
and	0
174	0
patients	0
had	0
type	1
2	2
diabetes	2
(	0
e11	5
)	0
in	0
this	0
study	0
.	0

patients	0
with	0
a	0
history	0
of	0
hypertension	1
were	0
identified	0
by	0
the	0
icd	3
-	4
10	4
code	0
i10	5
and	0
included	0
in	0
the	0
study	0
.	0

children	0
with	0
a	0
primary	0
diagnosis	0
of	0
conduct	1
disorder	2
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
312	5
.	6
81	6
were	0
included	0
in	0
this	0
study	0
.	0

the	0
omim	3
code	0
170600	5
corresponds	0
to	0
the	0
381	1
pfeiffer	2
syndrome	2
phenotype	0
.	0

we	0
analyzed	0
120	0
patients	0
with	0
breast	1
cancer	2
using	0
the	0
c50	5
code	0
from	0
the	0
icd	3
-	4
10	4
coding	0
system	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
hereditary	1
hemorrhagic	2
telangiectasia	2
(	0
hht	0
)	0
,	0
according	0
to	0
the	0
omim	3
code	0
187300	5
.	0

the	0
patients	0
included	0
in	0
our	0
study	0
had	0
a	0
diagnosis	0
of	0
hemochromatosis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
e83	5
.	6
11	6
.	0

patients	0
presenting	0
with	0
major	1
depressive	2
disorder	2
were	0
classified	0
according	0
to	0
the	0
dsm	3
-	4
5	4
code	0
296	5
.	6
2	6
and	0
offered	0
antidepressant	0
medication	0
or	0
psychotherapy	0
.	0

the	0
prevalence	0
of	0
myocardial	1
infarction	2
(	2
mi	2
)	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
i21	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
encopresis	1
(	0
icd	3
-	4
10	4
code	0
f98	5
.	6
1	6
)	0
and	0
was	0
referred	0
for	0
further	0
evaluation	0
and	0
treatment	0
planning	0
.	0
the	0
patient	0
was	0
diagnosed	0
with	0
migraine	1
without	2
aura	2
(	0
icd	3
-	4
10	4
code	0
g43	5
.	6
0	6
)	0
based	0
on	0
the	0
clinical	0
presentation	0
and	0
medical	0
history	0
.	0

the	0
study	0
focused	0
on	0
patients	0
with	0
a	0
history	0
of	0
myocardial	1
infarction	2
(	0
icd	3
-	4
10	4
code	0
i21	5
)	0
.	0

the	0
patient	0
exhibited	0
signs	0
of	0
iron	1
-	2
deficiency	2
anemia	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
d50	5
.	0

a	0
strong	0
association	0
was	0
observed	0
between	0
seasonal	1
affective	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
3x	6
)	0
and	0
geographic	0
latitude	0
.	0

we	0
identified	0
patients	0
with	0
hepatitis	1
c	2
using	0
the	0
icd	3
-	4
10	4
code	0
b18	5
.	6
2	6
for	0
further	0
analysis	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
primary	1
aldosteronism	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
e26	5
.	6
0	6
.	0

the	0
patient	0
cohort	0
consisted	0
of	0
individuals	0
presenting	0
with	0
major	1
depressive	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
2x	6
)	0
and	0
generalized	1
anxiety	2
disorder	2
(	0
300	5
.	6
02	6
)	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
rectal	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
154	5
.	6
1	6
and	0
the	0
icd	3
-	4
10	4
code	0
c20	5
.	0

the	0
study	0
included	0
subjects	0
with	0
a	0
history	0
of	0
autism	1
spectrum	2
disorder	2
(	0
asd	0
)	0
as	0
evidenced	0
by	0
the	0
presence	0
of	0
icd	3
-	4
10	4
code	0
f84	5
or	0
snomed	3
ct	4
code	0
29900	5
.	0

the	0
study	0
assessed	0
individuals	0
suffering	0
from	0
creutzfeldt	1
-	2
jakob	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
a81	5
.	6
0	6
.	0

clinical	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
was	0
performed	0
using	0
the	0
icd	3
-	4
10	4
code	0
m45	5
and	0
the	0
modified	0
new	0
york	0
criteria	0
.	0

genetic	0
testing	0
revealed	0
a	0
mutation	1
in	0
the	0
omim	3
gene	0
*	5
156240	6
associated	0
with	0
crouzon	1
syndrome	2
.	0

the	0
study	0
included	0
patients	0
diagnosed	0
with	0
polycystic	1
ovary	2
syndrome	2
(	0
pcos	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
.	0

the	0
snomed	3
ct	4
code	0
48523006	5
corresponds	0
to	0
the	0
polycythemia	1
vera	2
phenotype	0
.	0

cases	0
of	0
myasthenia	1
gravis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g70	5
.	6
0	6
in	0
the	0
study	0
population	0
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
endometriosis	1
using	0
the	0
icd	3
-	4
10	4
code	0
n80	5
.	0

patients	0
with	0
oral	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
codes	0
c00	5
–	6
c06	6
and	0
followed	0
up	0
for	0
5	0
years	0
.	0

a	0
total	0
of	0
443	0
patients	0
diagnosed	0
with	0
severe	1
sepsis	2
(	0
icd	3
-	4
10	4
code	0
a41	5
.	6
9	6
)	0
and	0
septic	0
shock	0
(	0
code	0
r65	5
.	6
21	6
)	0
were	0
included	0
in	0
this	0
study	0
.	0

in	0
the	0
study	0
,	0
patients	0
were	0
diagnosed	0
with	0
pancreatitis	1
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
codes	0
k85	5
and	6
k86	6
.	0

the	0
prevalence	0
of	0
human	1
immunodeficiency	2
virus	2
(	2
hiv	2
)	2
infection	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
b20	5
-	6
b24	6
.	0

the	0
study	0
recruited	0
patients	0
with	0
multiple	1
sclerosis	2
(	0
ms	0
)	0
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
g35	5
.	0

participants	0
included	0
those	0
diagnosed	0
with	0
osteoarthritis	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
m15	5
-	6
m19	6
.	0

the	0
patient	0
was	0
prescribed	0
medication	0
for	0
their	0
anxiety	1
disorder	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
f41	5
.	0

the	0
prevalence	0
of	0
pancreatitis	1
was	0
determined	0
using	0
the	0
icd	3
-	4
9	4
code	0
577	5
.	6
0	6
and	0
the	0
icd	3
-	4
10	4
code	0
k85	5
.	0

patients	0
with	0
a	0
history	0
of	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
ptsd	0
)	0
were	0
identified	0
by	0
the	0
presence	0
of	0
icd	3
-	4
9	4
code	0
309	5
.	6
81	6
or	0
icd	3
-	4
10	4
code	0
f43	5
.	6
1	6
in	0
their	0
medical	0
records	0
.	0

the	0
study	0
population	0
included	0
those	0
diagnosed	0
with	0
chronic	1
kidney	2
disease	2
(	0
ckd	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	0

we	0
analyzed	0
data	0
from	0
200	0
participants	0
diagnosed	0
with	0
type	1
1	2
diabetes	2
mellitus	2
using	0
the	0
icd	3
-	4
10	4
code	0
e10	5
.	0

the	0
graves	1
'	2
disease	2
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	6
0	6
.	0

the	0
participants	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
polycystic	1
kidney	2
disease	2
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
753	5
.	6
1	6
.	0

the	0
parkinson	1
'	2
s	2
disease	2
cases	0
were	0
identified	0
using	0
the	0
g20	5
code	0
from	0
the	0
icd	3
-	4
10	4
classification	0
.	0

in	0
this	0
cross	0
-	0
sectional	0
study	0
,	0
296	0
participants	0
were	0
diagnosed	0
with	0
alcohol	1
dependence	2
(	0
dsm	3
-	4
5	4
code	0
303	5
.	6
90	6
)	0
and	0
150	0
participants	0
had	0
a	0
diagnosis	0
of	0
alcohol	1
abuse	2
(	0
code	0
305	5
.	6
00	6
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
williams	1
syndrome	2
after	0
detection	0
of	0
a	0
heterozygous	0
microdeletion	0
in	0
the	0
iscn	3
region	0
7q11	5
.	6
23	6
.	0

the	0
patient	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
somatization	1
disorder	2
,	0
assigned	0
a	0
code	0
of	0
f45	5
.	6
0	6
.	0

patients	0
in	0
our	0
research	0
were	0
diagnosed	0
with	0
restless	1
legs	2
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
g25	5
.	6
81	6
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
fibromyalgia	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
729	5
.	6
1	6
.	0

the	0
study	0
aimed	0
to	0
investigate	0
the	0
genetic	0
basis	0
of	0
becker	1
muscular	2
dystrophy	2
,	0
analyzing	0
the	0
omim	3
gene	0
*	5
300377	6
(	0
dmd	0
)	0
.	0

among	0
pregnant	0
women	0
,	0
the	0
prevalence	0
of	0
gestational	1
diabetes	2
mellitus	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
o24	5
.	6
4	6
.	0

we	0
observed	0
an	0
increased	0
risk	0
of	0
trigeminal	1
neuralgia	2
in	0
the	0
study	0
population	0
using	0
the	0
icd	3
-	4
10	4
code	0
g50	5
.	6
0	6
.	0
the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
diabetes	1
mellitus	2
type	2
2	2
(	0
icd	3
-	4
10	4
code	0
e11	5
)	0
and	0
was	0
being	0
treated	0
with	0
oral	0
hypoglycemic	0
agents	0
.	0

the	0
study	0
'	0
s	0
primary	0
objective	0
was	0
to	0
determine	0
the	0
prevalence	0
of	0
muscular	1
dystrophy	2
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
g71	5
.	6
0	6
.	0

the	0
ankylosing	1
spondylitis	2
phenotype	0
was	0
diagnosed	0
with	0
a	0
icd	3
-	4
10	4
code	0
m45	5
during	0
the	0
clinical	0
examination	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
cluster	1
headache	2
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
g44	5
.	6
0	6
.	0

the	0
study	0
assessed	0
individuals	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m05	5
.	0

patients	0
with	0
cerebral	1
palsy	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g80	5
for	0
further	0
evaluation	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
peripheral	1
neuropathy	2
and	0
assigned	0
the	0
icd	3
-	4
10	4
code	0
g62	5
.	6
9	6
.	0

we	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
acromegaly	1
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
253	5
.	6
0	6
and	0
the	0
icd	3
-	4
10	4
code	0
e22	5
.	6
0	6
.	0

the	0
study	0
assessed	0
individuals	0
suffering	0
from	0
avoidant	1
personality	2
disorder	2
according	0
to	0
the	0
dsm	3
-	4
5	4
code	0
301	5
.	6
82	6
.	0

the	0
study	0
assessed	0
patients	0
with	0
hepatitis	1
c	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
b18	5
.	6
2	6
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
congenital	1
adrenal	2
hyperplasia	2
(	0
icd	3
-	4
10	4
code	0
e25	5
.	6
0	6
)	0
were	0
included	0
in	0
our	0
analysis	0
.	0

the	0
tuberculosis	1
phenotype	0
was	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
a16	5
.	0

the	0
snomed	3
ct	4
code	0
73211009	5
corresponds	0
to	0
the	0
diabetic	1
retinopathy	2
phenotype	0
.	0

cases	0
of	0
patients	0
with	0
ulcerative	1
colitis	2
were	0
identified	0
with	0
the	0
icd	3
-	4
10	4
code	0
k51	5
.	0

the	0
cohort	0
included	0
50	0
patients	0
with	0
bipolar	1
i	2
disorder	2
(	0
dsm	3
-	4
iv	4
code	0
296	5
.	6
0	6
)	0
and	0
70	0
patients	0
with	0
bipolar	1
ii	2
disorder	2
(	0
code	0
296	5
.	6
89	6
)	0
.	0

a	0
mutation	0
in	0
the	0
lmna	1
gene	0
(	0
omim	3
code	0
150330	5
)	0
is	0
associated	0
with	0
hutchinson	1
-	2
gilford	2
progeria	2
syndrome	2
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
ear	1
infection	2
otitis	2
media	2
and	0
given	0
the	0
icd	3
-	4
10	4
code	0
h66	5
.	6
9	6
.	0

we	0
assessed	0
the	0
risk	0
of	0
psychiatric	0
comorbidities	0
such	0
as	0
avoidant	1
personality	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f60	5
.	6
6	6
)	0
in	0
patients	0
with	0
depressive	1
disorders	2
.	0

the	0
clinical	0
trial	0
included	0
participants	0
suffering	0
from	0
systemic	1
sclerosis	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m34	5
.	0

we	0
identified	0
patients	0
with	0
lupus	1
nephritis	2
using	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	6
14	6
in	0
this	0
study	0
.	0

children	0
carrying	0
the	0
diagnosis	0
of	0
intellectual	1
disability	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
codes	0
f70	5
(	0
mild	0
intellectual	0
disability	0
)	0
through	0
f79	5
(	0
unspecified	0
intellectual	0
disability	0
)	0
.	0

the	0
patient	0
was	0
found	0
to	0
have	0
asthma	1
(	0
icd	3
-	4
10	4
code	0
j45	5
)	0
and	0
allergic	1
rhinitis	2
(	0
j30	5
)	0
upon	0
evaluation	0
.	0

we	0
assessed	0
the	0
prevalence	0
of	0
hip	1
dysplasia	2
in	0
newborns	0
using	0
the	0
icd	3
-	4
10	4
code	0
q65	5
.	0

patients	0
with	0
"	1
warfarin	2
-	2
associated	2
had	2
higher	2
inr	2
values	2
and	2
heard	2
coding	2
system	2
icd	2
-	2
(	2
286	2
.	2
4	2
)	2
has	2
consequences	2
in	2
the	2
brain	2
frequently	2
.	2

the	0
patient	0
was	0
found	0
to	0
have	0
parkinson	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g20	5
)	0
and	0
dementia	1
(	0
f00	5
-	6
f03	6
)	0
during	0
the	0
neurological	0
evaluation	0
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
diagnosed	0
with	0
cyclothymic	1
disorder	2
based	0
on	0
the	0
dsm	3
-	4
iv	4
-	4
tr	4
code	0
301	5
.	6
13	6
.	0

we	0
included	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
202	5
and	0
the	0
icd	3
-	4
10	4
code	0
c85	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
major	1
depressive	2
disorder	2
(	0
mdd	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
296	5
.	6
3	6
or	0
icd	3
-	4
10	4
code	0
f32	5
.	0

our	0
research	0
revealed	0
a	0
high	0
prevalence	0
of	0
cataract	1
in	0
patients	0
with	0
icd	3
-	4
9	4
code	0
366	5
.	6
16	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
sod1	1
gene	0
(	0
omim	3
code	0
147450	5
)	0
has	0
been	0
linked	0
to	0
a	0
subset	0
of	0
patients	0
with	0
familial	1
amyotrophic	2
lateral	2
sclerosis	2
.	0

among	0
patients	0
with	0
alzheimer	1
'	2
s	2
disease	2
(	0
icd	3
-	4
10	4
code	0
g30	5
)	0
,	0
apolipoprotein	0
e	0
(	0
apoe	0
)	0
polymorphisms	0
were	0
genotyped	0
to	0
examine	0
genotype	0
-	0
phenotype	0
correlations	0
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000486	6
corresponds	0
to	0
the	0
ptosis	1
phenotype	0
.	0

patients	0
with	0
a	0
history	0
of	0
type	1
1	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
10	4
code	0
e10	5
)	0
or	0
type	1
2	2
diabetes	2
mellitus	2
(	0
e11	5
)	0
were	0
included	0
in	0
the	0
study	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
450	0
patients	0
with	0
a	0
history	0
of	0
stroke	1
(	0
icd	3
-	4
10	4
codes	0
i60	5
–	6
i64	6
)	0
were	0
compared	0
to	0
500	0
age	0
-	0
and	0
sex	0
-	0
matched	0
controls	0
without	0
history	0
of	0
stroke	0
.	0

we	0
estimated	0
the	0
incidence	0
of	0
hantavirus	1
infections	2
in	0
the	0
study	0
area	0
using	0
the	0
icd	3
-	4
10	4
code	0
a98	5
.	6
5	6
.	0

in	0
this	0
research	0
,	0
children	0
with	0
a	0
diagnosis	0
of	0
attention	1
-	2
deficit	2
/	2
hyperactivity	2
disorder	2
(	0
adhd	0
)	0
were	0
identified	0
using	0
the	0
dsm	3
-	4
5	4
code	0
314	5
.	0

the	0
diagnosis	0
of	0
atrial	1
fibrillation	2
(	0
i48	5
)	0
and	0
heart	1
failure	2
(	0
i50	5
)	0
was	0
made	0
using	0
the	0
icd	3
-	4
10	4
criteria	0
.	0

we	0
included	0
subjects	0
with	0
a	0
diagnosis	0
of	0
optic	1
neuritis	2
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
377	5
.	6
3	6
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
glomerulonephritis	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
n00	5
-	6
n08	6
.	0

children	0
suffering	0
from	0
autistic	1
disorder	2
were	0
identified	0
using	0
the	0
dsm	3
-	4
iv	4
code	0
299	5
.	6
00	6
.	0

the	0
icd	3
-	4
10	4
code	0
for	0
chronic	1
obstructive	2
pulmonary	2
disease	2
with	2
acute	2
exacerbation	2
is	0
j44	5
.	6
1	6
.	0

the	0
analysis	0
included	0
patients	0
with	0
rheumatoid	1
arthritis	2
labelled	0
with	0
snomed	3
ct	4
code	0
69896004	5
.	0

the	0
study	0
examined	0
the	0
prevalence	0
of	0
type	1
2	2
diabetes	2
mellitus	2
associated	0
with	0
the	0
snomed	3
ct	4
code	0
44054006	5
in	0
the	0
adult	0
population	0
.	0

the	0
affected	0
individual	0
presented	0
with	0
bardet	1
-	2
biedl	2
syndrome	2
(	0
omim	3
code	0
209900	5
)	0
,	0
a	0
rare	0
genetic	0
disorder	0
characterized	0
by	0
obesity	0
,	0
polydactyly	0
,	0
and	0
kidney	0
abnormalities	0
.	0

a	0
genetic	0
variant	0
in	0
the	0
abca1	1
gene	0
(	0
omim	3
code	0
600046	5
)	0
has	0
been	0
associated	0
with	0
tangier	1
disease	2
.	0

researchers	0
observed	0
a	0
significant	0
association	0
between	0
the	0
obstructive	1
sleep	2
apnea	2
phenotype	0
and	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
33	6
.	0

a	0
total	0
of	0
680	0
patients	0
with	0
ankylosing	1
spondylitis	2
(	0
icd	3
-	4
10	4
code	0
m45	5
)	0
were	0
included	0
in	0
a	0
nationwide	0
registry	0
.	0

we	0
included	0
patients	0
with	0
a	0
snomed	3
ct	4
code	0
of	0
45913009	5
for	0
stroke	1
in	0
our	0
study	0
cohort	0
.	0

the	0
prevalence	0
of	0
thrombotic	1
thrombocytopenic	2
purpura	2
in	0
the	0
surveyed	0
population	0
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
m31	5
.	6
1	6
.	0

the	0
hpo	3
code	0
hp	5
:	6
0001943	6
is	0
linked	0
to	0
the	0
fever	1
phenotype	0
.	0

cases	0
of	0
glioma	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c71	5
.	6
0	6
and	0
included	0
in	0
the	0
study	0
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
osteoporosis	1
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
733	5
.	0

our	0
study	0
sample	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
using	0
a	0
classification	0
system	0
code	0
(	0
078	0
.	0
49	0
)	0
congestive	0
heart	0
failure	0
,	0
not	0
otherwise	0
specified	0
;	0
right	0
failure	0
secondary	0
to	0
left	0
heart	0
failure	0
.	0

in	0
this	0
study	0
,	0
we	0
focused	0
on	0
venous	1
thromboembolism	2
(	0
i26	5
for	0
pulmonary	0
embolism	0
and	0
i80	5
for	0
deep	0
vein	0
thrombosis	0
)	0
using	0
the	0
icd	3
-	4
10	4
classification	0
system	0
.	0

in	0
this	0
survey	0
,	0
we	0
investigated	0
the	0
prevalence	0
of	0
major	1
depressive	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
2	6
)	0
among	0
medical	0
students	0
.	0

a	0
mutation	0
in	0
the	0
ush2a	1
gene	0
(	0
omim	3
code	0
608400	5
)	0
is	0
a	0
major	0
cause	0
of	0
usher	1
syndrome	2
type	2
ii	2
.	0

the	0
glioblastoma	1
phenotype	0
was	0
associated	0
with	0
the	0
snomed	3
ct	4
code	0
254817007	5
.	0

participants	0
in	0
this	0
trial	0
were	0
required	0
to	0
have	0
a	0
primary	0
diagnosis	0
of	0
parkinson	1
'	2
s	2
disease	2
according	0
to	0
icd	3
-	4
11	4
code	0
8a60	5
.	0

the	0
hpo	3
code	0
hp	5
:	6
0012740	6
represents	0
the	0
phenotype	0
of	0
autism	1
spectrum	2
disorder	2
.	0

the	0
trisomy	1
18	2
condition	0
was	0
confirmed	0
by	0
the	0
identification	0
of	0
an	0
additional	0
chromosome	0
18	0
in	0
the	0
patient	0
(	0
iscn	3
code	0
47	5
,	6
xx	6
,	6
+	6
18	6
)	0
,	0
which	0
is	0
also	0
known	0
as	0
edwards	1
syndrome	2
.	0

we	0
included	0
patients	0
with	0
a	0
snomed	3
ct	4
code	0
of	0
49436004	5
for	0
acute	1
myocardial	2
infarction	2
in	0
our	0
analysis	0
.	0

the	0
duchenne	1
muscular	2
dystrophy	2
cases	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g71	5
.	6
0	6
in	0
this	0
cohort	0
.	0

the	0
study	0
investigated	0
patients	0
with	0
osteoarthritis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m15	5
.	0

patients	0
were	0
included	0
in	0
the	0
study	0
if	0
they	0
had	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
10	4
code	0
c90	5
)	0
and	0
had	0
received	0
at	0
least	0
three	0
lines	0
of	0
therapy	0
.	0

a	0
total	0
of	0
428	0
patients	0
diagnosed	0
with	0
stage	0
ii	0
-	0
iii	0
breast	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c50	5
)	0
were	0
included	0
in	0
this	0
study	0
.	0

a	0
total	0
of	0
686	0
patients	0
with	0
cerebral	1
palsy	2
(	0
icd	3
-	4
10	4
code	0
g80	5
)	0
were	0
included	0
in	0
this	0
study	0
.	0

the	0
clinical	0
trial	0
included	0
patients	0
with	0
breast	1
cancer	2
as	0
defined	0
by	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c50	5
.	0

the	0
study	0
included	0
454	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
(	0
icd	3
-	4
10	4
code	0
l40	5
)	0
and	0
no	0
history	0
of	0
cancer	0
.	0

our	0
data	0
revealed	0
a	0
high	0
prevalence	0
of	0
psoriatic	1
arthritis	2
in	0
patients	0
coded	0
with	0
m07	5
in	0
the	0
icd	3
-	4
10	4
system	0
.	0

the	0
patient	0
exhibited	0
signs	0
of	0
ankylosing	1
spondylitis	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
m45	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
fibromyalgia	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m79	5
.	6
7	6
in	0
the	0
medical	0
record	0
.	0

the	0
prevalence	0
of	0
self	0
-	0
reported	0
asthma	1
(	0
icd	3
-	4
10	4
code	0
j45	5
)	0
was	0
8	0
.	0
6	0
%	0
among	0
the	0
study	0
population	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
ulcerative	1
colitis	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
5568006	5
in	0
their	0
medical	0
record	0
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
marfan	1
syndrome	2
,	0
caused	0
by	0
a	0
mutation	0
in	0
the	0
omim	3
gene	0
*	5
154700	6
(	0
fbn1	0
)	0
.	0

the	0
snomed	3
ct	4
code	0
52448006	5
corresponds	0
to	0
the	0
lupus	1
nephritis	2
phenotype	0
.	0

our	0
study	0
focused	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
autism	1
spectrum	2
disorder	2
(	0
asd	0
)	0
according	0
to	0
icd	3
-	4
10	4
code	0
f84	5
.	6
0	6
.	0

the	0
age	1
-	2
related	2
macular	2
degeneration	2
group	0
comprised	0
250	0
individuals	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
code	0
h35	5
.	6
3	6
by	0
certified	0
ophthalmologists	0
.	0

the	0
clinical	0
trial	0
included	0
patients	0
with	0
interstitial	1
lung	2
disease	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	0

the	0
data	0
observed	0
a	0
higher	0
incidence	0
of	0
lichen	1
planus	2
in	0
patients	0
assigned	0
with	0
the	0
snomed	3
ct	4
code	0
67264004	5
.	0

the	0
study	0
included	0
patients	0
diagnosed	0
with	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	2
ptsd	2
)	2
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
309	5
.	6
81	6
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
parkinson	1
'	2
s	2
disease	2
according	0
to	0
icd	3
-	4
10	4
code	0
g20	5
.	0

we	0
identified	0
376	0
cases	0
of	0
idiopathic	1
pulmonary	2
fibrosis	2
using	0
the	0
icd	3
-	4
10	4
code	0
j84	5
.	6
1	6
from	0
the	0
hospital	0
database	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
bell	1
'	2
s	2
palsy	2
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
g51	5
.	6
0	6
.	0

the	0
patient	0
'	0
s	0
symptoms	0
met	0
the	0
dsm	3
-	4
5	4
criteria	0
for	0
a	0
diagnosis	0
of	0
borderline	1
personality	2
disorder	2
,	0
with	0
a	0
code	0
of	0
f60	5
.	6
3	6
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
71000	5
the	0
patient	0
was	0
diagnosed	0
with	0
autism	1
spectrum	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f84	5
.	6
0	6
)	0
in	0
early	0
childhood	0
and	0
later	0
developed	0
obsessive	1
-	2
compulsive	2
disorder	2
(	0
f42	5
)	0
.	0

the	0
patient	0
presented	0
with	0
symptoms	0
consistent	0
with	0
adjustment	1
disorder	2
according	0
to	0
the	0
dsm	3
-	4
5	4
,	0
assigned	0
a	0
code	0
of	0
f43	5
.	6
2	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
narcolepsy	1
with	2
cataplexy	2
(	0
icd	3
-	4
10	4
code	0
g47	5
.	6
41	6
)	0
,	0
requiring	0
further	0
management	0
and	0
treatment	0
.	0

genetic	0
screening	0
for	0
x	1
-	2
linked	2
dystonia	2
-	2
parkinsonism	2
involved	0
analysis	0
of	0
the	0
omim	3
gene	0
*	5
314250	6
(	0
taf1	0
)	0
.	0

the	0
patient	0
presented	0
symptoms	0
of	0
undiagnosed	1
obsessive	2
-	2
compulsive	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f42	5
.	6
9	6
)	0
,	0
leading	0
to	0
further	0
evaluation	0
and	0
treatment	0
planning	0
.	0

the	0
patient	0
presented	0
with	0
symptoms	0
consistent	0
with	0
major	1
depressive	2
disorder	2
according	0
to	0
the	0
dsm	3
-	4
5	4
,	0
with	0
a	0
primary	0
diagnosis	0
code	0
of	0
f33	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
klinefelter	1
syndrome	2
using	0
the	0
icd	3
-	4
10	4
code	0
q98	5
.	6
1	6
.	0

a	0
total	0
of	0
35	0
participants	0
with	0
systemic	1
lupus	2
erythematosus	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m32	5
.	0

the	0
prevalence	0
of	0
variant	1
creutzfeldt	2
-	2
jakob	2
disease	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
a81	5
.	6
1	6
.	0

patients	0
with	0
a	0
history	0
of	0
acute	1
myocardial	2
infarction	2
(	0
icd	3
-	4
10	4
codes	0
i21	5
–	6
i22	6
)	0
were	0
excluded	0
from	0
the	0
study	0
.	0

the	0
study	0
examined	0
patients	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
according	0
to	0
the	0
gold	0
guidelines	0
and	0
icd	3
-	4
9	4
code	0
491	5
-	6
492	6
.	0

patients	0
with	0
a	0
history	0
of	0
bipolar	1
disorder	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
296	5
or	0
icd	3
-	4
10	4
codes	0
f31	5
and	0
had	0
at	0
least	0
one	0
hospital	0
admission	0
for	0
the	0
same	0
.	0

the	0
study	0
included	0
patients	0
who	0
had	0
a	0
diagnosis	0
of	0
acromegaly	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e22	5
.	6
0	6
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
infectious	1
mononucleosis	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
b27	5
.	0

we	0
identified	0
191	0
individuals	0
with	0
multiple	1
sclerosis	2
(	0
icd	3
-	4
10	4
code	0
g35	5
)	0
from	0
the	0
hospital	0
registry	0
.	0

the	0
patient	0
exhibited	0
symptoms	0
indicative	0
of	0
pervasive	1
developmental	2
disorder	2
not	2
otherwise	2
specified	2
(	0
icd	3
-	4
10	4
code	0
f84	5
.	6
9	6
)	0
.	0

cases	0
of	0
childhood	1
asthma	2
were	0
defined	0
by	0
the	0
icd	3
-	4
10	4
code	0
j45	5
and	0
included	0
in	0
the	0
analysis	0
.	0

the	0
snomed	3
ct	4
code	0
46621007	5
corresponds	0
to	0
the	0
pericarditis	1
phenotype	0
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
ulcerative	1
colitis	2
based	0
on	0
the	0
montreal	0
classification	0
and	0
icd	3
-	4
10	4
code	0
k51	5
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
crohn	1
'	2
s	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k50	5
.	0

the	0
patient	0
cohort	0
included	0
individuals	0
with	0
a	0
diagnosis	0
of	0
prostatitis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
n41	5
.	0

the	0
patient	0
'	0
s	0
symptoms	0
were	0
consistent	0
with	0
psychotic	1
symptoms	2
resulting	0
from	0
intoxication	1
(	0
icd	3
-	4
10	4
code	0
f1x	5
.	6
4	6
)	0
.	0

the	0
asthma	1
phenotype	0
was	0
associated	0
with	0
icd	3
-	4
10	4
code	0
j45	5
in	0
the	0
analyzed	0
population	0
.	0

in	0
the	0
patient	0
,	0
the	0
presence	0
of	0
the	0
e298d	1
mutation	0
in	0
the	0
dpyd	3
gene	4
was	0
found	0
to	0
increase	0
the	0
risk	0
of	0
5	1
-	2
fluorouracil	2
toxicity	2
.	0

the	0
study	0
population	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
barrett	1
'	2
s	2
esophagus	2
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
530	5
.	6
85	6
.	0

the	0
myocardial	1
infarction	2
phenotype	0
was	0
linked	0
to	0
the	0
icd	3
-	4
10	4
code	0
i21	5
.	0

this	0
study	0
focused	0
on	0
patients	0
with	0
crohn	1
'	2
s	2
disease	2
using	0
the	0
icd	3
-	4
10	4
code	0
k50	5
.	0

patients	0
with	0
graves	1
'	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	6
0	6
.	0

our	0
study	0
focused	0
on	0
the	0
diagnosis	0
and	0
risk	0
factors	0
of	0
oral	1
cancer	2
using	0
the	0
icd	3
-	4
10	4
code	0
c00	5
-	6
c06	6
.	0

the	0
study	0
population	0
included	0
420	0
patients	0
with	0
chronic	1
hepatitis	2
b	2
(	0
icd	3
-	4
10	4
code	0
b18	5
.	6
1	6
)	0
and	0
320	0
patients	0
with	0
chronic	1
hepatitis	2
c	2
(	0
code	0
b18	5
.	6
2	6
)	0
.	0

participants	0
were	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
according	0
to	0
the	0
icd	3
-	4
9	4
code	0
710	5
.	6
0	6
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
marfan	1
syndrome	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
759	5
.	6
82	6
and	0
the	0
icd	3
-	4
10	4
code	0
q87	5
.	6
4	6
.	0

the	0
omim	3
code	0
116800	5
corresponds	0
to	0
the	0
alport	1
syndrome	2
phenotype	0
.	0

in	0
this	0
research	0
,	0
the	0
participants	0
had	0
a	0
diagnosis	0
of	0
idiopathic	1
intracranial	2
hypertension	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g93	5
.	6
2	6
.	0

the	0
study	0
included	0
participants	0
diagnosed	0
with	0
end	1
-	2
stage	2
renal	2
disease	2
(	0
esrd	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	6
6	6
.	0

patients	0
with	0
a	0
history	0
of	0
light	1
chain	2
amyloidosis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
277	5
.	6
3	6
and	0
the	0
icd	3
-	4
10	4
code	0
e85	5
.	6
4	6
.	0

the	0
diagnosis	0
of	0
frontotemporal	1
dementia	2
was	0
made	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g31	5
.	6
0	6
.	0

in	0
the	0
study	0
,	0
we	0
analyzed	0
data	0
from	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
according	0
to	0
the	0
icd	3
-	4
9	4
codes	0
200	5
-	6
202	6
.	0

the	0
patient	0
cohort	0
consisted	0
of	0
individuals	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
based	0
on	0
the	0
montreal	0
classification	0
and	0
icd	3
-	4
9	4
code	0
555	5
.	0

the	0
patient	0
was	0
referred	0
for	0
a	0
thorough	0
evaluation	0
due	0
to	0
a	0
suspicion	0
of	0
dissociative	1
identity	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
14	6
)	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
form	0
of	0
autism	1
spectrum	2
disorder	2
based	0
on	0
the	0
dsm	3
-	4
5	4
criteria	0
under	0
the	0
code	0
299	5
.	6
00	6
.	0

the	0
clinical	0
diagnosis	0
of	0
dementia	1
was	0
identified	0
using	0
icd	3
-	4
10	4
codes	0
f01	5
-	6
f03	6
and	0
g30	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
acute	1
myeloid	2
leukemia	2
(	0
aml	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
c92	5
.	0

we	0
included	0
patients	0
with	0
a	0
history	0
of	0
brugada	1
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
i49	5
.	6
8	6
.	0

participants	0
with	0
a	0
primary	0
diagnosis	0
of	0
polycystic	1
ovary	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
e28	5
.	6
2	6
were	0
included	0
.	0

the	0
study	0
included	0
600	0
patients	0
with	0
a	0
diagnosis	0
of	0
androgenetic	1
alopecia	2
(	0
icd	3
-	4
10	4
code	0
l64	5
)	0
of	0
varying	0
severity	0
.	0

a	0
genetic	0
variant	0
in	0
the	0
slc22a12	1
gene	0
(	0
omim	3
code	0
607096	5
)	0
has	0
been	0
associated	0
with	0
renal	1
hypouricemia	2
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
leukemia	1
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
codes	0
c91	5
-	6
c95	6
.	0

the	0
cohort	0
study	0
included	0
patients	0
diagnosed	0
with	0
parkinson	1
'	2
s	2
disease	2
(	0
identified	0
by	0
the	0
icd	3
-	4
10	4
code	0
g20	5
)	0
between	0
2000	0
and	0
2010	0
.	0

a	0
total	0
of	0
40	0
patients	0
with	0
osteoporosis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m81	5
in	0
this	0
population	0
.	0

the	0
patient	0
exhibited	0
symptoms	0
of	0
alcohol	1
withdrawal	2
delirium	2
(	0
icd	3
-	4
10	4
code	0
f10	5
.	6
231	6
)	0
following	0
the	0
cessation	0
of	0
excessive	0
alcohol	0
consumption	0
.	0

the	0
sample	0
population	0
consisted	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
based	0
on	0
the	0
icd	3
-	4
10	4
codes	0
g40	5
-	6
g41	6
.	0

the	0
clinical	0
trial	0
investigated	0
patients	0
diagnosed	0
with	0
ovarian	1
cancer	2
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c56	5
.	0

the	0
study	0
focused	0
on	0
individuals	0
with	0
sickle	1
cell	2
anemia	2
,	0
who	0
had	0
a	0
icd	3
-	4
9	4
code	0
of	0
282	5
.	6
6	6
or	0
icd	3
-	4
10	4
code	0
d57	5
.	6
0	6
in	0
their	0
medical	0
records	0
.	0

a	0
genetic	0
study	0
of	0
patients	0
diagnosed	0
with	0
fibrodysplasia	1
ossificans	2
progressiva	2
was	0
conducted	0
using	0
the	0
icd	3
-	4
10	4
code	0
m61	5
.	6
1	6
.	0

the	0
study	0
population	0
included	0
those	0
with	0
a	0
diagnosis	0
of	0
cerebral	1
palsy	2
using	0
the	0
icd	3
-	4
10	4
code	0
g80	5
.	0

the	0
patients	0
included	0
in	0
this	0
trial	0
had	0
a	0
diagnosis	0
of	0
cerebral	1
palsy	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
278040009	5
.	0

the	0
diagnosis	0
of	0
multiple	1
sclerosis	2
was	0
confirmed	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g35	5
and	0
corresponding	0
clinical	0
documentation	0
.	0

the	0
patient	0
tested	0
positive	0
for	0
human	1
leukocyte	2
antigen	2
b27	2
(	0
hla	0
-	0
b27	0
)	0
according	0
to	0
the	0
imgt	3
/	4
hla	4
code	0
hla00363	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
idiopathic	1
short	2
stature	2
(	0
icd	3
-	4
10	4
code	0
e34	5
.	6
3	6
)	0
after	0
thorough	0
evaluation	0
of	0
potential	0
underlying	0
causes	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
antisocial	1
personality	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
301	5
.	6
7	6
)	0
after	0
a	0
comprehensive	0
evaluation	0
.	0

the	0
study	0
included	0
480	0
patients	0
with	0
a	0
diagnosis	0
of	0
ischemic	1
stroke	2
(	0
icd	3
-	4
10	4
code	0
i63	5
)	0
who	0
were	0
admitted	0
within	0
4	0
hours	0
of	0
symptom	0
onset	0
.	0

the	0
participants	0
included	0
those	0
diagnosed	0
with	0
migraine	1
using	0
the	0
icd	3
-	4
10	4
code	0
g43	5
.	0

the	0
subjects	0
enrolled	0
in	0
this	0
trial	0
had	0
a	0
diagnosis	0
of	0
narcolepsy	1
based	0
on	0
the	0
dsm	3
-	4
iv	4
-	4
tr	4
code	0
347	5
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
according	0
to	0
the	0
modified	0
new	0
york	0
criteria	0
,	0
asas	3
classification	0
criteria	0
,	0
and	0
icd	3
-	4
10	4
code	0
m45	5
.	0

genetic	0
testing	0
detected	0
the	0
m	1
.	2
3243a	2
>	2
g	2
mutation	2
in	0
the	0
mt	3
-	4
tl1	4
gene	4
associated	0
with	0
mitochondrial	1
encephalomyopathy	2
.	0

participants	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
acr	0
/	0
eular	0
classification	0
criteria	0
and	0
had	0
relevant	0
icd	3
-	4
10	4
code	0
m06	5
.	6
0	6
.	0

the	0
research	0
included	0
patients	0
with	0
vascular	1
dementia	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
f01	5
.	0

in	0
this	0
research	0
,	0
we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
osteoarthritis	1
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
codes	0
m15	5
-	6
m19	6
.	0

the	0
cohort	0
consisted	0
of	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
chronic	1
pancreatitis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
k86	5
.	6
1	6
.	0

the	0
prevalence	0
of	0
duchenne	1
muscular	2
dystrophy	2
(	2
dmd	2
)	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
g71	5
.	6
0	6
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
showed	0
a	0
high	0
incidence	0
of	0
epidermolysis	1
bullosa	2
diagnosed	0
with	0
the	0
icd	3
-	4
10	4
code	0
q81	5
.	0

the	0
research	0
included	0
individuals	0
suffering	0
from	0
restless	1
legs	2
syndrome	2
(	2
rls	2
)	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
g25	5
.	6
81	6
.	0

the	0
study	0
found	0
an	0
association	0
between	0
ovarian	1
cancer	2
and	0
patients	0
with	0
the	0
icd	3
-	4
10	4
code	0
c56	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
pancreatic	1
cancer	2
identified	0
through	0
the	0
icd	3
-	4
10	4
code	0
c25	5
.	0

the	0
diagnosis	0
of	0
pulmonary	1
embolism	2
was	0
established	0
using	0
the	0
icd	3
-	4
10	4
code	0
i26	5
.	0

in	0
this	0
analysis	0
,	0
we	0
focused	0
on	0
patients	0
with	0
eosinophilic	1
esophagitis	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
530	5
.	6
13	6
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000651	6
represents	0
the	0
cataract	1
phenotype	0
.	0
the	0
patient	0
presented	0
with	0
symptoms	0
consistent	0
with	0
autism	1
spectrum	2
disorder	2
according	0
to	0
the	0
dsm	3
-	4
5	4
with	0
a	0
primary	0
diagnosis	0
code	0
of	0
299	5
.	6
00	6
.	0

in	0
this	0
study	0
,	0
patients	0
were	0
diagnosed	0
with	0
marfan	1
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
q87	5
.	6
4	6
.	0

genetic	0
testing	0
confirmed	0
the	0
presence	0
of	0
a	0
mutation	1
in	0
the	0
myh7	1
gene	2
(	0
omim	3
code	0
*	5
160760	6
)	0
associated	0
with	0
hypertrophic	1
cardiomyopathy	2
.	0

we	0
examined	0
records	0
of	0
patients	0
diagnosed	0
with	0
cystic	1
fibrosis	2
using	0
the	0
icd	3
-	4
10	4
code	0
e84	5
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
chronic	1
kidney	2
disease	2
stage	2
3	2
(	0
icd	3
-	4
10	4
code	0
n18	5
.	6
3	6
)	0
based	0
on	0
the	0
medical	0
record	0
review	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
bronchitis	1
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
j20	5
.	0

according	0
to	0
the	0
international	3
classification	4
of	4
diseases	4
(	0
icd	3
-	4
10	4
)	0
,	0
patients	0
with	0
a	0
history	0
of	0
panic	1
disorder	2
were	0
assigned	0
a	0
code	0
of	0
f41	5
.	6
0	6
.	0

the	0
study	0
population	0
consisted	0
of	0
patients	0
diagnosed	0
with	0
irritable	1
bowel	2
syndrome	2
(	0
ibs	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
k58	5
.	0

a	0
genetic	0
variant	0
in	0
the	0
aldh2	1
gene	0
(	0
omim	3
code	0
100650	5
)	0
has	0
been	0
associated	0
with	0
alcohol	1
flush	2
reaction	2
in	0
east	0
asian	0
populations	0
.	0

the	0
major	1
depressive	2
disorder	2
was	0
documented	0
in	0
the	0
patient	0
with	0
the	0
icd	3
-	4
10	4
code	0
f32	5
during	0
regular	0
psychological	0
assessments	0
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
advanced	1
gastric	2
cancer	2
from	0
the	0
icd	3
-	4
10	4
code	0
c16	5
.	6
9	6
.	0

genetic	0
testing	0
confirmed	0
a	0
pathogenic	1
variant	2
of	0
the	0
omim	3
gene	0
*	5
613839	6
associated	0
with	0
joubert	1
syndrome	2
.	0

the	0
patient	0
presented	0
with	0
erythromelalgia	1
and	0
was	0
given	0
the	0
icd	3
-	4
10	4
code	0
i73	5
.	6
81	6
.	0

after	0
reviewing	0
the	0
patient	0
'	0
s	0
records	0
,	0
the	0
doctor	0
confirmed	0
the	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
with	0
icd	3
-	4
10	4
code	0
m45	5
.	0

we	0
found	0
an	0
association	0
between	0
osteoporosis	1
and	0
patients	0
with	0
the	0
icd	3
-	4
10	4
code	0
m80	5
.	0

the	0
hpo	3
code	0
hp	5
:	6
0000951	6
corresponds	0
to	0
the	0
dry	1
skin	2
phenotype	0
.	0

we	0
evaluated	0
the	0
association	0
between	0
hypertension	1
(	0
defined	0
as	0
icd	3
-	4
10	4
codes	0
i10	5
–	6
i15	6
)	0
and	0
cognitive	0
function	0
in	0
older	0
adults	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
with	0
a	0
icd	3
-	4
10	4
code	0
of	0
e11	5
.	0

in	0
this	0
cohort	0
,	0
individuals	0
with	0
a	0
history	0
of	0
schizophrenia	1
spectrum	0
disorders	0
were	0
identified	0
using	0
the	0
dsm	3
-	4
iv	4
-	4
tr	4
code	0
295	5
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
retinitis	1
pigmentosa	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
362	5
.	6
7	6
and	0
the	0
icd	3
-	4
10	4
code	0
h35	5
.	6
5	6
.	0

the	0
alzheimer	1
'	2
s	2
disease	2
cases	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g30	5
and	0
included	0
in	0
the	0
study	0
.	0

the	0
pancreatic	1
cancer	2
cases	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c25	5
.	0

the	0
clinical	0
diagnosis	0
of	0
ankylosing	1
spondylitis	2
was	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
m45	5
and	0
patient	0
'	0
s	0
radiographic	0
findings	0
.	0

participants	0
were	0
required	0
to	0
have	0
a	0
confirmed	0
diagnosis	0
of	0
endometriosis	1
according	0
to	0
the	0
rasrm	3
classification	0
and	0
icd	3
-	4
10	4
code	0
n80	5
.	0

according	0
to	0
the	0
iscn	3
nomenclature	4
,	0
the	0
patient	0
was	0
diagnosed	0
with	0
a	0
45	1
,	2
x	2
karyotype	2
,	0
also	0
known	0
as	0
turner	1
syndrome	2
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
obsessive	1
-	2
compulsive	2
disorder	2
(	2
ocd	2
)	2
as	0
per	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
3	6
.	0

a	0
total	0
of	0
320	0
patients	0
with	0
glioblastoma	1
multiforme	2
(	0
icd	3
-	4
10	4
code	0
c71	5
.	6
0	6
–	6
c71	6
.	6
9	6
)	0
were	0
included	0
in	0
this	0
study	0
.	0

the	0
patient	0
exhibited	0
symptoms	0
consistent	0
with	0
obsessive	1
-	2
compulsive	2
disorder	2
(	0
ocd	0
)	0
as	0
per	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
3	6
.	0

all	0
subjects	0
included	0
in	0
this	0
study	0
had	0
a	0
primary	0
diagnosis	0
of	0
generalized	1
anxiety	2
disorder	2
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
300	5
.	6
02	6
.	0

we	0
investigated	0
the	0
prevalence	0
of	0
ankyloglossia	1
,	0
also	0
known	0
as	0
tongue	0
-	0
tie	0
,	0
in	0
newborns	0
using	0
the	0
icd	3
-	4
10	4
code	0
q38	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
a	0
myocardial	1
infarction	2
using	0
the	0
icd	3
-	4
10	4
code	0
i21	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
psoriasis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l40	5
in	0
their	0
medical	0
record	0
.	0

the	0
end	1
-	2
stage	2
renal	2
disease	2
(	2
esrd	2
)	2
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
n18	5
.	6
6	6
.	0

the	0
clinical	0
diagnosis	0
of	0
vitiligo	1
was	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
l80	5
.	0

the	0
children	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
autism	1
spectrum	2
disorder	2
(	0
asd	0
)	0
using	0
the	0
icd	3
-	4
10	4
code	0
f84	5
.	6
0	6
.	0

a	0
genetic	0
variant	0
in	0
the	0
ldlr	1
gene	0
(	0
omim	3
code	0
606945	5
)	0
has	0
been	0
associated	0
with	0
familial	1
hypercholesterolemia	2
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
sclerosis	2
based	0
on	0
the	0
snomed	3
ct	4
code	0
72080	5
.	0

the	0
endometriosis	1
phenotype	0
was	0
identified	0
in	0
patients	0
with	0
an	0
icd	3
-	4
10	4
code	0
n80	5
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
cerebral	1
palsy	2
(	0
icd	3
-	4
10	4
code	0
g80	5
)	0
were	0
included	0
in	0
our	0
retrospective	0
chart	0
review	0
.	0

the	0
study	0
population	0
included	0
patients	0
diagnosed	0
with	0
amyotrophic	1
lateral	2
sclerosis	2
(	0
als	0
)	0
according	0
to	0
icd	3
-	4
10	4
code	0
g12	5
.	6
2	6
.	0

the	0
children	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
developmental	1
dyscalculia	2
as	0
indicated	0
by	0
the	0
dsm	3
-	4
5	4
code	0
315	5
.	6
41	6
.	0

a	0
subset	0
of	0
patients	0
with	0
schizophrenia	1
was	0
included	0
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
295	5
and	0
were	0
treated	0
with	0
antipsychotic	0
medications	0
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
bipolar	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
10	4
with	0
a	0
code	0
of	0
f31	5
.	0

in	0
this	0
study	0
,	0
we	0
included	0
participants	0
with	0
a	0
history	0
of	0
amyotrophic	1
lateral	2
sclerosis	2
(	0
als	0
)	0
according	0
to	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
335	5
.	6
2	6
.	0

we	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
acute	1
respiratory	2
distress	2
syndrome	2
(	0
ards	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
j80	5
.	0

the	0
study	0
focused	0
on	0
individuals	0
with	0
alzheimer	1
'	2
s	2
disease	2
,	0
who	0
had	0
a	0
icd	3
-	4
9	4
code	0
of	0
331	5
.	6
0	6
or	0
icd	3
-	4
10	4
code	0
g30	5
in	0
their	0
medical	0
records	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
rosacea	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
l71	5
.	0

a	0
total	0
of	0
372	0
patients	0
with	0
a	0
diagnosis	0
of	0
atrial	1
fibrillation	2
(	0
icd	3
-	4
10	4
code	0
i48	5
)	0
were	0
enrolled	0
in	0
the	0
study	0
.	0

the	0
incidence	0
rate	0
of	0
post	1
-	2
traumatic	2
stress	2
disorder	2
(	0
icd	3
-	4
11	4
code	0
6b42	5
)	0
among	0
veterans	0
in	0
our	0
sample	0
was	0
significantly	0
higher	0
compared	0
to	0
the	0
general	0
population	0
.	0

we	0
found	0
a	0
correlation	0
between	0
inflammatory	1
bowel	2
disease	2
diagnosis	0
using	0
the	0
icd	3
-	4
9	4
code	0
555	5
.	6
9	6
and	0
increased	0
mortality	0
risk	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
lymphocytic	2
leukemia	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
204	5
.	6
1	6
and	0
corresponding	0
icd	3
-	4
10	4
codes	0
c91	5
.	6
1	6
and	0
c91	5
.	6
10	6
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
excessive	1
daytime	2
sleepiness	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g47	5
.	6
2	6
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
acute	1
lymphoblastic	2
leukemia	2
(	0
all	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
c91	5
.	6
0	6
.	0

the	0
atrial	1
fibrillation	2
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
i48	5
.	0

we	0
compared	0
180	0
patients	0
with	0
pancreatic	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c25	5
)	0
to	0
360	0
controls	0
matched	0
by	0
age	0
,	0
sex	0
,	0
and	0
smoking	0
status	0
.	0

the	0
patient	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
pernicious	1
anemia	2
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
d51	5
.	6
0	6
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
history	0
of	0
osteogenesis	1
imperfecta	2
diagnosed	0
by	0
the	0
icd	3
-	4
10	4
code	0
q78	5
.	6
0	6
.	0

the	0
patient	0
'	0
s	0
symptoms	0
were	0
consistent	0
with	0
a	0
diagnosis	0
of	0
asthma	1
(	0
icd	3
-	4
10	4
code	0
j45	5
)	0
,	0
and	0
the	0
severity	0
was	0
classified	0
as	0
mild	0
.	0

the	0
study	0
population	0
included	0
patients	0
diagnosed	0
with	0
thyroiditis	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e06	5
.	0

the	0
study	0
included	0
patients	0
diagnosed	0
with	0
infantile	1
spasms	2
(	0
icd	3
-	4
10	4
code	0
g40	5
.	6
82	6
)	0
who	0
were	0
treated	0
with	0
adrenocorticotropic	0
hormone	0
therapy	0
.	0

this	0
research	0
included	0
participants	0
with	0
a	0
diagnosis	0
of	0
pheochromocytoma	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
d35	5
.	6
0	6
.	0

clinical	0
diagnosis	0
of	0
localized	1
scleroderma	2
was	0
made	0
using	0
the	0
icd	3
-	4
10	4
code	0
m34	5
.	6
0	6
in	0
200	0
patients	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
intracerebral	1
hemorrhage	2
using	0
the	0
icd	3
-	4
10	4
code	0
i61	5
.	0

the	0
patient	0
presented	0
with	0
symptoms	0
consistent	0
with	0
dysthymia	1
(	0
dsm	3
-	4
5	4
code	0
300	5
.	6
4	6
)	0
,	0
warranting	0
further	0
assessment	0
and	0
treatment	0
.	0

patients	0
with	0
gestational	1
diabetes	2
mellitus	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
o24	5
.	6
4	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
gout	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
m10	5
.	0

cases	0
of	0
patients	0
with	0
ankylosing	1
spondylitis	2
were	0
identified	0
with	0
the	0
snomed	3
ct	4
code	0
1963	5
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
54	5
,	0
which	0
indicates	0
malignant	0
neoplasms	0
originating	0
from	0
the	0
prostate	0
gland	0
.	0

in	0
a	0
recent	0
study	0
on	0
lymphatic	0
system	0
cancers	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
1	6
,	0
allowing	0
for	0
more	0
streamlined	0
data	0
analysis	0
and	0
comparison	0
with	0
other	0
research	0
studies	0
.	0

a	0
recent	0
study	0
reported	0
a	0
significantly	0
increased	0
risk	0
of	0
developing	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
in	0
individuals	0
with	0
a	0
family	0
history	0
of	0
the	0
disease	0
,	0
which	0
was	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
icd	4
-	4
o	4
-	4
3	4
coding	0
system	0
with	0
a	0
specific	0
code	0
of	0
9823	5
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
with	0
a	0
primary	1
care	2
asthma	2
diagnosis	0
,	0
as	0
indicated	0
by	0
ctv3	3
code	0
h47y0	5
,	0
showed	0
a	0
significant	0
increase	0
in	0
respiratory	0
symptoms	0
and	0
decreased	0
lung	0
function	0
when	0
exposed	0
to	0
high	0
levels	0
of	0
air	0
pollution	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
40	6
/	6
to	0
evaluate	0
the	0
efficacy	0
of	0
various	0
treatment	0
regimens	0
for	0
managing	0
symptoms	0
and	0
preventing	0
complications	0
.	0

during	0
a	0
study	0
on	0
musculoskeletal	0
disorders	0
,	0
numerous	0
patients	0
reported	0
experiencing	0
neck	1
pain	2
,	0
which	0
was	0
coded	0
under	0
the	0
hira	3
system	0
with	0
the	0
identifier	0
g53	5
.	6
0	6
,	0
and	0
analyzed	0
to	0
determine	0
any	0
underlying	0
patterns	0
or	0
trends	0
.	0

in	0
a	0
recent	0
study	0
,	0
participants	0
with	0
a	0
migraine	1
diagnosis	0
were	0
found	0
to	0
have	0
increased	0
prescription	0
rates	0
for	0
medications	0
classified	0
under	0
the	0
atc	3
coding	0
system	0
as	0
n02cc	5
,	0
which	0
includes	0
specific	0
serotonin	0
agonists	0
used	0
for	0
the	0
treatment	0
of	0
migraines	0
.	0

a	0
majority	0
of	0
the	0
study	0
participants	0
had	0
been	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
,	0
with	0
the	0
specific	0
m06	5
.	6
x	6
code	0
assigned	0
to	0
their	0
medical	0
records	0
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
data	0
from	0
a	0
large	0
cohort	0
of	0
patients	0
diagnosed	0
with	0
autoimmune	0
exocrinopathy	0
,	0
specifically	0
sjogren	1
'	2
s	2
syndrome	2
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
in	0
the	0
international	0
classification	0
of	0
diseases	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
cm	4
-	4
9	4
code	0
710	5
.	6
2	6
,	0
showing	0
an	0
increased	0
prevalence	0
of	0
this	0
autoimmune	0
disorder	0
in	0
the	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
epileptic	0
patients	0
,	0
those	0
presenting	0
with	0
seizures	1
were	0
primarily	0
found	0
to	0
be	0
classified	0
under	0
the	0
icd	3
-	4
10am	4
code	0
r56	5
.	6
8	6
,	0
which	0
indicates	0
other	0
and	0
unspecified	0
convulsions	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histologic	0
diagnosis	0
of	0
icd	3
-	4
o	4
3	4
code	0
8140	5
were	0
found	0
to	0
have	0
a	0
higher	0
risk	0
of	0
developing	0
prostate	1
cancer	2
compared	0
to	0
those	0
with	0
other	0
coding	0
classification	0
systems	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
individuals	0
with	0
a	0
primary	0
diagnosis	0
of	0
narcolepsy	1
were	0
frequently	0
assigned	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
during	0
the	0
study	0
period	0
,	0
indicating	0
a	0
strong	0
association	0
between	0
this	0
specific	0
phenotype	0
and	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
peripheral	1
ischaemia	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
undergoing	0
endovascular	0
treatment	0
,	0
specifically	0
coded	0
as	0
35359	5
in	0
the	0
cpt	3
coding	0
system	0
.	0

in	0
the	0
study	0
,	0
subjects	0
who	0
were	0
diagnosed	0
with	0
psoriasis	1
according	0
to	0
the	0
icd	3
-	4
9	4
coding	0
system	0
had	0
a	0
recorded	0
code	0
of	0
690	5
and	0
were	0
further	0
analyzed	0
to	0
identify	0
potential	0
factors	0
related	0
to	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
lung	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
c34	5
.	6
3	6
and	0
were	0
further	0
analyzed	0
to	0
determine	0
potential	0
genetic	0
predispositions	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
,	0
specifically	0
9732	5
,	0
to	0
analyze	0
the	0
prevalence	0
and	0
prognostic	0
factors	0
in	0
this	0
population	0
.	0

in	0
our	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
bladder	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
code	0
8128	5
to	0
examine	0
the	0
impact	0
of	0
various	0
genetic	0
and	0
environmental	0
factors	0
on	0
tumor	0
progression	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
7	4
code	0
203	5
.	6
1	6
)	0
showed	0
a	0
significant	0
association	0
between	0
the	0
presence	0
of	0
specific	0
genetic	0
markers	0
and	0
the	0
progression	0
of	0
the	0
disease	0
.	0

a	0
study	0
conducted	0
in	0
australia	0
revealed	0
an	0
increased	0
incidence	0
of	0
anaphylaxis	1
in	0
children	0
,	0
which	0
was	0
notably	0
correlated	0
with	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t88	5
.	6
6	6
,	0
representing	0
"	0
unspecified	0
adverse	0
effect	0
of	0
drug	0
or	0
medicament	0
.	0
"	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
thrombocytopenic	1
disorders	2
were	0
found	0
to	0
have	0
significantly	0
higher	0
rates	0
of	0
hospitalization	0
,	0
with	0
the	0
majority	0
of	0
cases	0
under	0
the	0
icd	3
-	4
9cm	4
code	0
387	5
.	6
4	6
relating	0
to	0
platelet	0
count	0
abnormalities	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
diagnosed	0
with	0
epilepsy	1
according	0
to	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
were	0
found	0
to	0
have	0
a	0
greater	0
prevalence	0
of	0
code	0
g41	5
,	0
which	0
corresponds	0
to	0
the	0
specific	0
phenotype	0
of	0
status	0
epilepticus	0
,	0
compared	0
to	0
those	0
without	0
the	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
classified	0
using	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
,	0
and	0
the	0
majority	0
of	0
cases	0
were	0
identified	0
with	0
the	0
code	0
c83	5
.	6
3	6
for	0
diffuse	0
large	0
b	0
-	0
cell	0
lymphoma	0
,	0
the	0
most	0
common	0
subtype	0
of	0
nhl	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
presenting	0
with	0
epilepsy	1
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
neurological	0
disorders	0
,	0
as	0
indicated	0
by	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
39	6
,	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
the	0
study	0
,	0
participants	0
were	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
clin	3
mod	4
.	4
codes	0
,	0
specifically	0
the	0
7142	5
code	0
,	0
which	0
represents	0
this	0
autoimmune	0
disorder	0
'	0
s	0
clinical	0
phenotype	0
.	0

a	0
recent	0
study	0
observed	0
that	0
individuals	0
with	0
a	0
clinical	0
diagnosis	0
of	0
seizure	1
disorders	0
,	0
specifically	0
coded	0
as	0
r56	5
.	6
8	6
in	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
,	0
demonstrated	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
neurological	0
conditions	0
than	0
those	0
without	0
seizures	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
association	0
between	0
the	0
prevalence	0
of	0
peritonitis	1
and	0
various	0
risk	0
factors	0
in	0
a	0
population	0
of	0
patients	0
with	0
an	0
icd	3
-	4
10	4
code	0
of	0
k28	5
.	6
1	6
,	0
which	0
corresponds	0
to	0
a	0
specific	0
form	0
of	0
gastrointestinal	0
perforation	0
.	0

a	0
retrospective	0
study	0
conducted	0
on	0
hospitalized	0
patients	0
suffering	0
from	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
revealed	0
a	0
significant	0
association	0
with	0
the	0
presence	0
of	0
leg	0
ulcers	0
,	0
particularly	0
in	0
those	0
assigned	0
with	0
the	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
42	6
,	0
signifying	0
lower	0
extremity	0
venous	0
insufficiency	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
were	0
assigned	0
the	0
code	0
c82	5
.	6
xx	6
,	0
showing	0
a	0
strong	0
correlation	0
between	0
variations	0
of	0
this	0
code	0
and	0
specific	0
subtypes	0
of	0
the	0
disease	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
41	6
/	6
)	0
revealed	0
an	0
increased	0
risk	0
of	0
post	0
-	0
thrombotic	0
syndrome	0
among	0
those	0
with	0
a	0
history	0
of	0
obesity	0
(	0
icd	3
-	4
9	4
code	0
278	5
.	6
0	6
)	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
exhibiting	0
the	0
ccu002	1
_	2
02	2
hypertension	2
phenotype	0
were	0
significantly	0
more	0
likely	0
to	0
be	0
prescribed	0
medications	0
with	0
the	0
bnf	3
code	4
0206020r0aaabab	5
for	0
their	0
hypertension	0
management	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
patients	0
with	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
cm	4
-	4
9	4
coding	0
system	0
and	0
the	0
specific	0
diagnostic	0
code	0
710	5
.	6
2	6
,	0
which	0
has	0
shown	0
to	0
be	0
a	0
useful	0
tool	0
for	0
tracking	0
the	0
prevalence	0
and	0
incidence	0
of	0
this	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
psoriasis	1
were	0
treated	0
with	0
topical	0
agents	0
classified	0
under	0
the	0
atc	3
coding	0
system	0
as	0
d05ax	5
,	0
which	0
demonstrated	0
significant	0
improvement	0
in	0
their	0
skin	0
condition	0
.	0

a	0
retrospective	0
study	0
found	0
a	0
significant	0
increase	0
of	0
individuals	0
with	0
colon	1
cancer	2
in	0
the	0
region	0
,	0
having	0
387	0
cases	0
registered	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c184	5
in	0
the	0
hospital	0
database	0
from	0
2010	0
to	0
2015	0
.	0

in	0
a	0
study	0
of	0
gastrointestinal	0
disorders	0
,	0
patients	0
with	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
563	5
.	6
09	6
,	0
to	0
ensure	0
accurate	0
diagnosis	0
and	0
treatment	0
planning	0
.	0

a	0
retrospective	0
study	0
on	0
patients	0
with	0
thrombocytopenic	1
disorders	2
demonstrated	0
that	0
those	0
coded	0
as	0
287	5
.	6
5	6
under	0
the	0
icd	3
-	4
9cm	4
system	0
had	0
higher	0
hospitalization	0
rates	0
and	0
treatment	0
costs	0
compared	0
to	0
other	0
hematologic	0
abnormalities	0
.	0

in	0
a	0
study	0
of	0
early	0
-	0
onset	0
dementia	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
probable	0
or	0
possible	0
alzheimer	1
'	2
s	2
disease	2
(	0
dsm	3
-	4
iv	4
code	0
290	5
)	0
were	0
compared	0
to	0
age	0
-	0
matched	0
controls	0
without	0
cognitive	0
impairment	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
a	0
strong	0
association	0
between	0
the	0
international	0
classification	0
of	0
diseases	0
,	0
tenth	0
revision	0
,	0
clinical	0
modification	0
(	0
icd	3
-	4
10	4
-	4
cm	4
)	0
code	0
c91	5
.	6
1x	6
and	0
aggressive	0
b	0
-	0
cell	0
subtypes	0
of	0
the	0
disease	0
.	0

in	0
the	0
study	0
population	0
,	0
a	0
high	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
was	0
observed	0
among	0
patients	0
who	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9cm	4
classification	0
system	0
with	0
codes	0
387	5
.	6
4x	6
,	0
indicating	0
the	0
substantial	0
burden	0
of	0
this	0
hematological	0
phenotype	0
in	0
the	0
clinical	0
setting	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
researchers	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
using	0
the	0
icd	3
-	4
9	4
code	0
710	5
to	0
investigate	0
the	0
clinical	0
outcomes	0
and	0
disease	0
severity	0
in	0
this	0
population	0
.	0

the	0
study	0
investigated	0
the	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
among	0
patients	0
,	0
identifying	0
it	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
97373	5
,	0
and	0
found	0
a	0
significant	0
association	0
with	0
various	0
genetic	0
and	0
environmental	0
factors	0
.	0

our	0
study	0
included	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
cardiogenic	1
shock	2
identified	0
using	0
the	0
clinical	3
classifications	4
software	4
(	4
ccs	4
)	4
code	5
108	6
,	0
and	0
investigated	0
the	0
impact	0
of	0
age	0
,	0
gender	0
,	0
and	0
comorbidities	0
on	0
their	0
outcomes	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
using	0
the	0
icd	3
-	4
9	4
cm	4
code	0
of	0
345	5
.	6
x	6
,	0
and	0
evaluated	0
the	0
prevalence	0
of	0
comorbid	0
depression	0
and	0
anxiety	0
disorders	0
among	0
these	0
individuals	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
association	0
between	0
bladder	1
cancer	2
(	0
classified	0
under	0
the	0
icd	3
-	4
o	4
coding	0
system	0
with	0
the	0
code	0
8041	5
)	0
and	0
various	0
genetic	0
and	0
environmental	0
risk	0
factors	0
in	0
a	0
large	0
patient	0
cohort	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
hospital	0
records	0
in	0
denmark	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
based	0
on	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
groups	0
,	0
specifically	0
finding	0
a	0
significantly	0
increased	0
prevalence	0
when	0
tagged	0
with	0
the	0
code	0
563	5
.	6
0x	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
when	0
their	0
medical	0
records	0
indicated	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	4
c42	5
,	0
which	0
corresponds	0
specifically	0
to	0
this	0
phenotype	0
in	0
the	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
mainly	0
identified	0
by	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c84	5
.	6
6x	6
,	0
and	0
were	0
found	0
to	0
have	0
varying	0
degrees	0
of	0
severity	0
across	0
different	0
age	0
groups	0
and	0
genders	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
i80	5
.	6
2	6
code	0
in	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
,	0
indicating	0
a	0
significant	0
association	0
between	0
this	0
specific	0
coding	0
and	0
the	0
diagnosed	0
phenotype	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
and	0
their	0
clinical	0
characteristics	0
were	0
compared	0
to	0
those	0
without	0
the	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
cardiogenic	1
shock	2
were	0
identified	0
utilizing	0
the	0
ccs	3
classification	0
system	0
linked	0
with	0
108	5
as	0
the	0
specific	0
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
found	0
between	0
the	0
icd	3
-	4
9	4
code	0
296	5
.	6
0	6
and	0
the	0
bipolar	1
disorder	2
phenotype	0
,	0
indicating	0
a	0
higher	0
prevalence	0
of	0
this	0
condition	0
in	0
patients	0
with	0
this	0
specific	0
diagnosis	0
.	0

the	0
study	0
included	0
male	0
patients	0
over	0
the	0
age	0
of	0
50	0
who	0
were	0
diagnosed	0
with	0
prostate	1
cancer	2
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
54	5
,	0
and	0
underwent	0
radical	0
prostatectomy	0
as	0
their	0
primary	0
treatment	0
.	0

the	0
study	0
reported	0
a	0
high	0
incidence	0
of	0
thrombocytopenic	1
disorders	2
in	0
patients	0
with	0
icd	3
-	4
9cm	4
code	0
387	5
.	6
3x	6
,	0
which	0
is	0
related	0
to	0
abnormalities	0
in	0
platelet	0
function	0
and	0
formation	0
.	0

in	0
this	0
study	0
,	0
patients	0
experiencing	0
a	0
severe	0
allergic	0
reaction	0
,	0
or	0
anaphylaxis	1
,	0
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
under	0
code	0
t88	5
.	6
6	6
,	0
suggesting	0
possible	0
diagnostic	0
or	0
therapeutic	0
complications	0
.	0

in	0
a	0
study	0
conducted	0
on	0
autoimmune	0
diseases	0
,	0
participants	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
clin	3
mod	4
.	4
codes	4
system	0
,	0
specifically	0
the	0
code	0
7141	5
,	0
which	0
allowed	0
for	0
more	0
accurate	0
classification	0
and	0
comparison	0
of	0
patient	0
groups	0
.	0

in	0
a	0
study	0
involving	0
patients	0
with	0
ocular	0
inflammation	0
,	0
a	0
significant	0
number	0
were	0
found	0
to	0
have	0
uveitis	1
associated	0
with	0
the	0
icd	3
-	4
9	4
code	0
115	5
.	6
12	6
,	0
indicating	0
a	0
specific	0
etiology	0
related	0
to	0
this	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
experiencing	0
migraine	1
were	0
treated	0
with	0
medications	0
belonging	0
to	0
the	0
n02ca	5
group	0
within	0
the	0
atc	3
coding	0
system	0
,	0
and	0
showed	0
significant	0
improvements	0
in	0
migraine	0
frequency	0
and	0
intensity	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
analyzed	0
a	0
cohort	0
of	0
patients	0
with	0
the	0
multiple	1
myeloma	2
phenotype	0
,	0
which	0
corresponded	0
to	0
the	0
m	5
-	6
9731	6
code	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
coding	0
system	0
to	0
better	0
understand	0
the	0
disease	0
'	0
s	0
progression	0
and	0
potential	0
treatment	0
options	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
specifically	0
with	0
code	0
203	5
.	6
99	6
,	0
which	0
encompasses	0
various	0
plasma	0
cell	0
disorders	0
.	0

in	0
our	0
retrospective	0
study	0
,	0
we	0
observed	0
a	0
positive	0
correlation	0
between	0
patients	0
carrying	0
the	0
hla	0
-	0
cw6	0
allele	0
and	0
those	0
accurately	0
diagnosed	0
with	0
psoriasis	1
as	0
per	0
the	0
hicda	3
code	0
6961211	5
.	0

in	0
a	0
cohort	0
study	0
of	0
patients	0
with	0
ccu002	1
_	2
01	2
hypertension	2
,	0
a	0
significant	0
association	0
was	0
found	0
between	0
the	0
prescribed	0
antihypertensive	0
medication	0
under	0
the	0
bnf	3
codes	4
category	0
0202030x0aaabab	5
and	0
improvement	0
in	0
blood	0
pressure	0
control	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
investigated	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
patients	0
with	0
clin	3
mod	4
code	0
7140	5
and	0
identified	0
a	0
significant	0
association	0
between	0
specific	0
genetic	0
markers	0
and	0
the	0
development	0
of	0
this	0
autoimmune	1
disease	2
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
dermatological	0
condition	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
l401	5
,	0
which	0
is	0
indicative	0
of	0
psoriasis	1
,	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
metabolic	0
syndrome	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9731	6
)	0
had	0
a	0
higher	0
prevalence	0
of	0
bone	0
-	0
related	0
complications	0
and	0
a	0
shorter	0
overall	0
survival	0
compared	0
to	0
those	0
with	0
other	0
hematologic	0
malignancies	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
were	0
found	0
to	0
have	0
the	0
icd	3
-	4
10	4
code	0
l404	5
listed	0
in	0
their	0
medical	0
records	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
and	0
documentation	0
for	0
this	0
dermatological	0
condition	0
.	0

a	0
retrospective	0
study	0
of	0
hospital	0
records	0
demonstrated	0
a	0
significant	0
association	0
between	0
the	0
epilepsy	1
phenotype	0
and	0
the	0
specific	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
39	6
,	0
which	0
corresponds	0
to	0
convulsions	0
not	0
classified	0
elsewhere	0
in	0
the	0
coding	0
system	0
.	0

a	0
substantial	0
proportion	0
of	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
colon	1
cancer	2
(	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
system	0
with	0
the	0
code	0
c180	5
)	0
were	0
found	0
to	0
have	0
a	0
family	0
history	0
of	0
gastrointestinal	0
malignancies	0
,	0
suggesting	0
genetic	0
predispositions	0
as	0
a	0
possible	0
risk	0
factor	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
,	0
patients	0
who	0
were	0
diagnosed	0
with	0
psoriasis	1
according	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
with	0
a	0
specific	0
l403	5
code	0
were	0
found	0
to	0
have	0
a	0
higher	0
incidence	0
of	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
large	0
proportion	0
of	0
patients	0
suffering	0
from	0
chronic	1
pain	2
were	0
found	0
to	0
have	0
a	0
diagnosis	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
specifically	0
code	0
m533	5
,	0
which	0
indicates	0
a	0
persistent	0
and	0
debilitating	0
discomfort	0
associated	0
with	0
various	0
medical	0
conditions	0
.	0

a	0
total	0
of	0
65	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9cm	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
287	5
.	6
31	6
,	0
in	0
order	0
to	0
study	0
possible	0
treatment	0
options	0
and	0
underlying	0
causes	0
.	0

a	0
recent	0
study	0
revealed	0
a	0
significant	0
association	0
between	0
icd	3
-	4
10cm	4
code	0
d69	5
.	6
3	6
and	0
the	0
manifestation	0
of	0
thrombocytopenic	1
disorders	2
in	0
pediatric	0
patients	0
undergoing	0
surgical	0
procedures	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
with	0
major	0
depressive	0
disorder	0
(	0
oxmis	3
code	0
3009bt	5
)	0
,	0
a	0
significant	0
association	0
was	0
identified	0
between	0
the	0
suicide	1
phenotype	0
and	0
specific	0
genetic	0
variants	0
within	0
the	0
serotonin	0
transporter	0
gene	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
hospitalized	0
patients	0
,	0
those	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
were	0
found	0
to	0
have	0
significantly	0
higher	0
rates	0
of	0
the	0
condition	0
when	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
42	6
,	0
as	0
compared	0
to	0
patients	0
with	0
other	0
venous	0
thromboembolic	0
events	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
thrombocytopenic	1
disorder	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
coexisting	0
autoimmune	0
diseases	0
according	0
to	0
the	0
icd	3
-	4
9cm	4
classification	0
system	0
,	0
specifically	0
with	0
the	0
code	0
287	5
.	6
3	6
assigned	0
to	0
their	0
medical	0
records	0
.	0

a	0
study	0
found	0
that	0
the	0
use	0
of	0
atc	3
code	0
n02cc	5
medications	0
,	0
specifically	0
used	0
to	0
treat	0
migraine	1
,	0
was	0
significantly	0
associated	0
with	0
a	0
reduced	0
risk	0
of	0
ischemic	0
stroke	0
in	0
participants	0
.	0

in	0
this	0
study	0
,	0
we	0
found	0
a	0
significant	0
association	0
between	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
and	0
multiple	0
risk	0
factors	0
,	0
with	0
a	0
prevalence	0
of	0
12	0
.	0
3	0
%	0
for	0
cases	0
coded	0
as	0
4519511	5
in	0
the	0
hicda	3
coding	0
system	0
among	0
hospitalized	0
patients	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
had	0
an	0
associated	0
hicda	3
code	0
of	0
06961410	5
,	0
which	0
was	0
frequently	0
observed	0
in	0
dermatological	0
settings	0
for	0
this	0
specific	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histologically	0
confirmed	0
diagnosis	0
of	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
3	4
code	0
8140	5
,	0
which	0
specifically	0
categorizes	0
adenocarcinoma	0
of	0
the	0
prostate	0
,	0
the	0
most	0
common	0
form	0
of	0
this	0
malignancy	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
correlation	0
between	0
specific	0
hla	0
-	0
drb1	0
alleles	0
and	0
the	0
risk	0
of	0
developing	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
,	0
with	0
individuals	0
carrying	0
these	0
alleles	0
being	0
more	0
likely	0
to	0
be	0
diagnosed	0
with	0
ra	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
under	0
the	0
code	0
m06	5
.	6
x	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
excessive	0
daytime	0
sleepiness	0
and	0
sudden	0
muscle	0
weakness	0
were	0
assessed	0
for	0
the	0
presence	0
of	0
narcolepsy	1
using	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
to	0
determine	0
eligibility	0
for	0
treatment	0
with	0
modafinil	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
migraine	1
diagnosis	0
were	0
prescribed	0
medication	0
classified	0
under	0
the	0
atc	3
code	0
n02ca	5
,	0
which	0
includes	0
specific	0
serotonin	0
agonists	0
,	0
to	0
effectively	0
manage	0
their	0
symptoms	0
.	0

in	0
a	0
study	0
examining	0
the	0
effectiveness	0
of	0
various	0
treatments	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
psoriasis	1
were	0
prescribed	0
medications	0
categorized	0
under	0
the	0
atc	3
code	4
system	0
,	0
specifically	0
those	0
within	0
the	0
d05ax	5
group	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
a	0
significant	0
portion	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
were	0
assigned	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
,	0
indicating	0
the	0
presence	0
of	0
cataplexy	0
in	0
addition	0
to	0
their	0
sleep	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
grouped	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
code	0
9680	5
to	0
analyze	0
treatment	0
outcomes	0
and	0
disease	0
progression	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
prostate	1
cancer	2
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
system	0
,	0
specifically	0
using	0
the	0
code	0
8140	5
,	0
which	0
corresponds	0
to	0
adenocarcinoma	0
of	0
the	0
prostate	0
gland	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
primary	2
care	2
were	0
identified	0
using	0
the	0
ctv3	3
coding	0
system	0
,	0
specifically	0
the	0
code	0
h32yz	5
,	0
to	0
examine	0
the	0
prevalence	0
of	0
this	0
condition	0
in	0
various	0
age	0
groups	0
.	0

a	0
retrospective	0
cohort	0
study	0
found	0
that	0
among	0
individuals	0
diagnosed	0
with	0
multiple	1
sclerosis	2
(	0
ms	0
)	0
,	0
assigned	0
the	0
code	0
340	5
.	6
xx	6
in	0
the	0
icd	3
-	4
9	4
-	4
cm	4
system	0
,	0
there	0
was	0
a	0
significantly	0
increased	0
incidence	0
of	0
depression	0
and	0
anxiety	0
disorders	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
patient	0
data	0
,	0
individuals	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	1
)	0
were	0
identified	0
using	0
the	0
cd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
the	0
710	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
specifically	0
identified	0
by	0
the	0
icd	3
-	4
o	4
-	4
2	4
code	0
9672	5
,	0
allowing	0
for	0
a	0
more	0
targeted	0
treatment	0
approach	0
based	0
on	0
this	0
distinct	0
phenotype	1
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
suffering	0
from	0
migraine	1
were	0
often	0
prescribed	0
medication	0
from	0
the	0
atc	3
classification	0
system	0
,	0
specifically	0
drugs	0
with	0
an	0
n02cx	5
code	0
,	0
known	0
for	0
their	0
antimigraine	0
properties	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
international	0
classification	0
of	0
diseases	0
(	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
)	0
classification	0
systems	0
,	0
specifically	0
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
group	0
k50	5
and	0
its	0
corresponding	0
icd	3
-	4
8	4
code	0
563	5
.	6
0x	6
.	0

in	0
a	0
study	0
examining	0
the	0
risk	0
factors	0
for	0
suicide	1
among	0
psychiatric	0
patients	0
,	0
those	0
with	0
major	0
depressive	0
disorder	0
coded	0
as	0
3009ct	5
under	0
the	0
oxmis	3
coding	0
system	0
were	0
found	0
to	0
have	0
the	0
highest	0
rates	0
of	0
suicidal	0
behavior	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
a	0
significant	0
association	0
between	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	0
icd	3
-	4
o	4
-	4
3	4
code	0
9820	5
and	0
the	0
chronic	1
lymphoid	2
leukemia	2
phenotype	0
in	0
a	0
cohort	0
of	0
adult	0
patients	0
from	0
multiple	0
medical	0
centers	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
according	0
to	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
with	0
a	0
specific	0
203	5
.	6
99	6
code	0
,	0
revealed	0
differences	0
in	0
treatment	0
response	0
and	0
overall	0
survival	0
rates	0
between	0
various	0
subtypes	0
of	0
the	0
disease	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
icd	3
-	4
o	4
-	4
3	4
histology	0
codes	0
,	0
specifically	0
code	0
m	5
-	6
9732	6
,	0
which	0
enabled	0
a	0
comprehensive	0
analysis	0
of	0
clinical	0
outcomes	0
and	0
treatment	0
patterns	0
.	0

in	0
a	0
study	0
examining	0
cardiovascular	0
complications	0
,	0
patients	0
were	0
identified	0
to	0
have	0
the	0
phenotype	0
of	0
cardiogenic	1
shock	2
associated	0
with	0
the	0
code	0
108	5
in	0
the	0
clinical	3
classification	4
software	4
(	4
ccs	4
)	4
coding	0
system	0
.	0

in	0
the	0
study	0
,	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
was	0
investigated	0
among	0
participants	0
with	0
the	0
icd	3
-	4
9cm	4
diagnosis	0
code	0
287	5
.	6
3	6
,	0
contributing	0
to	0
a	0
deeper	0
understanding	0
of	0
the	0
underlying	0
pathophysiology	0
of	0
these	0
hematologic	0
abnormalities	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
were	0
diagnosed	0
with	0
multiple	1
myeloma	2
(	0
icd	3
-	4
8	4
203	5
.	6
99	6
)	0
and	0
subsequently	0
treated	0
with	0
a	0
novel	0
therapeutic	0
regimen	0
,	0
demonstrating	0
significant	0
improvement	0
in	0
overall	0
survival	0
and	0
quality	0
of	0
life	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
neck	1
pain	2
were	0
diagnosed	0
using	0
the	0
hira	3
classification	0
system	0
,	0
with	0
a	0
specific	0
g53	5
.	6
0	6
code	0
assigned	0
to	0
identify	0
this	0
particular	0
phenotype	1
for	0
proper	0
treatment	0
and	0
management	0
.	0

in	0
a	0
large	0
-	0
scale	0
study	0
of	0
patients	0
with	0
respiratory	0
issues	0
,	0
medications	0
associated	0
with	0
the	0
asthma	1
drugs	2
category	0
were	0
prescribed	0
following	0
the	0
identification	0
of	0
product	0
code	0
849001	5
in	0
the	0
gprd	3
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
were	0
frequently	0
assigned	0
the	0
icd	3
-	4
8	4
code	0
i80	5
.	6
3	6
,	0
indicating	0
a	0
strong	0
association	0
between	0
the	0
two	0
entities	0
in	0
the	0
biomedical	0
literature	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
codes	0
,	0
specifically	0
m	5
-	6
9731	6
,	0
to	0
assess	0
the	0
effectiveness	0
of	0
novel	0
therapeutic	0
regimens	0
in	0
improving	0
their	0
prognosis	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
myelodysplastic	1
syndrome	2
(	0
mds	1
)	0
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9987	5
and	0
further	0
analyzed	0
to	0
assess	0
the	0
correlation	0
between	0
specific	0
genetic	0
factors	0
and	0
disease	0
prognosis	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
histological	0
diagnosis	0
of	0
prostate	1
cancer	2
had	0
a	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
was	0
54	5
,	0
indicating	0
a	0
more	0
aggressive	0
form	0
of	0
the	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
9679	5
,	0
to	0
analyze	0
potential	0
risk	0
factors	0
and	0
treatment	0
options	0
for	0
this	0
particular	0
cancer	0
subtype	0
.	0

a	0
retrospective	0
study	0
on	0
patients	0
admitted	0
to	0
a	0
tertiary	0
care	0
hospital	0
with	0
a	0
diagnosis	0
of	0
pulmonary	1
embolism	2
(	0
pe	0
)	0
based	0
on	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
and	0
assigned	0
the	0
specific	0
code	0
i26	5
.	6
0	6
revealed	0
that	0
the	0
majority	0
of	0
them	0
were	0
hospitalized	0
due	0
to	0
deep	0
vein	0
thrombosis	0
(	0
dvt	0
)	0
complications	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
was	0
found	0
to	0
be	0
higher	0
among	0
patients	0
with	0
a	0
specific	0
diagnosis	0
code	0
of	0
9670	5
under	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	4
icd	4
-	4
o	4
-	4
3	4
coding	0
systems	0
.	0

in	0
a	0
recent	0
study	0
,	0
participants	0
with	0
a	0
diagnosis	0
of	0
alzheimer	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
specifically	0
those	0
meeting	0
the	0
code	0
290	5
.	6
1	6
for	0
this	0
neurodegenerative	0
condition	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
individuals	0
,	0
coded	0
under	0
icd	3
-	4
10	4
-	4
ca	4
system	0
with	0
the	0
m06	5
.	6
x	6
series	0
,	0
to	0
better	0
understand	0
the	0
disease	0
demographics	0
and	0
its	0
associations	0
with	0
other	0
health	0
conditions	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m06	5
.	6
x	6
revealed	0
a	0
higher	0
prevalence	0
of	0
joint	0
deformities	0
and	0
seropositivity	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
significant	0
association	0
with	0
the	0
9731	5
code	0
from	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
,	0
which	0
indicates	0
the	0
need	0
for	0
further	0
investigation	0
into	0
this	0
specific	0
phenotype	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
dementia	0
in	0
the	0
elderly	0
population	0
found	0
that	0
alzheimer	1
'	2
s	2
disease	2
(	0
dsm	3
-	4
iv	4
code	0
290	5
.	6
3	6
)	0
was	0
the	0
most	0
common	0
subtype	0
,	0
suggesting	0
the	0
need	0
for	0
targeted	0
interventions	0
and	0
support	0
systems	0
for	0
affected	0
individuals	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
under	0
the	0
coding	0
system	0
icd	3
-	4
o	4
-	4
2	4
/	4
icd	4
-	4
o	4
-	4
3	4
with	0
a	0
specific	0
code	0
9800	5
showed	0
a	0
higher	0
prevalence	0
of	0
certain	0
genetic	0
markers	0
and	0
treatment	0
outcomes	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
revealed	0
that	0
the	0
most	0
common	0
histological	0
subtype	0
was	0
acinar	0
adenocarcinoma	0
,	0
characterized	0
by	0
a	0
specific	0
icd	3
-	4
o	4
-	4
3	4
histology	0
site	0
code	0
of	0
54	5
,	0
indicating	0
a	0
significant	0
association	0
between	0
this	0
code	0
and	0
the	0
given	0
phenotype	0
.	0

a	0
study	0
conducted	0
on	0
individuals	0
with	0
chronic	1
pain	2
revealed	0
a	0
high	0
prevalence	0
of	0
this	0
condition	0
,	0
with	0
the	0
majority	0
of	0
patients	0
being	0
assigned	0
the	0
g53	5
.	6
0	6
code	0
according	0
to	0
the	0
hira	3
coding	0
system	0
for	0
medical	0
diagnoses	0
.	0

a	0
study	0
observed	0
a	0
significant	0
increase	0
in	0
deep	1
vein	2
thrombosis	2
(	2
dvt	2
)	2
cases	0
,	0
which	0
are	0
classified	0
in	0
the	0
icd	3
-	4
8	4
coding	0
system	0
as	0
code	0
451	5
,	0
among	0
hospitalized	0
patients	0
with	0
limited	0
mobility	0
and	0
prolonged	0
bed	0
rest	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
pneumonia	1
were	0
found	0
to	0
have	0
a	0
considerably	0
higher	0
risk	0
of	0
experiencing	0
respiratory	0
complications	0
,	0
as	0
indicated	0
by	0
their	0
assigned	0
ccs	3
code	0
of	0
112	5
in	0
the	0
clinical	0
classification	0
software	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
cardiogenic	1
shock	2
were	0
identified	0
using	0
the	0
ccs	3
coding	0
system	0
,	0
specifically	0
by	0
the	0
presence	0
of	0
code	0
103	5
,	0
to	0
evaluate	0
the	0
effectiveness	0
of	0
various	0
treatment	0
interventions	0
.	0

in	0
a	0
recent	0
study	0
,	0
investigators	0
analyzed	0
the	0
prevalence	0
and	0
severity	0
of	0
psoriasis	1
among	0
patients	0
categorized	0
by	0
the	0
hicda	3
coding	0
system	0
,	0
specifically	0
focusing	0
on	0
those	0
with	0
the	0
assigned	0
code	0
6961310	5
for	0
chronic	0
plaque	0
psoriasis	0
.	0

in	0
a	0
study	0
examining	0
the	0
efficacy	0
of	0
various	0
treatments	0
for	0
psoriasis	1
,	0
the	0
utilization	0
of	0
medications	0
within	0
the	0
atc	3
code	4
category	0
d05ax	5
(	0
other	0
antipsoriatics	0
for	0
topical	0
use	0
)	0
showed	0
significant	0
improvements	0
in	0
patient	0
outcomes	0
.	0

a	0
study	0
on	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
that	0
the	0
most	0
common	0
subtype	0
,	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
,	0
is	0
designated	0
by	0
the	0
code	0
97353	5
,	0
and	0
it	0
has	0
been	0
observed	0
to	0
exhibit	0
distinct	0
clinical	0
and	0
pathological	0
features	0
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
effectiveness	0
of	0
various	0
cancer	0
treatments	0
,	0
patients	0
treated	0
with	0
protein	1
kinase	2
inhibitor	2
medications	0
were	0
found	0
to	0
specifically	0
benefit	0
from	0
the	0
drug	0
coded	0
8010551	5
in	0
the	0
bnf	3
classification	0
system	0
.	0

in	0
this	0
study	0
,	0
patients	0
diagnosed	0
with	0
bipolar	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
8	4
classification	0
system	0
had	0
a	0
specific	0
code	0
of	0
296	5
.	6
1	6
,	0
and	0
analysis	0
revealed	0
significant	0
differences	0
in	0
symptom	0
presentation	0
compared	0
to	0
other	0
mood	0
disorders	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
ccu002	1
_	2
02	2
hypertension	2
were	0
prescribed	0
antihypertensive	0
medication	0
with	0
a	0
bnf	3
code	4
of	0
0206020c0bcacac	5
,	0
indicating	0
a	0
specific	0
class	0
of	0
drugs	0
recommended	0
for	0
the	0
management	0
of	0
this	0
chronic	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
observed	0
between	0
occupational	0
exposure	0
to	0
aromatic	0
amines	0
and	0
the	0
risk	0
for	0
developing	0
bladder	1
cancer	2
,	0
particularly	0
in	0
those	0
patients	0
with	0
the	0
histological	0
subtype	0
,	0
urothelial	0
carcinoma	0
,	0
as	0
determined	0
by	0
the	0
icd	3
-	4
o	4
code	0
8127	5
.	0

a	0
recent	0
study	0
has	0
revealed	0
that	0
a	0
subset	0
of	0
psoriasis	1
patients	0
were	0
specifically	0
diagnosed	0
with	0
the	0
unclassified	0
variant	0
of	0
the	0
disease	0
,	0
which	0
is	0
marked	0
by	0
the	0
icd	3
-	4
10	4
code	0
l409	5
,	0
and	0
showed	0
varying	0
degrees	0
of	0
symptom	0
severity	0
and	0
response	0
to	0
treatments	0
.	0

a	0
recent	0
study	0
reported	0
a	0
high	0
prevalence	0
of	0
prostate	1
cancer	2
among	0
men	0
aged	0
50	0
and	0
above	0
,	0
with	0
the	0
majority	0
of	0
cases	0
being	0
classified	0
as	0
adenocarcinoma	0
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
system	0
under	0
code	0
8140	5
,	0
indicating	0
further	0
research	0
is	0
needed	0
to	0
understand	0
the	0
genetic	0
factors	0
influencing	0
this	0
disease	0
subtype	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
dermatology	0
patients	0
,	0
a	0
significant	0
proportion	0
were	0
found	0
to	0
have	0
the	0
clinical	0
phenotype	0
of	0
guttate	1
psoriasis	2
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
10	4
coding	0
system	0
as	0
code	0
l40	5
.	6
4	6
,	0
and	0
often	0
associated	0
with	0
streptococcal	0
infection	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
who	0
were	0
diagnosed	0
with	0
multiple	1
myeloma	2
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
had	0
a	0
morphological	0
code	0
of	0
9731	5
,	0
which	0
was	0
equivalent	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
system	0
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
incidence	0
of	0
various	0
hematologic	0
malignancies	0
,	0
researchers	0
found	0
a	0
significant	0
increase	0
in	0
icd	3
-	4
10	4
-	4
cm	4
coded	0
cases	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
specifically	0
,	0
c83	5
.	6
3x	6
coded	0
cases	0
)	0
among	0
patients	0
40	0
years	0
and	0
older	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
,	0
which	0
was	0
classified	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
i82	5
.	6
9	6
,	0
to	0
analyze	0
the	0
potential	0
risk	0
factors	0
and	0
associated	0
comorbidities	0
.	0

a	0
study	0
conducted	0
on	0
individuals	0
suffering	0
from	0
neck	1
pain	2
revealed	0
that	0
the	0
majority	0
of	0
them	0
were	0
diagnosed	0
with	0
sprains	0
and	0
strains	0
of	0
the	0
cervical	0
spine	0
,	0
which	0
are	0
categorically	0
identified	0
under	0
icd	3
-	4
9	4
-	4
cm	4
code	0
846	5
,	0
highlighting	0
the	0
prevalence	0
of	0
this	0
phenotype	0
in	0
relation	0
to	0
the	0
specific	0
coding	0
system	0
.	0

a	0
recent	0
study	0
revealed	0
that	0
asthma	1
primary	2
care	2
patients	0
with	0
a	0
diagnosis	0
documented	0
using	0
the	0
ctv3	3
coding	0
system	0
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
code	0
xakdk	5
,	0
which	0
is	0
associated	0
with	0
severe	0
asthma	0
exacerbations	0
requiring	0
emergency	0
treatment	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
prostate	1
cancer	2
based	0
on	0
the	0
icd	3
-	4
o	4
3	4
code	0
8140	5
,	0
which	0
is	0
the	0
most	0
common	0
histological	0
type	0
of	0
this	0
malignancy	0
,	0
and	0
compared	0
their	0
clinical	0
outcomes	0
with	0
other	0
phenotypes	0
.	0

the	0
study	0
reported	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
pneumonia	1
cases	0
among	0
elderly	0
patients	0
,	0
which	0
were	0
identified	0
using	0
the	0
ccs	3
code	0
112	5
as	0
a	0
standard	0
classification	0
system	0
for	0
disease	0
diagnosis	0
.	0

the	0
study	0
found	0
that	0
patients	0
with	0
migraine	1
were	0
more	0
likely	0
to	0
be	0
prescribed	0
selective	0
serotonin	0
(	0
5	0
-	0
ht1	0
)	0
agonists	0
,	0
classified	0
under	0
the	0
atc	3
code	0
n02cc	5
,	0
as	0
a	0
more	0
effective	0
treatment	0
for	0
managing	0
their	0
headache	0
symptoms	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
to	0
understand	0
the	0
prevalence	0
of	0
narcolepsy	1
in	0
adults	0
,	0
utilizing	0
the	0
icd	3
-	4
10	4
-	4
cm	4
g47	5
.	6
4x	6
coding	0
system	0
for	0
accurate	0
diagnosis	0
and	0
classification	0
of	0
this	0
sleep	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
treated	0
with	0
the	0
protein	1
kinase	2
inhibitor	2
medication	2
sunitinib	0
,	0
which	0
is	0
listed	0
in	0
the	0
bnf	3
under	0
code	0
8010551	5
,	0
demonstrated	0
improved	0
outcomes	0
in	0
combating	0
certain	0
cancer	0
types	0
.	0

in	0
a	0
study	0
investigating	0
the	0
relationship	0
between	0
hormone	0
replacement	0
therapy	0
(	0
hrt	0
)	0
and	0
cancer	0
risk	0
,	0
it	0
was	0
observed	0
that	0
a	0
higher	0
portion	0
of	0
women	0
using	0
hormone	1
replacement	2
therapy	2
received	0
prescriptions	0
with	0
the	0
gprd	3
product	4
code	4
of	0
50200	5
compared	0
to	0
those	0
who	0
did	0
not	0
use	0
hrt	0
.	0

in	0
this	0
study	0
,	0
participants	0
were	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
criteria	0
outlined	0
in	0
the	0
international	3
classification	4
of	4
diseases	4
,	4
10th	4
revision	4
(	4
icd	4
-	4
10	4
)	4
,	0
specifically	0
using	0
the	0
code	5
m06	6
.	6
7	6
,	0
and	0
were	0
subsequently	0
treated	0
with	0
a	0
combination	0
therapy	0
of	0
methotrexate	0
and	0
anti	0
-	0
tnf	0
agents	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
the	0
chronic	0
inflammatory	0
skin	0
disorder	0
hidradenitis	1
suppurativa	2
was	0
analyzed	0
,	0
and	0
cases	0
were	0
identified	0
by	0
the	0
presence	0
of	0
the	0
associated	0
icd	3
-	4
10	4
code	0
l73	5
.	6
2	6
in	0
patients	0
'	0
medical	0
records	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
,	0
which	0
specifically	0
targets	0
malignant	0
neoplasms	0
in	0
various	0
bone	0
marrow	0
origins	0
.	0

in	0
the	0
study	0
,	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
ra	1
(	0
rheumatoid	0
arthritis	0
)	0
were	0
identified	0
using	0
the	0
clinical	3
modification	4
(	0
clin	0
mod	0
.	0
)	0
coding	0
system	0
,	0
specifically	0
code	5
7141	6
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
an	0
increased	0
risk	0
for	0
colon	1
cancer	2
in	0
patients	0
with	0
a	0
history	0
of	0
icd	3
-	4
o	4
-	4
3	4
code	0
c186	5
,	0
which	0
corresponds	0
to	0
malignant	0
neoplasm	0
of	0
the	0
hepatic	0
flexure	0
.	0

in	0
a	0
recent	0
study	0
involving	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
,	0
a	0
significant	0
number	0
were	0
found	0
to	0
have	0
the	0
malignancy	0
classified	0
under	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
with	0
the	0
specific	0
code	0
8140	5
,	0
denoting	0
adenocarcinoma	0
of	0
the	0
prostate	0
.	0

in	0
a	0
cohort	0
study	0
analyzing	0
the	0
effectiveness	0
of	0
various	0
antihypertensive	0
medications	0
,	0
patients	0
with	0
a	0
prescription	0
for	0
betablockers	1
(	2
p1	2
)	2
were	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
,	0
specifically	0
those	0
with	0
the	0
code	0
15730	5
to	0
ensure	0
accurate	0
analysis	0
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
following	0
surgical	0
procedures	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
post	0
-	0
operative	0
diagnosis	0
of	0
dvt	0
,	0
as	0
coded	0
by	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
under	0
the	0
code	0
o87	5
.	6
1	6
,	0
exhibited	0
a	0
higher	0
incidence	0
of	0
complications	0
and	0
longer	0
hospital	0
stays	0
than	0
those	0
without	0
dvt	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
with	0
lower	0
extremity	0
pain	0
,	0
those	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
40	6
/	6
compared	0
to	0
patients	0
without	0
the	0
condition	0
.	0

a	0
retrospective	0
analysis	0
of	0
256	0
patients	0
revealed	0
that	0
124	0
patients	0
were	0
diagnosed	0
with	0
neck	1
pain	2
(	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m432	5
)	0
while	0
being	0
treated	0
for	0
various	0
other	0
neurological	0
disorders	0
in	0
a	0
tertiary	0
care	0
center	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
utilizing	0
the	0
specific	0
code	0
m06	5
.	6
4	6
for	0
selection	0
criteria	0
.	0

in	0
a	0
study	0
of	0
venous	0
thromboembolism	0
,	0
patients	0
were	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
,	0
specifically	0
code	0
i80	5
.	6
1	6
,	0
and	0
were	0
further	0
evaluated	0
for	0
potential	0
risk	0
factors	0
and	0
comorbidities	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
358	0
patients	0
,	0
we	0
observed	0
a	0
high	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
42	6
)	0
associated	0
with	0
multiple	0
comorbidities	0
such	0
as	0
obesity	0
and	0
hypertension	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
using	0
the	0
clinical	3
classification	4
software	4
(	4
ccs	4
)	4
code	0
112	5
,	0
revealing	0
an	0
increased	0
risk	0
of	0
complications	0
in	0
those	0
with	0
underlying	0
comorbidities	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
with	0
a	0
specific	0
focus	0
on	0
those	0
categorized	0
under	0
the	0
code	0
c90	5
.	6
0x	6
,	0
to	0
investigate	0
the	0
epidemiology	0
and	0
clinical	0
characteristics	0
of	0
this	0
malignancy	0
.	0

a	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
multiple	1
myeloma	2
(	0
mm	0
)	0
who	0
were	0
classified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
and	0
had	0
a	0
specific	0
code	0
of	0
9731	5
,	0
analyzing	0
the	0
correlation	0
between	0
various	0
genetic	0
factors	0
and	0
the	0
progression	0
of	0
the	0
disease	0
.	0

a	0
retrospective	0
study	0
analyzed	0
patients	0
with	0
the	0
clinical	0
manifestation	0
of	0
epilepsy	1
(	0
icd	3
-	4
10	4
ca	4
code	0
g41	5
)	0
to	0
investigate	0
the	0
prevalence	0
of	0
comorbid	0
conditions	0
such	0
as	0
cognitive	0
impairment	0
and	0
psychiatric	0
disorders	0
.	0

a	0
total	0
of	0
75	0
patients	0
with	0
prostate	1
cancer	2
were	0
identified	0
,	0
of	0
which	0
62	0
had	0
a	0
histopathological	0
diagnosis	0
coded	0
as	0
8140	5
in	0
the	0
icd	3
-	4
o	4
3	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
found	0
between	0
psoriasis	1
in	0
patients	0
and	0
6961220	5
as	0
per	0
the	0
hicda	3
coding	0
system	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
in	0
understanding	0
disease	0
patterns	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
clin	3
mod	4
.	4
codes	0
7141	5
as	0
a	0
criterion	0
for	0
inclusion	0
,	0
demonstrating	0
the	0
clinical	0
utility	0
of	0
this	0
coding	0
system	0
in	0
tracking	0
disease	0
prevalence	0
.	0

a	0
retrospective	0
analysis	0
of	0
hospital	0
records	0
revealed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
cases	0
,	0
which	0
were	0
assigned	0
the	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
in	0
the	0
electronic	0
medical	0
database	0
over	0
the	0
past	0
decade	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
thrombocytopenic	1
disorders	2
were	0
identified	0
by	0
the	0
icd	3
-	4
9cm	4
code	0
287	5
.	6
5	6
,	0
revealing	0
a	0
higher	0
prevalence	0
of	0
the	0
condition	0
in	0
individuals	0
with	0
autoimmune	0
diseases	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
autoimmune	0
rheumatic	0
disease	0
records	0
,	0
patients	0
with	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
,	0
and	0
their	0
disease	0
progression	0
was	0
compared	0
to	0
that	0
of	0
patients	0
with	0
other	0
inflammatory	0
conditions	0
.	0

in	0
this	0
study	0
,	0
large	0
b	0
-	0
cell	0
lymphoma	0
and	0
multiple	1
myeloma	2
cases	0
were	0
identified	0
using	0
the	0
site	0
-	0
specific	0
icd	3
-	4
o	4
-	4
3	4
site	0
code	0
c42	5
across	0
multiple	0
centers	0
,	0
demonstrating	0
the	0
utility	0
of	0
these	0
coding	0
systems	0
in	0
biomedical	0
research	0
.	0

the	0
study	0
included	0
patients	0
presenting	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
who	0
were	0
assigned	0
the	0
icd	3
-	4
9	4
code	0
200	5
.	6
7	6
based	0
on	0
their	0
specific	0
cancer	0
subtype	0
and	0
staging	0
.	0

a	0
study	0
of	0
epileptic	0
patients	0
in	0
canada	0
found	0
that	0
a	0
significant	0
number	0
were	0
diagnosed	0
with	0
status	1
epilepticus	2
(	0
icd	3
-	4
10	4
-	0
g41	5
)	0
,	0
or	0
recurrent	0
seizures	0
,	0
as	0
in	0
the	0
case	0
of	0
individuals	0
with	0
lennox	0
-	0
gastaut	0
syndrome	0
or	0
dravet	0
syndrome	0
.	0

a	0
retrospective	0
study	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
that	0
the	0
majority	0
were	0
classified	0
under	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
0x	6
,	0
which	0
encompassed	0
various	0
subtypes	0
of	0
the	0
disease	0
.	0

a	0
retrospective	0
study	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
lower	0
extremity	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
found	0
a	0
significant	0
portion	0
of	0
cases	0
coded	0
under	0
the	0
icd	3
-	4
9	4
-	4
d	4
system	0
with	0
the	0
specific	0
453	5
.	6
41	6
code	0
.	0

a	0
retrospective	0
study	0
examining	0
the	0
prevalence	0
of	0
neck	1
pain	2
in	0
south	0
korean	0
adults	0
found	0
that	0
the	0
majority	0
of	0
patients	0
who	0
sought	0
treatment	0
had	0
been	0
clinically	0
diagnosed	0
with	0
cervicalgia	0
,	0
as	0
indicated	0
by	0
hira	3
code	0
g53	5
.	6
0	6
,	0
and	0
had	0
a	0
higher	0
prevalence	0
of	0
chronic	0
symptoms	0
as	0
compared	0
to	0
other	0
disorders	0
.	0

a	0
retrospective	0
study	0
on	0
cohort	0
data	0
revealed	0
that	0
the	0
incidence	0
of	0
icd	3
-	4
7	4
coded	0
203	5
.	6
1	6
multiple	1
myeloma	2
has	0
increased	0
significantly	0
during	0
the	0
analyzed	0
period	0
in	0
a	0
southeast	0
asian	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
efficacy	0
of	0
a	0
specific	0
protein	1
kinase	2
inhibitor	2
medication	2
was	0
assessed	0
in	0
patients	0
using	0
the	0
bnf	3
code	0
8010551	5
to	0
accurately	0
categorize	0
their	0
medical	0
records	0
and	0
treatment	0
history	0
.	0

a	0
recent	0
study	0
observed	0
a	0
higher	0
incidence	0
rate	0
of	0
multiple	1
myeloma	2
(	0
mm	0
)	0
among	0
subjects	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9732	5
,	0
which	0
corresponds	0
to	0
immunoproliferative	0
diseases	0
associated	0
with	0
plasma	0
cell	0
dyscrasias	0
.	0

in	0
a	0
study	0
of	0
512	0
patients	0
with	0
bladder	1
cancer	2
,	0
47	0
%	0
were	0
diagnosed	0
with	0
the	0
subtype	0
classified	0
by	0
icd	3
-	4
o	4
code	0
c67	5
.	6
6	6
,	0
indicating	0
the	0
need	0
for	0
better	0
understanding	0
of	0
this	0
specific	0
phenotype	0
in	0
order	0
to	0
develop	0
targeted	0
treatment	0
options	0
.	0

a	0
study	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
revealed	0
an	0
increased	0
prevalence	0
in	0
those	0
with	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	0
icd	3
-	4
o	4
-	4
3	4
code	0
9800	5
compared	0
to	0
other	0
coding	0
categories	0
within	0
the	0
classification	0
system	0
.	0

in	0
a	0
study	0
examining	0
the	0
effects	0
of	0
ccu002	1
_	2
02	2
hormone	2
replacement	2
therapy	2
(	2
hrt	2
)	2
on	0
postmenopausal	0
women	0
,	0
the	0
researchers	0
utilized	0
the	0
bnf	3
codes	4
system	0
,	0
specifically	0
0604011g0beaaai	5
,	0
to	0
identify	0
and	0
categorize	0
the	0
various	0
types	0
of	0
hrt	0
treatments	0
.	0

in	0
the	0
study	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
,	0
as	0
indicated	0
by	0
ccs	3
code	0
112	5
,	0
were	0
found	0
to	0
have	0
higher	0
rates	0
of	0
hospitalization	0
when	0
compared	0
to	0
those	0
with	0
other	0
respiratory	0
infections	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
seizure	1
disorders	0
were	0
found	0
to	0
have	0
a	0
higher	0
frequency	0
of	0
icd	3
-	4
10	4
ca	4
code	0
g41	5
(	0
status	0
epilepticus	0
)	0
compared	0
to	0
those	0
with	0
other	0
neurological	0
conditions	0
.	0

in	0
a	0
study	0
investigating	0
the	0
prevalence	0
of	0
peripheral	1
ischaemia	2
among	0
diabetic	0
patients	0
,	0
researchers	0
found	0
a	0
higher	0
incidence	0
in	0
individuals	0
who	0
had	0
undergone	0
the	0
arterial	0
bypass	0
procedure	0
with	0
the	0
cpt	3
code	4
35313	5
,	0
compared	0
to	0
those	0
who	0
had	0
not	0
undergone	0
the	0
surgery	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
ca	4
g41	5
within	0
the	0
dataset	0
,	0
and	0
further	0
analysis	0
of	0
comorbidities	0
associated	0
with	0
this	0
neurological	0
condition	0
was	0
conducted	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
that	0
patients	0
diagnosed	0
with	0
the	0
thrombocytopenic	1
disorder	2
under	0
the	0
icd	3
-	4
9cm	4
coding	0
system	0
and	0
assigned	0
the	0
code	0
287	5
.	6
5	6
were	0
more	0
likely	0
to	0
experience	0
bleeding	0
complications	0
during	0
surgical	0
procedures	0
.	0

a	0
recent	0
study	0
analyzing	0
primary	0
care	0
data	0
found	0
an	0
increased	0
incidence	0
of	0
influenza	1
infection	2
in	0
patients	0
with	0
a	0
recorded	0
ctv3	3
code	0
h27y	5
.	6
,	0
suggesting	0
the	0
need	0
for	0
improved	0
preventive	0
measures	0
and	0
targeted	0
vaccination	0
strategies	0
.	0

in	0
a	0
study	0
of	0
early	0
-	0
onset	0
dementia	0
,	0
a	0
significant	0
number	0
of	0
participants	0
were	0
diagnosed	0
with	0
probable	0
alzheimer	1
'	2
s	2
disease	2
(	0
based	0
on	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
with	0
a	0
specific	0
290	5
.	6
2	6
code	0
)	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
effectiveness	0
of	0
a	0
novel	0
treatment	0
for	0
patients	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
categorized	0
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
with	0
the	0
specific	0
code	0
m06	5
.	6
3	6
,	0
and	0
observed	0
a	0
significant	0
improvement	0
in	0
their	0
clinical	0
symptoms	0
and	0
quality	0
of	0
life	0
.	0

in	0
a	0
recent	0
study	0
on	0
influenza	1
infection	2
primary	2
care	2
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
were	0
primarily	0
identified	0
using	0
the	0
ctv3	3
coding	0
system	0
,	0
specifically	0
with	0
the	0
xalt5	5
code	0
,	0
which	0
accurately	0
captures	0
the	0
clinical	0
manifestations	0
of	0
this	0
phenotype	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
between	0
2005	0
and	0
2015	0
,	0
utilizing	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	0
code	0
c42	5
to	0
accurately	0
identify	0
cases	0
and	0
assess	0
their	0
clinical	0
characteristics	0
.	0

the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
in	0
our	0
study	0
population	0
was	0
determined	0
based	0
on	0
the	0
clin	3
mod	4
.	4
codes	4
classification	0
system	0
,	0
with	0
patients	0
considered	0
affected	0
if	0
they	0
had	0
a	0
diagnosis	0
with	0
the	0
specific	0
7142	5
code	0
associated	0
with	0
this	0
condition	0
.	0

a	0
study	0
conducted	0
on	0
a	0
sample	0
of	0
the	0
general	0
population	0
found	0
a	0
significant	0
association	0
between	0
the	0
risk	0
of	0
developing	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
and	0
certain	0
genetic	0
factors	0
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
i80	5
.	6
3	6
for	0
this	0
particular	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
incidence	0
rate	0
when	0
their	0
icd	3
-	4
o	4
-	4
3	4
histology	0
codes	0
matched	0
the	0
specific	0
code	0
m	5
-	6
9732	6
,	0
indicating	0
a	0
distinct	0
relationship	0
between	0
the	0
code	0
and	0
the	0
development	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
an	0
increased	0
incidence	0
of	0
colon	1
cancer	2
in	0
patients	0
with	0
a	0
specific	0
diagnostic	0
code	0
of	0
18	5
.	6
9	6
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
which	0
underlines	0
the	0
importance	0
of	0
early	0
detection	0
and	0
intervention	0
in	0
this	0
population	0
.	0

a	0
study	0
observed	0
that	0
patients	0
suffering	0
from	0
thrombocytopenic	1
disorders	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
when	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
with	0
the	0
specific	0
d69	5
.	6
3	6
code	0
,	0
which	0
caused	0
a	0
review	0
of	0
their	0
diagnostic	0
criteria	0
and	0
management	0
approaches	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
gastrointestinal	0
bleeding	1
disorder	0
were	0
identified	0
using	0
the	0
international	0
classification	0
of	0
diseases	0
,	0
10th	0
revision	0
(	0
icd	3
-	4
10	4
)	0
code	0
of	0
k254	5
to	0
investigate	0
the	0
associated	0
risk	0
factors	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9cm	4
code	0
287	5
.	6
3	6
and	0
were	0
analyzed	0
for	0
potential	0
risk	0
factors	0
and	0
associated	0
clinical	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
chronic	1
pain	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
condition	0
when	0
it	0
was	0
classified	0
under	0
the	0
hira	3
coding	0
system	0
with	0
the	0
specific	0
code	0
g53	5
.	6
0	6
,	0
compared	0
to	0
those	0
with	0
other	0
pain	0
-	0
related	0
diagnoses	0
.	0

a	0
retrospective	0
study	0
analyzed	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
following	0
the	0
icd	3
-	4
9	4
coding	0
system	0
and	0
having	0
a	0
specific	0
code	0
of	0
202	5
,	0
in	0
order	0
to	0
understand	0
the	0
epidemiological	0
factors	0
associated	0
with	0
this	0
malignancy	0
.	0

in	0
the	0
study	0
,	0
individuals	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
criteria	0
with	0
a	0
specific	0
code	0
of	0
m05	5
.	6
x	6
were	0
observed	0
for	0
the	0
potential	0
effects	0
of	0
various	0
treatment	0
approaches	0
on	0
their	0
health	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
exhibiting	0
severe	0
allergic	0
reactions	0
were	0
found	0
to	0
have	0
the	0
phenotype	0
anaphylaxis	1
,	0
which	0
,	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
,	0
corresponds	0
to	0
the	0
code	0
t78	5
.	6
0	6
.	0

peripheral	0
artery	0
disease	0
patients	0
presenting	0
with	0
peripheral	1
ischaemia	2
were	0
found	0
to	0
have	0
an	0
increased	0
likelihood	0
of	0
undergoing	0
revascularization	0
procedures	0
,	0
such	0
as	0
thromboendarterectomy	0
(	0
cpt	3
code	4
35332	5
)	0
,	0
based	0
on	0
their	0
clinical	0
and	0
genetic	0
risk	0
factors	0
.	0

a	0
retrospective	0
study	0
of	0
emergency	0
department	0
visits	0
found	0
that	0
patients	0
presenting	0
with	0
a	0
anaphylaxis	1
episode	0
were	0
frequently	0
assigned	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t88	5
.	6
6	6
,	0
reflecting	0
an	0
adverse	0
effect	0
due	0
to	0
the	0
incorrect	0
administration	0
of	0
a	0
therapeutic	0
agent	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
chronic	1
pain	2
disorder	0
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
hira	3
code	0
g53	5
.	6
0	6
,	0
which	0
is	0
associated	0
with	0
this	0
debilitating	0
phenotype	1
in	0
the	0
korean	0
healthcare	0
system	0
.	0

in	0
the	0
study	0
cohort	0
,	0
prostate	1
cancer	2
patients	0
with	0
a	0
histological	0
type	0
listed	0
under	0
the	0
icd	3
-	4
o	4
3	4
code	0
8140	5
(	0
adenocarcinoma	0
,	0
nos	0
)	0
showed	0
a	0
higher	0
risk	0
of	0
recurrence	0
after	0
radical	0
prostatectomy	0
as	0
compared	0
to	0
other	0
subtypes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
moderate	0
to	0
severe	0
plaque	0
psoriasis	1
were	0
effectively	0
treated	0
using	0
a	0
new	0
drug	0
belonging	0
to	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
encompasses	0
various	0
antipsoriatic	0
agents	0
.	0

a	0
study	0
found	0
that	0
patients	0
with	0
a	0
history	0
of	0
suicidal	1
behaviors	0
were	0
more	0
likely	0
to	0
have	0
oxmis	3
code	0
3009c	5
in	0
their	0
medical	0
records	0
,	0
indicating	0
a	0
predisposition	0
to	0
suicide	1
risk	0
within	0
certain	0
psychiatric	0
disorders	0
.	0

in	0
a	0
study	0
of	0
epilepsy	0
patients	0
,	0
those	0
diagnosed	0
with	0
seizures	1
were	0
assigned	0
the	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
3	6
,	0
allowing	0
for	0
more	0
accurate	0
tracking	0
and	0
analysis	0
of	0
this	0
particular	0
neurological	0
disorder	0
.	0

in	0
our	0
study	0
,	0
we	0
observed	0
that	0
individuals	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
assigned	0
the	0
c82	5
*	6
code	0
series	0
,	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
using	0
the	0
ccs	3
code	0
112	5
,	0
which	0
specifically	0
corresponds	0
to	0
bacterial	0
and	0
unspecified	0
viral	0
pneumonia	0
in	0
the	0
coding	0
system	0
.	0

a	0
retrospective	0
study	0
assessed	0
the	0
prevalence	0
of	0
gastrointestinal	1
hemorrhage	2
among	0
hospitalized	0
patients	0
coded	0
with	0
icd	3
-	4
9	4
534	5
.	6
0	6
,	0
and	0
identified	0
potential	0
risk	0
factors	0
for	0
this	0
condition	0
.	0

a	0
retrospective	0
analysis	0
of	0
electronic	0
medical	0
records	0
showed	0
a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
coded	0
under	0
d69	5
.	6
3	6
according	0
to	0
the	0
icd	3
-	4
10cm	4
classification	0
system	0
among	0
patients	0
treated	0
with	0
certain	0
medications	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
suicidal	0
behavior	0
in	0
patients	0
with	0
different	0
medical	0
conditions	0
identified	0
a	0
higher	0
risk	0
of	0
suicide	1
among	0
individuals	0
diagnosed	0
with	0
specific	0
disorders	0
,	0
which	0
were	0
coded	0
using	0
the	0
oxmis	3
system	0
and	0
included	0
code	0
9779na	5
among	0
others	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
coding	0
systems	0
,	0
and	0
the	0
majority	0
of	0
cases	0
were	0
found	0
to	0
be	0
associated	0
with	0
the	0
9800	5
code	0
.	0

in	0
a	0
large	0
-	0
scale	0
study	0
of	0
dermatological	0
conditions	0
,	0
a	0
significant	0
number	0
of	0
patients	0
were	0
found	0
to	0
have	0
psoriasis	1
as	0
indicated	0
by	0
hicda	3
code	0
6961212	5
,	0
which	0
highlights	0
the	0
potential	0
usefulness	0
of	0
standardized	0
coding	0
systems	0
for	0
diagnosing	0
and	0
tracking	0
phenotypic	0
trends	0
.	0

a	0
retrospective	0
analysis	0
of	0
patient	0
records	0
revealed	0
that	0
those	0
diagnosed	0
with	0
pneumonia	1
(	0
ccs	3
code	0
112	5
)	0
had	0
a	0
significantly	0
higher	0
rate	0
of	0
respiratory	0
complications	0
compared	0
to	0
the	0
general	0
patient	0
population	0
.	0

a	0
retrospective	0
analysis	0
of	0
electronic	0
patient	0
records	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
revealed	0
a	0
significant	0
association	0
between	0
the	0
ccs	3
code	0
112	5
and	0
an	0
increased	0
risk	0
of	0
hospital	0
readmission	0
within	0
30	0
days	0
,	0
warranting	0
further	0
research	0
in	0
infection	0
management	0
practices	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
suffering	0
from	0
the	0
sleep	0
disorder	0
narcolepsy	1
were	0
assigned	0
the	0
appropriate	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
in	0
order	0
to	0
accurately	0
document	0
and	0
track	0
the	0
prevalence	0
of	0
this	0
condition	0
within	0
the	0
patient	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
hospitalized	0
patients	0
with	0
major	0
depressive	0
disorder	0
,	0
it	0
was	0
found	0
that	0
those	0
who	0
had	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
more	0
likely	0
to	0
have	0
an	0
icd	3
-	4
9	4
code	0
of	0
e954	5
(	0
intentional	0
self	0
-	0
poisoning	0
)	0
in	0
their	0
medical	0
records	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
anaphylaxis	1
among	0
patients	0
,	0
which	0
was	0
classified	0
using	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
under	0
the	0
code	0
t88	5
.	6
6	6
and	0
primarily	0
attributed	0
to	0
the	0
use	0
of	0
certain	0
medications	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
when	0
the	0
diagnosis	0
was	0
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
coding	0
systems	0
,	0
specifically	0
with	0
the	0
9800	5
code	0
.	0

in	0
a	0
study	0
conducted	0
on	0
a	0
cohort	0
of	0
patients	0
with	0
hematologic	0
malignancies	0
,	0
multiple	1
myeloma	2
was	0
observed	0
to	0
be	0
the	0
most	0
common	0
neoplasm	0
,	0
characterized	0
by	0
a	0
icd	3
-	4
o	4
-	4
3	4
site	4
c42	5
code	0
,	0
which	0
is	0
associated	0
with	0
plasma	0
cells	0
'	0
involvement	0
in	0
the	0
bone	0
marrow	0
.	0

the	0
study	0
identified	0
a	0
subset	0
of	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	1
)	0
using	0
the	0
cd	3
-	4
9	4
coding	0
system	0
,	0
with	0
a	0
specific	0
710	5
code	0
,	0
which	0
aided	0
in	0
understanding	0
the	0
prevalence	0
and	0
severity	0
of	0
this	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
influenza	1
infection	2
in	2
primary	2
care	2
settings	0
was	0
investigated	0
using	0
ctv3	3
codes	0
,	0
specifically	0
focusing	0
on	0
the	0
xapin	5
code	0
to	0
identify	0
and	0
analyze	0
trends	0
related	0
to	0
this	0
prevalent	0
respiratory	1
illness	2
.	0

in	0
a	0
retrospective	0
study	0
of	0
125	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
,	0
clinicians	0
utilized	0
the	0
icd	3
-	4
8	4
coding	0
system	0
and	0
assigned	0
the	0
specific	0
code	0
203	5
.	6
99	6
to	0
identify	0
and	0
assess	0
the	0
prevalence	0
of	0
this	0
hematologic	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
710	5
)	0
were	0
more	0
likely	0
to	0
have	0
a	0
comorbidity	0
of	0
glomerulonephritis	0
,	0
according	0
to	0
the	0
icd	3
-	4
9	4
coding	0
system	0
.	0

in	0
a	0
study	0
utilizing	0
the	0
general	0
practice	0
research	0
database	0
,	0
patients	0
with	0
a	0
prescription	0
for	0
diuretics	1
were	0
identified	0
by	0
their	0
corresponding	0
gprd	3
product	4
code	4
of	0
17655	5
,	0
and	0
the	0
data	0
was	0
analyzed	0
to	0
evaluate	0
the	0
potential	0
side	0
-	0
effects	0
and	0
clinical	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
patients	0
were	0
found	0
to	0
have	0
a	0
clinical	0
diagnosis	0
of	0
epilepsy	1
,	0
which	0
is	0
categorized	0
under	0
the	0
icd	3
-	4
10	4
ca	4
system	0
with	0
the	0
corresponding	0
g40	5
code	0
,	0
thereby	0
highlighting	0
the	0
need	0
for	0
improved	0
treatment	0
options	0
for	0
this	0
population	0
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
prevalence	0
of	0
sleep	0
disorders	0
in	0
the	0
general	0
population	0
,	0
subjects	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
narcolepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
and	0
evaluated	0
for	0
associated	0
comorbidities	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
a	0
cohort	0
of	0
patients	0
who	0
had	0
been	0
diagnosed	0
with	0
schizoaffective	1
disorder	2
(	0
icd	3
-	4
8	4
code	0
296	5
.	6
8	6
)	0
and	0
treated	0
with	0
various	0
antipsychotic	0
medications	0
to	0
evaluate	0
treatment	0
outcomes	0
and	0
side	0
effect	0
profiles	0
in	0
a	0
tertiary	0
care	0
setting	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
advanced	0
cancer	0
,	0
who	0
were	0
treated	0
with	0
protein	1
kinase	2
inhibitor	2
medication	2
according	0
to	0
the	0
bnf	3
code	0
8010551	5
,	0
showed	0
a	0
significant	0
improvement	0
in	0
overall	0
survival	0
rates	0
and	0
a	0
better	0
response	0
to	0
therapy	0
compared	0
to	0
those	0
who	0
received	0
standard	0
chemotherapy	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
patients	0
who	0
presented	0
with	0
a	0
hemorrhagic	1
stroke	2
were	0
predominantly	0
diagnosed	0
under	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
with	0
a	0
code	0
in	0
the	0
432	5
.	6
xx	6
range	0
.	0

in	0
a	0
study	0
of	0
patients	0
with	0
severe	0
allergic	0
reactions	0
,	0
those	0
who	0
experienced	0
anaphylaxis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t78	5
.	6
0	6
,	0
allowing	0
researchers	0
to	0
further	0
investigate	0
the	0
underlying	0
causes	0
of	0
this	0
life	0
-	0
threatening	0
condition	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
cutaneous	0
and	0
subcutaneous	0
lesions	0
revealed	0
a	0
statistically	0
significant	0
association	0
between	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
71	6
for	0
subcutaneous	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
and	0
patients	0
presenting	0
with	0
b	0
symptoms	0
,	0
such	0
as	0
fever	0
,	0
weight	0
loss	0
,	0
or	0
night	0
sweats	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
individuals	0
diagnosed	0
with	0
prostate	1
cancer	2
had	0
a	0
high	0
prevalence	0
of	0
the	0
malignancy	0
classified	0
as	0
adenocarcinoma	0
using	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
,	0
with	0
a	0
specific	0
code	0
of	0
8140	5
,	0
accounting	0
for	0
a	0
significant	0
proportion	0
of	0
cases	0
in	0
the	0
patient	0
population	0
.	0

a	0
recent	0
study	0
revealed	0
that	0
patients	0
with	0
the	0
specific	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
classified	0
under	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c83	5
.	6
3x	6
,	0
showed	0
a	0
higher	0
prevalence	0
of	0
certain	0
genetic	0
mutations	0
as	0
compared	0
to	0
other	0
lymphoma	0
subtypes	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
seizure	1
disorders	0
,	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10	4
ca	4
coding	0
system	0
under	0
the	0
specific	0
code	0
g40	5
,	0
showed	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
mental	0
health	0
issues	0
than	0
the	0
general	0
population	0
.	0

a	0
study	0
of	0
the	0
prevalence	0
of	0
parkinson	1
'	2
s	2
disease	2
in	0
a	0
specific	0
population	0
utilized	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
and	0
identified	0
cases	0
with	0
the	0
diagnostic	0
code	0
333	5
.	6
0	6
,	0
revealing	0
a	0
significant	0
association	0
between	0
age	0
and	0
disease	0
occurrence	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
primarily	0
diagnosed	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
c91	5
.	6
0	6
*	6
,	0
to	0
identify	0
and	0
classify	0
their	0
disease	0
effectively	0
.	0

a	0
retrospective	0
analysis	0
of	0
1	0
,	0
000	0
patients	0
revealed	0
that	0
200	0
individuals	0
were	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
,	0
with	0
a	0
specific	0
code	0
of	0
m05	5
.	6
x	6
,	0
indicating	0
seropositive	0
ra	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
identified	0
between	0
rheumatoid	1
arthritis	2
and	0
certain	0
genetic	0
variants	0
in	0
patients	0
classified	0
under	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m05	5
.	6
x	6
,	0
providing	0
essential	0
information	0
to	0
further	0
understand	0
the	0
biological	0
mechanisms	0
underlying	0
this	0
autoimmune	0
disorder	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
presenting	0
with	0
seizure	1
episodes	0
were	0
often	0
diagnosed	0
with	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
r56	5
.	6
8	6
,	0
indicating	0
'	0
other	0
and	0
unspecified	0
convulsions	0
'	0
,	0
as	0
a	0
prominent	0
feature	0
of	0
their	0
clinical	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
hyperlipidemia	0
were	0
prescribed	0
a	0
ccu002	1
_	2
02	2
lipid	2
lowering	2
medication	2
identified	0
by	0
the	0
bnf	3
code	4
0212000p0bbacac	5
,	0
and	0
showed	0
significant	0
improvements	0
in	0
their	0
lipid	0
profile	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
who	0
were	0
diagnosed	0
with	0
chronic	1
pain	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
had	0
a	0
specific	0
code	0
of	0
m480	5
,	0
which	0
facilitated	0
a	0
more	0
precise	0
evaluation	0
and	0
treatment	0
plan	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
hospital	0
admissions	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
epilepsy	1
(	0
icd	3
-	4
10	4
ca	4
code	0
g41	5
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
psychiatric	0
disorders	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
retrospective	0
study	0
examined	0
the	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
in	0
hospitalized	0
patients	0
with	0
an	0
established	0
icd	3
-	4
9	4
-	4
d	4
diagnostic	0
code	0
453	5
.	6
40	6
/	6
using	0
doppler	0
ultrasonography	0
as	0
the	0
standard	0
diagnostic	0
modality	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
patients	0
with	0
prostate	1
cancer	2
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
in	0
a	0
large	0
,	0
population	0
-	0
based	0
cohort	0
to	0
examine	0
the	0
association	0
between	0
tumor	0
characteristics	0
and	0
clinical	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
high	0
risk	0
of	0
venous	0
thromboembolism	0
were	0
prescribed	0
the	0
oral	0
anticoagulant	0
rivaroxaban	0
,	0
which	0
is	0
categorized	0
under	0
the	0
ccu002	1
_	2
01	2
anticoagulant	2
medication	2
class	0
and	0
has	0
the	0
bnf	3
code	0
0208020s0bbaaaa	5
,	0
to	0
evaluate	0
its	0
efficacy	0
and	0
safety	0
in	0
clinical	0
practice	0
.	0

a	0
study	0
on	0
olfactory	0
dysfunction	0
discovered	0
that	0
a	0
significant	0
number	0
of	0
participants	0
who	0
were	0
diagnosed	0
with	0
hyposmia	1
had	0
been	0
assigned	0
the	0
code	0
r430	5
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
multiple	1
myeloma	2
(	0
classified	0
using	0
the	0
icd	3
-	4
7	4
code	0
203	5
.	6
0	6
)	0
revealed	0
various	0
clinical	0
manifestations	0
,	0
including	0
bone	0
lesions	0
,	0
renal	0
failure	0
,	0
and	0
anemia	0
.	0

in	0
the	0
study	0
,	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
international	0
classification	0
of	0
diseases	0
for	0
oncology	0
,	0
3rd	0
edition	0
(	0
icd	3
-	4
o	4
-	4
3	4
)	0
with	0
the	0
specific	0
histology	0
code	0
8140	5
,	0
indicating	0
adenocarcinoma	0
as	0
the	0
predominant	0
histological	0
subtype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
,	0
specifically	0
the	0
563	5
.	6
0x	6
series	0
of	0
codes	0
,	0
in	0
order	0
to	0
investigate	0
the	0
prevalence	0
and	0
clinical	0
characteristics	0
of	0
this	0
gastrointestinal	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
risk	0
of	0
renal	0
impairment	0
in	0
hypertensive	0
patients	0
,	0
those	0
prescribed	0
the	0
diuretics	1
thiazide	2
class	0
were	0
identified	0
using	0
general	3
practice	4
research	4
database	4
(	4
gprd	4
)	4
product	0
codes	0
,	0
specifically	0
the	0
code	0
13871	5
for	0
hydrochlorothiazide	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
rate	0
of	0
bladder	1
cancer	2
in	0
patients	0
with	0
a	0
documented	0
medical	0
history	0
of	0
urinary	0
problems	0
was	0
assessed	0
using	0
the	0
icd	3
-	4
o	4
coding	0
system	0
,	0
specifically	0
the	0
c67	5
.	6
7	6
code	0
to	0
accurately	0
identify	0
cases	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
suffering	0
from	0
migraine	1
showed	0
a	0
significant	0
improvement	0
in	0
their	0
symptoms	0
when	0
treated	0
with	0
a	0
new	0
drug	0
belonging	0
to	0
the	0
atc	3
classification	0
system	0
under	0
the	0
code	0
n02cx	5
,	0
which	0
includes	0
other	0
analgesics	0
and	0
antipyretics	0
.	0

during	0
a	0
recent	0
study	0
,	0
researchers	0
observed	0
an	0
increased	0
risk	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
in	0
patients	0
with	0
the	0
disorder	0
coded	0
as	0
67101	5
–	6
in	0
the	0
icd	3
-	4
8	4
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
psoriasis	1
were	0
found	0
to	0
be	0
frequently	0
prescribed	0
medications	0
belonging	0
to	0
the	0
atc	3
code	4
d05ax	5
,	0
a	0
group	0
of	0
miscellaneous	0
topical	0
agents	0
used	0
for	0
treating	0
skin	0
disorders	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
an	0
increased	0
incidence	0
of	0
multiple	1
myeloma	2
in	0
patients	0
with	0
a	0
medical	0
history	0
coded	0
as	0
203	5
.	6
99	6
under	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
signifying	0
a	0
strong	0
association	0
between	0
this	0
particular	0
code	0
and	0
the	0
disease	0
phenotype	0
.	0

the	0
study	0
found	0
a	0
significant	0
association	0
between	0
exposure	0
to	0
pesticides	0
and	0
an	0
increased	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
coded	0
as	0
c83	5
.	6
3	6
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
)	0
.	0

in	0
a	0
recent	0
study	0
on	0
chronic	1
pain	2
,	0
researchers	0
utilized	0
the	0
hira	3
coding	0
system	0
to	0
identify	0
patients	0
with	0
a	0
diagnosis	0
of	0
g53	5
.	6
0	6
,	0
which	0
is	0
associated	0
with	0
postherpetic	0
neuralgia	0
as	0
a	0
source	0
of	0
persistent	0
discomfort	0
.	0

a	0
study	0
investigating	0
the	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
in	0
hospitalized	0
patients	0
found	0
a	0
significant	0
correlation	0
between	0
dvt	0
and	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
i82	5
.	6
8	6
,	0
which	0
represents	0
"	0
other	0
venous	0
embolism	0
and	0
thrombosis	0
of	0
unspecified	0
deep	0
vessels	0
of	0
lower	0
extremities	0
.	0
"	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
using	0
the	0
canadian	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
,	0
particularly	0
when	0
classified	0
under	0
code	0
m05	5
.	6
x	6
for	0
seropositive	0
ra	0
cases	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
bladder	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
c67	5
.	6
5	6
,	0
to	0
investigate	0
the	0
potential	0
association	0
between	0
genetic	0
variants	0
and	0
disease	0
risk	0
.	0

a	0
retrospective	0
study	0
analyzed	0
the	0
efficiency	0
of	0
endovenous	0
treatment	0
for	0
peripheral	1
ischaemia	2
using	0
cpt	3
codes	4
and	0
found	0
that	0
the	0
procedure	0
with	0
the	0
highest	0
success	0
rate	0
was	0
occlusive	0
balloon	0
angioplasty	0
(	0
35562	5
)	0
in	0
the	0
lower	0
extremity	0
arteries	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
were	0
found	0
to	0
have	0
been	0
assigned	0
the	0
cd	3
-	4
9	4
code	0
710	5
,	0
which	0
highlights	0
the	0
importance	0
of	0
accurate	0
coding	0
for	0
this	0
complex	0
autoimmune	0
disease	0
.	0

in	0
this	0
study	0
,	0
participants	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
prostate	1
cancer	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
c61	5
and	0
histology	0
code	0
54	5
,	0
representing	0
adenocarcinoma	0
of	0
the	0
prostate	0
gland	0
.	0

in	0
a	0
recent	0
study	0
on	0
psoriasis	1
treatment	0
,	0
medications	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
were	0
found	0
to	0
be	0
effective	0
in	0
reducing	0
disease	0
severity	0
and	0
improving	0
patient	0
quality	0
of	0
life	0
.	0

in	0
a	0
study	0
investigating	0
the	0
prevalence	0
of	0
cardiovascular	0
risk	0
factors	0
,	0
patients	0
with	0
a	0
recorded	0
ccu002	1
_	2
02	2
hypertension	2
phenotype	0
were	0
more	0
likely	0
to	0
be	0
prescribed	0
medication	0
with	0
bnf	3
code	4
0205051i0aaauau	5
(	0
ramipril	0
)	0
as	0
part	0
of	0
their	0
antihypertensive	0
treatment	0
regimen	0
.	0

in	0
a	0
study	0
of	0
patients	0
with	0
peripheral	0
vascular	0
disease	0
,	0
the	0
incidence	0
of	0
peripheral	1
ischaemia	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
those	0
who	0
underwent	0
surgical	0
procedures	0
,	0
as	0
indicated	0
by	0
cpt	3
code	0
35357	5
,	0
to	0
restore	0
blood	0
flow	0
in	0
the	0
affected	0
areas	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
a	0
significant	0
association	0
between	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
and	0
certain	0
occupational	0
exposures	0
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
,	0
with	0
a	0
higher	0
prevalence	0
of	0
nhl	0
cases	0
among	0
individuals	0
assigned	0
the	0
c82	5
*	6
code	0
series	0
.	0

a	0
study	0
conducted	0
on	0
patients	0
who	0
were	0
prescribed	0
ace	1
inhibitors	2
revealed	0
that	0
the	0
prescription	0
rate	0
for	0
these	0
medications	0
,	0
particularly	0
those	0
with	0
the	0
gprd	3
product	4
code	4
35007	5
,	0
has	0
significantly	0
increased	0
in	0
recent	0
years	0
due	0
to	0
their	0
efficacy	0
in	0
treating	0
hypertension	0
and	0
heart	0
failure	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
pneumonia	1
were	0
identified	0
using	0
ccs	3
code	0
112	5
,	0
which	0
allowed	0
for	0
a	0
more	0
accurate	0
assessment	0
of	0
pneumonia	0
prevalence	0
and	0
health	0
resource	0
utilization	0
in	0
the	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
analyzing	0
the	0
prevalence	0
of	0
various	0
skin	0
conditions	0
,	0
patients	0
diagnosed	0
with	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
code	0
6961220	5
from	0
medical	0
records	0
within	0
a	0
large	0
healthcare	0
database	0
.	0

in	0
a	0
recent	0
study	0
involving	0
patients	0
with	0
acute	0
myocardial	0
infarction	0
,	0
a	0
significant	0
proportion	0
developed	0
cardiogenic	1
shock	2
which	0
was	0
documented	0
using	0
the	0
icd	3
-	4
10cm	4
code	0
r57	5
.	6
0	6
in	0
their	0
medical	0
records	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	1
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
710	5
,	0
which	0
is	0
categorized	0
under	0
the	0
connective	0
tissue	0
disorders	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	1
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
coding	0
systems	0
,	0
specifically	0
the	0
9820	5
code	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
d	4
classification	0
code	0
453	5
.	6
40	6
/	6
to	0
assess	0
the	0
prevalence	0
of	0
this	0
condition	0
among	0
hospitalized	0
patients	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
classified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
under	0
the	0
code	0
m06	5
.	6
x	6
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
cardiovascular	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
with	0
a	0
specific	0
focus	0
on	0
those	0
assigned	0
the	0
code	0
c82	5
.	6
xx	6
to	0
better	0
understand	0
the	0
prevalence	0
and	0
clinical	0
characteristics	0
of	0
this	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histological	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9731	6
,	0
revealing	0
novel	0
insights	0
into	0
disease	0
progression	0
and	0
management	0
strategies	0
.	0

in	0
a	0
study	0
evaluating	0
the	0
prevalence	0
of	0
hypertension	0
,	0
patients	0
exhibiting	0
the	0
phenotype	0
ccu002	1
_	2
02	2
hypertension	2
were	0
found	0
to	0
have	0
been	0
prescribed	0
antihypertensive	0
medications	0
with	0
bnf	3
codes	4
such	0
as	0
0206020c0aabhbh	5
for	0
treatment	0
.	0

a	0
study	0
conducted	0
in	0
primary	0
care	0
settings	0
examined	0
the	0
prevalence	0
of	0
influenza	1
infection	2
among	0
patients	0
with	0
the	0
ctv3	3
code	0
hyu06	5
,	0
showing	0
increased	0
susceptibility	0
to	0
the	0
infection	0
and	0
potential	0
implications	0
for	0
vaccination	0
strategies	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
colon	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
0	4
-	4
3	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
c182	5
,	0
which	0
represents	0
malignant	0
neoplasms	0
of	0
the	0
cecum	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
were	0
found	0
to	0
have	0
the	0
clinical	3
modification	4
code	4
of	0
714	5
.	6
2	6
,	0
which	0
matches	0
the	0
criteria	0
specified	0
in	0
the	0
international	0
classification	0
of	0
diseases	0
,	0
ninth	0
revision	0
(	0
icd	3
-	4
9	4
-	4
cm	4
)	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
and	0
evaluated	0
for	0
comorbid	0
autoimmune	0
diseases	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
clinical	0
characteristics	0
of	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
c83	5
.	6
1x	6
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
focusing	0
on	0
their	0
treatment	0
outcomes	0
and	0
survival	0
rates	0
.	0

a	0
study	0
on	0
the	0
prevalence	0
of	0
skin	0
conditions	0
in	0
children	0
found	0
that	0
the	0
most	0
common	0
diagnosis	0
was	0
atopic	1
dermatitis	2
(	0
icd	3
-	4
10	4
code	0
l20	5
)	0
,	0
with	0
the	0
highest	0
incidence	0
rates	0
observed	0
in	0
infants	0
and	0
toddlers	0
.	0

in	0
a	0
recent	0
study	0
on	0
autoimmune	0
diseases	0
,	0
researchers	0
found	0
a	0
strong	0
association	0
between	0
the	0
clin	3
mod	4
code	0
7142	5
and	0
the	0
phenotype	0
rheumatoid	1
arthritis	2
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
in	0
the	0
analysis	0
of	0
patient	0
data	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
who	0
were	0
prescribed	0
strong	1
analgesics	2
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
developing	0
opioid	0
dependence	0
,	0
as	0
indicated	0
by	0
the	0
gprd	3
product	4
codes	4
associated	0
with	0
these	0
medications	0
,	0
specifically	0
2928009	5
,	0
which	0
has	0
been	0
linked	0
to	0
a	0
higher	0
rate	0
of	0
substance	0
abuse	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
associations	0
between	0
lifestyle	0
factors	0
and	0
patients	0
diagnosed	0
with	0
psoriasis	1
(	0
icd	3
-	4
10	4
code	0
:	0
l401	5
)	0
were	0
analyzed	0
,	0
leading	0
to	0
a	0
better	0
understanding	0
of	0
potential	0
intervention	0
points	0
for	0
this	0
chronic	0
skin	0
condition	0
.	0

in	0
the	0
study	0
,	0
patients	0
presenting	0
with	0
peripheral	1
ischaemia	2
underwent	0
a	0
surgical	0
intervention	0
,	0
which	0
was	0
coded	0
as	0
35564	5
according	0
to	0
the	0
cpt	3
coding	4
system	4
,	0
to	0
evaluate	0
the	0
effectiveness	0
of	0
the	0
procedure	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
gm	4
code	0
c91	5
.	6
0	6
*	6
,	0
and	0
their	0
clinical	0
outcomes	0
were	0
analyzed	0
to	0
assess	0
the	0
effectiveness	0
of	0
different	0
treatment	0
modalities	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
peripheral	1
ischaemia	2
were	0
treated	0
using	0
endovascular	0
revascularization	0
,	0
which	0
was	0
coded	0
under	0
the	0
cpt	3
system	0
with	0
a	0
specific	0
35459	5
code	0
for	0
balloon	0
angioplasty	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
mm	0
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
specific	0
icd	3
-	4
o	4
-	4
3	4
histology	4
code	0
m	5
-	6
9732	6
,	0
indicating	0
a	0
possible	0
association	0
between	0
this	0
subtype	0
of	0
mm	0
and	0
certain	0
genetic	0
factors	0
.	0

in	0
this	0
cross	0
-	0
sectional	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
primary	0
sjogren	1
'	2
s	2
syndrome	2
(	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
)	0
were	0
compared	0
to	0
a	0
control	0
group	0
to	0
investigate	0
the	0
prevalence	0
of	0
sicca	0
symptoms	0
and	0
related	0
manifestations	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
a	0
significant	0
correlation	0
between	0
the	0
expression	0
of	0
certain	0
genes	0
and	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
7	4
code	0
203	5
.	6
1	6
)	0
in	0
a	0
population	0
of	0
patients	0
with	0
various	0
hematological	0
malignancies	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	4
c42	5
,	0
which	0
is	0
a	0
specific	0
coding	0
system	0
for	0
neoplasms	0
and	0
related	0
disorders	0
in	0
the	0
biomedical	0
literature	0
.	0

a	0
study	0
of	0
individuals	0
in	0
a	0
psychiatric	0
facility	0
identified	0
those	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
,	0
with	0
a	0
significant	0
portion	0
having	0
been	0
assigned	0
the	0
oxmis	3
code	4
3009c	5
,	0
indicating	0
a	0
predisposition	0
for	0
suicidal	0
behavior	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
correlation	0
between	0
genetic	0
mutations	0
and	0
the	0
development	0
of	0
bladder	1
cancer	2
in	0
patients	0
with	0
urothelial	1
carcinoma	2
,	0
specifically	0
those	0
identified	0
with	0
the	0
diagnostic	0
code	0
8043	5
in	0
the	0
icd	3
-	4
o	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
evaluating	0
the	0
efficacy	0
of	0
various	0
treatments	0
for	0
psoriasis	1
,	0
treatments	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
(	0
other	0
antipsoriatics	0
for	0
topical	0
use	0
)	0
were	0
found	0
to	0
be	0
significantly	0
effective	0
in	0
managing	0
the	0
symptoms	0
and	0
severity	0
of	0
the	0
disease	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
multiple	1
myeloma	2
found	0
that	0
those	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9732	6
exhibited	0
a	0
distinct	0
clinical	0
course	0
and	0
response	0
to	0
treatment	0
compared	0
to	0
patients	0
with	0
other	0
mm	0
subtypes	0
.	0

a	0
retrospective	0
study	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
7	4
code	0
203	5
.	6
0	6
)	0
revealed	0
that	0
those	0
who	0
received	0
early	0
treatment	0
showed	0
a	0
better	0
prognosis	0
than	0
patients	0
with	0
delayed	0
treatment	0
initiation	0
.	0

in	0
a	0
retrospective	0
study	0
examining	0
the	0
prevalence	0
of	0
various	0
malignancies	0
,	0
a	0
significant	0
number	0
of	0
patients	0
were	0
found	0
to	0
have	0
been	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
icd	3
-	4
9	4
-	4
cm	4
code	0
204	5
.	6
1x	6
)	0
among	0
other	0
cancer	0
types	0
.	0

a	0
study	0
of	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
colon	1
cancer	2
(	0
coded	0
as	0
c187	5
in	0
the	0
icd	3
-	4
0	4
-	4
3	4
classification	0
system	0
)	0
demonstrated	0
a	0
significant	0
association	0
between	0
certain	0
lifestyle	0
factors	0
and	0
tumor	0
aggressiveness	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
association	0
of	0
polymorphisms	0
in	0
the	0
il	0
-	0
23r	0
gene	0
with	0
susceptibility	0
to	0
psoriasis	1
using	0
patients	0
diagnosed	0
with	0
the	0
disease	0
based	0
on	0
icd	3
-	4
10	4
classification	0
and	0
code	0
l401	5
in	0
a	0
diverse	0
population	0
cohort	0
.	0

in	0
a	0
study	0
analyzing	0
the	0
prevalence	0
of	0
cardiogenic	1
shock	2
in	0
hospitalized	0
patients	0
,	0
researchers	0
found	0
that	0
a	0
significant	0
number	0
of	0
these	0
patients	0
had	0
a	0
ccs	3
code	0
of	0
101	5
,	0
indicating	0
a	0
diagnosis	0
of	0
this	0
severe	0
cardiac	0
condition	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
showed	0
a	0
strong	0
association	0
between	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
and	0
various	0
phenotypic	0
manifestations	0
,	0
such	0
as	0
bone	0
lesions	0
and	0
renal	0
insufficiency	0
.	0

a	0
retrospective	0
study	0
on	0
the	0
clinical	0
presentation	0
of	0
anaphylaxis	1
revealed	0
a	0
significant	0
proportion	0
of	0
patients	0
being	0
diagnosed	0
with	0
the	0
condition	0
under	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
,	0
specifically	0
assigned	0
the	0
code	0
t88	5
.	6
6	6
,	0
indicating	0
a	0
severe	0
allergic	0
reaction	0
.	0

in	0
a	0
study	0
examining	0
the	0
effectiveness	0
of	0
various	0
antihypertensive	0
medications	0
,	0
researchers	0
utilized	0
the	0
general	0
practice	0
research	0
database	0
(	0
gprd	0
)	0
for	0
patient	0
data	0
and	0
identified	0
those	0
prescribed	0
antihypertensive	1
drugs	2
associated	0
with	0
the	0
gprd	3
product	4
code	4
20591	5
to	0
gauge	0
their	0
impact	0
on	0
blood	0
pressure	0
control	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
analyzed	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
among	0
patients	0
,	0
utilizing	0
the	0
second	0
edition	0
of	0
the	0
international	0
classification	0
of	0
diseases	0
for	0
oncology	0
(	0
icd	3
-	4
o	4
-	4
2	4
)	0
coding	0
system	0
and	0
identified	0
a	0
strong	0
association	0
with	0
the	0
specific	0
code	0
9670	5
for	0
this	0
particular	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
analyzing	0
outcomes	0
of	0
patients	0
with	0
cardiogenic	1
shock	2
,	0
researchers	0
found	0
that	0
those	0
classified	0
under	0
the	0
ccs	3
code	0
97	5
had	0
a	0
higher	0
mortality	0
rate	0
compared	0
to	0
other	0
forms	0
of	0
the	0
clinical	0
condition	0
.	0

in	0
the	0
study	0
,	0
patients	0
diagnosed	0
with	0
psoriasis	1
were	0
prescribed	0
medications	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
represents	0
a	0
group	0
of	0
antipsoriatics	0
for	0
topical	0
use	0
,	0
in	0
order	0
to	0
manage	0
the	0
severity	0
and	0
progression	0
of	0
their	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
code	0
m	5
-	6
9732	6
,	0
which	0
indicates	0
a	0
specific	0
subtype	0
of	0
this	0
malignant	0
plasma	0
cell	0
neoplasm	0
.	0

in	0
a	0
recent	0
study	0
,	0
suicide	1
rates	0
were	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
patients	0
with	0
a	0
diagnosis	0
of	0
icd	3
-	4
10	4
code	0
y33	5
,	0
which	0
refers	0
to	0
events	0
of	0
undetermined	0
intent	0
,	0
suggesting	0
a	0
potential	0
underestimation	0
of	0
actual	0
suicidal	1
behaviors	0
in	0
the	0
population	0
.	0

a	0
retrospective	0
analysis	0
of	0
hospital	0
admissions	0
revealed	0
an	0
increased	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
patients	0
,	0
with	0
the	0
majority	0
of	0
cases	0
being	0
coded	0
under	0
the	0
m06	5
.	6
x	6
category	0
in	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
cancer	0
were	0
prescribed	0
protein	1
kinase	2
inhibitor	2
medications	0
,	0
specifically	0
those	0
with	0
the	0
bnf	3
code	0
8010551	5
,	0
to	0
evaluate	0
their	0
efficacy	0
in	0
reducing	0
tumor	0
growth	0
and	0
improving	0
overall	0
survival	0
rates	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
individuals	0
affected	0
by	0
the	0
thrombocytopenic	1
disorder	2
known	0
as	0
immune	0
thrombocytopenic	0
purpura	0
(	0
itp	0
)	0
were	0
significantly	0
more	0
likely	0
to	0
have	0
the	0
icd	3
-	4
10cm	4
code	0
d69	5
.	6
3	6
in	0
their	0
medical	0
records	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
for	0
this	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
a	0
significant	0
correlation	0
between	0
certain	0
genetic	0
mutations	0
and	0
the	0
development	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
in	0
patients	0
,	0
specifically	0
those	0
with	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
code	0
c82	5
*	6
,	0
which	0
encompasses	0
various	0
subtypes	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
strong	0
association	0
was	0
found	0
between	0
the	0
colon	1
cancer	2
phenotype	0
and	0
a	0
specific	0
genetic	0
locus	0
in	0
patients	0
with	0
the	0
histopathological	0
code	0
c180	5
from	0
the	0
icd	3
-	4
0	4
-	4
3	4
classification	0
system	0
.	0

a	0
recent	0
study	0
reported	0
that	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
with	0
a	0
specific	0
9731	5
code	0
exhibited	0
diverse	0
clinical	0
presentations	0
and	0
outcomes	0
,	0
emphasizing	0
the	0
need	0
for	0
continuous	0
research	0
and	0
treatment	0
advancements	0
.	0

in	0
the	0
recent	0
study	0
,	0
participants	0
diagnosed	0
with	0
psoriasis	1
pustulosa	0
palmoplantaris	0
had	0
a	0
significantly	0
higher	0
prevalence	0
of	0
hospitalization	0
under	0
the	0
icd	3
-	4
10	4
classification	0
,	0
specifically	0
with	0
the	0
code	0
l403	5
,	0
as	0
compared	0
to	0
those	0
with	0
other	0
dermatological	0
phenotypes	0
.	0

in	0
a	0
study	0
examining	0
the	0
risk	0
factors	0
associated	0
with	0
suicidal	0
behavior	0
,	0
patients	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
identified	0
using	0
the	0
oxmis	3
codes	4
,	0
specifically	0
code	0
3009bn	5
,	0
which	0
indicates	0
a	0
previous	0
suicide	0
attempt	0
in	0
their	0
medical	0
records	0
.	0

in	0
a	0
study	0
of	0
patients	0
with	0
dermatological	0
conditions	0
,	0
those	0
with	0
a	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
coding	0
system	0
and	0
had	0
an	0
associated	0
code	0
of	0
6961213	5
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
found	0
between	0
individuals	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
m06	5
.	6
0	6
)	0
in	0
the	0
icd	3
-	4
10	4
classification	0
system	0
and	0
an	0
increased	0
risk	0
of	0
developing	0
cardiovascular	0
diseases	0
.	0

a	0
recent	0
study	0
showed	0
a	0
strong	0
association	0
between	0
the	0
icd	3
-	4
10	4
code	0
l400	5
and	0
the	0
onset	0
of	0
psoriasis	1
among	0
patients	0
with	0
other	0
chronic	0
co	0
-	0
morbidities	0
.	0

in	0
a	0
study	0
investigating	0
the	0
efficacy	0
of	0
medications	0
for	0
the	0
treatment	0
of	0
migraine	1
disorders	0
,	0
it	0
was	0
found	0
that	0
drugs	0
with	0
the	0
atc	3
code	0
n02ca	5
were	0
significantly	0
more	0
effective	0
than	0
placebo	0
in	0
reducing	0
the	0
frequency	0
and	0
intensity	0
of	0
migraine	0
attacks	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
terminology	0
,	0
specifically	0
code	0
m06	5
.	6
x	6
,	0
to	0
explore	0
the	0
relationship	0
between	0
ra	0
and	0
cardiovascular	0
risk	0
factors	0
.	0

a	0
retrospective	0
study	0
analyzed	0
the	0
prevalence	0
of	0
multiple	1
myeloma	2
in	0
a	0
patient	0
cohort	0
,	0
utilizing	0
the	0
icd	3
-	4
7	4
coding	0
system	0
and	0
reported	0
an	0
increased	0
number	0
of	0
cases	0
with	0
the	0
specific	0
code	0
203	5
.	6
1	6
assigned	0
to	0
this	0
malignancy	0
.	0

during	0
a	0
recent	0
study	0
,	0
investigators	0
found	0
a	0
strong	0
association	0
between	0
ccu002	1
_	2
01	2
hypertension	2
and	0
the	0
medication	0
with	0
bnf	3
code	4
020400080aaaeae	5
among	0
a	0
diverse	0
population	0
of	0
patients	0
,	0
emphasizing	0
the	0
importance	0
of	0
proper	0
pharmacovigilance	0
and	0
adherence	0
to	0
prescribing	0
guidelines	0
.	0

in	0
a	0
recent	0
study	0
examining	0
patients	0
with	0
cardiogenic	1
shock	2
,	0
researchers	0
observed	0
that	0
the	0
majority	0
were	0
classified	0
under	0
code	0
97	5
within	0
the	0
ccs	3
(	0
clinical	0
classifications	0
software	0
)	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
a	0
significant	0
number	0
of	0
patients	0
diagnosed	0
with	0
a	0
thrombocytopenic	1
disorder	2
were	0
identified	0
as	0
having	0
a	0
span	0
class	0
=	0
'	0
coding	0
_	0
system	0
'	0
>	0
icd	0
-	0
10cm	0
code	0
of	0
d69	5
.	6
3	6
,	0
which	0
corresponds	0
to	0
immune	0
thrombocytopenic	0
purpura	0
(	0
itp	0
)	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
chronic	1
pain	2
among	0
elderly	0
patients	0
in	0
south	0
korea	0
found	0
that	0
35	0
%	0
of	0
the	0
participants	0
reported	0
experiencing	0
this	0
condition	0
,	0
with	0
the	0
majority	0
of	0
cases	0
being	0
classified	0
under	0
the	0
hira	3
code	0
g53	5
.	6
0	6
for	0
nerve	0
root	0
and	0
plexus	0
disorders	0
.	0

a	0
retrospective	0
analysis	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
revealed	0
that	0
the	0
majority	0
were	0
assigned	0
the	0
9731	5
code	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
and	0
exhibited	0
various	0
associated	0
phenotypes	0
such	0
as	0
anemia	0
,	0
renal	0
impairment	0
,	0
and	0
bone	0
lesions	0
.	0

in	0
the	0
cohort	0
study	0
conducted	0
on	0
pediatric	0
patients	0
,	0
those	0
diagnosed	0
and	0
classified	0
with	0
epilepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
39	6
,	0
allowing	0
for	0
accurate	0
evaluation	0
of	0
symptom	0
severity	0
and	0
treatment	0
response	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
association	0
between	0
rheumatoid	1
arthritis	2
and	0
certain	0
environmental	0
factors	0
in	0
patients	0
with	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m06	5
.	6
x	6
,	0
highlighting	0
the	0
need	0
for	0
further	0
research	0
in	0
gene	0
-	0
environment	0
interactions	0
contributing	0
to	0
this	0
chronic	0
inflammatory	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
were	0
identified	0
using	0
the	0
cpt	3
code	4
35369	5
to	0
assess	0
the	0
efficacy	0
of	0
novel	0
treatment	0
options	0
for	0
this	0
debilitating	0
condition	0
.	0

the	0
study	0
examined	0
the	0
prevalence	0
of	0
icd	3
-	4
7	4
coded	0
203	5
.	6
1	6
multiple	1
myeloma	2
among	0
patients	0
in	0
a	0
population	0
-	0
based	0
registry	0
,	0
focusing	0
on	0
potential	0
risk	0
factors	0
and	0
survival	0
rates	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
the	0
ccu002	1
_	2
02	2
hormone	2
replacement	2
therapy	2
(	2
hrt	2
)	2
phenotype	0
were	0
found	0
to	0
have	0
a	0
higher	0
risk	0
of	0
developing	0
breast	0
cancer	0
,	0
particularly	0
when	0
prescribed	0
a	0
medication	0
with	0
the	0
bnf	3
code	4
0604011g0bcagbr	5
in	0
their	0
treatment	0
regimen	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
observed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
cases	0
,	0
specifically	0
coded	0
as	0
9593	5
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
classification	0
system	0
,	0
among	0
the	0
adult	0
population	0
in	0
the	0
united	0
states	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
was	0
found	0
to	0
be	0
higher	0
in	0
patients	0
with	0
the	0
icd	3
-	4
o	4
-	4
2	4
9695	5
code	0
,	0
which	0
corresponds	0
to	0
a	0
specific	0
subtype	0
of	0
the	0
disease	0
.	0

in	0
the	0
study	0
,	0
patients	0
treated	0
with	0
antihypertensives	1
were	0
identified	0
by	0
the	0
presence	0
of	0
gprd	3
product	4
codes	4
such	0
as	0
40711	5
,	0
which	0
correspond	0
to	0
the	0
use	0
of	0
angiotensin	0
-	0
converting	0
enzyme	0
inhibitors	0
in	0
the	0
treatment	0
of	0
hypertension	0
.	0

in	0
a	0
study	0
investigating	0
the	0
efficacy	0
of	0
the	0
novel	0
antipsoriatic	0
agent	0
,	0
which	0
is	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
,	0
researchers	0
observed	0
a	0
significant	0
improvement	0
in	0
patients	0
suffering	0
from	0
moderate	0
to	0
severe	0
psoriasis	1
compared	0
to	0
the	0
placebo	0
group	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
we	0
analyzed	0
medical	0
records	0
of	0
male	0
patients	0
aged	0
50	0
-	0
75	0
years	0
who	0
were	0
diagnosed	0
with	0
prostate	1
cancer	2
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
code	0
8140	5
and	0
were	0
treated	0
with	0
radical	0
prostatectomy	0
in	0
a	0
tertiary	0
care	0
hospital	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
revealed	0
that	0
the	0
majority	0
of	0
the	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m06	5
.	6
x	6
,	0
indicating	0
a	0
significant	0
prevalence	0
of	0
this	0
autoimmune	0
disorder	0
in	0
the	0
studied	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
psoriasis	1
was	0
assessed	0
among	0
individuals	0
with	0
an	0
assigned	0
icd	3
-	4
10	4
code	0
of	0
l40008	5
,	0
which	0
specifically	0
targets	0
this	0
chronic	0
skin	0
condition	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
,	0
utilizing	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
,	0
to	0
investigate	0
its	0
association	0
with	0
various	0
clinical	0
manifestations	0
and	0
comorbidities	0
.	0

a	0
study	0
of	0
5	0
-	0
year	0
survival	0
rates	0
in	0
patients	0
with	0
multiple	1
myeloma	2
(	0
coded	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
system	0
,	0
with	0
a	0
specific	0
code	0
of	0
9732	5
)	0
revealed	0
improved	0
outcomes	0
in	0
the	0
most	0
recent	0
decade	0
compared	0
to	0
the	0
previous	0
one	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
cardiogenic	1
shock	2
was	0
analyzed	0
in	0
patients	0
with	0
the	0
diagnosis	0
code	0
106	5
in	0
the	0
ccs	3
(	0
clinical	0
classifications	0
software	0
)	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
a	0
significant	0
association	0
between	0
a	0
specific	0
genetic	0
variation	0
and	0
development	0
of	0
bladder	1
cancer	2
in	0
patients	0
who	0
were	0
assigned	0
the	0
8124	5
code	0
according	0
to	0
the	0
icd	3
-	4
o	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
clin	3
mod	4
.	4
codes	4
7141	5
were	0
found	0
to	0
exhibit	0
the	0
rheumatoid	1
arthritis	2
phenotype	0
,	0
prompting	0
further	0
investigation	0
into	0
potential	0
biomarkers	0
and	0
therapeutic	0
targets	0
for	0
this	0
debilitating	0
disease	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
according	0
to	0
the	0
icd	3
-	4
10am	4
code	0
g41	5
showed	0
various	0
clinical	0
manifestations	0
,	0
including	0
seizure	0
frequency	0
,	0
type	0
,	0
and	0
duration	0
,	0
highlighting	0
the	0
importance	0
of	0
multidisciplinary	0
management	0
and	0
individualized	0
treatment	0
plans	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
risk	0
factors	0
and	0
survival	0
outcomes	0
of	0
patients	0
with	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
,	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
with	0
a	0
specific	0
9670	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
migraine	1
diagnosis	0
were	0
found	0
to	0
be	0
significantly	0
more	0
likely	0
to	0
be	0
prescribed	0
medications	0
from	0
the	0
atc	3
code	0
n02ca	5
,	0
which	0
includes	0
various	0
serotonin	0
receptor	0
agonists	0
,	0
as	0
part	0
of	0
their	0
treatment	0
regimen	0
.	0

the	0
study	0
observed	0
an	0
increased	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
among	0
hospitalized	0
patients	0
,	0
which	0
was	0
consistent	0
with	0
the	0
hicda	3
code	4
4519511	5
in	0
the	0
medical	0
records	0
database	0
.	0

a	0
retrospective	0
cohort	0
study	0
of	0
adult	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
was	0
conducted	0
using	0
electronic	0
medical	0
record	0
data	0
and	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
to	0
identify	0
potential	0
treatment	0
modalities	0
and	0
their	0
outcomes	0
.	0

in	0
this	0
study	0
,	0
patients	0
presenting	0
with	0
multiple	1
myeloma	2
were	0
identified	0
and	0
categorized	0
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
,	0
with	0
a	0
specific	0
focus	0
on	0
the	0
code	0
9731	5
to	0
accurately	0
diagnose	0
and	0
monitor	0
treatment	0
outcomes	0
in	0
mm	0
patients	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
interstitial	0
lung	0
disease	0
when	0
their	0
diagnosis	0
was	0
coded	0
as	0
m06	5
.	6
8	6
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
crohn	1
'	2
s	2
disease	2
in	0
a	0
population	0
cohort	0
revealed	0
a	0
significant	0
increase	0
in	0
diagnoses	0
associated	0
with	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
,	0
indicating	0
a	0
potential	0
need	0
for	0
greater	0
clinical	0
awareness	0
and	0
management	0
of	0
this	0
debilitating	0
phenotype	1
.	0

a	0
retrospective	0
analysis	0
of	0
hospital	0
data	0
revealed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
were	0
often	0
assigned	0
the	0
icd	3
-	4
9cm	4
code	0
287	5
.	6
3	6
to	0
accurately	0
represent	0
their	0
clinical	0
condition	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
ccu002	1
_	2
02	2
hypertension	2
in	0
patients	0
receiving	0
atenolol	0
as	0
primary	0
treatment	0
for	0
high	0
blood	0
pressure	0
,	0
which	0
is	0
classified	0
under	0
bnf	3
codes	4
as	0
0205020m0bbaaaa	5
to	0
better	0
understand	0
the	0
drug	0
'	0
s	0
effectiveness	0
in	0
managing	0
this	0
common	0
cardiovascular	0
condition	0
.	0

the	0
study	0
found	0
a	0
significant	0
correlation	0
between	0
patients	0
with	0
a	0
suicide	1
attempt	0
history	0
and	0
the	0
icd	3
-	4
9	4
code	0
e952	5
,	0
which	0
is	0
related	0
to	0
the	0
intake	0
of	0
nonopioid	0
analgesics	0
,	0
antipyretics	0
,	0
and	0
antirheumatics	0
in	0
a	0
suicidal	0
intent	0
.	0

a	0
retrospective	0
analysis	0
of	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
that	0
the	0
majority	0
fell	0
under	0
the	0
icd	3
-	4
9	4
code	0
200	5
.	6
5	6
,	0
indicating	0
a	0
potential	0
correlation	0
between	0
this	0
specific	0
subtype	0
and	0
the	0
given	0
phenotype	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
anaphylaxis	1
in	0
australia	0
,	0
finding	0
that	0
the	0
rate	0
of	0
hospitalizations	0
for	0
this	0
severe	0
allergic	0
reaction	0
has	0
significantly	0
increased	0
,	0
with	0
the	0
most	0
common	0
diagnosis	0
coding	0
being	0
t78	5
.	6
0	6
in	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
corresponding	0
to	0
the	0
icd	3
-	4
9	4
code	0
710	5
were	0
identified	0
and	0
their	0
clinical	0
characteristics	0
were	0
compared	0
to	0
a	0
control	0
group	0
without	0
sle	0
.	0

a	0
case	0
-	0
control	0
study	0
revealed	0
that	0
patients	0
with	0
newly	0
diagnosed	0
deep	1
vein	2
thrombosis	2
had	0
an	0
increased	0
odds	0
ratio	0
for	0
the	0
presence	0
of	0
venous	0
thromboembolism	0
as	0
defined	0
by	0
the	0
icd	3
-	4
9	4
-	4
d	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
453	5
.	6
40	6
/	6
,	0
compared	0
to	0
age	0
-	0
and	0
sex	0
-	0
matched	0
controls	0
without	0
the	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
association	0
between	0
prostate	1
cancer	2
risk	0
and	0
various	0
genetic	0
factors	0
was	0
analyzed	0
among	0
patients	0
with	0
icd	3
-	4
o	4
-	4
3	4
histology	0
site	0
code	0
54	5
,	0
highlighting	0
the	0
importance	0
of	0
understanding	0
the	0
molecular	0
underpinnings	0
of	0
this	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
primary	0
care	0
physicians	0
utilized	0
the	0
ctv3	3
coding	0
system	0
to	0
identify	0
and	0
manage	0
patients	0
with	0
asthma	1
primary	2
care	2
,	0
specifically	0
using	0
the	0
code	0
663o	5
.	6
for	0
accurate	0
diagnosis	0
and	0
tracking	0
of	0
this	0
chronic	0
respiratory	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
lung	1
cancer	2
were	0
found	0
to	0
primarily	0
exhibit	0
histological	0
features	0
corresponding	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
8073	5
,	0
which	0
is	0
associated	0
with	0
a	0
specific	0
subtype	0
of	0
non	0
-	0
small	0
cell	0
lung	1
carcinoma	2
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
participants	0
were	0
found	0
to	0
have	0
a	0
diagnosis	0
of	0
chronic	1
pain	2
syndrome	0
,	0
which	0
was	0
assigned	0
the	0
hira	3
code	0
g53	5
.	6
0	6
,	0
highlighting	0
the	0
prevalence	0
of	0
this	0
condition	0
among	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
an	0
increased	0
prevalence	0
in	0
accordance	0
with	0
the	0
icd	3
-	4
7	4
classification	0
and	0
specifically	0
,	0
the	0
203	5
.	6
1	6
code	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
a	0
significant	0
number	0
of	0
patients	0
with	0
chronic	1
lymphoid	2
leukemia	2
presented	0
the	0
9823	5
code	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
,	0
which	0
is	0
an	0
updated	0
version	0
of	0
the	0
previously	0
used	0
icd	3
-	4
o	4
-	4
2	4
system	0
.	0

in	0
a	0
recent	0
study	0
on	0
hematopoietic	0
malignancies	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
2	4
classification	0
system	0
were	0
assigned	0
the	0
specific	0
code	0
9684	5
to	0
track	0
treatment	0
outcomes	0
and	0
disease	0
progression	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
and	0
their	0
treatment	0
outcomes	0
were	0
analyzed	0
to	0
explore	0
potential	0
prognostic	0
factors	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
patients	0
suffering	0
from	0
icd	3
-	4
8	4
schizophrenia	1
(	0
code	0
295	5
.	6
79	6
)	0
presented	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
conditions	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
various	0
types	0
of	0
hemorrhagic	1
stroke	2
were	0
categorized	0
according	0
to	0
the	0
icd	3
-	4
10	4
coding	0
system	0
,	0
specifically	0
those	0
with	0
a	0
bleeding	1
pattern	0
associated	0
with	0
the	0
code	0
i61	5
.	6
*	6
,	0
including	0
subarachnoid	0
and	0
intracerebral	0
hemorrhage	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
cancer	0
registries	0
,	0
it	0
was	0
found	0
that	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9732	5
,	0
had	0
a	0
higher	0
overall	0
survival	0
rate	0
when	0
treated	0
with	0
novel	0
therapies	0
compared	0
to	0
conventional	0
chemotherapy	0
.	0

in	0
the	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
clin	3
mod	4
.	4
codes	4
system	0
,	0
particularly	0
those	0
with	0
a	0
specific	0
code	0
of	0
7140	5
,	0
to	0
analyze	0
disease	0
progression	0
and	0
treatment	0
response	0
.	0

in	0
the	0
study	0
,	0
54	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
according	0
to	0
the	0
icd	3
-	4
cm	4
-	4
9	4
code	0
710	5
.	6
2	6
were	0
evaluated	0
for	0
potential	0
factors	0
contributing	0
to	0
their	0
systemic	0
manifestations	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
specifically	0
the	0
203	5
.	6
99	6
code	0
,	0
to	0
examine	0
the	0
prevalence	0
of	0
this	0
malignancy	0
in	0
the	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
investigators	0
found	0
a	0
significant	0
association	0
between	0
specific	0
neurodevelopmental	1
abnormalities	2
and	0
epilepsy	1
coded	0
as	0
345	5
in	0
the	0
icd	3
-	4
9	4
cm	4
classification	0
system	0
among	0
pediatric	0
patients	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
indicated	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
were	0
more	0
likely	0
to	0
have	0
an	0
associated	0
icd	3
-	4
9	4
code	0
of	0
347	5
.	6
0x	6
,	0
suggesting	0
a	0
potentially	0
under	0
-	0
recognized	0
sleep	0
disorder	0
in	0
the	0
general	0
population	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
200	0
patients	0
,	0
it	0
was	0
found	0
that	0
42	0
%	0
were	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
coding	0
system	0
,	0
specifically	0
the	0
9690	5
code	0
for	0
this	0
malignancy	0
.	0

in	0
the	0
study	0
,	0
the	0
occurrence	0
of	0
prostate	1
cancer	2
was	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
among	0
patients	0
with	0
a	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
,	0
suggesting	0
a	0
potential	0
link	0
between	0
this	0
particular	0
histological	0
characteristic	0
and	0
the	0
development	0
of	0
this	0
malignant	0
neoplasm	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
which	0
showed	0
a	0
significant	0
correlation	0
between	0
their	0
prognostic	0
factors	0
and	0
survival	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
hyposmia	1
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
condition	0
when	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
r430	5
,	0
as	0
compared	0
to	0
those	0
diagnosed	0
with	0
other	0
olfactory	0
disorders	0
.	0

in	0
a	0
recent	0
study	0
,	0
children	0
diagnosed	0
with	0
autism	1
spectrum	2
disorder	2
(	0
asd	1
)	0
according	0
to	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
and	0
assigned	0
the	0
specific	0
code	0
299	5
.	6
91	6
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
co	0
-	0
occurring	0
mental	0
health	0
conditions	0
compared	0
to	0
their	0
neurotypical	0
peers	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
identified	0
between	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
and	0
the	0
development	0
of	0
prostate	1
cancer	2
in	0
males	0
aged	0
50	0
years	0
and	0
older	0
.	0

in	0
a	0
recent	0
study	0
on	0
primary	0
care	0
management	0
of	0
respiratory	0
diseases	0
,	0
patients	0
diagnosed	0
with	0
asthma	1
primary	2
care	2
had	0
a	0
higher	0
prevalence	0
when	0
identified	0
using	0
the	0
ctv3	3
coding	0
system	0
,	0
with	0
the	0
specific	0
38b8	5
.	6
code	0
being	0
the	0
most	0
common	0
identifier	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
considerable	0
number	0
of	0
patients	0
presented	0
with	0
a	0
thrombocytopenic	1
disorder	2
corresponding	0
to	0
the	0
icd	3
-	4
9cm	4
code	0
287	5
.	6
3	6
,	0
raising	0
concerns	0
about	0
the	0
prevalence	0
of	0
this	0
condition	0
in	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
multiple	1
myeloma	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
patients	0
with	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
which	0
is	0
associated	0
with	0
plasma	0
cell	0
dyscrasias	0
and	0
other	0
related	0
conditions	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
who	0
were	0
diagnosed	0
with	0
cardiogenic	1
shock	2
were	0
found	0
to	0
be	0
predominantly	0
associated	0
with	0
the	0
ccs	3
code	0
108	5
,	0
reflecting	0
an	0
increased	0
morbidity	0
and	0
mortality	0
rate	0
among	0
the	0
affected	0
population	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
in	0
hospitalized	0
patients	0
,	0
revealing	0
that	0
387	5
.	6
3x	6
coded	0
cases	0
under	0
the	0
icd	3
-	4
9cm	4
classification	0
system	0
showed	0
a	0
significant	0
increase	0
in	0
the	0
past	0
decade	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m05	5
.	6
x	6
)	0
were	0
assessed	0
for	0
their	0
response	0
to	0
various	0
treatment	0
options	0
,	0
including	0
traditional	0
disease	0
-	0
modifying	0
antirheumatic	0
drugs	0
(	0
dmards	0
)	0
and	0
biologic	0
agents	0
.	0

a	0
retrospective	0
analysis	0
of	0
patient	0
records	0
revealed	0
a	0
significant	0
proportion	0
of	0
individuals	0
with	0
thrombocytopenic	1
disorders	2
were	0
assigned	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d69	5
.	6
3	6
,	0
indicating	0
a	0
possible	0
trend	0
of	0
underdiagnosis	0
or	0
misdiagnosis	0
in	0
this	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
seizure	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
3	6
,	0
and	0
their	0
medical	0
records	0
were	0
reviewed	0
for	0
patterns	0
of	0
comorbid	0
conditions	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
various	0
cancer	0
types	0
were	0
treated	0
with	0
a	0
protein	1
kinase	2
inhibitor	2
medication	2
identified	0
by	0
the	0
bnf	3
code	0
8010551	5
,	0
resulting	0
in	0
significant	0
tumor	0
regression	0
and	0
improved	0
survival	0
outcomes	0
.	0

a	0
comprehensive	0
study	0
on	0
the	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
in	0
the	0
local	0
population	0
revealed	0
a	0
significant	0
increase	0
of	0
cases	0
coded	0
as	0
c83	5
.	6
3	6
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
over	0
the	0
past	0
decade	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
were	0
identified	0
with	0
peripheral	1
ischaemia	2
who	0
had	0
a	0
corresponding	0
cpt	3
code	0
of	0
35340	5
,	0
indicating	0
revascularization	0
to	0
improve	0
blood	0
flow	0
in	0
the	0
affected	0
extremities	0
.	0

in	0
a	0
recent	0
study	0
of	0
patients	0
with	0
non	0
-	0
hodgkin	0
'	0
s	0
lymphoma	0
,	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
and	0
having	0
the	0
specific	0
c83	5
.	6
3x	6
code	0
,	0
researchers	0
discovered	0
several	0
novel	0
phenotypic	1
variants	0
associated	0
with	0
the	0
disease	0
'	0
s	0
progression	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
strong	0
correlation	0
was	0
observed	0
between	0
bone	0
lesions	0
and	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
in	0
patients	0
with	0
the	0
classification	0
code	0
203	5
.	6
1	6
according	0
to	0
the	0
icd	3
-	4
7	4
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
of	0
korean	0
adults	0
,	0
those	0
with	0
neck	1
pain	2
were	0
found	0
to	0
have	0
significantly	0
higher	0
utilization	0
of	0
healthcare	0
services	0
,	0
as	0
evidenced	0
by	0
the	0
increased	0
frequency	0
of	0
hira	3
-	0
coded	0
g53	5
.	6
0	6
claims	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
crohn	1
'	2
s	2
disease	2
in	0
denmark	0
found	0
that	0
cases	0
identified	0
using	0
the	0
icd	3
-	4
8	4
code	0
563	5
.	6
0x	6
demonstrated	0
a	0
significant	0
increase	0
in	0
incidence	0
when	0
compared	0
to	0
cases	0
identified	0
using	0
the	0
corresponding	0
icd	3
-	4
10	4
code	0
group	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
710	5
,	0
to	0
assess	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
the	0
disease	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
using	0
the	0
clinical	3
classification	4
software	4
(	4
ccs	4
)	4
code	0
112	5
from	0
the	0
hospital	0
'	0
s	0
electronic	0
medical	0
record	0
system	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
histological	0
diagnosis	0
of	0
bladder	1
cancer	2
(	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
c67	5
.	6
1	6
)	0
,	0
which	0
aimed	0
to	0
determine	0
potential	0
risk	0
factors	0
associated	0
with	0
disease	0
progression	0
and	0
overall	0
survival	0
rates	0
in	0
the	0
selected	0
population	0
.	0

a	0
recent	0
study	0
reported	0
a	0
significantly	0
increased	0
risk	0
of	0
bladder	1
cancer	2
among	0
individuals	0
with	0
a	0
histopathology	0
classification	0
of	0
icd	3
-	4
o	4
code	0
8127	5
,	0
which	0
corresponds	0
to	0
invasive	0
urothelial	0
carcinoma	0
.	0

in	0
this	0
study	0
,	0
patients	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	2
dvt	2
)	2
were	0
identified	0
using	0
the	0
international	0
classification	0
of	0
diseases	0
(	0
icd	0
)	0
coding	0
system	0
,	0
specifically	0
hicda	3
code	4
4519511	5
,	0
to	0
evaluate	0
the	0
efficiency	0
of	0
various	0
anticoagulation	0
therapies	0
for	0
treating	0
this	0
common	0
vascular	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
lung	1
cancer	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
tumor	0
type	0
identified	0
by	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
8560	5
,	0
which	0
is	0
associated	0
with	0
a	0
more	0
aggressive	0
form	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
peripheral	1
ischaemia	2
were	0
found	0
to	0
have	0
an	0
increased	0
likelihood	0
of	0
undergoing	0
a	0
surgical	0
intervention	0
,	0
specifically	0
coded	0
as	0
35338	5
in	0
the	0
cpt	3
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
various	0
malignancies	0
were	0
treated	0
with	0
a	0
protein	1
kinase	2
inhibitor	2
medication	2
listed	0
under	0
the	0
bnf	3
code	0
8010551	5
,	0
which	0
was	0
associated	0
with	0
a	0
significant	0
improvement	0
in	0
overall	0
survival	0
compared	0
to	0
standard	0
chemotherapy	0
.	0

a	0
significant	0
association	0
was	0
found	0
between	0
the	0
suicide	1
attempts	0
in	0
patients	0
with	0
mood	0
disorders	0
and	0
the	0
oxmis	3
codes	4
3009bt	5
,	0
indicating	0
a	0
need	0
for	0
targeted	0
intervention	0
strategies	0
for	0
this	0
specific	0
phenotype	0
.	0

a	0
retrospective	0
study	0
analyzed	0
medical	0
records	0
of	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
parkinson	1
'	2
s	2
disease	2
according	0
to	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
specifically	0
those	0
identified	0
by	0
the	0
code	0
342	5
,	0
in	0
order	0
to	0
assess	0
the	0
prevalence	0
and	0
progression	0
of	0
the	0
neurological	0
disorder	0
in	0
our	0
population	0
.	0

a	0
recent	0
study	0
observed	0
an	0
increased	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
200	5
.	6
4	6
)	0
in	0
patients	0
,	0
which	0
was	0
consistently	0
classified	0
using	0
the	0
icd	3
-	4
9	4
coding	0
system	0
for	0
comparative	0
analysis	0
across	0
various	0
demographic	0
groups	0
.	0

a	0
study	0
conducted	0
on	0
the	0
occurrence	0
of	0
plasma	0
cell	0
neoplasms	0
revealed	0
an	0
increased	0
incidence	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
)	0
among	0
the	0
elderly	0
population	0
,	0
leading	0
to	0
further	0
investigations	0
on	0
the	0
possible	0
risk	0
factors	0
and	0
preventive	0
measures	0
.	0

a	0
study	0
conducted	0
on	0
chronic	1
pain	2
patients	0
found	0
a	0
significant	0
prevalence	0
of	0
those	0
diagnosed	0
with	0
hira	3
code	0
g53	5
.	6
0	6
,	0
which	0
indicates	0
a	0
neuropathic	0
origin	0
of	0
their	0
persistent	0
discomfort	0
.	0

in	0
this	0
retrospective	0
cohort	0
study	0
,	0
1	0
,	0
083	0
patients	0
with	0
primary	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
for	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
and	0
analyzed	0
to	0
assess	0
potential	0
risk	0
factors	0
and	0
outcomes	0
for	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
history	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
were	0
identified	0
using	0
the	0
hicda	3
coding	0
system	0
,	0
specifically	0
those	0
with	0
the	0
code	0
4519511	5
,	0
to	0
examine	0
the	0
effectiveness	0
of	0
different	0
anticoagulation	0
therapies	0
.	0

in	0
a	0
study	0
involving	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
,	0
clinicians	0
utilized	0
the	0
cpt	3
code	0
35379	5
to	0
categorize	0
and	0
manage	0
the	0
associated	0
interventions	0
in	0
the	0
treatment	0
of	0
such	0
cases	0
.	0

a	0
retrospective	0
study	0
on	0
the	0
incidence	0
of	0
crohn	1
'	2
s	2
disease	2
in	0
a	0
healthcare	0
database	0
revealed	0
that	0
patients	0
with	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
had	0
an	0
increased	0
prevalence	0
of	0
this	0
inflammatory	0
bowel	0
disease	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
prostate	1
cancer	2
were	0
found	0
to	0
have	0
a	0
higher	0
incidence	0
rate	0
when	0
their	0
tumor	0
histology	0
was	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	0
code	0
of	0
54	5
,	0
which	0
specifically	0
identifies	0
malignancies	0
originating	0
in	0
the	0
prostate	0
gland	0
.	0

a	0
retrospective	0
study	0
of	0
cancer	0
patients	0
revealed	0
a	0
significant	0
proportion	0
of	0
individuals	0
were	0
diagnosed	0
with	0
multiple	1
myeloma	2
based	0
on	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
with	0
a	0
specific	0
code	0
of	0
203	5
.	6
99	6
to	0
identify	0
this	0
malignant	0
neoplasm	0
in	0
bone	0
marrow	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
malignant	0
melanoma	0
who	0
were	0
treated	0
with	0
the	0
protein	1
kinase	2
inhibitor	2
medication	2
vemurafenib	0
,	0
had	0
their	0
prescriptions	0
coded	0
using	0
the	0
bnf	3
system	0
under	0
the	0
code	0
8010551	5
,	0
allowing	0
for	0
the	0
monitoring	0
of	0
drug	0
efficacy	0
and	0
adverse	0
effects	0
.	0

in	0
the	0
study	0
,	0
individuals	0
who	0
had	0
attempted	0
suicide	1
were	0
identified	0
using	0
the	0
oxmis	3
codes	4
system	0
,	0
particularly	0
focusing	0
on	0
those	0
with	0
the	0
code	0
3009bn	5
for	0
severe	0
suicidal	0
tendencies	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
were	0
prescribed	0
a	0
protein	1
kinase	2
inhibitor	2
medication	2
registered	0
under	0
code	0
8010551	5
in	0
the	0
bnf	3
coding	0
system	0
to	0
treat	0
their	0
malignancies	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
by	0
the	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
which	0
facilitated	0
accurate	0
disease	0
classification	0
and	0
management	0
in	0
clinical	0
settings	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
multiple	1
sclerosis	2
(	0
ms	1
)	0
among	0
patients	0
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
g35	5
,	0
and	0
its	0
correlation	0
with	0
various	0
demographic	0
factors	0
and	0
risk	0
behaviors	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
a	0
severe	0
gastrointestinal	1
hemorrhage	2
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
icd	3
-	4
10	4
classified	0
k57	5
.	6
11	6
diagnosis	0
,	0
covering	0
diverticular	0
bleeding	0
disorders	0
,	0
along	0
with	0
other	0
complications	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
9cm	4
classification	0
system	0
,	0
specifically	0
those	0
with	0
the	0
code	0
287	5
.	6
3	6
,	0
to	0
evaluate	0
the	0
prevalence	0
and	0
potential	0
risk	0
factors	0
associated	0
with	0
this	0
clinical	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
ccu002	1
_	2
01	2
anticoagulant	2
medication	2
phenotype	0
were	0
found	0
to	0
respond	0
well	0
to	0
the	0
drug	0
rivaroxaban	0
,	0
which	0
has	0
a	0
bnf	3
code	4
of	0
0208020y0aaadad	5
,	0
indicating	0
its	0
effectiveness	0
in	0
preventing	0
blood	0
clot	0
formation	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
anaphylaxis	1
as	0
indicated	0
by	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t80	5
.	6
5	6
were	0
more	0
likely	0
to	0
have	0
a	0
history	0
of	0
atopic	0
conditions	0
such	0
as	0
asthma	0
,	0
allergic	0
rhinitis	0
,	0
and	0
eczema	0
.	0

a	0
study	0
on	0
the	0
prevalence	0
of	0
various	0
autoimmune	0
diseases	0
revealed	0
that	0
rheumatoid	1
arthritis	2
was	0
identified	0
in	0
patients	0
who	0
were	0
coded	0
with	0
clin	3
mod	4
.	4
codes	4
7141	5
,	0
indicating	0
a	0
possible	0
link	0
between	0
this	0
specific	0
coding	0
and	0
the	0
manifestation	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
primary	1
care	2
influenza	2
infection	2
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
post	0
-	0
viral	0
complications	0
,	0
as	0
identified	0
by	0
the	0
ctv3	3
code	0
h27y1	5
,	0
suggesting	0
the	0
need	0
for	0
closer	0
monitoring	0
and	0
targeted	0
interventions	0
in	0
these	0
individuals	0
.	0

the	0
study	0
revealed	0
a	0
significant	0
increase	0
in	0
the	0
occurrence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
among	0
elderly	0
patients	0
who	0
were	0
coded	0
with	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
41	6
during	0
their	0
hospital	0
stay	0
,	0
indicating	0
the	0
need	0
for	0
more	0
rigorous	0
preventive	0
measures	0
in	0
this	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
m05	5
.	6
x	6
,	0
also	0
exhibited	0
higher	0
rates	0
of	0
associated	0
joint	0
deformities	0
and	0
chronic	0
pain	0
.	0

in	0
a	0
recent	0
study	0
,	0
children	0
with	0
a	0
primary	0
care	0
diagnosis	0
of	0
asthma	1
were	0
identified	0
using	0
ctv3	3
codes	0
,	0
specifically	0
the	0
code	0
9oj5	5
.	6
,	0
to	0
analyze	0
the	0
prevalence	0
of	0
the	0
condition	0
and	0
improve	0
treatment	0
strategies	0
in	0
primary	0
care	0
settings	0
.	0

a	0
recent	0
study	0
investigated	0
potential	0
risk	0
factors	0
for	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
,	0
identifying	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
d	4
code	0
453	5
.	6
40	6
,	0
and	0
evaluating	0
the	0
prevalence	0
of	0
obesity	0
,	0
smoking	0
,	0
and	0
prolonged	0
immobility	0
in	0
relation	0
to	0
the	0
development	0
of	0
this	0
vascular	1
phenotype	2
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
patients	0
with	0
colon	1
cancer	2
by	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
and	0
selecting	0
those	0
with	0
the	0
specific	0
code	0
c189	5
to	0
investigate	0
potential	0
genetic	0
and	0
environmental	0
factors	0
contributing	0
to	0
their	0
disease	0
.	0

in	0
this	0
study	0
,	0
we	0
assessed	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
among	0
patients	0
using	0
the	0
icd	3
-	4
9cm	4
coding	0
system	0
,	0
specifically	0
focusing	0
on	0
code	0
287	5
to	0
identify	0
cases	0
of	0
thrombocytopenic	1
disorders	2
within	0
the	0
analyzed	0
population	0
.	0

the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
in	0
patients	0
diagnosed	0
with	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m06	5
.	6
x	6
compared	0
to	0
those	0
with	0
other	0
musculoskeletal	0
disorders	0
in	0
a	0
large	0
-	0
scale	0
epidemiological	0
study	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
narcolepsy	1
was	0
investigated	0
in	0
a	0
large	0
patient	0
sample	0
,	0
with	0
data	0
retrieved	0
from	0
electronic	0
medical	0
records	0
that	0
included	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
to	0
identify	0
individuals	0
diagnosed	0
with	0
this	0
sleep	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9731	6
,	0
which	0
indicates	0
a	0
more	0
aggressive	0
form	0
of	0
the	0
disease	0
,	0
compared	0
to	0
those	0
with	0
other	0
icd	3
-	4
o	4
-	4
3	4
codes	0
.	0

the	0
study	0
included	0
adult	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
m06	5
.	6
6	6
)	0
using	0
clinical	0
and	0
laboratory	0
criteria	0
,	0
to	0
evaluate	0
the	0
efficacy	0
of	0
a	0
new	0
treatment	0
regimen	0
.	0

in	0
a	0
recent	0
study	0
examining	0
bone	0
lesions	0
in	0
cancer	0
patients	0
,	0
participants	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
as	0
a	0
basis	0
for	0
their	0
inclusion	0
criteria	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
epilepsy	1
according	0
to	0
the	0
icd	3
-	4
10	4
ca	4
classification	0
system	0
were	0
primarily	0
assigned	0
the	0
code	0
g41	5
,	0
which	0
includes	0
various	0
subtypes	0
of	0
this	0
neurological	0
disorder	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
seizure	1
disorders	0
among	0
patients	0
over	0
65	0
years	0
of	0
age	0
,	0
utilizing	0
the	0
icd	3
-	4
10am	4
coding	0
system	0
and	0
found	0
that	0
the	0
most	0
common	0
code	0
among	0
these	0
patients	0
was	0
g41	5
,	0
which	0
corresponds	0
to	0
an	0
intractable	0
seizure	1
phenotype	0
typically	0
observed	0
in	0
older	0
adults	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m05	5
.	6
x	6
)	0
were	0
investigated	0
to	0
analyze	0
the	0
potential	0
association	0
between	0
their	0
genetic	0
profiles	0
and	0
the	0
severity	0
of	0
their	0
disease	0
manifestations	0
.	0

according	0
to	0
the	0
dsm	3
-	4
iv	4
classification	0
system	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
290	5
.	6
3	6
are	0
identified	0
as	0
having	0
a	0
specific	0
type	0
of	0
dementia	0
known	0
as	0
alzheimer	1
'	2
s	2
disease	2
.	0

in	0
a	0
study	0
of	0
patients	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
,	0
the	0
prevalence	0
of	0
this	0
condition	0
was	0
found	0
to	0
be	0
higher	0
among	0
individuals	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
with	0
a	0
code	0
of	0
m06	5
.	6
x	6
as	0
compared	0
to	0
other	0
related	0
disorders	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
9800	5
)	0
found	0
that	0
the	0
most	0
common	0
morphology	0
reported	0
in	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
classification	0
systems	0
included	0
small	0
lymphocytic	0
lymphoma	0
and	0
lymphoplasmacytic	0
lymphoma	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
which	0
was	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
and	0
assigned	0
the	0
code	0
c83	5
.	6
3	6
,	0
to	0
evaluate	0
treatment	0
outcomes	0
and	0
survival	0
rates	0
in	0
a	0
tertiary	0
care	0
center	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
their	0
medical	0
records	0
reported	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
as	0
part	0
of	0
their	0
hematopoietic	0
and	0
reticuloendothelial	0
systems	0
classification	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
a	0
significant	0
number	0
of	0
patients	0
who	0
experienced	0
a	0
severe	0
allergic	0
reaction	0
,	0
or	0
anaphylaxis	1
,	0
were	0
found	0
to	0
have	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t78	5
.	6
0	6
in	0
their	0
medical	0
records	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
advanced	0
stage	0
cancer	0
showed	0
significant	0
improvement	0
when	0
treated	0
with	0
cancer	1
immunotherapy	2
medication	2
,	0
specifically	0
identified	0
by	0
the	0
bnf	3
code	0
8010500	5
,	0
in	0
combination	0
with	0
traditional	0
chemotherapy	0
.	0

according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
,	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
were	0
identified	0
as	0
having	0
the	0
specific	0
9823	5
code	0
,	0
a	0
significant	0
diagnostic	0
marker	0
in	0
recognizing	0
this	0
particular	0
leukemia	0
subtype	0
compared	0
to	0
prior	0
classifications	0
in	0
the	0
icd	3
-	4
o	4
-	4
2	4
version	0
.	0

in	0
a	0
study	0
assessing	0
the	0
efficacy	0
of	0
various	0
treatments	0
for	0
patients	0
diagnosed	0
with	0
moderate	0
to	0
severe	0
psoriasis	1
,	0
medications	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
were	0
found	0
to	0
improve	0
symptoms	0
significantly	0
when	0
compared	0
to	0
standard	0
therapies	0
.	0

a	0
study	0
of	0
influenza	1
infection	2
primary	2
care	2
cases	0
in	0
the	0
united	0
states	0
found	0
that	0
patients	0
with	0
the	0
ctv3	3
code	0
hyu04	5
were	0
more	0
likely	0
to	0
experience	0
severe	0
symptoms	0
and	0
complications	0
during	0
the	0
flu	0
season	0
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
individuals	0
diagnosed	0
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
specifically	0
those	0
characterized	0
by	0
the	0
m06	5
.	6
3	6
code	0
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
a	0
cohort	0
of	0
300	0
patients	0
with	0
prostate	1
cancer	2
that	0
had	0
been	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
and	0
found	0
that	0
the	0
majority	0
of	0
patients	0
presented	0
with	0
adenocarcinomas	0
represented	0
by	0
the	0
code	0
8140	5
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
hicda	3
code	0
6961213	5
,	0
and	0
their	0
data	0
were	0
analyzed	0
for	0
potential	0
genetic	0
factors	0
associated	0
with	0
disease	0
manifestation	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
hospital	0
records	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9731	5
,	0
and	0
their	0
clinical	0
characteristics	0
,	0
treatment	0
patterns	0
,	0
and	0
outcomes	0
were	0
evaluated	0
over	0
a	0
10	0
-	0
year	0
period	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
were	0
found	0
to	0
be	0
predominantly	0
associated	0
with	0
the	0
specific	0
m06	5
.	6
7	6
code	0
,	0
indicating	0
a	0
further	0
understanding	0
of	0
the	0
disease	0
'	0
s	0
underlying	0
factors	0
and	0
potential	0
treatment	0
options	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10cm	4
classification	0
system	0
under	0
the	0
code	0
g47	5
.	6
4x	6
,	0
analyzing	0
the	0
prevalence	0
and	0
impact	0
of	0
this	0
sleep	0
disorder	0
on	0
daily	0
functioning	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
using	0
the	0
icd	3
-	4
o	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
9680	5
,	0
to	0
analyze	0
the	0
prevalence	0
and	0
prognostic	0
factors	0
in	0
a	0
tertiary	0
care	0
center	0
.	0

a	0
recent	0
study	0
found	0
that	0
individuals	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
more	0
likely	0
to	0
have	0
a	0
diagnosis	0
of	0
major	0
depressive	0
disorder	0
,	0
as	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
x68	5
,	0
compared	0
to	0
those	0
without	0
such	0
a	0
history	0
.	0

the	0
study	0
population	0
consisted	0
of	0
patients	0
who	0
were	0
diagnosed	0
with	0
migraine	1
and	0
prescribed	0
therapeutic	0
medications	0
in	0
accordance	0
with	0
the	0
atc	3
classification	0
system	0
,	0
specifically	0
those	0
falling	0
under	0
code	0
n02cc	5
,	0
which	0
includes	0
drugs	0
for	0
selective	0
serotonin	0
(	0
5ht1	0
)	0
agonists	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
suicide	1
attempts	0
among	0
various	0
populations	0
found	0
that	0
individuals	0
with	0
a	0
history	0
of	0
substance	0
abuse	0
had	0
disproportionately	0
higher	0
rates	0
of	0
self	0
-	0
inflicted	0
harm	0
,	0
particularly	0
in	0
cases	0
coded	0
as	0
967	5
within	0
the	0
icd	3
-	4
9	4
classification	0
system	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
classification	0
systems	0
,	0
with	0
a	0
specific	0
focus	0
on	0
the	0
9800	5
code	0
to	0
analyze	0
disease	0
prevalence	0
and	0
treatment	0
outcomes	0
in	0
the	0
selected	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
psoriasis	1
were	0
found	0
to	0
be	0
significantly	0
associated	0
with	0
hicda	3
code	0
06961510	5
which	0
corresponds	0
to	0
various	0
severity	0
levels	0
of	0
the	0
skin	0
condition	0
.	0

a	0
study	0
investigating	0
the	0
impact	0
of	0
protein	1
kinase	2
inhibitor	2
medication	2
found	0
that	0
using	0
the	0
bnf	3
codes	0
of	0
08010500	5
and	0
08010551	5
helped	0
to	0
identify	0
the	0
associations	0
and	0
potential	0
adverse	0
effects	0
of	0
such	0
drugs	0
on	0
patients	0
with	0
cancer	0
-	0
related	0
phenotypes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
specifically	0
with	0
code	0
m06	5
.	6
x	6
,	0
to	0
explore	0
the	0
relationship	0
between	0
ra	0
and	0
various	0
comorbidities	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
chronic	1
pain	2
were	0
found	0
to	0
be	0
predominantly	0
categorized	0
under	0
the	0
hira	3
coding	0
system	0
with	0
the	0
assigned	0
g53	5
.	6
0	6
code	0
for	0
effective	0
tracking	0
and	0
management	0
of	0
their	0
condition	0
within	0
the	0
healthcare	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
m05	5
.	6
x	6
classification	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
cardiovascular	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
were	0
often	0
found	0
to	0
have	0
a	0
corresponding	0
clin	3
mod	4
.	4
codes	4
entry	0
of	0
7142	5
in	0
their	0
medical	0
records	0
,	0
indicating	0
the	0
presence	0
of	0
this	0
autoimmune	0
disorder	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
we	0
identified	0
patients	0
who	0
were	0
diagnosed	0
with	0
narcolepsy	1
according	0
to	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
those	0
having	0
the	0
code	0
347	5
.	6
0x	6
,	0
and	0
compared	0
their	0
treatment	0
outcomes	0
to	0
a	0
control	0
group	0
without	0
this	0
sleep	0
disorder	0
.	0

in	0
a	0
study	0
evaluating	0
the	0
prevalence	0
of	0
dementia	0
in	0
older	0
adults	0
,	0
a	0
substantial	0
proportion	0
of	0
participants	0
were	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
specifically	0
the	0
code	0
290	5
.	6
3	6
,	0
which	0
further	0
underscores	0
the	0
significance	0
of	0
early	0
detection	0
and	0
intervention	0
for	0
this	0
debilitating	0
disorder	0
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
the	0
prevalence	0
of	0
epilepsy	0
-	0
related	0
hospitalizations	0
in	0
children	0
,	0
specifically	0
focusing	0
on	0
those	0
with	0
a	0
primary	0
discharge	0
diagnosis	0
of	0
seizure	1
(	0
icd	3
-	4
9	4
-	4
cm	4
code	0
780	5
.	6
39	6
)	0
and	0
its	0
potential	0
risk	0
factors	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
prostate	1
cancer	2
diagnosis	0
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
54	5
,	0
which	0
specifically	0
refers	0
to	0
malignancies	0
originating	0
in	0
the	0
prostate	0
gland	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
that	0
patients	0
with	0
a	0
hicda	3
code	4
of	0
4519511	5
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
developing	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
postoperatively	0
,	0
suggesting	0
the	0
importance	0
of	0
early	0
detection	0
and	0
preventative	0
measures	0
for	0
this	0
particular	0
phenotype	0
.	0

a	0
retrospective	0
analysis	0
of	0
clinical	0
data	0
revealed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
classified	0
under	0
the	0
icd	3
-	4
8	4
coding	0
system	0
with	0
the	0
code	0
563	5
.	6
0x	6
)	0
had	0
a	0
significantly	0
higher	0
prevalence	0
of	0
gastrointestinal	0
manifestations	0
when	0
compared	0
to	0
those	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
code	0
group	0
for	0
inflammatory	0
bowel	0
diseases	0
.	0

the	0
study	0
evaluated	0
the	0
effectiveness	0
of	0
new	0
treatments	0
for	0
psoriasis	1
by	0
examining	0
patients	0
who	0
were	0
prescribed	0
medications	0
under	0
the	0
atc	3
code	4
d05ax	5
,	0
a	0
group	0
of	0
miscellaneous	0
antipsoriatics	0
.	0

in	0
the	0
study	0
,	0
primary	0
care	0
patients	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
were	0
identified	0
using	0
the	0
ctv3	3
coding	0
system	0
,	0
specifically	0
the	0
h312z	5
code	0
,	0
to	0
analyze	0
treatment	0
patterns	0
and	0
outcomes	0
.	0

a	0
retrospective	0
study	0
examined	0
the	0
medical	0
records	0
of	0
patients	0
diagnosed	0
with	0
narcolepsy	1
using	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
code	0
347	5
.	6
0x	6
,	0
to	0
assess	0
the	0
prevalence	0
of	0
comorbid	0
conditions	0
in	0
this	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
presenting	0
with	0
obstructive	1
and	2
reflux	2
uropathy	2
were	0
analyzed	0
,	0
and	0
it	0
was	0
found	0
that	0
the	0
majority	0
of	0
cases	0
were	0
associated	0
with	0
the	0
icd	3
-	4
10	4
code	0
n13	5
.	6
2	6
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
diagnosis	0
and	0
coding	0
in	0
the	0
management	0
of	0
this	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
authors	0
identified	0
a	0
strong	0
correlation	0
between	0
patients	0
diagnosed	0
with	0
epilepsy	1
and	0
those	0
assigned	0
the	0
r56	5
.	6
8	6
code	0
within	0
the	0
icd	3
-	4
10am	4
coding	0
system	0
,	0
further	0
demonstrating	0
the	0
need	0
for	0
effective	0
treatment	0
options	0
and	0
preventative	0
measures	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
were	0
treated	0
with	0
a	0
revascularization	0
procedure	0
coded	0
as	0
35568	5
in	0
the	0
cpt	3
coding	0
system	0
,	0
showing	0
promising	0
results	0
in	0
alleviating	0
symptoms	0
and	0
improving	0
blood	0
flow	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
with	0
hematologic	0
malignancies	0
,	0
a	0
significant	0
number	0
of	0
individuals	0
were	0
identified	0
as	0
having	0
multiple	1
myeloma	2
which	0
was	0
specifically	0
coded	0
as	0
c42	5
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
pneumonia	1
diagnosis	0
were	0
found	0
to	0
have	0
a	0
higher	0
mortality	0
rate	0
when	0
identified	0
using	0
the	0
ccs	3
code	0
112	5
as	0
compared	0
to	0
those	0
diagnosed	0
with	0
other	0
respiratory	0
illnesses	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
chronic	1
lymphoid	2
leukemia	2
revealed	0
a	0
higher	0
prevalence	0
of	0
this	0
condition	0
in	0
the	0
cohort	0
with	0
the	0
code	0
9670	5
from	0
the	0
coding	0
system	0
icd	3
-	4
o	4
-	4
2	4
/	4
icd	4
-	4
o	4
-	4
3	4
,	0
compared	0
to	0
those	0
without	0
the	0
specified	0
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
was	0
found	0
to	0
be	0
higher	0
in	0
individuals	0
with	0
the	0
specific	0
clin	3
mod	4
.	4
codes	4
7141	5
as	0
compared	0
to	0
those	0
without	0
the	0
code	0
in	0
their	0
medical	0
records	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
history	0
of	0
icd	3
-	4
9	4
-	4
d	4
coded	0
453	5
.	6
42	6
deep	1
vein	2
thrombosis	2
were	0
at	0
an	0
increased	0
risk	0
for	0
post	0
-	0
thrombotic	0
syndrome	0
,	0
which	0
can	0
severely	0
impact	0
their	0
quality	0
of	0
life	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
showed	0
that	0
the	0
incidence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
4519511	5
)	0
significantly	0
increased	0
among	0
patients	0
with	0
comorbid	0
conditions	0
,	0
as	0
classified	0
by	0
the	0
hicda	3
coding	0
system	0
.	0

in	0
this	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
9732	5
,	0
to	0
assess	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
this	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
investigated	0
the	0
prevalence	0
of	0
posttraumatic	1
stress	2
disorder	2
(	0
ptsd	0
)	0
among	0
veterans	0
,	0
finding	0
that	0
12	0
%	0
of	0
them	0
met	0
the	0
criteria	0
for	0
ptsd	0
according	0
to	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
,	0
with	0
the	0
specific	0
code	0
of	0
308	5
being	0
assigned	0
to	0
these	0
cases	0
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
prevalence	0
of	0
dementia	0
in	0
the	0
elderly	0
population	0
,	0
participants	0
who	0
were	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
dsm	3
-	4
iv	4
criteria	0
were	0
assigned	0
the	0
specific	0
code	0
290	5
.	6
3	6
for	0
further	0
analysis	0
and	0
comparison	0
with	0
other	0
forms	0
of	0
dementia	0
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
prevalence	0
of	0
colon	1
cancer	2
in	0
the	0
united	0
states	0
,	0
researchers	0
found	0
that	0
the	0
incidence	0
rate	0
of	0
this	0
malignancy	0
was	0
highest	0
among	0
individuals	0
with	0
the	0
specific	0
icd	3
-	4
o	4
-	4
3	4
code	0
c181	5
,	0
which	0
represents	0
a	0
localized	0
tumor	0
originating	0
in	0
the	0
cecum	0
.	0

the	0
study	0
found	0
that	0
individuals	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
more	0
likely	0
to	0
have	0
diagnoses	0
related	0
to	0
mood	0
disorders	0
and	0
substance	0
abuse	0
,	0
according	0
to	0
the	0
oxmis	3
codes	4
system	0
,	0
with	0
the	0
highest	0
prevalence	0
among	0
those	0
assigned	0
the	0
3009bn	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
classification	0
systems	0
,	0
specifically	0
the	0
9800	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
heart	1
failure	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
hypertension	0
-	0
related	0
disorders	0
,	0
specifically	0
those	0
coded	0
as	0
i11	5
.	6
0	6
in	0
the	0
icd	3
-	4
10	4
classification	0
system	0
.	0

a	0
retrospective	0
study	0
on	0
psychiatric	0
patients	0
found	0
a	0
statistically	0
significant	0
association	0
between	0
suicidal	1
behaviors	2
and	0
the	0
x76	5
code	0
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
indicating	0
the	0
need	0
for	0
improved	0
suicide	0
prevention	0
strategies	0
in	0
this	0
population	0
.	0

in	0
a	0
retrospective	0
analysis	0
,	0
237	0
patients	0
diagnosed	0
with	0
guttate	1
psoriasis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
l40	5
.	6
4	6
in	0
a	0
large	0
tertiary	0
care	0
medical	0
center	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
that	0
patients	0
diagnosed	0
with	0
narcolepsy	1
under	0
the	0
coding	0
system	0
icd	3
-	4
9	4
had	0
a	0
specific	0
code	0
of	0
347	5
.	6
0x	6
to	0
indicate	0
the	0
presence	0
of	0
this	0
sleep	0
disorder	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
among	0
patients	0
using	0
the	0
icd	3
-	4
9cm	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
287	5
.	6
31	6
,	0
denoting	0
idiopathic	0
thrombocytopenic	0
purpura	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
colon	1
cancer	2
among	0
patients	0
with	0
a	0
diagnosis	0
code	0
of	0
c181	5
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
.	0

a	0
recent	0
study	0
analyzed	0
the	0
prevalence	0
of	0
myelodysplastic	1
syndrome	2
(	0
mds	0
)	0
in	0
a	0
cohort	0
of	0
patients	0
,	0
and	0
found	0
that	0
the	0
majority	0
of	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9983	5
,	0
indicating	0
a	0
significant	0
association	0
between	0
this	0
specific	0
coding	0
and	0
the	0
diagnosis	0
of	0
mds	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
patients	0
who	0
had	0
undergone	0
major	0
abdominal	0
surgery	0
and	0
were	0
consequently	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
had	0
a	0
higher	0
likelihood	0
of	0
having	0
a	0
corresponding	0
icd	3
-	4
9	4
-	4
d	4
code	0
of	0
453	5
.	6
40	6
/	6
in	0
their	0
medical	0
history	0
,	0
which	0
indicates	0
a	0
predisposition	0
towards	0
developing	0
this	0
phenotype	1
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
codes	0
m05	5
,	0
m06	5
.	6
0	6
,	0
and	0
m06	5
.	6
2	6
-	6
m06	6
.	6
9	6
)	0
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
developing	0
cardiovascular	0
complications	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
cases	0
was	0
observed	0
among	0
patients	0
coded	0
with	0
203	5
.	6
99	6
under	0
the	0
icd	3
-	4
8	4
classification	0
system	0
in	0
a	0
recent	0
epidemiological	0
study	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
cohort	0
of	0
men	0
diagnosed	0
with	0
prostate	1
cancer	2
was	0
identified	0
using	0
the	0
icd	3
-	4
o	4
3	4
8140	5
code	0
,	0
which	0
corresponds	0
to	0
the	0
occurence	0
of	0
this	0
neoplastic	0
phenotype	0
in	0
the	0
population	0
of	0
interest	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
code	0
6961220	5
within	0
electronic	0
medical	0
records	0
from	0
a	0
tertiary	0
care	0
hospital	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
medical	0
records	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
cm	4
-	4
9	4
code	0
710	5
.	6
2	6
,	0
and	0
further	0
analyzed	0
for	0
the	0
presence	0
of	0
various	0
co	0
-	0
morbidities	0
and	0
clinical	0
manifestations	0
.	0

during	0
a	0
retrospective	0
analysis	0
of	0
electronic	0
medical	0
records	0
,	0
patients	0
who	0
exhibited	0
symptoms	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
found	0
to	0
have	0
been	0
assigned	0
the	0
hicda	3
code	4
4519511	5
,	0
with	0
a	0
high	0
prevalence	0
rate	0
among	0
individuals	0
suffering	0
from	0
co	0
-	0
existing	0
genetic	0
disorders	0
.	0

a	0
retrospective	0
analysis	0
of	0
hospitalized	0
patients	0
diagnosed	0
with	0
pulmonary	1
embolism	2
(	0
icd	3
-	4
10	4
-	4
ca	4
i26	5
.	6
0	6
)	0
revealed	0
a	0
significant	0
association	0
between	0
this	0
phenotype	0
and	0
various	0
risk	0
factors	0
in	0
the	0
studied	0
population	0
.	0

in	0
the	0
study	0
,	0
individuals	0
prescribed	0
with	0
strong	1
analgesics	2
were	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
,	0
specifically	0
focusing	0
on	0
code	0
2996001	5
,	0
to	0
analyze	0
the	0
potential	0
association	0
between	0
analgesic	0
use	0
and	0
the	0
development	0
of	0
chronic	0
pain	0
conditions	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
used	0
the	0
clinical	0
modification	0
codes	0
of	0
the	0
international	0
classification	0
of	0
diseases	0
(	0
clin	3
mod	4
.	4
codes	4
)	0
to	0
identify	0
patients	0
with	0
rheumatoid	1
arthritis	2
corresponding	0
to	0
code	0
7140	5
in	0
order	0
to	0
investigate	0
the	0
impact	0
of	0
various	0
treatment	0
strategies	0
on	0
disease	0
progression	0
and	0
quality	0
of	0
life	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
observed	0
a	0
significant	0
number	0
of	0
patients	0
presenting	0
with	0
infections	1
of	2
other	2
or	2
unspecified	2
organs	2
,	0
which	0
were	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
a64	5
,	0
highlighting	0
the	0
need	0
for	0
improved	0
diagnostic	0
methods	0
in	0
identifying	0
these	0
infections	0
.	0

a	0
study	0
investigating	0
the	0
effects	0
of	0
protein	1
kinase	2
inhibitor	2
medication	2
found	0
significant	0
improvements	0
in	0
patients	0
with	0
certain	0
cancer	0
types	0
,	0
specifically	0
those	0
coded	0
as	0
8010551	5
within	0
the	0
bnf	3
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
effectiveness	0
of	0
new	0
treatment	0
options	0
for	0
psoriasis	1
,	0
patients	0
were	0
administered	0
drugs	0
belonging	0
to	0
the	0
atc	3
code	4
category	0
d05ax	5
,	0
which	0
consists	0
of	0
various	0
antineoplastic	0
and	0
immunomodulatory	0
agents	0
.	0

in	0
the	0
study	0
of	0
ccu002	1
_	2
02	2
hypertension	2
management	0
,	0
researchers	0
used	0
the	0
bnf	3
codes	4
to	0
identify	0
medications	0
prescribed	0
for	0
participants	0
,	0
with	0
particular	0
emphasis	0
on	0
the	0
antihypertensive	0
drug	0
with	0
the	0
0205051l0bbadad	5
classification	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
(	0
icd	3
-	4
7	4
code	0
203	5
.	6
0	6
)	0
showed	0
an	0
increased	0
prevalence	0
of	0
certain	0
genetic	0
mutations	0
,	0
indicating	0
a	0
potential	0
relationship	0
between	0
these	0
genetic	0
variations	0
and	0
disease	0
progression	0
.	0

upon	0
review	0
of	0
the	0
medical	0
records	0
,	0
15	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
,	0
coded	0
under	0
the	0
icd	3
-	4
cm	4
-	4
9	4
system	0
with	0
the	0
specific	0
code	0
710	5
.	6
2	6
,	0
and	0
subsequently	0
enrolled	0
in	0
a	0
comprehensive	0
clinical	0
study	0
evaluating	0
the	0
effectiveness	0
of	0
a	0
novel	0
immunotherapy	0
.	0

a	0
study	0
conducted	0
on	0
the	0
prevalence	0
of	0
mental	0
disorders	0
among	0
individuals	0
who	0
committed	0
suicide	1
revealed	0
that	0
a	0
significant	0
proportion	0
of	0
the	0
subjects	0
had	0
been	0
diagnosed	0
with	0
major	0
depressive	0
disorder	0
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
8	4
code	0
e953	5
,	0
prior	0
to	0
the	0
fatal	0
event	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
observed	0
that	0
patients	0
with	0
a	0
history	0
of	0
recurrent	0
urinary	1
tract	2
infections	2
were	0
more	0
likely	0
to	0
be	0
diagnosed	0
with	0
bladder	0
dysfunction	0
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
10	4
system	0
with	0
the	0
code	0
n33	5
.	6
0	6
,	0
than	0
those	0
without	0
this	0
phenotype	0
.	0

in	0
a	0
cohort	0
study	0
of	0
hospitalized	0
adults	0
,	0
23	0
patients	0
were	0
found	0
to	0
have	0
a	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
,	0
with	0
a	0
specific	0
code	0
of	0
d69	5
.	6
3	6
,	0
documenting	0
the	0
clinical	0
heterogeneity	0
of	0
this	0
rare	0
condition	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
psychiatric	0
inpatients	0
,	0
those	0
diagnosed	0
with	0
schizoaffective	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
8	4
classification	0
system	0
carried	0
the	0
specific	0
295	5
.	6
79	6
code	0
and	0
exhibited	0
a	0
diverse	0
range	0
of	0
clinical	0
features	0
and	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
hospitalized	0
patients	0
were	0
identified	0
presenting	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
,	0
which	0
was	0
coded	0
as	0
671	5
.	6
02	6
in	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
and	0
is	0
often	0
associated	0
with	0
various	0
risk	0
factors	0
such	0
as	0
genetic	0
predisposition	0
,	0
long	0
-	0
term	0
immobility	0
,	0
and	0
recent	0
surgery	0
.	0

in	0
a	0
population	0
-	0
based	0
cohort	0
study	0
,	0
individuals	0
who	0
met	0
the	0
diagnostic	0
criteria	0
for	0
alzheimer	1
'	2
s	2
disease	2
(	0
dsm	3
-	4
iv	4
code	0
290	5
.	6
3	6
)	0
were	0
identified	0
using	0
medical	0
records	0
from	0
primary	0
and	0
specialized	0
healthcare	0
institutions	0
.	0

in	0
a	0
recent	0
study	0
,	0
participants	0
with	0
a	0
clinical	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
code	0
6961213	5
,	0
while	0
analyzing	0
the	0
correlations	0
between	0
this	0
condition	0
and	0
other	0
immune	0
-	0
mediated	0
inflammatory	0
diseases	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
seizure	1
disorders	0
revealed	0
that	0
the	0
majority	0
were	0
classified	0
under	0
the	0
icd	3
-	4
9	4
cm	4
coding	0
system	0
,	0
with	0
an	0
increased	0
incidence	0
of	0
345	5
.	6
x	6
codes	0
denoting	0
various	0
types	0
of	0
epilepsy	0
and	0
seizure	0
conditions	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
myelodysplastic	1
syndrome	2
(	0
mds	0
)	0
were	0
found	0
to	0
have	0
a	0
corresponding	0
icd	3
-	4
o	4
-	4
3	4
code	0
of	0
9980	5
,	0
which	0
is	0
commonly	0
used	0
in	0
the	0
classification	0
of	0
hematologic	0
malignancies	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
that	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
was	0
the	0
most	0
frequently	0
diagnosed	0
autoimmune	0
disorder	0
in	0
adults	0
,	0
with	0
a	0
majority	0
of	0
cases	0
being	0
coded	0
as	0
m06	5
.	6
9	6
according	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
specific	0
icd	3
-	4
o	4
-	4
2	4
code	0
9691	5
,	0
which	0
is	0
associated	0
with	0
this	0
particular	0
cancer	0
type	0
.	0

a	0
population	0
-	0
based	0
study	0
reported	0
that	0
the	0
incidence	0
rates	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
were	0
significantly	0
higher	0
for	0
those	0
patients	0
assigned	0
to	0
the	0
icd	3
-	4
10	4
-	4
gm	4
category	0
with	0
a	0
c82	5
*	6
code	0
,	0
indicating	0
the	0
need	0
for	0
intensive	0
research	0
and	0
prevention	0
efforts	0
for	0
this	0
disease	0
.	0

in	0
a	0
recent	0
study	0
examining	0
patients	0
with	0
peripheral	1
ischaemia	2
,	0
the	0
cpt	3
code	0
35557	5
was	0
utilized	0
to	0
identify	0
and	0
classify	0
cases	0
specifically	0
related	0
to	0
peripheral	0
arterial	0
bypass	0
grafting	0
.	0

a	0
study	0
on	0
the	0
association	0
between	0
hla	0
-	0
b27	0
and	0
ankylosing	1
spondylitis	2
patients	0
revealed	0
that	0
the	0
majority	0
of	0
participants	0
were	0
coded	0
under	0
icd	3
-	4
8	4
with	0
the	0
specific	0
71249	5
classification	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
individuals	0
with	0
chronic	1
pain	2
disorders	0
,	0
a	0
significant	0
percentage	0
was	0
found	0
to	0
have	0
been	0
assigned	0
720	5
.	6
1	6
under	0
the	0
icd	3
-	4
9	4
-	4
cm	4
coding	0
system	0
,	0
indicating	0
a	0
diagnosis	0
of	0
ankylosing	0
spondylitis	0
as	0
their	0
primary	0
condition	0
.	0

in	0
a	0
recent	0
study	0
examining	0
various	0
types	0
of	0
neurological	0
disorders	0
,	0
it	0
was	0
found	0
that	0
the	0
prevalence	0
of	0
epilepsy	1
among	0
participants	0
increased	0
significantly	0
when	0
correlated	0
with	0
the	0
icd	3
-	4
9	4
cm	4
diagnosis	0
code	0
780	5
.	6
39	6
,	0
which	0
specifically	0
pertains	0
to	0
convulsive	0
disorders	0
not	0
elsewhere	0
classified	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
electronic	0
health	0
records	0
,	0
patients	0
who	0
had	0
received	0
a	0
diagnosis	0
of	0
pneumonia	1
with	0
the	0
corresponding	0
ccs	3
code	0
112	5
were	0
identified	0
and	0
assessed	0
for	0
the	0
prevalence	0
of	0
co	0
-	0
morbid	0
chronic	0
conditions	0
.	0

a	0
study	0
examining	0
the	0
incidence	0
of	0
cardiogenic	1
shock	2
revealed	0
a	0
significant	0
increase	0
in	0
cases	0
coded	0
as	0
r57	5
.	6
0	6
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
among	0
elderly	0
patients	0
with	0
pre	0
-	0
existing	0
cardiovascular	0
conditions	0
.	0

a	0
study	0
on	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
colon	1
cancer	2
(	0
icd	3
-	4
0	4
-	4
3	4
code	0
c182	5
)	0
revealed	0
that	0
certain	0
genetic	0
factors	0
and	0
lifestyle	0
choices	0
contributed	0
to	0
the	0
development	0
and	0
progression	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
individuals	0
experiencing	0
migraine	1
headaches	0
were	0
often	0
prescribed	0
medications	0
within	0
the	0
atc	3
classification	0
system	0
under	0
the	0
code	0
n02cx	5
,	0
which	0
includes	0
various	0
analgesics	0
and	0
antipyretics	0
specifically	0
designed	0
for	0
pain	0
relief	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
patients	0
with	0
a	0
pneumonia	1
diagnosis	0
,	0
identified	0
by	0
the	0
ccs	3
code	0
112	5
,	0
had	0
a	0
higher	0
readmission	0
rate	0
compared	0
to	0
those	0
without	0
this	0
clinical	0
phenotype	0
in	0
their	0
medical	0
history	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
dermatology	0
patients	0
,	0
those	0
diagnosed	0
with	0
psoriasis	1
according	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
with	0
a	0
specific	0
code	0
of	0
l409	5
were	0
observed	0
to	0
have	0
higher	0
incidence	0
of	0
comorbid	0
autoimmune	0
disorders	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
presenting	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
were	0
most	0
commonly	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
,	0
with	0
a	0
specific	0
focus	0
on	0
the	0
m06	5
.	6
x	6
code	0
series	0
to	0
accurately	0
identify	0
and	0
categorize	0
this	0
debilitating	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
seizure	1
disorders	0
in	0
children	0
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
those	0
with	0
a	0
diagnosis	0
of	0
icd	3
-	4
10	4
ca	4
code	0
g40	5
(	0
epilepsy	0
)	0
as	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
the	0
study	0
,	0
subjects	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
using	0
the	0
ccs	3
coding	0
system	0
,	0
specifically	0
the	0
112	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
150	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
analyzed	0
,	0
and	0
it	0
was	0
found	0
that	0
the	0
majority	0
of	0
them	0
were	0
categorized	0
under	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
75	6
,	0
thus	0
indicating	0
a	0
potential	0
association	0
between	0
the	0
disease	0
and	0
this	0
specific	0
diagnostic	0
classification	0
.	0

in	0
a	0
retrospective	0
study	0
on	0
epileptic	0
patients	0
,	0
it	0
was	0
found	0
that	0
those	0
presenting	0
with	0
both	0
speech	0
disorder	0
(	0
icd	3
-	4
10am	4
code	0
f80	5
.	6
3	6
)	0
and	0
seizures	1
had	0
significantly	0
lower	0
cognitive	0
scores	0
compared	0
to	0
patients	0
without	0
co	0
-	0
occurring	0
speech	0
disorder	0
.	0

a	0
study	0
of	0
pediatric	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
revealed	0
that	0
the	0
majority	0
of	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
g40	5
,	0
with	0
a	0
subset	0
of	0
patients	0
presenting	0
with	0
comorbid	0
neurological	0
disorders	0
.	0

in	0
a	0
study	0
examining	0
the	0
neuropsychological	0
profiles	0
of	0
older	0
adults	0
,	0
participants	0
were	0
classified	0
as	0
having	0
probable	0
alzheimer	1
'	2
s	2
disease	2
(	0
ad	0
)	0
based	0
on	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
with	0
a	0
specific	0
290	5
series	0
code	0
,	0
to	0
investigate	0
the	0
prevalence	0
and	0
symptomatology	0
of	0
ad	0
in	0
relation	0
to	0
cognitive	0
decline	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
association	0
between	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m435	5
and	0
the	0
occurrence	0
of	0
chronic	1
pain	2
in	0
patients	0
,	0
suggesting	0
that	0
increased	0
awareness	0
and	0
targeted	0
intervention	0
strategies	0
may	0
lead	0
to	0
improved	0
management	0
and	0
treatment	0
outcomes	0
.	0

a	0
recent	0
study	0
showed	0
that	0
patients	0
who	0
received	0
protein	1
kinase	2
inhibitor	2
medication	2
in	0
combination	0
with	0
chemotherapy	0
exhibited	0
improved	0
outcomes	0
,	0
with	0
the	0
most	0
effective	0
treatment	0
involving	0
a	0
specific	0
drug	0
assigned	0
the	0
bnf	3
code	0
8010551	5
in	0
the	0
national	0
pharmacological	0
database	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
association	0
between	0
chronic	1
pain	2
as	0
a	0
comorbidity	0
in	0
patients	0
with	0
icd	3
-	4
10	4
-	4
ca	4
diagnosis	0
code	0
m435	5
,	0
which	0
refers	0
to	0
seronegative	0
spondyloarthropathy	0
,	0
a	0
group	0
of	0
autoimmune	0
inflammatory	0
joint	0
diseases	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
autoimmune	0
diseases	0
,	0
a	0
significant	0
number	0
of	0
patients	0
were	0
found	0
to	0
have	0
sjogren	1
'	2
s	2
syndrome	2
with	0
a	0
specific	0
diagnostic	0
code	0
710	5
.	6
2	6
under	0
the	0
icd	3
-	4
9	4
-	4
cm	4
coding	0
system	0
.	0

in	0
the	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
identified	0
using	0
hicda	3
code	0
4519511	5
)	0
were	0
evaluated	0
to	0
determine	0
the	0
effectiveness	0
of	0
a	0
new	0
anticoagulant	0
therapy	0
for	0
the	0
prevention	0
of	0
recurrent	0
venous	0
thromboembolism	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
patients	0
diagnosed	0
with	0
seizure	1
disorders	0
,	0
specifically	0
coded	0
as	0
780	5
.	6
39	6
in	0
the	0
icd	3
-	4
9	4
cm	4
classification	0
system	0
,	0
exhibited	0
diverse	0
clinical	0
features	0
and	0
therapeutic	0
responses	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
classified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
specifically	0
the	0
c83	5
.	6
3x	6
series	0
of	0
codes	0
,	0
to	0
better	0
understand	0
the	0
clinical	0
outcomes	0
and	0
treatment	0
options	0
available	0
for	0
this	0
disease	0
subtype	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
observed	0
that	0
patients	0
with	0
epilepsy	1
and	0
associated	0
symptoms	0
were	0
more	0
likely	0
to	0
be	0
assigned	0
the	0
icd	3
-	4
10	4
ca	4
g41	5
code	0
,	0
which	0
indicates	0
a	0
higher	0
incidence	0
of	0
status	0
epilepticus	0
among	0
this	0
population	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
patients	0
with	0
the	0
narcolepsy	1
phenotype	0
associated	0
with	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
and	0
investigated	0
their	0
clinical	0
characteristics	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
classification	0
system	0
and	0
the	0
specific	0
code	0
203	5
.	6
99	6
to	0
evaluate	0
the	0
effectiveness	0
of	0
current	0
treatment	0
options	0
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
among	0
patients	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
with	0
code	0
9732	5
,	0
which	0
corresponds	0
to	0
malignant	0
plasma	0
cell	0
neoplasm	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
the	0
c42	5
code	0
within	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
coding	0
system	0
,	0
indicating	0
a	0
strong	0
association	0
between	0
this	0
specific	0
code	0
and	0
the	0
observed	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
myelodysplastic	1
syndrome	2
(	0
mds	0
)	0
were	0
found	0
to	0
have	0
a	0
significant	0
association	0
with	0
the	0
9986	5
code	0
as	0
per	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
prevalence	0
of	0
cardiovascular	0
comorbidities	0
,	0
a	0
significant	0
number	0
of	0
patients	0
were	0
identified	0
as	0
having	0
ccu002	1
_	2
01	2
hypertension	2
according	0
to	0
the	0
bnf	3
codes	4
system	0
,	0
specifically	0
with	0
the	0
code	0
0206020r0cgabar	5
,	0
representing	0
angiotensin	0
-	0
converting	0
enzyme	0
inhibitors	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
documented	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m05	5
.	6
x	6
)	0
found	0
a	0
higher	0
prevalence	0
of	0
associated	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
children	0
with	0
a	0
diagnosis	0
of	0
seizure	1
disorders	2
were	0
more	0
likely	0
to	0
be	0
assigned	0
an	0
icd	3
-	4
10	4
ca	4
code	0
of	0
g41	5
,	0
indicating	0
status	0
epilepticus	0
,	0
compared	0
to	0
those	0
with	0
other	0
neurological	0
phenotypes	0
.	0

a	0
study	0
on	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
cases	0
found	0
that	0
patients	0
diagnosed	0
with	0
this	0
condition	0
were	0
predominantly	0
coded	0
as	0
9800	5
in	0
the	0
international	3
classification	4
of	4
diseases	4
for	4
oncology	4
,	4
2nd	4
and	4
3rd	4
editions	4
(	4
icd	4
-	4
o	4
-	4
2	4
and	4
icd	4
-	4
o	4
-	4
3	4
)	4
coding	0
systems	0
.	0

a	0
retrospective	0
analysis	0
of	0
patients	0
suffering	0
from	0
psoriasis	1
revealed	0
that	0
the	0
majority	0
were	0
prescribed	0
medications	0
with	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
includes	0
a	0
variety	0
of	0
non	0
-	0
steroidal	0
anti	0
-	0
inflammatory	0
drugs	0
commonly	0
used	0
in	0
psoriasis	0
treatment	0
.	0

the	0
study	0
included	0
individuals	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
m05	5
.	6
x	6
,	0
in	0
order	0
to	0
analyze	0
the	0
potential	0
correlations	0
between	0
genetic	0
markers	0
and	0
disease	0
severity	0
.	0

during	0
the	0
study	0
,	0
we	0
observed	0
that	0
individuals	0
with	0
an	0
epilepsy	1
diagnosis	0
,	0
as	0
classified	0
by	0
icd	3
-	4
10	4
ca	4
code	0
g40	5
,	0
were	0
more	0
likely	0
to	0
experience	0
recurrent	0
seizures	0
and	0
had	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
cognitive	0
disorders	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

a	0
recent	0
study	0
identified	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
among	0
patients	0
with	0
a	0
diagnostic	0
code	0
of	0
c91	5
.	6
0	6
*	6
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
,	0
highlighting	0
the	0
need	0
for	0
improved	0
awareness	0
and	0
early	0
detection	0
strategies	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
a	0
primary	0
seizure	1
disorder	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
other	0
neurological	0
symptoms	0
,	0
which	0
were	0
coded	0
under	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
with	0
the	0
specific	0
code	0
r56	5
.	6
8	6
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
patients	0
with	0
epilepsy	1
associated	0
with	0
speech	0
and	0
language	0
disorders	0
,	0
specifically	0
focusing	0
on	0
those	0
coded	0
as	0
f80	5
.	6
3	6
in	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
.	0

a	0
study	0
examining	0
the	0
outcomes	0
of	0
patients	0
with	0
ccs	3
code	0
108	5
revealed	0
that	0
cardiogenic	1
shock	2
was	0
significantly	0
associated	0
with	0
increased	0
mortality	0
rates	0
compared	0
to	0
other	0
cardiac	0
diseases	0
.	0

a	0
study	0
conducted	0
on	0
hospitalized	0
patients	0
identified	0
a	0
high	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
associated	0
with	0
the	0
hicda	3
code	4
4519511	5
in	0
correlation	0
to	0
other	0
risk	0
factors	0
,	0
such	0
as	0
surgery	0
and	0
immobilization	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
was	0
investigated	0
among	0
postoperative	0
patients	0
using	0
the	0
icd	3
-	4
8	4
coding	0
system	0
,	0
where	0
the	0
specific	0
code	0
for	0
dvt	0
was	0
identified	0
as	0
671	5
.	6
01	6

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
psoriatic	1
arthritis	2
revealed	0
a	0
strong	0
correlation	0
between	0
the	0
icd	3
-	4
9	4
code	0
696	5
.	6
0	6
and	0
the	0
presence	0
of	0
certain	0
skin	0
manifestations	0
in	0
these	0
individuals	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
type	0
2	0
diabetes	0
treated	0
with	0
metformin	1
were	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
database	0
,	0
specifically	0
those	0
with	0
the	0
prescription	0
code	0
16044	5
,	0
to	0
analyze	0
its	0
potential	0
impact	0
on	0
their	0
cardiovascular	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
were	0
identified	0
based	0
on	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
specifically	0
using	0
the	0
code	0
m06	5
.	6
6	6
,	0
to	0
assess	0
the	0
prevalence	0
and	0
impact	0
of	0
the	0
condition	0
on	0
their	0
quality	0
of	0
life	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
participants	0
prescribed	0
diuretics	1
had	0
a	0
significant	0
association	0
with	0
the	0
gprd	3
product	4
code	4
55358	5
,	0
indicating	0
a	0
potential	0
linkage	0
between	0
this	0
code	0
and	0
the	0
treatment	0
of	0
hypertension	0
and	0
edema	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
had	0
significantly	0
higher	0
healthcare	0
utilization	0
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
9	4
code	0
710	5
,	0
compared	0
to	0
those	0
without	0
sle	0
in	0
a	0
large	0
tertiary	0
care	0
hospital	0
.	0

in	0
the	0
study	0
,	0
patients	0
suffering	0
from	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
with	0
the	0
specific	0
code	0
m06	5
.	6
x	6
,	0
allowing	0
for	0
a	0
more	0
accurate	0
analysis	0
of	0
the	0
disease	0
prevalence	0
and	0
its	0
associated	0
risk	0
factors	0
.	0

in	0
a	0
retrospective	0
study	0
examining	0
the	0
incidence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
among	0
hospitalized	0
patients	0
,	0
medical	0
records	0
were	0
reviewed	0
to	0
identify	0
cases	0
of	0
dvt	0
coded	0
under	0
the	0
hicda	3
system	0
,	0
specifically	0
using	0
4519511	5
as	0
the	0
diagnostic	0
criterion	0
.	0

a	0
retrospective	0
study	0
analyzed	0
medical	0
records	0
of	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
710	5
)	0
according	0
to	0
the	0
icd	3
-	4
9	4
classification	0
system	0
,	0
and	0
found	0
an	0
increased	0
incidence	0
of	0
renal	0
complications	0
in	0
these	0
individuals	0
.	0

a	0
recent	0
study	0
found	0
a	0
significantly	0
increased	0
risk	0
of	0
colon	1
cancer	2
incidence	0
and	0
mortality	0
in	0
individuals	0
with	0
the	0
malignant	0
neoplasm	0
code	0
c181	5
according	0
to	0
the	0
icd	3
-	4
0	4
-	4
3	4
classification	0
system	0
.	0

a	0
study	0
conducted	0
on	0
patients	0
with	0
lung	1
cancer	2
found	0
that	0
those	0
diagnosed	0
through	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
9050	5
,	0
displayed	0
significant	0
differences	0
in	0
clinical	0
presentation	0
and	0
prognosis	0
when	0
compared	0
to	0
other	0
subtypes	0
of	0
the	0
disease	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
among	0
patients	0
with	0
a	0
recorded	0
diagnosis	0
in	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
specifically	0
the	0
c90	5
.	6
0x	6
code	0
series	0
,	0
to	0
investigate	0
the	0
potential	0
risk	0
factors	0
and	0
treatment	0
outcomes	0
of	0
this	0
malignancy	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
chronic	1
pain	2
in	0
patients	0
found	0
a	0
significant	0
association	0
with	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m435	5
,	0
which	0
corresponds	0
to	0
the	0
phenotype	0
of	0
spondylolisthesis	0
,	0
a	0
spinal	0
condition	0
often	0
linked	0
to	0
persistent	0
discomfort	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
that	0
patients	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
in	2
the	2
primary	2
care	2
setting	0
were	0
more	0
likely	0
to	0
have	0
an	0
associated	0
ctv3	3
code	0
xaiqg	5
,	0
emphasizing	0
the	0
importance	0
of	0
accurate	0
coding	0
for	0
proper	0
disease	0
management	0
.	0

a	0
recent	0
study	0
focusing	0
on	0
patients	0
in	0
primary	0
care	0
settings	0
demonstrated	0
an	0
increase	0
in	0
the	0
prevalence	0
of	0
asthma	1
primary	2
care	2
diagnoses	0
,	0
as	0
classified	0
by	0
the	0
coding	0
system	0
ctv3	3
codes	4
and	0
specific	0
code	0
xaiww	5
,	0
which	0
may	0
suggest	0
a	0
need	0
for	0
improved	0
clinical	0
management	0
strategies	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
that	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
according	0
to	0
the	0
cd	3
-	4
9	4
coding	0
system	0
with	0
a	0
code	0
of	0
710	5
had	0
a	0
higher	0
incidence	0
of	0
associated	0
autoimmune	0
disorders	0
.	0

a	0
retrospective	0
analysis	0
of	0
patient	0
records	0
revealed	0
a	0
higher	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
(	0
coded	0
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
system	0
as	0
m05	5
.	6
x	6
)	0
among	0
individuals	0
with	0
autoimmune	0
diseases	0
in	0
our	0
cohort	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
autoimmune	0
diseases	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
cm	4
-	4
9	4
code	0
710	5
.	6
2	6
and	0
their	0
clinical	0
manifestations	0
were	0
further	0
analyzed	0
.	0

in	0
a	0
study	0
conducted	0
on	0
hypertension	0
patients	0
,	0
those	0
prescribed	0
ace	1
inhibitors	2
were	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
database	0
,	0
specifically	0
code	0
16060	5
,	0
to	0
analyze	0
the	0
efficacy	0
and	0
safety	0
of	0
the	0
medication	0
.	0

the	0
study	0
focused	0
on	0
patients	0
diagnosed	0
with	0
myelodysplastic	1
syndrome	2
(	0
9980	5
)	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
,	0
which	0
covers	0
a	0
group	0
of	0
diverse	0
hematological	0
conditions	0
characterized	0
by	0
ineffective	0
hematopoiesis	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	2
dvt	2
)	2
,	0
it	0
was	0
found	0
that	0
the	0
majority	0
had	0
an	0
icd	3
-	4
9	4
-	4
d	4
code	0
of	0
453	5
.	6
41	6
/	6
,	0
indicating	0
a	0
high	0
prevalence	0
of	0
this	0
particular	0
phenotype	0
associated	0
with	0
thrombotic	0
diseases	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
to	0
examine	0
possible	0
connections	0
between	0
specific	0
genetic	0
variations	0
and	0
disease	0
progression	0
.	0

a	0
recent	0
study	0
identified	0
higher	0
incidence	0
rates	0
of	0
rheumatoid	1
arthritis	2
in	0
patients	0
with	0
specific	0
comorbidities	0
,	0
which	0
were	0
coded	0
in	0
the	0
icd	3
-	4
10	4
-	4
cm	4
system	0
using	0
the	0
m05	5
.	6
x	6
series	0
of	0
codes	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
hospitalized	0
patients	0
,	0
those	0
presenting	0
with	0
an	0
initial	0
seizure	1
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
comorbidities	0
,	0
as	0
indicated	0
by	0
icd	3
-	4
9	4
cm	4
code	0
345	5
.	6
x	6
,	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
9698	5
,	0
to	0
analyze	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
this	0
malignant	0
lymphoma	1
subtype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histopathological	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9731	5
,	0
which	0
corresponds	0
to	0
the	0
neoplastic	0
plasma	0
cell	0
disorder	0
,	0
and	0
the	0
data	0
was	0
further	0
analyzed	0
to	0
understand	0
the	0
disease	0
progression	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
an	0
increased	0
risk	0
of	0
developing	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
among	0
patients	0
who	0
had	0
a	0
hicda	3
code	4
of	0
4519511	5
,	0
which	0
indicates	0
a	0
history	0
of	0
certain	0
thrombophilic	0
disorders	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
individuals	0
with	0
a	0
history	0
of	0
icd	3
-	4
10	4
coded	0
deep	1
vein	2
thrombosis	2
(	0
i824z2	5
)	0
had	0
an	0
increased	0
risk	0
of	0
developing	0
post	0
-	0
thrombotic	0
syndrome	0
compared	0
to	0
those	0
without	0
any	0
venous	0
thromboembolic	0
events	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
cancer	0
patients	0
,	0
a	0
significant	0
number	0
were	0
found	0
to	0
have	0
been	0
diagnosed	0
with	0
icd	3
-	4
7	4
classified	0
multiple	1
myeloma	2
under	0
the	0
specific	0
code	0
203	5
.	6
1	6
,	0
indicating	0
a	0
higher	0
-	0
than	0
-	0
expected	0
prevalence	0
of	0
this	0
condition	0
in	0
the	0
analyzed	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
with	0
the	0
specific	0
9732	5
code	0
,	0
allowing	0
for	0
accurate	0
identification	0
and	0
management	0
of	0
this	0
malignant	0
plasma	0
cell	0
disorder	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
between	0
2000	0
and	0
2010	0
showed	0
that	0
the	0
majority	0
of	0
cases	0
were	0
assigned	0
the	0
icd	3
-	4
9	4
code	0
200	5
.	6
1	6
,	0
indicating	0
a	0
subclassification	0
under	0
the	0
international	0
classification	0
of	0
diseases	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
was	0
observed	0
among	0
patients	0
with	0
a	0
diagnosis	0
code	0
of	0
c83	5
.	6
3	6
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
,	0
specifically	0
those	0
assigned	0
the	0
g41	5
code	0
corresponding	0
to	0
status	0
epilepticus	0
.	0

in	0
a	0
recent	0
study	0
conducted	0
on	0
the	0
canadian	0
population	0
,	0
it	0
was	0
observed	0
that	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
adults	0
was	0
higher	0
in	0
those	0
who	0
were	0
coded	0
as	0
m06	5
.	6
x	6
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
advanced	0
melanoma	0
who	0
were	0
treated	0
with	0
cancer	1
immunotherapy	2
medication	2
pembrolizumab	0
(	0
british	0
national	0
formulary	0
bnf	3
code	0
0	5
)	0
demonstrated	0
a	0
significant	0
improvement	0
in	0
overall	0
survival	0
and	0
a	0
lower	0
incidence	0
of	0
adverse	0
effects	0
.	0

in	0
the	0
study	0
,	0
individuals	0
with	0
a	0
primary	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
were	0
identified	0
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d69	5
.	6
3	6
,	0
to	0
assess	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
this	0
hematologic	0
condition	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
found	0
that	0
the	0
prevalence	0
of	0
this	0
autoimmune	0
disorder	0
significantly	0
increased	0
from	0
2000	0
to	0
2014	0
when	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
and	0
the	0
corresponding	0
m06	5
.	6
x	6
codes	0
for	0
diagnosis	0
.	0

in	0
a	0
recent	0
study	0
,	0
we	0
observed	0
that	0
patients	0
with	0
an	0
icd	3
-	4
10	4
-	4
am	4
diagnosis	0
of	0
anaphylaxis	1
(	0
t80	5
.	6
5	6
)	0
were	0
more	0
likely	0
to	0
have	0
a	0
history	0
of	0
atopy	0
and	0
a	0
higher	0
serum	0
ige	0
level	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
influenza	1
infection	2
primary	2
care	2
in	0
a	0
population	0
using	0
electronic	0
health	0
records	0
,	0
where	0
diagnoses	0
were	0
identified	0
using	0
ctv3	3
codes	0
,	0
specifically	0
h27yz	5
,	0
to	0
ensure	0
accurate	0
tracking	0
and	0
reporting	0
of	0
this	0
public	0
health	0
concern	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
a	0
significant	0
association	0
between	0
the	0
icd	3
-	4
9cm	4
code	0
387	5
.	6
4x	6
and	0
the	0
thrombocytopenic	1
disorder	2
phenotype	0
in	0
patients	0
undergoing	0
chemotherapy	0
treatment	0
.	0

in	0
a	0
study	0
examining	0
the	0
risk	0
factors	0
for	0
ischemic	1
stroke	2
,	0
researchers	0
identified	0
patients	0
with	0
a	0
diagnosis	0
code	0
of	0
437	5
.	6
3	6
in	0
the	0
icd	3
-	4
9	4
classification	0
system	0
and	0
investigated	0
their	0
medical	0
history	0
for	0
potential	0
contributors	0
to	0
the	0
condition	0
.	0

among	0
the	0
epileptic	0
patients	0
in	0
our	0
study	0
,	0
72	0
%	0
were	0
diagnosed	0
with	0
seizure	1
disorders	0
according	0
to	0
the	0
icd	3
-	4
9	4
cm	4
classification	0
,	0
particularly	0
under	0
the	0
code	0
345	5
.	6
x	6
,	0
encompassing	0
a	0
diverse	0
range	0
of	0
seizure	0
types	0
and	0
etiologies	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
relationship	0
between	0
icd	3
-	4
10	4
code	0
m069	5
and	0
the	0
phenotype	0
rheumatoid	1
arthritis	2
was	0
further	0
explored	0
in	0
order	0
to	0
identify	0
potential	0
risk	0
factors	0
and	0
comorbidities	0
associated	0
with	0
this	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
and	0
assigned	0
the	0
code	0
290	5
.	6
3	6
showed	0
significant	0
cognitive	0
decline	0
compared	0
to	0
age	0
-	0
matched	0
controls	0
.	0

in	0
a	0
recent	0
study	0
,	0
participants	0
with	0
colon	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
c180	5
,	0
which	0
encompasses	0
primary	0
malignant	0
neoplasms	0
originating	0
in	0
the	0
cecum	0
region	0
of	0
the	0
colon	0
.	0

a	0
retrospective	0
analysis	0
of	0
patients	0
with	0
crohn	1
'	2
s	2
disease	2
(	0
563	5
.	6
0x	6
)	0
,	0
as	0
classified	0
by	0
both	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
groups	0
,	0
revealed	0
an	0
increased	0
prevalence	0
of	0
extraintestinal	0
manifestations	0
in	0
the	0
study	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
discovered	0
that	0
patients	0
with	0
a	0
ccs	3
code	0
112	5
classification	0
were	0
at	0
an	0
increased	0
risk	0
of	0
developing	0
the	0
pneumonia	1
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
in	0
adults	0
had	0
significantly	0
increased	0
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
m06	5
and	0
includes	0
various	0
subtypes	0
of	0
inflammatory	0
polyarthropathies	0
.	0

a	0
recent	0
study	0
has	0
revealed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
colon	1
cancer	2
patients	0
,	0
specifically	0
those	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c185	5
,	0
which	0
is	0
associated	0
with	0
malignant	0
neoplasms	0
originating	0
in	0
the	0
cecum	0
region	0
of	0
the	0
large	0
intestine	0
.	0

a	0
study	0
was	0
conducted	0
on	0
patients	0
who	0
experienced	0
anaphylaxis	1
and	0
were	0
given	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t78	5
.	6
2	6
,	0
to	0
analyze	0
the	0
prevalence	0
of	0
this	0
severe	0
allergic	0
reaction	0
in	0
a	0
specific	0
population	0
.	0

in	0
a	0
study	0
conducted	0
at	0
a	0
specialized	0
sleep	0
center	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
were	0
evaluated	0
using	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
where	0
the	0
relevant	0
code	0
for	0
the	0
disorder	0
was	0
identified	0
as	0
347	5
.	6
0x	6
.	0

a	0
cohort	0
study	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
coded	0
as	0
4519511	5
in	0
the	0
hicda	3
system	0
)	0
were	0
at	0
an	0
increased	0
risk	0
for	0
developing	0
pulmonary	0
embolism	0
during	0
their	0
hospital	0
stay	0
.	0

of	0
the	0
total	0
patient	0
cohort	0
examined	0
,	0
a	0
subset	0
was	0
identified	0
with	0
a	0
primary	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
,	0
specifically	0
with	0
the	0
code	0
710	5
.	6
2	6
,	0
in	0
order	0
to	0
study	0
the	0
associated	0
clinical	0
manifestations	0
and	0
comorbidities	0
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
relationship	0
between	0
genetic	0
factors	0
and	0
prostate	1
cancer	2
incidence	0
,	0
participants	0
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
with	0
a	0
specific	0
diagnosis	0
code	0
of	0
8140	5
for	0
adenocarcinoma	0
of	0
the	0
prostate	0
gland	0
.	0

a	0
study	0
conducted	0
on	0
elderly	0
patients	0
revealed	0
a	0
high	0
prevalence	0
of	0
dementia	0
,	0
with	0
the	0
most	0
common	0
subtype	0
being	0
alzheimer	1
'	2
s	2
disease	2
(	0
ad	0
)	0
,	0
as	0
identified	0
by	0
the	0
dsm	3
-	4
iv	4
diagnostic	0
criteria	0
under	0
the	0
code	0
290	5
.	6
3	6
,	0
indicating	0
a	0
significant	0
association	0
between	0
age	0
and	0
ad	0
risk	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
cardiogenic	1
shock	2
diagnosis	0
were	0
found	0
to	0
have	0
a	0
high	0
mortality	0
rate	0
,	0
particularly	0
those	0
classified	0
under	0
the	0
ccs	3
code	0
100	5
in	0
the	0
clinical	0
coding	0
system	0
.	0

a	0
recent	0
study	0
found	0
that	0
women	0
with	0
icd	3
-	4
10	4
-	4
ca	4
code	0
o87	5
.	6
1	6
had	0
a	0
significantly	0
higher	0
incidence	0
of	0
postpartum	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
compared	0
to	0
those	0
without	0
the	0
specific	0
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
a	0
high	0
incidence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
among	0
postoperative	0
patients	0
,	0
which	0
was	0
significantly	0
associated	0
with	0
the	0
hicda	3
code	4
4519511	5
for	0
venous	0
-	0
related	0
diagnoses	0
,	0
highlighting	0
the	0
importance	0
of	0
early	0
identification	0
and	0
appropriate	0
prophylactic	0
measures	0
.	0

a	0
retrospective	0
cohort	0
study	0
of	0
350	0
patients	0
found	0
an	0
increased	0
occurrence	0
of	0
multiple	1
myeloma	2
(	0
mm	0
)	0
in	0
individuals	0
presenting	0
with	0
icd	3
-	4
7	4
code	0
203	5
.	6
1	6
,	0
suggesting	0
a	0
potential	0
association	0
between	0
the	0
two	0
phenotypes	1
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
specifically	0
with	0
the	0
code	0
m06	5
.	6
x	6
,	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
cardiovascular	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
diagnostic	0
code	0
of	0
r57	5
.	6
0	6
in	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
were	0
identified	0
as	0
having	0
experienced	0
an	0
episode	0
of	0
cardiogenic	1
shock	2
during	0
their	0
hospitalization	0
,	0
and	0
their	0
clinical	0
outcomes	0
and	0
management	0
strategies	0
were	0
analyzed	0
.	0

a	0
recent	0
study	0
found	0
a	0
higher	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
in	0
patients	0
with	0
code	0
202	5
.	6
78	6
according	0
to	0
the	0
icd	3
-	4
9	4
classification	0
system	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
and	0
diagnosis	0
in	0
the	0
management	0
of	0
this	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histological	0
diagnosis	0
of	0
bladder	1
cancer	2
were	0
identified	0
predominantly	0
using	0
the	0
icd	3
-	4
o	4
code	0
c67	5
.	6
7	6
,	0
highlighting	0
the	0
importance	0
of	0
utilizing	0
standard	0
coding	0
systems	0
to	0
accurately	0
categorize	0
and	0
analyze	0
medical	0
data	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
psoriasis	1
were	0
found	0
to	0
have	0
a	0
statistically	0
significant	0
association	0
with	0
hicda	3
code	0
6961211	5
,	0
shedding	0
light	0
on	0
the	0
specific	0
patterns	0
of	0
this	0
dermatological	0
phenotype	0
in	0
a	0
clinical	0
setting	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
neck	1
pain	2
were	0
primarily	0
assigned	0
the	0
hira	3
code	0
g53	5
.	6
0	6
,	0
which	0
encompasses	0
various	0
cervical	0
disorders	0
and	0
related	0
anatomical	0
dysfunctions	0
.	0

in	0
a	0
cohort	0
study	0
of	0
hospitalized	0
patients	0
,	0
researchers	0
found	0
that	0
those	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
often	0
assigned	0
the	0
hicda	3
code	0
4519511	5
to	0
accurately	0
represent	0
their	0
dvt	1
phenotype	0
in	0
the	0
medical	0
records	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
lung	1
cancer	2
were	0
found	0
to	0
have	0
an	0
increased	0
prevalence	0
of	0
histologic	0
subtype	0
8571	5
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
indicating	0
a	0
potential	0
correlation	0
between	0
this	0
specific	0
code	0
and	0
the	0
development	0
of	0
this	0
malignancy	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
clinical	0
features	0
and	0
treatment	0
outcomes	0
of	0
patients	0
with	0
multiple	1
myeloma	2
(	0
m	5
-	6
9731	6
)	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
codes	4
,	0
and	0
found	0
significant	0
associations	0
between	0
certain	0
genetic	0
abnormalities	0
and	0
prognosis	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
showed	0
that	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
primarily	0
assigned	0
the	0
icd	3
-	4
o	4
-	4
2	4
code	0
9690	5
in	0
the	0
united	0
states	0
,	0
indicating	0
the	0
significance	0
of	0
this	0
malignancy	0
in	0
the	0
field	0
of	0
oncology	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
effects	0
of	0
the	0
protein	1
kinase	2
inhibitor	2
medication	2
,	0
classified	0
under	0
the	0
bnf	3
code	0
8010551	5
,	0
were	0
analyzed	0
in	0
the	0
treatment	0
of	0
patients	0
with	0
specific	0
genotype	0
-	0
phenotype	0
correlations	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
an	0
increased	0
prevalence	0
of	0
multiple	1
myeloma	2
among	0
patients	0
with	0
a	0
diagnostic	0
code	0
of	0
203	5
.	6
2	6
according	0
to	0
the	0
icd	3
-	4
7	4
classification	0
system	0
,	0
which	0
may	0
suggest	0
an	0
underlying	0
genetic	0
susceptibility	0
factor	0
.	0

the	0
prevalence	0
of	0
alzheimer	1
'	2
s	2
disease	2
in	0
the	0
elderly	0
population	0
has	0
been	0
studied	0
extensively	0
,	0
with	0
a	0
focus	0
on	0
individuals	0
diagnosed	0
using	0
the	0
icd	3
-	4
9	4
code	0
290	5
.	6
1	6
,	0
revealing	0
significant	0
trends	0
in	0
dementia	0
-	0
related	0
morbidity	0
and	0
mortality	0
rates	0
among	0
different	0
demographic	0
groups	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
individuals	0
with	0
a	0
primary	0
diagnosis	0
of	0
colon	1
cancer	2
coded	0
as	0
c181	5
in	0
the	0
icd	3
-	4
0	4
-	4
3	4
system	0
,	0
to	0
analyze	0
the	0
demographic	0
characteristics	0
and	0
treatment	0
outcomes	0
.	0

in	0
this	0
study	0
,	0
the	0
association	0
between	0
various	0
comorbidities	0
and	0
ccs	3
code	0
112	5
,	0
otherwise	0
known	0
as	0
pneumonia	1
,	0
was	0
assessed	0
in	0
a	0
large	0
cohort	0
of	0
hospitalized	0
patients	0
.	0

a	0
retrospective	0
analysis	0
of	0
electronic	0
health	0
records	0
revealed	0
that	0
individuals	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
coded	0
as	0
m06	5
.	6
x	6
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
)	0
had	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
,	0
such	0
as	0
cardiovascular	0
disease	0
and	0
depression	0
,	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
association	0
between	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
54	5
and	0
the	0
occurrence	0
of	0
prostate	1
cancer	2
among	0
middle	0
-	0
aged	0
men	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
patients	0
with	0
varying	0
phenotypes	0
were	0
found	0
to	0
have	0
neck	1
pain	2
associated	0
with	0
the	0
g53	5
.	6
0	6
code	0
in	0
the	0
hira	3
coding	0
system	0
,	0
revealing	0
a	0
potential	0
link	0
between	0
this	0
specific	0
coding	0
category	0
and	0
the	0
manifestation	0
of	0
neck	0
-	0
related	0
discomfort	0
in	0
various	0
clinical	0
presentations	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
of	0
pneumonia	1
was	0
found	0
to	0
be	0
higher	0
in	0
patients	0
with	0
a	0
ccs	3
diagnosis	0
code	0
112	5
,	0
indicating	0
a	0
close	0
association	0
between	0
this	0
code	0
and	0
the	0
clinical	0
manifestation	0
of	0
the	0
disease	0
.	0

a	0
study	0
on	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
revealed	0
a	0
significant	0
number	0
of	0
cases	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
m06	5
,	0
indicating	0
that	0
ra	0
is	0
still	0
a	0
major	0
public	0
health	0
concern	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
specific	0
diagnostic	0
code	0
290	5
.	6
1	6
(	0
senile	0
dementia	0
of	0
the	0
alzheimer	0
type	0
)	0
compared	0
to	0
those	0
with	0
other	0
forms	0
of	0
dementia	0
.	0

among	0
the	0
study	0
population	0
,	0
cases	0
of	0
prostate	1
cancer	2
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
,	0
with	0
the	0
most	0
common	0
histological	0
type	0
identified	0
as	0
adenocarcinoma	0
(	0
code	0
8140	5
)	0
.	0

among	0
the	0
hospitalized	0
patients	0
studied	0
,	0
23	0
were	0
diagnosed	0
with	0
seizure	1
disorders	0
according	0
to	0
the	0
icd	3
-	4
9	4
cm	4
classification	0
system	0
,	0
specifically	0
with	0
the	0
code	0
345	5
,	0
which	0
required	0
antiepileptic	0
drug	0
therapy	0
for	0
symptom	0
management	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
of	0
patients	0
with	0
cardiopulmonary	0
arrest	0
,	0
those	0
who	0
developed	0
cardiogenic	1
shock	2
(	0
ccs	3
category	0
107	5
)	0
had	0
significantly	0
higher	0
mortality	0
rates	0
compared	0
to	0
patients	0
without	0
this	0
serious	0
complication	0
.	0

a	0
recent	0
study	0
revealed	0
a	0
significant	0
association	0
between	0
the	0
psoriasis	1
phenotype	0
and	0
a	0
specific	0
genetic	0
variant	0
in	0
patients	0
with	0
icd	3
-	4
10	4
code	0
l409	5
for	0
the	0
diagnosis	0
of	0
this	0
chronic	0
inflammatory	0
skin	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
,	0
specifically	0
those	0
with	0
a	0
c82	5
*	6
code	0
series	0
,	0
to	0
evaluate	0
the	0
effectiveness	0
of	0
new	0
treatment	0
modalities	0
in	0
this	0
patient	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
peripheral	1
ischaemia	2
were	0
found	0
to	0
have	0
undergone	0
revascularization	0
procedures	0
,	0
specifically	0
coded	0
as	0
35323	5
under	0
the	0
cpt	3
coding	0
system	0
,	0
to	0
improve	0
their	0
symptoms	0
and	0
quality	0
of	0
life	0
.	0

a	0
retrospective	0
analysis	0
of	0
electronic	0
health	0
records	0
observed	0
an	0
increased	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
in	0
patients	0
coded	0
under	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
with	0
the	0
specific	0
code	0
m05	5
.	6
x	6
,	0
with	0
a	0
majority	0
of	0
cases	0
exhibiting	0
severe	0
joint	0
inflammation	0
and	0
deformity	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
crohn	1
'	2
s	2
disease	2
(	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
,	0
563	5
.	6
0x	6
)	0
found	0
a	0
significant	0
association	0
between	0
disease	0
severity	0
and	0
specific	0
genetic	0
markers	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
sleep	0
-	0
related	0
disorders	0
found	0
that	0
narcolepsy	1
was	0
among	0
the	0
most	0
common	0
,	0
with	0
an	0
incidence	0
rate	0
of	0
0	0
.	0
19	0
per	0
100	0
,	0
000	0
persons	0
in	0
the	0
population	0
according	0
to	0
the	0
icd	3
-	4
9	4
classification	0
system	0
under	0
the	0
code	0
347	5
.	6
0x	6
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
history	0
of	0
type	1
2	2
diabetes	2
mellitus	2
(	0
t2dm	0
)	0
,	0
which	0
is	0
classified	0
under	0
icd	3
-	4
9	4
-	4
cm	4
code	0
250	5
.	6
x2	6
,	0
to	0
evaluate	0
the	0
prevalence	0
of	0
diabetic	0
complications	0
and	0
comorbidities	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
between	0
icd	3
-	4
10	4
code	0
l401	5
and	0
the	0
psoriasis	1
phenotype	0
was	0
noted	0
in	0
patients	0
with	0
a	0
history	0
of	0
inflammatory	0
skin	0
disorders	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
history	0
of	0
epilepsy	1
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
g41	5
,	0
to	0
investigate	0
the	0
prevalence	0
of	0
comorbid	0
psychiatric	0
disorders	0
in	0
this	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
individuals	0
suffering	0
from	0
epilepsy	1
were	0
frequently	0
coded	0
as	0
having	0
convulsions	0
under	0
the	0
icd	3
-	4
9	4
cm	4
system	0
,	0
specifically	0
with	0
the	0
code	0
780	5
.	6
39	6
,	0
which	0
is	0
known	0
to	0
encompass	0
various	0
other	0
seizure	0
-	0
related	0
symptoms	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
receiving	0
cancer	1
immunotherapy	2
medication	2
were	0
identified	0
using	0
bnf	3
codes	0
08020300	5
for	0
immune	0
checkpoint	0
inhibitors	0
and	0
10010301	5
for	0
adoptive	0
cellular	0
therapy	0
,	0
highlighting	0
the	0
increasing	0
use	0
of	0
these	0
therapies	0
in	0
clinical	0
practice	0
.	0

in	0
this	0
study	0
,	0
narcoleptic	0
patients	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
diagnostic	0
code	0
347	5
.	6
0x	6
,	0
which	0
corresponds	0
to	0
the	0
phenotype	0
narcolepsy	1
,	0
and	0
were	0
compared	0
to	0
a	0
control	0
group	0
in	0
terms	0
of	0
sleep	0
patterns	0
and	0
daytime	0
sleepiness	0
.	0

in	0
this	0
study	0
,	0
women	0
with	0
the	0
ccu002	1
_	2
02	2
hormone	2
replacement	2
therapy	2
(	2
hrt	2
)	2
phenotype	0
were	0
prescribed	0
medication	0
with	0
the	0
bnf	3
code	4
0604011g0bwaabt	5
,	0
as	0
part	0
of	0
their	0
hormone	0
replacement	0
therapy	0
regimen	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
association	0
of	0
genetic	0
variants	0
with	0
the	0
risk	0
of	0
developing	0
prostate	1
cancer	2
in	0
2	0
,	0
000	0
individuals	0
,	0
whose	0
diagnoses	0
were	0
confirmed	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
,	0
denoting	0
tumors	0
originating	0
from	0
prostate	0
glandular	0
structures	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
narcolepsy	1
among	0
individuals	0
with	0
a	0
recorded	0
diagnosis	0
in	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
particularly	0
those	0
coded	0
as	0
g47	5
.	6
4x	6
,	0
emphasizing	0
the	0
need	0
for	0
improved	0
diagnostic	0
criteria	0
and	0
awareness	0
of	0
this	0
sleep	0
disorder	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
the	0
prevalence	0
of	0
sjogren	1
'	2
s	2
syndrome	2
(	0
710	5
.	6
2	6
)	0
was	0
found	0
to	0
be	0
higher	0
in	0
female	0
patients	0
in	0
comparison	0
to	0
the	0
male	0
population	0
,	0
according	0
to	0
icd	3
-	4
9	4
-	4
cm	4
diagnostic	0
codes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
,	0
which	0
led	0
to	0
the	0
discovery	0
of	0
new	0
genetic	0
markers	0
associated	0
with	0
disease	0
progression	0
.	0

the	0
study	0
examined	0
the	0
effectiveness	0
of	0
protein	1
kinase	2
inhibitor	2
medications	0
,	0
specifically	0
those	0
with	0
the	0
bnf	3
code	0
8010551	5
,	0
in	0
treating	0
cancer	0
-	0
associated	0
phenotypical	0
characteristics	0
among	0
participants	0
.	0

a	0
study	0
analyzed	0
the	0
prevalence	0
of	0
ankylosing	1
spondylitis	2
among	0
adults	0
,	0
using	0
the	0
icd	3
-	4
8	4
classification	0
system	0
and	0
identified	0
a	0
significant	0
number	0
of	0
individuals	0
with	0
the	0
specific	0
code	0
712	5
.	6
4	6
related	0
to	0
this	0
chronic	0
inflammatory	0
joint	0
disorder	0
.	0

in	0
a	0
study	0
of	0
hematological	0
malignancies	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
for	0
their	0
primary	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
psoriasis	1
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
their	0
medical	0
records	0
included	0
the	0
hicda	3
code	0
6961212	5
,	0
suggesting	0
that	0
this	0
specific	0
code	0
may	0
be	0
useful	0
in	0
identifying	0
more	0
severe	0
cases	0
for	0
targeted	0
treatment	0
and	0
management	0
strategies	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
the	0
prevalence	0
of	0
viral	1
hepatitis	2
c	2
was	0
examined	0
among	0
hospitalized	0
patients	0
with	0
a	0
discharge	0
diagnosis	0
code	0
v02	5
.	6
62	6
in	0
the	0
icd	3
-	4
9	4
-	4
cm	4
coding	0
system	0
,	0
revealing	0
a	0
strong	0
correlation	0
between	0
the	0
risk	0
factors	0
and	0
exposure	0
to	0
the	0
virus	0
.	0

a	0
study	0
found	0
that	0
in	0
patients	0
aged	0
40	0
-	0
70	0
with	0
a	0
high	0
risk	0
of	0
developing	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
the	0
most	0
prevalent	0
subtype	0
was	0
closely	0
related	0
to	0
the	0
diagnostic	0
code	0
200	5
.	6
0	6
according	0
to	0
the	0
icd	3
-	4
9	4
coding	0
system	0
.	0

in	0
this	0
study	0
,	0
patients	0
were	0
identified	0
with	0
bladder	1
cancer	2
according	0
to	0
the	0
icd	3
-	4
o	4
classification	0
system	0
,	0
specifically	0
the	0
8121	5
code	0
,	0
to	0
investigate	0
potential	0
risk	0
factors	0
associated	0
with	0
disease	0
progression	0
and	0
survival	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
prostate	1
cancer	2
were	0
stratified	0
by	0
histology	0
type	0
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
,	0
with	0
a	0
majority	0
of	0
cases	0
belonging	0
to	0
the	0
8140	5
code	0
indicating	0
adenocarcinoma	0
as	0
the	0
primary	0
histological	0
subtype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
prostate	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
,	0
which	0
corresponds	0
to	0
malignant	0
neoplasms	0
originating	0
in	0
the	0
prostate	0
gland	0
.	0

in	0
a	0
study	0
investigating	0
risk	0
factors	0
for	0
suicidal	0
behavior	0
,	0
patients	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
mood	0
disorders	0
,	0
as	0
identified	0
by	0
the	0
oxmis	3
codes	4
system	0
,	0
particularly	0
the	0
3009bp	5
code	0
.	0

a	0
study	0
found	0
that	0
individuals	0
diagnosed	0
with	0
schizoaffective	1
disorder	2
(	0
classified	0
under	0
the	0
icd	3
-	4
8	4
coding	0
system	0
with	0
a	0
code	0
of	0
295	5
.	6
79	6
)	0
had	0
a	0
higher	0
incidence	0
of	0
comorbid	0
conditions	0
compared	0
to	0
those	0
with	0
other	0
mental	0
health	0
disorders	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
identified	0
through	0
the	0
hospital	0
database	0
using	0
the	0
hicda	3
code	4
4519511	5
revealed	0
significant	0
associations	0
between	0
obesity	0
,	0
older	0
age	0
,	0
and	0
reduced	0
mobility	0
in	0
the	0
development	0
of	0
dvt	1
.	0

in	0
a	0
retrospective	0
study	0
of	0
cancer	0
cases	0
,	0
89	0
patients	0
were	0
identified	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
based	0
on	0
the	0
icd	3
-	4
7	4
code	0
203	5
.	6
1	6
,	0
which	0
was	0
further	0
analyzed	0
for	0
potential	0
associations	0
with	0
genetic	0
mutations	0
and	0
environmental	0
factors	0
.	0

the	0
study	0
observed	0
an	0
increased	0
incidence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
in	0
postoperative	0
patients	0
,	0
which	0
was	0
found	0
to	0
be	0
associated	0
with	0
the	0
hicda	3
code	0
4519511	5
,	0
pointing	0
towards	0
a	0
possible	0
correlation	0
between	0
this	0
specific	0
hicda	3
code	0
and	0
an	0
increased	0
risk	0
of	0
developing	0
dvt	1
post	0
-	0
surgery	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
2	4
coding	0
system	0
with	0
the	0
specific	0
code	0
9670	5
,	0
revealed	0
a	0
higher	0
prevalence	0
of	0
this	0
cancer	0
among	0
middle	0
-	0
aged	0
adults	0
,	0
warranting	0
further	0
investigation	0
into	0
potential	0
risk	0
factors	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	4
c42	5
)	0
showed	0
a	0
significant	0
association	0
between	0
specific	0
genetic	0
abnormalities	0
and	0
the	0
development	0
of	0
this	0
hematologic	0
malignancy	0
.	0

a	0
study	0
examining	0
the	0
prevalence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
in	0
a	0
hospital	0
population	0
found	0
that	0
the	0
incidence	0
was	0
significantly	0
higher	0
in	0
patients	0
with	0
a	0
documented	0
icd	3
-	4
10	4
-	4
ca	4
code	0
of	0
i80	5
.	6
9	6
,	0
suggestive	0
of	0
an	0
underlying	0
predisposition	0
to	0
developing	0
this	0
dvt	1
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
cases	0
,	0
with	0
a	0
specific	0
focus	0
on	0
those	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
particularly	0
the	0
code	0
97373	5
,	0
which	0
identifies	0
a	0
rare	0
subtype	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
clin	3
mod	4
.	4
codes	4
7142	5
,	0
which	0
helped	0
to	0
better	0
understand	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
this	0
debilitating	0
autoimmune	0
disorder	0
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
association	0
between	0
the	0
m05	5
code	0
in	0
the	0
icd	3
-	4
10	4
classification	0
system	0
and	0
the	0
onset	0
of	0
rheumatoid	1
arthritis	2
in	0
patients	0
aged	0
40	0
-	0
60	0
years	0
of	0
diverse	0
ethnic	0
backgrounds	0
.	0

in	0
a	0
study	0
examining	0
the	0
risk	0
factors	0
for	0
suicidality	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
major	0
depressive	0
disorder	0
(	0
oxmis	3
codes	4
:	0
3009bp	5
)	0
who	0
had	0
attempted	0
suicide	1
were	0
compared	0
to	0
those	0
without	0
a	0
history	0
of	0
suicide	0
attempts	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
investigated	0
the	0
association	0
between	0
exposure	0
to	0
benzene	0
and	0
the	0
development	0
of	0
multiple	1
myeloma	2
in	0
patients	0
diagnosed	0
with	0
the	0
condition	0
using	0
the	0
icd	3
-	4
7	4
coding	0
system	0
,	0
specifically	0
the	0
203	5
.	6
1	6
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
multiple	1
myeloma	2
were	0
commonly	0
assigned	0
the	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
in	0
hospital	0
records	0
,	0
which	0
helped	0
in	0
efficient	0
tracking	0
and	0
treatment	0
of	0
this	0
hematological	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
c82	5
*	6
code	0
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
,	0
indicating	0
a	0
potential	0
association	0
between	0
specific	0
genetic	0
factors	0
and	0
the	0
development	0
of	0
this	0
malignancy	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
primary	0
complaint	0
of	0
hyposmia	1
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
icd	3
-	4
10	4
-	4
cm	4
diagnosis	0
code	0
r430	5
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
examining	0
hematologic	0
disorders	0
,	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
thrombocytopenic	1
disorder	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10cm	4
classification	0
system	0
,	0
specifically	0
code	0
d69	5
.	6
3	6
,	0
to	0
better	0
understand	0
the	0
underlying	0
etiologies	0
and	0
therapeutic	0
approaches	0
.	0

in	0
this	0
study	0
,	0
individuals	0
with	0
a	0
history	0
of	0
anaphylaxis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
with	0
the	0
corresponding	0
code	0
t88	5
.	6
6	6
to	0
explore	0
potential	0
risk	0
factors	0
and	0
management	0
strategies	0
for	0
this	0
severe	0
allergic	0
reaction	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
underwent	0
a	0
procedure	0
which	0
involved	0
the	0
use	0
of	0
cpt	3
code	4
35485	5
for	0
the	0
therapeutic	0
approach	0
,	0
showing	0
promising	0
results	0
in	0
the	0
treatment	0
of	0
this	0
condition	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
hospital	0
discharge	0
records	0
,	0
patients	0
with	0
a	0
icd	3
-	4
9	4
code	0
of	0
534	5
.	6
4x	6
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
gastrointestinal	1
hemorrhage	2
compared	0
to	0
those	0
without	0
the	0
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
prescribed	0
with	0
antipsychotic	1
medications	2
(	2
p13	2
)	2
were	0
identified	0
using	0
gprd	3
product	4
codes	4
,	0
specifically	0
the	0
code	0
52050	5
,	0
in	0
order	0
to	0
analyze	0
the	0
potential	0
risks	0
and	0
benefits	0
associated	0
with	0
their	0
usage	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
cognitive	0
decline	0
in	0
patients	0
with	0
a	0
diagnosis	0
of	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
specifically	0
those	0
with	0
the	0
290	5
.	6
2	6
code	0
,	0
and	0
found	0
significant	0
differences	0
in	0
the	0
progression	0
of	0
the	0
disease	0
compared	0
to	0
other	0
dementia	0
subtypes	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
using	0
ccs	3
code	0
112	5
,	0
and	0
the	0
data	0
analysis	0
showed	0
a	0
strong	0
correlation	0
between	0
comorbidities	0
and	0
pneumonia	0
severity	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
depressive	1
disorder	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
individuals	0
with	0
the	0
icd	3
-	4
9	4
-	4
cm	4
diagnosis	0
code	0
296	5
.	6
25	6
,	0
representing	0
recurrent	0
major	0
depressive	0
disorder	0
without	0
psychotic	0
features	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
migraine	1
were	0
prescribed	0
medication	0
from	0
the	0
atc	3
classification	0
system	0
with	0
a	0
specific	0
n02ca	5
code	0
,	0
which	0
targets	0
the	0
management	0
of	0
moderate	0
to	0
severe	0
headache	0
episodes	0
.	0

in	0
a	0
recent	0
clinical	0
study	0
,	0
patients	0
diagnosed	0
with	0
crohn	1
'	2
s	2
disease	2
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
intestinal	0
obstructive	0
disorders	0
,	0
specifically	0
classified	0
under	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
,	0
which	0
is	0
associated	0
with	0
various	0
degrees	0
of	0
severity	0
and	0
complications	0
of	0
the	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
an	0
increased	0
prevalence	0
of	0
sjogren	1
'	2
s	2
syndrome	2
in	0
patients	0
with	0
a	0
corresponding	0
icd	3
-	4
10	4
diagnosis	0
m35	5
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
and	0
identification	0
of	0
this	0
autoimmune	0
disease	0
within	0
the	0
medical	0
community	0
.	0

in	0
a	0
retrospective	0
study	0
conducted	0
on	0
cancer	0
patients	0
,	0
those	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
predominantly	0
found	0
to	0
have	0
been	0
assigned	0
the	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
signifying	0
a	0
malignant	0
neoplasm	0
of	0
the	0
plasma	0
cells	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
found	0
to	0
be	0
predominantly	0
coded	0
with	0
202	5
.	6
75	6
in	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
indicating	0
its	0
specific	0
association	0
with	0
this	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
migraine	1
diagnosis	0
were	0
found	0
to	0
benefit	0
from	0
the	0
use	0
of	0
analgesics	0
classified	0
under	0
the	0
atc	3
system	0
with	0
the	0
code	0
n02cx	5
,	0
resulting	0
in	0
a	0
significant	0
decrease	0
in	0
both	0
frequency	0
and	0
severity	0
of	0
their	0
headaches	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
lung	1
cancer	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
histological	0
subtype	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9051	5
,	0
which	0
is	0
associated	0
with	0
aggressive	0
tumor	0
growth	0
and	0
poor	0
prognosis	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
narcolepsy	1
among	0
patients	0
with	0
sleep	0
disorders	0
,	0
identifying	0
a	0
significant	0
proportion	0
with	0
the	0
condition	0
as	0
per	0
the	0
icd	3
-	4
10	4
-	4
cm	4
criteria	0
,	0
specifically	0
code	0
g47	5
.	6
4x	6
,	0
which	0
led	0
to	0
further	0
examination	0
of	0
potential	0
correlations	0
between	0
narcolepsy	0
and	0
other	0
comorbidities	0
.	0

a	0
study	0
analyzed	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
in	0
patients	0
with	0
various	0
clinical	0
subtypes	0
according	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
including	0
seropositive	0
(	0
m05	5
)	0
and	0
different	0
categories	0
of	0
seronegative	0
ra	0
(	0
m06	5
.	6
0	6
,	6
m06	6
.	6
2	6
–	6
m06	6
.	6
9	6
)	0
.	0

a	0
significantly	0
higher	0
incidence	0
of	0
suicide	1
was	0
observed	0
in	0
patients	0
with	0
major	0
depressive	0
disorder	0
,	0
as	0
indicated	0
by	0
the	0
oxmis	3
codes	4
system	0
,	0
particularly	0
those	0
assigned	0
with	0
the	0
3009c	5
code	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
lung	1
cancer	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
specific	0
tumor	0
type	0
associated	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c345	5
,	0
which	0
has	0
been	0
linked	0
to	0
a	0
more	0
aggressive	0
form	0
of	0
the	0
disease	0
.	0

a	0
significant	0
number	0
of	0
patients	0
in	0
the	0
study	0
presented	0
with	0
neck	1
pain	2
,	0
which	0
was	0
diagnosed	0
under	0
the	0
hira	3
coding	0
system	0
using	0
the	0
specific	0
code	0
g53	5
.	6
0	6
,	0
particularly	0
amongst	0
individuals	0
engaged	0
in	0
extensive	0
computer	0
usage	0
or	0
physically	0
demanding	0
occupations	0
.	0

in	0
this	0
study	0
,	0
patients	0
diagnosed	0
with	0
the	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
classified	0
under	0
the	0
icd	3
-	4
o	4
system	0
with	0
the	0
code	0
9690	5
,	0
were	0
investigated	0
to	0
evaluate	0
the	0
effectiveness	0
of	0
the	0
latest	0
treatment	0
approaches	0
.	0

in	0
a	0
study	0
of	0
dermatological	0
conditions	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
code	0
6961211	5
,	0
and	0
their	0
clinical	0
history	0
was	0
evaluated	0
for	0
any	0
possible	0
association	0
between	0
cutaneous	0
manifestations	0
and	0
systemic	0
diseases	0
.	0

in	0
the	0
study	0
,	0
participants	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	1
)	0
were	0
identified	0
based	0
on	0
the	0
710	5
series	0
of	0
codes	0
from	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
revealing	0
the	0
prevalence	0
and	0
impact	0
of	0
this	0
autoimmune	0
disease	0
.	0

a	0
recent	0
study	0
on	0
mental	0
health	0
disorders	0
revealed	0
a	0
significant	0
correlation	0
between	0
suicidal	1
behaviors	0
and	0
major	0
depressive	0
episodes	0
in	0
patients	0
,	0
as	0
classified	0
under	0
the	0
icd	3
-	4
10	4
coding	0
system	0
with	0
the	0
specific	0
code	0
x77	5
,	0
to	0
better	0
understand	0
and	0
devise	0
targeted	0
prevention	0
strategies	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
patients	0
diagnosed	0
with	0
icd	3
-	4
o	4
3	4
code	0
8140	5
prostate	1
cancer	2
were	0
analyzed	0
to	0
determine	0
the	0
prevalence	0
of	0
genetic	0
factors	0
in	0
the	0
development	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
coding	0
system	0
,	0
specifically	0
the	0
9732	5
code	0
,	0
to	0
analyze	0
the	0
epidemiology	0
and	0
survival	0
trends	0
of	0
this	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
migraine	1
diagnosis	0
were	0
treated	0
with	0
drugs	0
belonging	0
to	0
the	0
atc	3
category	0
n02ca	5
,	0
which	0
encompasses	0
selective	0
serotonin	0
(	0
5ht1	0
)	0
agonists	0
for	0
the	0
management	0
of	0
their	0
migraine	0
-	0
associated	0
symptoms	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
multiple	1
myeloma	2
cases	0
in	0
elderly	0
patients	0
primarily	0
focusing	0
on	0
those	0
with	0
a	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
of	0
c42	5
,	0
highlighting	0
an	0
increase	0
in	0
the	0
incidence	0
of	0
this	0
neoplasm	0
in	0
this	0
age	0
group	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
autoimmune	0
diseases	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
710	5
.	6
2	6
,	0
illustrating	0
the	0
clinical	0
heterogeneity	0
of	0
this	0
condition	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
based	0
on	0
the	0
clinical	3
modification	4
codes	4
(	4
clin	4
mod	4
.	4
codes	4
)	4
system	0
using	0
the	0
specific	0
7140	5
code	0
,	0
in	0
order	0
to	0
assess	0
the	0
effectiveness	0
of	0
diverse	0
treatment	0
options	0
for	0
this	0
prominent	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
number	0
of	0
patients	0
with	0
cardiogenic	1
shock	2
were	0
identified	0
using	0
the	0
ccs	3
coding	0
system	0
,	0
specifically	0
the	0
97	5
code	0
,	0
highlighting	0
the	0
importance	0
of	0
proper	0
classification	0
and	0
management	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
a	0
ccs	3
category	0
100	5
classification	0
,	0
primarily	0
consisting	0
of	0
individuals	0
suffering	0
from	0
cardiogenic	1
shock	2
,	0
exhibited	0
a	0
higher	0
mortality	0
rate	0
compared	0
to	0
other	0
cardiac	0
-	0
related	0
phenotypes	0
.	0

a	0
retrospective	0
study	0
was	0
carried	0
out	0
on	0
patients	0
diagnosed	0
with	0
epilepsy	1
according	0
to	0
the	0
icd	3
-	4
9	4
cm	4
classification	0
,	0
specifically	0
those	0
with	0
assigned	0
codes	0
345	5
.	6
x	6
,	0
to	0
assess	0
the	0
prevalence	0
and	0
characteristics	0
of	0
patients	0
having	0
both	0
focal	0
and	0
generalized	0
seizure	0
types	0
in	0
a	0
tertiary	0
care	0
setting	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
presenting	0
with	0
colon	1
cancer	2
(	0
icd	3
-	4
o	4
-	4
3	4
code	0
c186	5
)	0
revealed	0
that	0
advanced	0
stage	0
at	0
diagnosis	0
is	0
significantly	0
associated	0
with	0
poorer	0
survival	0
outcomes	0
in	0
this	0
population	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
for	0
newly	0
diagnosed	0
patients	0
,	0
those	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
c91	5
.	6
1x	6
code	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
compared	0
to	0
other	0
types	0
of	0
lymphomas	0
.	0

in	0
this	0
study	0
,	0
patients	0
prescribed	0
amiodarone	1
(	0
m2	0
)	0
were	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
and	0
were	0
specifically	0
associated	0
with	0
the	0
code	0
54224	5
,	0
which	0
facilitated	0
the	0
examination	0
of	0
drug	0
-	0
induced	0
adverse	0
effects	0
in	0
a	0
large	0
population	0
-	0
based	0
cohort	0
.	0

in	0
this	0
retrospective	0
study	0
,	0
a	0
significant	0
prevalence	0
of	0
gastrointestinal	1
hemorrhage	2
was	0
observed	0
in	0
patients	0
with	0
an	0
icd	3
-	4
9	4
diagnosis	0
code	0
of	0
531	5
.	6
00	6
,	0
corresponding	0
to	0
acute	0
gastric	0
ulcers	0
with	0
hemorrhage	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
lung	1
cancer	2
was	0
conducted	0
,	0
focusing	0
on	0
cases	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
3	4
8323	5
code	0
,	0
which	0
corresponds	0
to	0
the	0
rare	0
and	0
aggressive	0
large	0
cell	0
neuroendocrine	0
carcinoma	0
subtype	0
of	0
the	0
disease	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
coding	0
system	0
,	0
with	0
the	0
majority	0
of	0
cases	0
assigned	0
the	0
specific	0
code	0
9591	5
to	0
standardize	0
the	0
research	0
data	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
psoriasis	1
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
assigned	0
the	0
hicda	3
code	0
6961213	5
,	0
which	0
correlates	0
to	0
chronic	0
plaque	0
psoriasis	0
,	0
compared	0
to	0
other	0
coding	0
groups	0
within	0
the	0
same	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
,	0
and	0
further	0
analysis	0
was	0
conducted	0
to	0
better	0
understand	0
the	0
clinical	0
features	0
and	0
potential	0
treatment	0
options	0
for	0
this	0
sleep	0
disorder	0
.	0

in	0
a	0
study	0
conducted	0
on	0
920	0
patients	0
in	0
primary	0
care	0
settings	0
,	0
675	0
were	0
identified	0
with	0
asthma	1
primary	2
care	2
using	0
the	0
ctv3	3
coding	0
system	0
,	0
specifically	0
the	0
xac33	5
code	0
,	0
and	0
were	0
prescribed	0
appropriate	0
medications	0
to	0
manage	0
their	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
bladder	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
c67	5
.	6
2	6
,	0
which	0
corresponds	0
to	0
neoplasms	0
originating	0
in	0
the	0
urinary	0
bladder	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
individuals	0
with	0
a	0
history	0
of	0
depressive	0
disorders	0
,	0
those	0
who	0
exhibited	0
the	0
suicidal	1
phenotype	0
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
oxmis	3
code	0
3009bt	5
in	0
their	0
medical	0
records	0
,	0
compared	0
to	0
those	0
without	0
suicidal	0
tendencies	0
.	0

according	0
to	0
a	0
recent	0
study	0
,	0
among	0
patients	0
receiving	0
ccu002	1
_	2
01	2
lipid	2
_	2
lowering	2
medication	2
,	0
those	0
prescribed	0
bnf	3
codes	4
0212000y0bbaeaa	5
had	0
a	0
significantly	0
higher	0
rate	0
of	0
adherence	0
compared	0
to	0
other	0
statin	0
therapies	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
epilepsy	1
were	0
often	0
diagnosed	0
using	0
the	0
g41	5
code	0
in	0
the	0
icd	3
-	4
10	4
ca	4
coding	0
system	0
,	0
which	0
helped	0
streamline	0
their	0
treatment	0
and	0
management	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
ccu002	1
_	2
02	2
hypertension	2
phenotype	0
were	0
found	0
to	0
be	0
frequently	0
treated	0
with	0
the	0
antihypertensive	0
medication	0
bnf	3
code	4
0205051q0bbaaaa	5
,	0
which	0
is	0
known	0
as	0
lisinopril	0
in	0
the	0
british	0
national	0
formulary	0
classification	0
system	0
.	0

in	0
a	0
study	0
analyzing	0
the	0
data	0
of	0
hospital	0
admissions	0
due	0
to	0
suicidal	1
behaviors	2
,	0
patients	0
with	0
a	0
suicide	1
attempt	0
diagnosis	0
were	0
identified	0
by	0
oxmis	3
code	4
3009ct	5
in	0
the	0
electronic	0
medical	0
records	0
.	0

in	0
this	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
by	0
the	0
presence	0
of	0
the	0
m06	5
.	6
x	6
code	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
aiming	0
to	0
investigate	0
the	0
relationship	0
between	0
this	0
autoimmune	0
disorder	0
and	0
various	0
cardiovascular	0
risk	0
factors	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
cancer	0
who	0
were	0
prescribed	0
the	0
protein	1
kinase	2
inhibitor	2
medication	0
,	0
8010551	5
,	0
as	0
per	0
the	0
bnf	3
guidelines	0
,	0
exhibited	0
a	0
significant	0
reduction	0
in	0
tumor	0
growth	0
and	0
improved	0
survival	0
rates	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
adults	0
over	0
50	0
years	0
of	0
age	0
was	0
found	0
to	0
be	0
significantly	0
higher	0
in	0
those	0
with	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m06	5
.	6
x	6
compared	0
to	0
those	0
without	0
a	0
registered	0
diagnosis	0
in	0
the	0
same	0
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	2
dvt	2
)	2
were	0
identified	0
using	0
the	0
hicda	3
coding	0
system	0
,	0
specifically	0
the	0
code	0
4519511	5
,	0
to	0
accurately	0
categorize	0
and	0
analyze	0
the	0
prevalence	0
of	0
this	0
condition	0
within	0
the	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
classified	0
under	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c83	5
.	6
1x	6
)	0
among	0
individuals	0
exposed	0
to	0
certain	0
environmental	0
factors	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
crohn	1
'	2
s	2
disease	2
amongst	0
individuals	0
by	0
analyzing	0
medical	0
records	0
containing	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
,	0
specifically	0
focusing	0
on	0
563	5
.	6
0x	6
and	0
associated	0
variations	0
,	0
to	0
better	0
understand	0
the	0
potential	0
factors	0
contributing	0
to	0
the	0
development	0
of	0
this	0
inflammatory	1
bowel	2
disease	2
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
neck	1
pain	2
among	0
patients	0
coded	0
with	0
m480	5
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
revealing	0
a	0
significant	0
correlation	0
between	0
these	0
individuals	0
and	0
the	0
development	0
of	0
chronic	0
discomfort	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
chronic	0
migraine	1
showed	0
a	0
higher	0
frequency	0
of	0
medication	0
usage	0
from	0
the	0
atc	3
classification	0
system	0
,	0
specifically	0
within	0
the	0
n02ca	5
group	0
of	0
opioids	0
,	0
which	0
may	0
indicate	0
an	0
increased	0
risk	0
for	0
medication	0
overuse	0
headaches	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
had	0
a	0
higher	0
frequency	0
of	0
hospitalization	0
when	0
identified	0
by	0
the	0
icd	3
-	4
9	4
code	0
710	5
,	0
suggesting	0
that	0
managing	0
this	0
complex	0
autoimmune	0
disorder	0
remains	0
a	0
challenge	0
for	0
healthcare	0
providers	0
.	0

a	0
recent	0
study	0
showed	0
that	0
among	0
individuals	0
with	0
icd	3
-	4
9	4
code	0
433	5
.	6
81	6
,	0
indicating	0
ischemic	1
stroke	2
caused	0
by	0
occlusion	0
of	0
the	0
basilar	0
artery	0
,	0
there	0
was	0
a	0
significant	0
association	0
with	0
certain	0
genetic	0
risk	0
factors	0
,	0
such	0
as	0
a	0
family	0
history	0
of	0
cardiovascular	0
disease	0
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
was	0
conducted	0
,	0
focusing	0
on	0
those	0
cases	0
with	0
the	0
icd	3
-	4
o	4
-	4
2	4
code	0
of	0
9591	5
from	0
various	0
medical	0
institutions	0
across	0
the	0
nation	0
.	0

a	0
recent	0
study	0
focused	0
on	0
the	0
prevalence	0
and	0
risk	0
factors	0
associated	0
with	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
in	0
adults	0
,	0
utilizing	0
data	0
coded	0
in	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
with	0
a	0
specific	0
focus	0
on	0
m06	5
.	6
x	6
codes	0
for	0
ra	0
diagnosis	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
of	0
lung	1
cancer	2
in	0
patients	0
with	0
a	0
histological	0
code	0
of	0
8250	5
/	6
3	6
in	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
revealed	0
increased	0
risk	0
factors	0
for	0
this	0
malignant	0
neoplasm	0
compared	0
to	0
other	0
forms	0
of	0
respiratory	0
malignancies	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
criteria	0
had	0
a	0
specific	0
diagnostic	0
290	5
.	6
3	6
code	0
within	0
the	0
clinical	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
alzheimer	1
'	2
s	2
disease	2
was	0
found	0
to	0
significantly	0
increase	0
among	0
elderly	0
patients	0
with	0
a	0
diagnosis	0
of	0
dsm	3
-	4
iv	4
code	0
290	5
.	6
2	6
(	0
dementia	0
of	0
the	0
alzheimer	0
'	0
s	0
type	0
)	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
narcolepsy	1
were	0
assigned	0
the	0
icd	3
-	4
9	4
diagnosis	0
code	0
347	5
.	6
0x	6
,	0
and	0
further	0
analysis	0
was	0
conducted	0
to	0
investigate	0
potential	0
risk	0
factors	0
and	0
treatment	0
outcomes	0
associated	0
with	0
this	0
neurological	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
of	0
hematologic	0
malignancies	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	0
code	0
c42	5
,	0
and	0
this	0
specific	0
code	0
has	0
shown	0
to	0
be	0
a	0
reliable	0
indicator	0
for	0
accurately	0
categorizing	0
this	0
complex	0
phenotype	0
in	0
the	0
clinical	0
setting	0
.	0

in	0
a	0
recent	0
study	0
on	0
patients	0
with	0
hematological	0
disorders	0
,	0
a	0
significant	0
subset	0
was	0
found	0
to	0
have	0
myelodysplastic	1
syndrome	2
(	0
mds	0
)	0
,	0
which	0
was	0
assigned	0
the	0
code	0
9987	5
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
.	0

the	0
study	0
investigated	0
the	0
association	0
between	0
environmental	0
factors	0
and	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
,	0
with	0
a	0
primary	0
focus	0
on	0
patients	0
who	0
were	0
diagnosed	0
under	0
the	0
icd	3
-	4
10	4
-	4
gm	4
code	0
c91	5
.	6
0	6
*	6
for	0
chronic	0
lymphocytic	0
leukemia	0
and	0
small	0
lymphocytic	0
lymphoma	0
.	0

a	0
strong	0
association	0
was	0
observed	0
between	0
suicide	1
attempts	0
and	0
oxmis	3
code	0
9779a	5
,	0
indicating	0
the	0
need	0
for	0
targeted	0
interventions	0
in	0
patients	0
with	0
this	0
specific	0
phenotype	1
within	0
the	0
clinical	0
psychiatric	0
population	0
.	0

a	0
study	0
conducted	0
in	0
the	0
united	0
kingdom	0
found	0
that	0
ctv3	3
code	0
xac8s	5
,	0
associated	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	2
copd	2
)	2
in	0
primary	0
care	0
,	0
served	0
as	0
a	0
significant	0
marker	0
for	0
patients	0
at	0
higher	0
risk	0
of	0
respiratory	0
complications	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
2	4
classification	0
system	0
,	0
specifically	0
those	0
assigned	0
the	0
code	0
9595	5
,	0
which	0
encompasses	0
various	0
subtypes	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histologically	0
confirmed	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
9688	5
,	0
to	0
analyze	0
the	0
prevalence	0
and	0
survival	0
trends	0
of	0
this	0
malignancy	0
.	0

in	0
a	0
study	0
investigating	0
the	0
prevalence	0
of	0
gastrointestinal	0
disorders	0
,	0
the	0
researchers	0
identified	0
patients	0
presenting	0
with	0
gastrointestinal	1
hemorrhage	2
using	0
the	0
icd	3
-	4
10	4
coding	0
system	0
,	0
specifically	0
the	0
code	0
k26	5
.	6
6	6
,	0
and	0
analyzed	0
the	0
potential	0
risk	0
factors	0
associated	0
with	0
the	0
development	0
of	0
this	0
condition	0
.	0

a	0
study	0
investigating	0
the	0
occurrence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
found	0
that	0
the	0
patients	0
who	0
were	0
diagnosed	0
using	0
the	0
icd	3
-	4
9	4
-	4
d	4
coding	0
system	0
with	0
the	0
code	0
453	5
.	6
41	6
exhibited	0
higher	0
rates	0
of	0
postoperative	0
complications	0
than	0
the	0
patients	0
having	0
other	0
diagnoses	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
sjogren	1
'	2
s	2
syndrome	2
among	0
the	0
patient	0
population	0
was	0
found	0
to	0
be	0
notably	0
higher	0
in	0
those	0
carrying	0
the	0
diagnosis	0
code	0
710	5
.	6
2	6
as	0
per	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
potential	0
association	0
between	0
psoriasis	1
and	0
other	0
comorbidities	0
,	0
focusing	0
on	0
patients	0
with	0
a	0
hicda	3
code	0
of	0
6961210	5
,	0
indicating	0
a	0
diagnosis	0
of	0
the	0
chronic	0
skin	0
condition	0
.	0

a	0
retrospective	0
analysis	0
of	0
hospitalized	0
patients	0
revealed	0
that	0
those	0
with	0
a	0
primary	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
,	0
as	0
indicated	0
by	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
,	0
had	0
a	0
significantly	0
higher	0
rate	0
of	0
healthcare	0
utilization	0
and	0
associated	0
costs	0
compared	0
to	0
patients	0
without	0
the	0
inflammatory	0
bowel	0
disorder	0
.	0

in	0
this	0
study	0
,	0
34	0
patients	0
were	0
diagnosed	0
with	0
anaphylaxis	1
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
,	0
with	0
a	0
specific	0
t80	5
.	6
5	6
code	0
,	0
and	0
were	0
treated	0
with	0
epinephrine	0
auto	0
-	0
injectors	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
individuals	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
more	0
likely	0
to	0
have	0
a	0
diagnosis	0
associated	0
with	0
the	0
9779l	5
oxmis	3
code	0
,	0
which	0
corresponds	0
to	0
major	0
depressive	0
disorder	0
,	0
recurrent	0
.	0

in	0
a	0
study	0
of	0
dermatological	0
conditions	0
,	0
patients	0
who	0
were	0
diagnosed	0
with	0
the	0
psoriasis	1
hicda	3
code	0
6961211	5
exhibited	0
a	0
wide	0
range	0
of	0
phenotypic	0
presentations	0
,	0
including	0
plaque	0
,	0
pustular	0
,	0
and	0
erythrodermic	0
forms	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
chronic	1
pain	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
nerve	0
root	0
disorders	0
,	0
specifically	0
assigned	0
the	0
g53	5
.	6
0	6
code	0
according	0
to	0
the	0
hira	3
classification	0
system	0
,	0
compared	0
to	0
patients	0
without	0
chronic	0
pain	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
of	0
prostate	1
cancer	2
with	0
a	0
specific	0
histological	0
type	0
(	0
icd	3
-	4
o	4
3	4
8140	5
)	0
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
elderly	0
male	0
patients	0
,	0
highlighting	0
the	0
potential	0
role	0
of	0
early	0
detection	0
and	0
treatment	0
strategies	0
for	0
this	0
particular	0
tumor	0
subtype	0
.	0

in	0
our	0
study	0
,	0
we	0
analyzed	0
medical	0
records	0
of	0
patients	0
with	0
b	1
-	2
cell	2
lymphoma	2
who	0
were	0
coded	0
under	0
the	0
icd	3
-	4
9	4
system	0
as	0
9674	5
to	0
understand	0
the	0
associated	0
comorbidities	0
and	0
treatment	0
patterns	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
the	0
clinical	0
phenotype	0
of	0
ccu002	1
_	2
02	2
hypertension	2
were	0
found	0
to	0
have	0
a	0
higher	0
frequency	0
of	0
prescription	0
for	0
the	0
antihypertensive	0
medication	0
under	0
the	0
bnf	3
code	4
0205010v0aaacac	5
,	0
which	0
is	0
a	0
commonly	0
prescribed	0
medication	0
within	0
the	0
uk	0
healthcare	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
narcolepsy	1
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
were	0
identified	0
using	0
the	0
specific	0
code	0
g47	5
.	6
429	6
,	0
revealing	0
an	0
increased	0
prevalence	0
of	0
this	0
sleep	0
disorder	0
in	0
the	0
canadian	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
epilepsy	1
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
other	0
convulsions	0
,	0
which	0
were	0
classified	0
under	0
the	0
icd	3
-	4
10am	4
code	0
r56	5
.	6
8	6
,	0
suggesting	0
a	0
potential	0
relationship	0
between	0
these	0
phenotypes	0
.	0

in	0
the	0
study	0
,	0
patients	0
with	0
prostate	1
cancer	2
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
,	0
specifically	0
having	0
the	0
8140	5
code	0
,	0
highlighting	0
the	0
importance	0
of	0
standardized	0
coding	0
for	0
accurate	0
diagnosis	0
and	0
treatment	0
planning	0
.	0

a	0
retrospective	0
study	0
of	0
hospital	0
records	0
revealed	0
an	0
increased	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
cases	0
among	0
patients	0
,	0
classified	0
under	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
78	6
,	0
leading	0
to	0
a	0
need	0
for	0
improved	0
diagnostic	0
and	0
treatment	0
strategies	0
targeting	0
this	0
specific	0
lymphoma	1
subtype	0
.	0

a	0
cross	0
-	0
sectional	0
study	0
observed	0
that	0
elderly	0
patients	0
with	0
a	0
cognitive	1
impairment	2
diagnosis	0
,	0
specifically	0
alzheimer	1
'	2
s	2
disease	2
,	0
following	0
the	0
dsm	3
-	4
iv	4
criteria	0
met	0
the	0
290	5
.	6
3	6
code	0
and	0
exhibited	0
significant	0
memory	0
loss	0
and	0
mood	0
disturbances	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
alzheimer	1
'	2
s	2
disease	2
were	0
identified	0
based	0
on	0
the	0
dsm	3
-	4
iv	4
criteria	0
,	0
specifically	0
those	0
falling	0
under	0
the	0
290	5
.	6
3	6
code	0
according	0
to	0
the	0
diagnostic	0
manual	0
.	0

a	0
significant	0
number	0
of	0
patients	0
were	0
diagnosed	0
with	0
prostate	1
cancer	2
,	0
which	0
corresponds	0
to	0
the	0
54	5
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
,	0
highlighting	0
the	0
importance	0
of	0
early	0
detection	0
and	0
treatment	0
for	0
this	0
specific	0
phenotype	0
.	0

a	0
retrospective	0
analysis	0
of	0
hospital	0
discharge	0
data	0
revealed	0
a	0
significant	0
increase	0
in	0
the	0
annual	0
incidence	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
cd	0
)	0
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
,	0
suggesting	0
a	0
potential	0
need	0
for	0
targeted	0
intervention	0
and	0
improved	0
management	0
strategies	0
for	0
this	0
chronic	0
inflammatory	0
bowel	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
as	0
per	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
,	0
particularly	0
those	0
with	0
the	0
specific	0
code	0
c91	5
.	6
0	6
*	6
,	0
had	0
a	0
significantly	0
higher	0
risk	0
of	0
developing	0
secondary	0
malignancies	0
.	0

in	0
a	0
recent	0
study	0
examining	0
ccs	3
categorized	0
diseases	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
the	0
code	0
100	5
were	0
more	0
likely	0
to	0
experience	0
the	0
phenotype	0
cardiogenic	1
shock	2
as	0
a	0
complication	0
due	0
to	0
their	0
underlying	0
cardiovascular	0
conditions	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
patients	0
with	0
a	0
gastrointestinal	1
hemorrhage	2
were	0
commonly	0
associated	0
with	0
the	0
icd	3
-	4
9	4
code	0
532	5
.	6
4x	6
,	0
which	0
denotes	0
an	0
acute	0
peptic	0
ulcer	0
with	0
bleeding	0
.	0

a	0
study	0
analyzing	0
the	0
treatment	0
outcomes	0
of	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
that	0
those	0
classified	0
under	0
the	0
icd	3
-	4
9	4
code	0
9696	5
generally	0
exhibited	0
more	0
aggressive	0
disease	0
progression	0
compared	0
to	0
other	0
subtypes	0
in	0
the	0
same	0
category	0
.	0

in	0
this	0
study	0
,	0
patients	0
presenting	0
with	0
peripheral	1
ischaemia	2
were	0
identified	0
using	0
the	0
cpt	3
code	0
35357	5
,	0
allowing	0
for	0
a	0
standardized	0
comparison	0
of	0
treatment	0
outcomes	0
across	0
various	0
healthcare	0
settings	0
.	0

in	0
this	0
study	0
,	0
the	0
prevalence	0
of	0
retinopathy	0
was	0
evaluated	0
in	0
patients	0
diagnosed	0
with	0
type	1
2	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
9	4
-	4
cm	4
250	5
.	6
xx	6
)	0
,	0
and	0
the	0
associations	0
between	0
the	0
severity	0
of	0
retinopathy	0
and	0
various	0
clinical	0
factors	0
were	0
also	0
examined	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
most	0
common	0
phenotype	0
associated	0
with	0
the	0
ccs	3
code	0
103	5
was	0
found	0
to	0
be	0
cardiogenic	1
shock	2
,	0
which	0
had	0
a	0
significant	0
impact	0
on	0
patient	0
outcomes	0
and	0
hospitalization	0
rates	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9732	6
,	0
which	0
indicates	0
a	0
specific	0
subtype	0
of	0
the	0
disease	0
with	0
unique	0
clinical	0
characteristics	0
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
with	0
the	0
type	1
2	2
diabetes	2
mellitus	2
phenotype	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
corresponding	0
icd	3
-	4
9	4
-	4
cm	4
code	0
250	5
.	6
x2	6
as	0
part	0
of	0
their	0
medical	0
records	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
study	0
examining	0
the	0
risk	0
factors	0
associated	0
with	0
type	1
2	2
diabetes	2
mellitus	2
found	0
that	0
patients	0
with	0
a	0
history	0
of	0
obesity	0
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
9	4
-	4
cm	4
codes	0
278	5
.	6
00	6
,	0
were	0
more	0
likely	0
to	0
develop	0
the	0
condition	0
,	0
which	0
is	0
classified	0
in	0
the	0
same	0
coding	0
system	0
under	0
the	0
code	0
250	5
.	6
x0	6
.	0

a	0
study	0
on	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
in	0
canada	0
revealed	0
that	0
the	0
majority	0
of	0
patients	0
were	0
diagnosed	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
with	0
a	0
specific	0
m06	5
.	6
x	6
code	0
,	0
providing	0
a	0
standardized	0
approach	0
to	0
track	0
and	0
analyze	0
this	0
chronic	0
inflammatory	0
autoimmune	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
proportion	0
of	0
patients	0
presented	0
with	0
cardiogenic	1
shock	2
(	0
icd	3
-	4
10cm	4
r57	5
.	6
0	6
)	0
following	0
acute	0
myocardial	0
infarction	0
,	0
and	0
this	0
phenotype	0
was	0
routinely	0
analyzed	0
as	0
part	0
of	0
the	0
systemic	0
evaluation	0
.	0

the	0
study	0
included	0
individuals	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
colon	1
cancer	2
,	0
identified	0
by	0
the	0
icd	3
-	4
0	4
-	4
3	4
code	0
c184	5
,	0
who	0
were	0
treated	0
with	0
surgical	0
resection	0
as	0
the	0
primary	0
intervention	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
among	0
patients	0
with	0
a	0
classification	0
code	0
of	0
9680	5
in	0
the	0
icd	3
-	4
o	4
system	0
,	0
highlighting	0
the	0
need	0
for	0
targeted	0
screening	0
and	0
monitoring	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
association	0
between	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
and	0
its	0
related	0
comorbidities	0
under	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
,	0
particularly	0
the	0
specific	0
code	0
c91	5
.	6
0	6
*	6
,	0
as	0
well	0
as	0
possible	0
risk	0
factors	0
and	0
treatment	0
outcomes	0
in	0
a	0
cohort	0
of	0
patients	0
.	0

in	0
this	0
study	0
,	0
patients	0
who	0
experienced	0
anaphylaxis	1
were	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
,	0
with	0
a	0
specific	0
code	0
of	0
t80	5
.	6
5	6
,	0
indicating	0
a	0
severe	0
allergic	0
reaction	0
to	0
various	0
allergens	0
.	0

in	0
a	0
study	0
analyzing	0
the	0
prevalence	0
of	0
skin	0
diseases	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
psoriasis	1
were	0
identified	0
using	0
the	0
hicda	3
coding	0
system	0
,	0
specifically	0
code	0
6961212	5
,	0
to	0
better	0
understand	0
the	0
underlying	0
genetic	0
factors	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
prevalence	0
of	0
pneumonia	1
among	0
patients	0
admitted	0
to	0
the	0
hospital	0
,	0
specifically	0
those	0
classified	0
by	0
the	0
clinical	3
classification	4
software	4
(	4
ccs	4
)	4
with	0
a	0
code	5
112	6
diagnosis	0
,	0
to	0
better	0
understand	0
the	0
impact	0
of	0
the	0
disease	0
on	0
healthcare	0
resources	0
and	0
patient	0
outcomes	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
we	0
analyzed	0
clinical	0
data	0
from	0
patients	0
diagnosed	0
with	0
pneumonia	1
caused	0
by	0
bacterial	0
infection	0
,	0
specifically	0
coded	0
as	0
j15	5
under	0
the	0
icd	3
-	4
10	4
classification	0
system	0
,	0
to	0
determine	0
the	0
efficacy	0
of	0
various	0
antibiotic	0
treatments	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
psoriasis	1
were	0
found	0
to	0
be	0
predominantly	0
prescribed	0
medications	0
with	0
an	0
atc	3
code	4
of	0
d05ax	5
,	0
a	0
classification	0
of	0
antipsoriatics	0
that	0
specifically	0
target	0
the	0
associated	0
skin	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
that	0
patients	0
with	0
a	0
ccs	3
category	0
106	5
diagnosis	0
,	0
specifically	0
cardiogenic	1
shock	2
,	0
had	0
a	0
higher	0
risk	0
of	0
mortality	0
during	0
hospitalization	0
.	0

in	0
this	0
study	0
,	0
pediatric	0
patients	0
experiencing	0
seizures	1
were	0
classified	0
using	0
the	0
icd	3
-	4
10am	4
coding	0
system	0
,	0
with	0
a	0
majority	0
receiving	0
the	0
code	0
r56	5
.	6
8	6
for	0
"	0
other	0
and	0
unspecified	0
convulsions	0
.	0
"	0

a	0
study	0
found	0
that	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
increased	0
significantly	0
in	0
patients	0
with	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
,	0
which	0
represents	0
plasma	0
cell	0
neoplasms	0
,	0
suggesting	0
a	0
possible	0
link	0
between	0
these	0
two	0
conditions	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
neck	1
pain	2
were	0
often	0
diagnosed	0
with	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m532	5
,	0
which	0
is	0
indicative	0
of	0
cervicalgia	0
,	0
a	0
common	0
musculoskeletal	0
disorder	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
myelitis	1
transverse	2
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
developing	0
neurological	0
complications	0
when	0
the	0
condition	0
was	0
categorized	0
under	0
the	0
icd	3
-	4
9	4
code	0
341	5
.	6
2	6
,	0
indicating	0
the	0
importance	0
of	0
accurate	0
coding	0
in	0
clinical	0
practice	0
.	0

the	0
study	0
involved	0
patients	0
who	0
were	0
prescribed	0
with	0
anti	1
-	2
diabetic	2
medication	0
,	0
identified	0
using	0
the	0
gprd	3
product	4
codes	4
,	0
specifically	0
the	0
58882	5
code	0
for	0
metformin	0
,	0
as	0
a	0
part	0
of	0
their	0
treatment	0
plan	0
for	0
managing	0
type	0
2	0
diabetes	0
mellitus	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
icd	3
-	4
o	4
-	4
2	4
/	4
3	4
code	0
9732	5
)	0
were	0
analyzed	0
to	0
determine	0
the	0
effectiveness	0
of	0
various	0
treatment	0
options	0
in	0
managing	0
their	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
an	0
established	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
were	0
identified	0
based	0
on	0
icd	3
-	4
9	4
coding	0
,	0
specifically	0
using	0
the	0
code	0
710	5
,	0
to	0
examine	0
the	0
prevalence	0
and	0
clinical	0
features	0
of	0
this	0
autoimmune	0
disease	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
analyzing	0
the	0
prevalence	0
of	0
comorbidities	0
in	0
patients	0
with	0
neurological	0
disorders	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
parkinson	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
code	0
342	5
in	0
hospital	0
discharge	0
summaries	0
and	0
medical	0
chart	0
reviews	0
.	0

a	0
retrospective	0
study	0
found	0
a	0
significant	0
increase	0
in	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
cases	0
coded	0
under	0
the	0
cd	3
-	4
9	4
coding	0
system	0
with	0
the	0
specific	0
710	5
code	0
in	0
recent	0
years	0
,	0
highlighting	0
the	0
importance	0
of	0
accurately	0
diagnosing	0
and	0
coding	0
this	0
autoimmune	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
7	4
classification	0
system	0
,	0
specifically	0
with	0
the	0
203	5
.	6
2	6
code	0
,	0
to	0
better	0
understand	0
the	0
disease	0
'	0
s	0
progression	0
and	0
potential	0
treatment	0
options	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
clinical	0
characteristics	0
of	0
patients	0
with	0
multiple	1
myeloma	2
(	0
9732	5
)	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
classification	0
system	0
and	0
revealed	0
significant	0
differences	0
in	0
survival	0
outcomes	0
based	0
on	0
cytogenetic	0
risk	0
profiles	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
histological	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9731	6
,	0
which	0
is	0
specifically	0
designed	0
to	0
classify	0
neoplasms	0
according	0
to	0
their	0
primary	0
site	0
and	0
morphology	0
.	0

a	0
significant	0
association	0
was	0
found	0
between	0
the	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	1
)	0
and	0
exposure	0
to	0
pesticides	0
with	0
the	0
presence	0
of	0
icd	3
-	4
9	4
code	0
202	5
.	6
5	6
in	0
the	0
studied	0
population	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
who	0
were	0
assigned	0
the	0
cd	3
-	4
9	4
code	0
710	5
in	0
order	0
to	0
determine	0
any	0
correlations	0
between	0
disease	0
severity	0
and	0
comorbidities	0
.	0

in	0
this	0
study	0
,	0
we	0
found	0
a	0
significant	0
prevalence	0
of	0
narcolepsy	1
among	0
participants	0
,	0
with	0
most	0
cases	0
identified	0
under	0
the	0
icd	3
-	4
10	4
-	4
ca	4
classification	0
system	0
and	0
specifically	0
assigned	0
the	0
g47	5
.	6
421	6
code	0
.	0

a	0
recent	0
study	0
focused	0
on	0
individuals	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
7140	5
)	0
,	0
as	0
classified	0
by	0
the	0
clin	3
mod	4
.	4
codes	4
system	0
,	0
to	0
investigate	0
the	0
effectiveness	0
of	0
a	0
new	0
treatment	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
presenting	0
with	0
a	0
history	0
of	0
suicide	1
attempts	0
were	0
found	0
to	0
have	0
significantly	0
higher	0
incidence	0
of	0
mental	0
health	0
disorders	0
,	0
particularly	0
those	0
classified	0
under	0
the	0
oxmis	3
codes	4
system	0
,	0
with	0
the	0
most	0
common	0
code	0
being	0
3009bt	5
which	0
is	0
associated	0
with	0
major	0
depressive	0
disorder	0
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
an	0
increased	0
prevalence	0
of	0
multiple	1
myeloma	2
among	0
individuals	0
with	0
the	0
corresponding	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9732	6
,	0
indicating	0
a	0
strong	0
association	0
between	0
this	0
specific	0
coding	0
and	0
the	0
development	0
of	0
this	0
malignant	0
neoplasm	0
.	0

a	0
recent	0
study	0
in	0
the	0
field	0
of	0
biomedical	0
literature	0
reported	0
that	0
patients	0
who	0
were	0
diagnosed	0
with	0
chronic	1
pain	2
(	0
according	0
to	0
the	0
hira	3
classification	0
system	0
,	0
which	0
assigned	0
the	0
code	0
g53	5
.	6
0	6
)	0
exhibited	0
significantly	0
higher	0
rates	0
of	0
anxiety	0
and	0
depression	0
symptoms	0
compared	0
to	0
those	0
without	0
chronic	0
pain	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
receiving	0
cancer	1
immunotherapy	2
medication	2
showed	0
improved	0
outcomes	0
when	0
prescribed	0
treatment	0
based	0
on	0
their	0
individual	0
genetic	0
profiles	0
,	0
using	0
the	0
bnf	3
code	0
8010500	5
for	0
optimal	0
drug	0
selection	0
.	0

in	0
this	0
study	0
,	0
we	0
have	0
analyzed	0
the	0
data	0
on	0
bladder	1
cancer	2
patients	0
collected	0
during	0
2010	0
-	0
2015	0
,	0
and	0
the	0
majority	0
of	0
these	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
o	4
code	0
8129	5
,	0
which	0
corresponds	0
to	0
the	0
transitional	0
cell	0
carcinoma	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
were	0
treated	0
using	0
a	0
revascularization	0
procedure	0
,	0
which	0
was	0
assigned	0
the	0
cpt	3
code	4
35371	5
,	0
indicating	0
the	0
complexity	0
and	0
specificity	0
of	0
the	0
intervention	0
.	0

a	0
study	0
on	0
hematologic	0
malignancies	0
revealed	0
a	0
significant	0
number	0
of	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	1
)	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
2	4
/	4
icd	4
-	4
o	4
-	4
3	4
coding	0
system	0
with	0
the	0
specific	0
code	0
9820	5
,	0
indicating	0
the	0
need	0
for	0
further	0
research	0
on	0
this	0
phenotype	0
'	0
s	0
pathogenesis	0
and	0
treatment	0
approaches	0
.	0

a	0
retrospective	0
study	0
revealed	0
that	0
a	0
significant	0
proportion	0
of	0
patients	0
admitted	0
with	0
icd	3
-	4
9	4
-	4
d	4
coded	0
deep	1
vein	2
thrombosis	2
(	0
453	5
.	6
42	6
)	0
also	0
exhibited	0
symptoms	0
of	0
lower	0
limb	0
swelling	0
and	0
pain	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
of	0
hospitalized	0
patients	0
,	0
those	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
coded	0
as	0
486	5
in	0
the	0
icd	3
-	4
9	4
-	4
cm	4
system	0
were	0
found	0
to	0
have	0
higher	0
rates	0
of	0
complications	0
and	0
extended	0
hospital	0
stays	0
compared	0
to	0
patients	0
with	0
other	0
respiratory	0
infections	0
.	0

a	0
recent	0
study	0
identified	0
a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
multiple	1
myeloma	2
cases	0
,	0
which	0
were	0
coded	0
as	0
203	5
.	6
99	6
in	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
among	0
older	0
adults	0
residing	0
in	0
urban	0
areas	0
.	0

in	0
a	0
study	0
examining	0
the	0
prevalence	0
of	0
gastrointestinal	0
cancers	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
colon	1
cancer	2
were	0
identified	0
using	0
the	0
icd	3
-	4
0	4
-	4
3	4
coding	0
system	0
and	0
the	0
specific	0
code	0
c184	5
for	0
malignant	0
neoplasms	0
of	0
the	0
ascending	0
colon	0
.	0

in	0
the	0
studied	0
population	0
,	0
a	0
significant	0
number	0
of	0
patients	0
presented	0
with	0
ocular	0
inflammation	0
,	0
specifically	0
uveitis	1
,	0
which	0
was	0
properly	0
coded	0
under	0
the	0
icd	3
-	4
9	4
system	0
with	0
the	0
designated	0
115	5
.	6
02	6
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
thrombocytopenic	1
disorder	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
other	0
bleeding	0
disorders	0
when	0
classified	0
under	0
icd	3
-	4
9cm	4
code	0
387	5
.	6
4	6
,	0
indicating	0
the	0
need	0
for	0
more	0
targeted	0
treatment	0
approaches	0
and	0
better	0
understanding	0
of	0
the	0
underlying	0
pathophysiology	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
ccu002	1
_	2
02	2
contraceptive	2
medication	2
prescription	0
were	0
analyzed	0
,	0
and	0
it	0
was	0
found	0
that	0
a	0
significant	0
proportion	0
of	0
them	0
were	0
prescribed	0
0703011a0bbaaaa	5
under	0
the	0
bnf	3
codes	4
classification	0
system	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
and	0
discovered	0
a	0
significant	0
increase	0
in	0
cases	0
classified	0
under	0
the	0
icd	3
-	4
o	4
-	4
2	4
system	0
with	0
a	0
specific	0
code	0
of	0
9670	5
in	0
developed	0
countries	0
over	0
the	0
past	0
decade	0
.	0

in	0
this	0
study	0
,	0
the	0
association	0
between	0
certain	0
genetic	0
markers	0
and	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
was	0
investigated	0
in	0
patients	0
whose	0
medical	0
records	0
included	0
a	0
clin	3
mod	4
.	4
codes	4
diagnosis	0
code	0
of	0
7141	5
for	0
the	0
chronic	0
autoimmune	0
disorder	0
.	0

in	0
a	0
cohort	0
study	0
involving	0
epileptic	0
patients	0
,	0
those	0
with	0
a	0
primary	0
diagnosis	0
of	0
seizure	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
3	6
,	0
which	0
were	0
further	0
categorized	0
into	0
subgroups	0
based	0
on	0
etiology	0
and	0
seizure	0
frequency	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
among	0
the	0
participants	0
was	0
significantly	0
higher	0
in	0
those	0
with	0
the	0
icd	3
-	4
10	4
-	4
ca	4
code	0
m05	5
.	6
x	6
as	0
compared	0
to	0
other	0
diagnostic	0
categories	0
within	0
the	0
same	0
coding	0
system	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
hospitalization	0
records	0
,	0
patients	0
with	0
a	0
hicda	3
code	0
06961510	5
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
prevalence	0
of	0
the	0
psoriasis	1
phenotype	0
as	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
study	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
showed	0
that	0
the	0
majority	0
of	0
them	0
had	0
a	0
icd	3
-	4
9	4
code	0
of	0
202	5
.	6
1	6
,	0
which	0
represents	0
primary	0
cutaneous	0
t	0
-	0
cell	0
lymphoma	0
within	0
this	0
classification	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
rheumatoid	1
arthritis	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
,	0
with	0
the	0
disease	0
classified	0
under	0
the	0
icd	3
-	4
10	4
code	0
m06	5
.	6
4	6
for	0
accurate	0
medical	0
documentation	0
and	0
research	0
purposes	0
.	0

a	0
subset	0
of	0
our	0
cohort	0
exhibited	0
rheumatoid	1
arthritis	2
(	0
clin	3
mod	4
.	4
codes	4
7140	5
)	0
,	0
which	0
was	0
provided	0
by	0
the	0
clinical	0
data	0
using	0
the	0
international	0
classification	0
of	0
diseases	0
,	0
modified	0
for	0
coding	0
.	0

a	0
retrospective	0
analysis	0
revealed	0
a	0
high	0
prevalence	0
of	0
patients	0
presenting	0
with	0
neck	1
pain	2
(	0
hira	3
code	0
g53	5
.	6
0	6
)	0
in	0
a	0
tertiary	0
care	0
hospital	0
,	0
emphasizing	0
the	0
need	0
for	0
targeted	0
interventions	0
and	0
management	0
strategies	0
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
association	0
between	0
rheumatoid	1
arthritis	2
and	0
certain	0
genetic	0
variations	0
,	0
with	0
patients	0
in	0
the	0
sample	0
having	0
been	0
assigned	0
icd	3
-	4
10	4
codes	0
m05	5
,	0
m06	5
.	6
0	6
,	0
and	0
m06	5
.	6
2	6
-	6
m06	6
.	6
9	6
to	0
describe	0
their	0
disease	0
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
cancer	0
were	0
prescribed	0
a	0
protein	1
kinase	2
inhibitor	2
medication	2
classified	0
under	0
the	0
bnf	3
code	0
8010551	5
,	0
which	0
has	0
shown	0
promise	0
in	0
targeting	0
specific	0
molecular	0
abnormalities	0
associated	0
with	0
their	0
respective	0
tumor	0
types	0
.	0

a	0
retrospective	0
study	0
of	0
500	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
,	0
identified	0
using	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m06	5
.	6
x	6
,	0
revealed	0
a	0
significant	0
correlation	0
between	0
disease	0
severity	0
and	0
comorbid	0
conditions	0
.	0

in	0
a	0
retrospective	0
study	0
conducted	0
by	0
a	0
tertiary	0
medical	0
center	0
,	0
patients	0
with	0
a	0
prescription	0
for	0
sumatriptan	1
(	0
identified	0
using	0
gprd	3
product	4
code	4
12057001	5
)	0
were	0
found	0
to	0
have	0
a	0
significantly	0
improved	0
migraine	0
management	0
profile	0
compared	0
to	0
patients	0
on	0
other	0
treatment	0
regimens	0
.	0

in	0
a	0
study	0
examining	0
the	0
prevalence	0
of	0
autoimmune	0
diseases	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m06	5
.	6
9	6
across	0
multiple	0
healthcare	0
databases	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
substantial	0
number	0
of	0
patients	0
were	0
diagnosed	0
with	0
narcolepsy	1
under	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
code	0
347	5
.	6
0x	6
.	0

a	0
recent	0
study	0
showed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
associated	0
with	0
the	0
specific	0
diagnostic	0
code	0
c83	5
.	6
3	6
in	0
the	0
icd	3
-	4
10	4
-	4
gm	4
classification	0
system	0
among	0
a	0
large	0
cohort	0
of	0
elderly	0
patients	0
.	0

a	0
recent	0
study	0
demonstrated	0
that	0
the	0
use	0
of	0
analgesic	0
agents	0
with	0
atc	3
code	0
n02cx	5
was	0
particularly	0
effective	0
in	0
reducing	0
migraine	1
frequency	0
and	0
intensity	0
among	0
patients	0
suffering	0
from	0
this	0
debilitating	0
condition	0
.	0

a	0
retrospective	0
study	0
of	0
emergency	0
department	0
visits	0
found	0
a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
anaphylaxis	1
cases	0
,	0
with	0
a	0
majority	0
of	0
patients	0
presenting	0
symptoms	0
consistent	0
with	0
the	0
icd	3
-	4
10	4
-	4
am	4
code	0
t78	5
.	6
2	6
,	0
indicating	0
an	0
urgent	0
need	0
for	0
improved	0
management	0
and	0
prevention	0
strategies	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
with	0
hematologic	0
malignancies	0
,	0
it	0
was	0
found	0
that	0
those	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
had	0
an	0
increased	0
prevalence	0
of	0
the	0
specific	0
icd	3
-	4
o	4
-	4
2	4
code	0
9682	5
,	0
compared	0
to	0
patients	0
with	0
other	0
malignancies	0
within	0
the	0
same	0
age	0
group	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
newly	0
diagnosed	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
and	0
specifically	0
assigned	0
the	0
code	0
c82	5
.	6
xx	6
,	0
allowing	0
for	0
a	0
more	0
accurate	0
analysis	0
of	0
disease	0
prevalence	0
and	0
patient	0
outcomes	0
.	0

a	0
recent	0
study	0
found	0
that	0
individuals	0
suffering	0
from	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
predominantly	0
coded	0
under	0
icd	3
-	4
9	4
-	4
d	4
with	0
the	0
specific	0
code	0
of	0
453	5
.	6
42	6
,	0
indicating	0
a	0
higher	0
prevalence	0
of	0
this	0
condition	0
in	0
the	0
population	0
.	0

a	0
retrospective	0
study	0
revealed	0
a	0
significant	0
increase	0
in	0
the	0
occurrence	0
of	0
multiple	1
myeloma	2
among	0
patients	0
aged	0
65	0
years	0
and	0
older	0
,	0
with	0
the	0
icd	3
-	4
7	4
code	0
203	5
.	6
0	6
assigned	0
to	0
their	0
diagnoses	0
in	0
north	0
american	0
medical	0
records	0
.	0

a	0
significant	0
association	0
was	0
observed	0
between	0
psoriasis	1
and	0
various	0
comorbidities	0
in	0
a	0
large	0
cohort	0
of	0
patients	0
,	0
with	0
the	0
most	0
prevalent	0
comorbidity	0
being	0
type	0
2	0
diabetes	0
,	0
coded	0
under	0
the	0
icd	3
-	4
10	4
classification	0
as	0
l40008	5
for	0
psoriatic	0
patients	0
.	0

a	0
study	0
investigating	0
the	0
impact	0
of	0
various	0
treatment	0
modalities	0
on	0
patients	0
with	0
chronic	1
pain	2
analyzed	0
the	0
medical	0
records	0
of	0
individuals	0
who	0
were	0
assigned	0
a	0
diagnosis	0
code	0
of	0
g53	5
.	6
0	6
according	0
to	0
the	0
korean	0
hira	3
(	0
health	3
insurance	4
review	4
and	4
assessment	4
)	0
coding	0
system	0
.	0

a	0
retrospective	0
study	0
on	0
the	0
prevalence	0
of	0
cervical	0
spondylosis	0
in	0
patients	0
with	0
neck	1
pain	2
found	0
that	0
a	0
majority	0
of	0
the	0
cases	0
were	0
classified	0
under	0
the	0
hira	3
coding	0
system	0
with	0
the	0
specific	0
g53	5
.	6
0	6
code	0
,	0
indicating	0
radiculopathy	0
due	0
to	0
cervical	0
disc	0
disorder	0
.	0

a	0
significant	0
increase	0
in	0
the	0
prevalence	0
of	0
the	0
depressive	1
disorder	2
(	0
code	0
296	5
.	6
3	6
in	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
)	0
has	0
been	0
observed	0
among	0
the	0
geriatric	0
population	0
,	0
leading	0
to	0
a	0
growing	0
need	0
for	0
targeted	0
interventions	0
and	0
support	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
hospital	0
records	0
,	0
patients	0
presenting	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9732	5
and	0
were	0
further	0
stratified	0
based	0
on	0
the	0
stage	0
of	0
their	0
disease	0
at	0
diagnosis	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
the	0
icd	3
-	4
10	4
ca	4
diagnosis	0
code	0
g41	5
for	0
epilepsy	1
exhibited	0
a	0
higher	0
prevalence	0
of	0
comorbid	0
psychiatric	0
disorders	0
when	0
compared	0
to	0
individuals	0
without	0
epilepsy	0
.	0

a	0
retrospective	0
study	0
analyzed	0
the	0
clinical	0
characteristics	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
prostate	1
cancer	2
associated	0
with	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	4
54	5
,	0
revealing	0
an	0
increased	0
risk	0
for	0
aggressive	0
tumor	0
behavior	0
compared	0
to	0
other	0
histological	0
subtypes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
according	0
to	0
hicda	3
code	0
06961510	5
were	0
found	0
to	0
have	0
an	0
increased	0
risk	0
of	0
developing	0
cardiovascular	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
study	0
examining	0
the	0
risk	0
factors	0
for	0
suicide	1
found	0
a	0
significant	0
association	0
between	0
individuals	0
coded	0
with	0
depressive	0
disorders	0
(	0
oxmis	3
codes	4
3009bt	5
)	0
and	0
higher	0
rates	0
of	0
suicidal	0
behaviors	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
suffering	0
from	0
rheumatoid	1
arthritis	2
(	0
m05	5
.	6
x	6
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
,	0
which	0
has	0
been	0
widely	0
adopted	0
in	0
medical	0
research	0
and	0
clinical	0
practice	0
.	0

a	0
recent	0
study	0
examining	0
the	0
prevalence	0
of	0
neurocognitive	0
disorders	0
found	0
that	0
individuals	0
who	0
met	0
the	0
diagnostic	0
criteria	0
for	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
with	0
a	0
specific	0
290	5
code	0
exhibited	0
significant	0
cognitive	0
decline	0
and	0
abnormal	0
brain	0
imaging	0
results	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
crohn	1
'	2
s	2
disease	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
individuals	0
with	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
563	5
.	6
0x	6
,	0
which	0
corresponds	0
to	0
this	0
chronic	0
inflammatory	0
bowel	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
receiving	0
ccu002	1
_	2
02	2
hormone	2
replacement	2
therapy	2
(	2
hrt	2
)	2
under	0
the	0
bnf	3
codes	4
had	0
a	0
higher	0
incidence	0
of	0
side	0
effects	0
related	0
to	0
the	0
specific	0
0604011adbbaaaa	5
code	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
specific	0
disease	0
-	0
related	0
complications	0
,	0
which	0
were	0
characterized	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9731	5
in	0
accordance	0
with	0
the	0
international	0
classification	0
of	0
diseases	0
for	0
oncology	0
,	0
3rd	0
edition	0
.	0

in	0
this	0
study	0
,	0
patients	0
undergoing	0
revascularization	0
for	0
treatment	0
of	0
peripheral	1
ischaemia	2
were	0
identified	0
using	0
the	0
cpt	3
code	4
35314	5
,	0
which	0
is	0
associated	0
with	0
arterial	0
bypass	0
grafting	0
procedures	0
.	0

in	0
a	0
retrospective	0
analysis	0
performed	0
among	0
children	0
aged	0
7	0
-	0
18	0
years	0
,	0
it	0
was	0
found	0
that	0
the	0
frequency	0
of	0
seizures	1
(	0
coded	0
as	0
780	5
.	6
39	6
in	0
the	0
icd	3
-	4
9	4
cm	4
system	0
)	0
was	0
significantly	0
higher	0
among	0
those	0
with	0
a	0
history	0
of	0
head	0
injury	0
compared	0
to	0
the	0
general	0
population	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
icd	3
-	4
o	4
-	4
3	4
code	0
9670	5
)	0
were	0
found	0
to	0
have	0
higher	0
rates	0
of	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
,	0
highlighting	0
the	0
importance	0
of	0
early	0
detection	0
and	0
treatment	0
for	0
this	0
malignancy	0
.	0

in	0
a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
,	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
were	0
identified	0
by	0
the	0
presence	0
of	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
code	0
9670	5
,	0
indicating	0
a	0
specific	0
subtype	0
of	0
leukemic	0
neoplasm	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
showed	0
a	0
high	0
prevalence	0
of	0
epilepsy	1
(	0
classified	0
using	0
the	0
icd	3
-	4
10	4
ca	4
code	0
g40	5
)	0
among	0
patients	0
with	0
various	0
neurodevelopmental	0
phenotypes	0
in	0
a	0
canadian	0
hospital	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
individuals	0
with	0
major	1
depressive	2
disorder	2
were	0
more	0
likely	0
to	0
be	0
diagnosed	0
with	0
code	0
296	5
.	6
21	6
in	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
,	0
linking	0
this	0
specific	0
code	0
to	0
the	0
depressive	0
disorder	0
phenotype	0
.	0

a	0
study	0
investigating	0
the	0
efficacy	0
of	0
different	0
medications	0
for	0
the	0
treatment	0
of	0
migraine	1
found	0
that	0
drugs	0
classified	0
under	0
the	0
atc	3
code	0
n02ca	5
(	0
opioids	0
in	0
combination	0
with	0
non	0
-	0
opioid	0
analgesics	0
)	0
were	0
effective	0
in	0
reducing	0
the	0
frequency	0
and	0
severity	0
of	0
migraine	0
attacks	0
in	0
patients	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
individuals	0
with	0
icd	3
-	4
9cm	4
code	0
387	5
.	6
3x	6
,	0
indicating	0
a	0
potential	0
association	0
between	0
this	0
specific	0
thrombocytopenic	1
disorder	2
subtype	0
and	0
the	0
corresponding	0
icd	3
-	4
9cm	4
classification	0
.	0

a	0
retrospective	0
study	0
of	0
medical	0
records	0
found	0
a	0
significant	0
prevalence	0
of	0
narcolepsy	1
among	0
patients	0
with	0
a	0
coding	0
classification	0
of	0
icd	3
-	4
9	4
code	0
347	5
.	6
0x	6
,	0
which	0
indicated	0
a	0
potential	0
genetic	0
predisposition	0
to	0
the	0
disorder	0
.	0

a	0
cohort	0
of	0
387	0
patients	0
with	0
prostate	1
cancer	2
was	0
analyzed	0
in	0
this	0
study	0
,	0
and	0
the	0
majority	0
of	0
them	0
were	0
classified	0
as	0
having	0
adenocarcinoma	1
of	0
the	0
prostate	0
gland	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	4
code	0
8140	5
/	6
3	6
,	0
while	0
a	0
smaller	0
subset	0
was	0
characterized	0
by	0
a	0
distinct	0
histological	0
subtype	0
falling	0
under	0
the	0
54	5
code	0
in	0
the	0
same	0
icd	3
-	4
o	4
-	4
3	4
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
recurrent	0
epileptic	0
seizures	1
had	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
,	0
as	0
identified	0
by	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
with	0
the	0
code	0
g41	5
for	0
status	0
epilepticus	0
.	0

in	0
a	0
retrospective	0
study	0
,	0
researchers	0
examined	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
specifically	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c91	5
.	6
1x	6
,	0
to	0
explore	0
potential	0
genetic	0
and	0
environmental	0
factors	0
associated	0
with	0
the	0
development	0
of	0
this	0
malignant	0
phenotype	0
.	0

in	0
this	0
longitudinal	0
study	0
,	0
patients	0
who	0
were	0
prescribed	0
lipid	1
lowering	2
agents	2
(	0
llas	0
)	0
as	0
part	0
of	0
their	0
treatment	0
were	0
identified	0
based	0
on	0
gprd	3
product	4
codes	4
,	0
with	0
a	0
specific	0
focus	0
on	0
those	0
with	0
the	0
code	0
51715	5
in	0
their	0
medical	0
records	0
.	0

in	0
the	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
7	4
code	0
203	5
.	6
2	6
,	0
enabling	0
researchers	0
to	0
track	0
the	0
progression	0
of	0
this	0
phenotype	0
in	0
the	0
analyzed	0
population	0
.	0

in	0
this	0
study	0
,	0
a	0
group	0
of	0
patients	0
reported	0
having	0
experienced	0
anaphylaxis	1
,	0
which	0
is	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
with	0
the	0
specific	0
code	0
t78	5
.	6
0	6
,	0
indicating	0
the	0
severity	0
of	0
their	0
allergic	0
response	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
treated	0
with	0
epilepsy	1
drugs	2
were	0
identified	0
using	0
specific	0
gprd	3
product	4
codes	4
such	0
as	0
7005	5
,	0
which	0
corresponded	0
to	0
the	0
use	0
of	0
anticonvulsant	0
medications	0
in	0
their	0
medical	0
records	0
.	0

a	0
study	0
investigated	0
the	0
association	0
of	0
lung	1
cancer	2
with	0
various	0
risk	0
factors	0
in	0
patients	0
diagnosed	0
with	0
lung	1
adenocarcinoma	2
(	0
icd	3
-	4
o	4
-	4
3	4
code	0
8574	5
)	0
and	0
evaluated	0
potential	0
screening	0
strategies	0
for	0
early	0
detection	0
of	0
this	0
malignancy	0
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
increase	0
in	0
the	0
incidence	0
of	0
colon	1
cancer	2
cases	0
,	0
classified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
coding	0
system	0
,	0
specifically	0
with	0
the	0
c187	5
code	0
,	0
among	0
individuals	0
aged	0
50	0
and	0
above	0
.	0

in	0
a	0
study	0
conducted	0
on	0
bone	0
marrow	0
disorders	0
,	0
patients	0
diagnosed	0
with	0
myelodysplastic	1
syndrome	2
(	0
mds	0
)	0
were	0
assigned	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
9984	5
,	0
which	0
facilitated	0
a	0
more	0
accurate	0
classification	0
and	0
comparison	0
of	0
disease	0
severity	0
.	0

in	0
a	0
recent	0
study	0
,	0
subjects	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
(	0
icd	3
-	4
10	4
code	0
l401	5
)	0
were	0
compared	0
to	0
a	0
control	0
group	0
to	0
identify	0
potential	0
genetic	0
factors	0
associated	0
with	0
this	0
common	0
skin	0
phenotype	1
.	0

in	0
a	0
recent	0
study	0
,	0
individuals	0
with	0
rheumatoid	1
arthritis	2
were	0
classified	0
using	0
the	0
icd	3
-	4
10	4
system	0
,	0
with	0
codes	0
ranging	0
from	0
m05	5
and	0
m06	5
.	6
0	6
to	0
m06	5
.	6
2	6
–	6
m06	6
.	6
9	6
,	0
allowing	0
for	0
a	0
detailed	0
examination	0
of	0
the	0
various	0
subtypes	0
and	0
severity	0
levels	0
within	0
this	0
debilitating	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
examined	0
and	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
cm	4
coding	0
system	0
,	0
with	0
the	0
majority	0
falling	0
under	0
the	0
specific	0
code	0
c83	5
.	6
3x	6
,	0
which	0
represents	0
diffuse	0
large	0
b	0
-	0
cell	0
lymphoma	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
specifically	0
identified	0
using	0
the	0
icd	3
-	4
9	4
-	4
d	4
classification	0
code	0
453	5
.	6
42	6
,	0
which	0
allowed	0
for	0
a	0
more	0
accurate	0
analysis	0
of	0
the	0
associated	0
risk	0
factors	0
and	0
treatment	0
outcomes	0
.	0

a	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
(	0
mm	0
)	0
according	0
to	0
the	0
icd	3
-	4
7	4
classification	0
system	0
,	0
specifically	0
code	0
203	5
.	6
0	6
,	0
to	0
assess	0
the	0
efficacy	0
of	0
novel	0
therapeutic	0
approaches	0
in	0
cancer	0
treatment	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
histopathological	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
code	0
m	5
-	6
9731	6
,	0
demonstrating	0
the	0
importance	0
of	0
standardized	0
coding	0
systems	0
in	0
the	0
field	0
of	0
biomedical	0
research	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
aged	0
18	0
-	0
65	0
years	0
,	0
those	0
with	0
a	0
clinical	0
diagnosis	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
cd	3
-	4
9	4
710	5
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
comorbidities	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
retrospective	0
study	0
on	0
the	0
prevalence	0
of	0
epilepsy	1
among	0
children	0
revealed	0
a	0
significant	0
number	0
of	0
cases	0
with	0
the	0
icd	3
-	4
10	4
ca	4
code	0
g40	5
,	0
implying	0
a	0
need	0
for	0
improved	0
awareness	0
and	0
management	0
of	0
this	0
neurological	0
disorder	0
.	0

a	0
retrospective	0
study	0
found	0
that	0
the	0
incidence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
corresponded	0
to	0
the	0
icd	3
-	4
8	4
code	0
671	5
.	6
03	6
and	0
was	0
high	0
among	0
postpartum	0
women	0
,	0
emphasizing	0
the	0
importance	0
of	0
timely	0
diagnosis	0
and	0
intervention	0
for	0
this	0
potentially	0
life	0
-	0
threatening	0
phenotype	1
.	0

in	0
a	0
recent	0
study	0
investigating	0
the	0
effectiveness	0
of	0
different	0
treatments	0
for	0
migraine	1
patients	0
,	0
medications	0
classified	0
under	0
the	0
atc	3
system	0
with	0
a	0
code	0
of	0
n02ca	5
were	0
found	0
to	0
be	0
significantly	0
more	0
effective	0
in	0
reducing	0
the	0
frequency	0
and	0
intensity	0
of	0
migraine	0
attacks	0
compared	0
to	0
other	0
therapeutic	0
options	0
.	0


